[
  {
    "question": "A junior orthopaedic surgery resident is completing a carpal tunnel repair with the department chairman as the attending physician. During the case, the resident inadvertently cuts a flexor tendon. The tendon is repaired without complication. The attending tells the resident that the patient will do fine, and there is no need to report this minor complication that will not harm the patient, as he does not want to make the patient worry unnecessarily. He tells the resident to leave this complication out of the operative report. Which of the following is the correct next action for the resident to take?",
    "answer": "[ERROR: 无法加载embedding模型 'sentence-transformers/all-MiniLM-L6-v2':\n  离线模式失败: (MaxRetryError(\"HTTPSConnectionPool(host='hf-mirror.com', port=443): Max retries exceeded with url: /api/models/sentence-transformers/all-MiniLM-L6-v2/tree/main/additional_chat_templates?recursive=Fal\n  在线模式失败: (MaxRetryError(\"HTTPSConnectionPool(host='hf-mirror.com', port=443): Max retries exceeded with url: /api/models/sentence-transformers/all-MiniLM-L6-v2/tree/main/additional_chat_templates?recursive=Fal\n请检查:\n  1. 网络连接是否正常（在线模式需要访问huggingface.co）\n  2. 模型是否已下载到本地缓存（~/.cache/huggingface/）\n  3. 可以手动下载: python -c \"from sentence_transformers import SentenceTransformer; SentenceTransformer('all-MiniLM-L6-v2')\"]",
    "expected_answer": "Tell the attending that he cannot fail to disclose this mistake",
    "time": 0,
    "answer_length": 0,
    "error": "无法加载embedding模型 'sentence-transformers/all-MiniLM-L6-v2':\n  离线模式失败: (MaxRetryError(\"HTTPSConnectionPool(host='hf-mirror.com', port=443): Max retries exceeded with url: /api/models/sentence-transformers/all-MiniLM-L6-v2/tree/main/additional_chat_templates?recursive=Fal\n  在线模式失败: (MaxRetryError(\"HTTPSConnectionPool(host='hf-mirror.com', port=443): Max retries exceeded with url: /api/models/sentence-transformers/all-MiniLM-L6-v2/tree/main/additional_chat_templates?recursive=Fal\n请检查:\n  1. 网络连接是否正常（在线模式需要访问huggingface.co）\n  2. 模型是否已下载到本地缓存（~/.cache/huggingface/）\n  3. 可以手动下载: python -c \"from sentence_transformers import SentenceTransformer; SentenceTransformer('all-MiniLM-L6-v2')\""
  },
  {
    "question": "A 67-year-old man with transitional cell carcinoma of the bladder comes to the physician because of a 2-day history of ringing sensation in his ear. He received this first course of neoadjuvant chemotherapy 1 week ago. Pure tone audiometry shows a sensorineural hearing loss of 45 dB. The expected beneficial effect of the drug that caused this patient's symptoms is most likely due to which of the following actions?",
    "answer": "To determine the answer, we first identify the drug causing the patient’s symptoms:  \n\nThe patient has bladder transitional cell carcinoma (TCC) treated with neoadjuvant chemotherapy, followed by tinnitus and sensorineural hearing loss (SNHL). **Cisplatin** (a platinum-based chemo agent) is a first-line neoadjuvant drug for bladder TCC and is well-known for ototoxicity (tinnitus/SNHL) and nephrotoxicity.  \n\nCisplatin’s therapeutic mechanism involves **forming covalent cross-links between DNA strands** (intrastrand and interstrand cross-links). These cross-links disrupt DNA replication and transcription, leading to cell cycle arrest and apoptosis of cancer cells.  \n\n\n**Answer:** Formation of DNA cross-links. (Or similar phrasing, e.g., DNA cross-linking.)  \n\n(Note: If options were provided, the correct choice would explicitly mention DNA cross-linking.)  \n\n\\boxed{Formation of DNA cross-links}",
    "expected_answer": "Cross-linking of DNA",
    "time": 25.855957984924316,
    "answer_length": 904,
    "retrieval_time": 0.02965092658996582,
    "generation_time": 25.835672855377197
  },
  {
    "question": "Two weeks after undergoing an emergency cardiac catherization with stenting for unstable angina pectoris, a 61-year-old man has decreased urinary output and malaise. He has type 2 diabetes mellitus and osteoarthritis of the hips. Prior to admission, his medications were insulin and naproxen. He was also started on aspirin, clopidogrel, and metoprolol after the coronary intervention. His temperature is 38°C (100.4°F), pulse is 93/min, and blood pressure is 125/85 mm Hg. Examination shows mottled, reticulated purplish discoloration of the feet. Laboratory studies show:\nHemoglobin count 14 g/dL\nLeukocyte count 16,400/mm3\nSegmented neutrophils 56%\nEosinophils 11%\nLymphocytes 31%\nMonocytes 2%\nPlatelet count 260,000/mm3\nErythrocyte sedimentation rate 68 mm/h\nSerum\nUrea nitrogen 25 mg/dL\nCreatinine 4.2 mg/dL\nRenal biopsy shows intravascular spindle-shaped vacuoles. Which of the following is the most likely cause of this patient's symptoms?\"",
    "answer": "To determine the cause of the patient’s symptoms, we analyze the key clinical findings and connect them to a likely diagnosis:\n\n\n### **Key Clinical Clues**  \n- **Timing**: 2 weeks post-emergency cardiac catheterization (vascular procedure).  \n- **Symptoms/Signs**: Decreased urine output (acute kidney injury, AKI), fever, malaise, mottled reticulated purplish feet (livedo reticularis).  \n- **Labs**: Eosinophilia (11% → normal 1-4%), elevated ESR, AKI (creatinine 4.2 mg/dL).  \n- **Renal Biopsy**: Intravascular spindle-shaped vacuoles.  \n\n\n### **Diagnosis: Cholesterol Embolism Syndrome (CES)**  \nCES occurs when cholesterol crystals break off from atherosclerotic plaques (often during invasive vascular procedures like cardiac catheterization) and embolize to organs.  \n\n**Why CES fits**:  \n1. **Timing**: Presents days to weeks after vascular procedures (matches 2 weeks post-cath).  \n2. **Organ Involvement**:  \n   - **Kidneys**: AKI (most common, due to renal artery emboli).  \n   - **Skin**: Livedo reticularis (from small vessel emboli in skin).  \n3. **Labs**: Eosinophilia (common in CES), elevated ESR (inflammatory response).  \n4. **Biopsy**: Cholesterol crystals dissolve during tissue fixation, leaving spindle-shaped vacuoles (exactly as described).  \n\n\n### **Other Ruled-Out Causes**  \n- **Contrast-induced nephropathy**: Acute (hours to days post-procedure, not 2 weeks).  \n- **Drug-induced interstitial nephritis**: No livedo reticularis; biopsy shows interstitial inflammation, not intravascular vacuoles.  \n- **Medication side effects**: Aspirin/clopidogrel/metoprolol do not cause this constellation of findings.  \n\n\n**Answer: Cholesterol embolism syndrome (secondary to cardiac catheterization)**\n\n\n\\boxed{Cholesterol embolism syndrome}",
    "expected_answer": "Cholesterol embolization",
    "time": 27.018054962158203,
    "answer_length": 1759,
    "retrieval_time": 0.020221948623657227,
    "generation_time": 27.00462818145752
  },
  {
    "question": "A 39-year-old woman is brought to the emergency department because of fevers, chills, and left lower quadrant pain. Her temperature is 39.1°C (102.3°F), pulse is 126/min, respirations are 28/min, and blood pressure is 80/50 mm Hg. There is blood oozing around the site of a peripheral intravenous line. Pelvic examination shows mucopurulent discharge from the cervical os and left adnexal tenderness. Laboratory studies show:\nPlatelet count 14,200/mm3\nFibrinogen 83 mg/mL (N = 200–430 mg/dL)\nD-dimer 965 ng/mL (N < 500 ng/mL)\nWhen phenol is applied to a sample of the patient's blood at 90°C, a phosphorylated N-acetylglucosamine dimer with 6 fatty acids attached to a polysaccharide side chain is identified. A blood culture is most likely to show which of the following?\"",
    "answer": "To answer this question, we analyze the patient’s clinical presentation, lab findings, and the key bacterial structure identified:\n\n\n### **Step 1: Clinical Context**  \nThe patient has:  \n- **Pelvic infection signs**: Mucopurulent cervical discharge + left adnexal tenderness (suggesting PID).  \n- **Sepsis**: Fever, hypotension (80/50 mmHg), tachycardia (126/min), tachypnea (28/min).  \n- **DIC**: Low platelets (14k/mm³), low fibrinogen (83 mg/dL), high D-dimer (965 ng/mL) + IV site oozing.  \n\n\n### **Step 2: Bacterial Structure Identification**  \nThe described structure—**phosphorylated glucosamine dimer with fatty acid chains**—is **lipid A**, a component of lipopolysaccharide (LPS) in the outer membrane of **gram-negative bacteria**.  \n\n\n### **Step 3: Causative Organism**  \nGram-negative bacteria associated with pelvic infections leading to sepsis/DIC:  \n- **Neisseria gonorrhoeae**: A gram-negative diplococcus, common cause of PID and severe systemic infections (including sepsis with DIC).  \n\n\n**Answer: Neisseria gonorrhoeae** (assuming this was an option; it is the most likely organism given the clinical and structural clues).  \n\n(Note: If options included other gram-negative pelvic pathogens, but Neisseria gonorrhoeae is the classic one here.)\n\n\n\\boxed{Neisseria gonorrhoeae}",
    "expected_answer": "Lactose-fermenting, gram-negative rods forming pink colonies on MacConkey agar",
    "time": 23.523240089416504,
    "answer_length": 1296,
    "retrieval_time": 0.04042410850524902,
    "generation_time": 23.511125802993774
  },
  {
    "question": "A 35-year-old man comes to the physician because of itchy, watery eyes for the past week. He has also been sneezing multiple times a day during this period. He had a similar episode 1 year ago around springtime. He has iron deficiency anemia and ankylosing spondylitis. Current medications include ferrous sulfate, artificial tear drops, and indomethacin. He works as an elementary school teacher. His vital signs are within normal limits. Visual acuity is 20/20 without correction. Physical examination shows bilateral conjunctival injection with watery discharge. The pupils are 3 mm, equal, and reactive to light. Examination of the anterior chamber of the eye is unremarkable. Which of the following is the most appropriate treatment?",
    "answer": "To determine the most appropriate treatment, we first analyze the patient’s clinical presentation:  \n\n### Key Clinical Features  \n- **Symptoms**: Itchy, watery eyes + sneezing, with a **seasonal recurrence** (similar episode last spring).  \n- **Signs**: Bilateral conjunctival injection (redness) with watery discharge; no purulent discharge, normal pupils, unremarkable anterior chamber.  \n\nThese findings are classic for **allergic conjunctivitis** (seasonal allergic rhinoconjunctivitis). Artificial tears (already used) provide symptomatic relief but do not target the underlying allergic mechanism.  \n\n\n### Treatment Rationale for Allergic Conjunctivitis  \nFirst-line therapy for allergic conjunctivitis is **topical antihistamines or dual-acting agents** (antihistamine + mast cell stabilizer). These agents:  \n- Rapidly relieve itching (antihistamine effect).  \n- Prevent future symptoms (mast cell stabilizer effect, blocking release of inflammatory mediators like histamine).  \n\nCommon examples include **olopatadine** or **ketotifen fumarate** eye drops.  \n\nOther options are less appropriate:  \n- **Oral antihistamines**: Less targeted for eye symptoms (may cause drowsiness with first-generation agents).  \n- **Topical steroids**: Reserved for severe cases (risk of glaucoma/cataracts if used long-term).  \n- **Antibiotics**: No role (no signs of bacterial infection).  \n\n\n**Answer**: Topical antihistamine-mast cell stabilizer eye drops (e.g., olopatadine or ketotifen fumarate).  \n\n(Note: If this were a multiple-choice question, the correct option would align with this category.)  \n\n\\boxed{Topical antihistamine-mast cell stabilizer eye drops}  \n\n(If specific drug names are expected, common choices are **olopatadine** or **ketotifen**.)  \n\nFor standard USMLE-style options, the answer is typically **Topical antihistamine eye drops** or the dual-acting agent variant.  \n\n\\boxed{Olopatadine eye drops} (example of a dual-acting agent)  \n\nAlternatively, if the option list includes \"Ketotifen fumarate eye drops,\" that is also correct.  \n\nFinal Answer (most concise standard): \\boxed{Topical antihistamine-mast cell stabilizer eye drops}",
    "expected_answer": "Ketotifen eye drops",
    "time": 24.195215702056885,
    "answer_length": 2153,
    "retrieval_time": 0.023252248764038086,
    "generation_time": 24.182069063186646
  },
  {
    "question": "A 39-year-old man presents to the emergency department because of progressively worsening chest pain and nausea that started at a local bar 30 minutes prior. The pain radiates to the epigastric area. He has a 5-year history of untreated hypertension. He has smoked 1 pack of cigarettes daily for the past 5 years and started abusing cocaine 2 weeks before his emergency room visit. The patient is diaphoretic and in marked distress. What should be the first step in management?",
    "answer": "To determine the first step in management, we analyze the patient’s clinical scenario: a 39-year-old man with suspected cocaine-induced acute coronary syndrome (ACS) (chest pain radiating to epigastrium, diaphoresis, distress, plus risk factors like untreated hypertension, smoking, and recent cocaine use).\n\n\n### Key Initial Management Principles  \nFor any acute chest pain patient with suspected ACS, the **first priority** is to stabilize and diagnose promptly. The standard initial steps follow the ABCs (Airway, Breathing, Circulation) framework, but the most critical diagnostic intervention for ACS is an immediate ECG to detect ST-segment elevation (STEMI) or ischemia, which guides urgent treatment.\n\n\n### Conclusion  \nThe first step in management is to **perform an immediate 12-lead ECG** to evaluate for myocardial ischemia or infarction, alongside assessing vital signs, initiating cardiac monitoring, and ensuring airway/breathing stability.\n\n\n**Answer:** Obtain an immediate 12-lead ECG to assess for myocardial ischemia or infarction. Additionally, prioritize ABCs (Airway, Breathing, Circulation) by monitoring vital signs and ensuring stability. The most critical diagnostic step here is the 12-lead ECG.  \n\nSimplified answer (as expected): **Perform an immediate 12-lead ECG.**  \n(Note: If ABCs are explicitly required, the answer would include \"Assess airway, breathing, and circulation first, then obtain an immediate 12-lead ECG.\")  \n\nFinal Answer: Obtain an immediate 12-lead ECG.  \n\\boxed{Obtain an immediate 12-lead ECG}",
    "expected_answer": "Reassurance and continuous monitoring",
    "time": 43.79280209541321,
    "answer_length": 1545,
    "retrieval_time": 0.01061391830444336,
    "generation_time": 43.78068780899048
  },
  {
    "question": "A 68-year-old male comes to the physician for evaluation of right flank pain. He has a history of diabetes and peripheral artery disease. His blood pressure is 160/90 mm Hg. Physical examination shows abdominal tenderness and right flank tenderness. An ultrasound shows dilation of the right ureter and renal pelvis. Which of the following is the most likely underlying cause of this patient's condition?",
    "answer": "To determine the most likely underlying cause of this patient’s hydronephrosis (dilation of the ureter and renal pelvis), we analyze key clinical details and common causes in older males:\n\n\n### Key Clinical Features  \n- **68-year-old male**: At high risk for age-related urologic conditions.  \n- **History of diabetes/PAD**: Comorbidities linked to vascular disease but not directly to hydronephrosis—instead, they highlight his age-related risk profile.  \n- **Right flank pain + abdominal tenderness**: Consistent with obstruction of the urinary tract (hydronephrosis).  \n- **Hypertension**: May be secondary to hydronephrosis (renin release) but not the cause of obstruction.  \n\n\n### Common Causes of Hydronephrosis in Older Males  \nHydronephrosis arises from **urinary tract obstruction**. For this patient:  \n1. **Benign Prostatic Hyperplasia (BPH)**: Extremely common in men >60 (affects ~50% of men over 60). Severe BPH causes bladder outlet obstruction, leading to urinary retention. Back pressure from retained urine travels up the ureters and kidneys, resulting in hydronephrosis (often bilateral, but occasionally unilateral if one ureter is more compromised).  \n2. **Prostate Cancer**: Metastatic disease can compress ureters, but it is less prevalent than BPH and lacks specific signs here (e.g., elevated PSA, weight loss).  \n3. **Nephrolithiasis (Stones)**: Possible, but no mention of hematuria (a classic sign) or acute colicky pain.  \n4. **Ureteral Stricture**: Less likely without prior infection/stones.  \n\n\n### Conclusion  \nThe most likely underlying cause is **benign prostatic hyperplasia (BPH)** due to its high prevalence in older males and association with urinary retention leading to hydronephrosis.\n\n\n**Answer: Benign prostatic hyperplasia** (assuming this is an option in the original question; this is the standard answer for such cases).  \n\nIf forced to select from typical USMLE-style options, this is the correct choice.  \n\n\\boxed{Benign prostatic hyperplasia}",
    "expected_answer": "Common iliac artery aneurysm",
    "time": 47.95081424713135,
    "answer_length": 1993,
    "retrieval_time": 0.016427993774414062,
    "generation_time": 47.923466205596924
  },
  {
    "question": "A 65-year-old man is brought to the emergency department 30 minutes after the onset of acute chest pain. He has hypertension and asthma. Current medications include atorvastatin, lisinopril, and an albuterol inhaler. He appears pale and diaphoretic. His pulse is 114/min and blood pressure is 130/88 mm Hg. An ECG shows ST-segment depressions in leads II, III, and aVF. Laboratory studies show an increased serum troponin T concentration. The patient is treated for acute coronary syndrome and undergoes percutaneous transluminal coronary angioplasty. At the time of discharge, echocardiography shows a left ventricular ejection fraction of 58%. In addition to aspirin, which of the following drugs should be added to this patient's medication regimen?",
    "answer": "To answer this question, we analyze the patient’s clinical scenario and apply post-acute coronary syndrome (ACS) guidelines, focusing on gaps in his current medication regimen:\n\n\n### Key Clinical Context  \nThe patient has **NSTEMI** (ST depressions, elevated troponin) treated with percutaneous coronary intervention (PCI). His current meds include aspirin, atorvastatin (statin), and lisinopril (ACE inhibitor). His left ventricular ejection fraction (EF=58%) is normal. He has asthma (a relative contraindication for non-selective beta-blockers but not for cardioselective agents or antiplatelets).\n\n\n### Standard Post-ACS/PCI Medication Requirements  \nFor patients post-PCI, **dual antiplatelet therapy (DAPT)** is mandatory to prevent stent thrombosis. DAPT consists of:  \n- Aspirin (already prescribed)  \n- A **P2Y12 inhibitor** (clopidogrel, prasugrel, ticagrelor) for 6–12 months.  \n\n\n### Why Other Options Are Less Likely  \n- **Beta-blockers**: Cardioselective beta-blockers are recommended for secondary prevention, but asthma is a relative contraindication (only preferred if asthma is stable and no alternative exists). However, DAPT is a higher priority post-PCI.  \n- **Statin/ACE inhibitor**: Already prescribed.  \n- **Spironolactone**: Only indicated for EF <35%.  \n\n\n### Conclusion  \nThe missing medication is a **P2Y12 inhibitor** (most commonly clopidogrel in this context).\n\n\n**Answer: Clopidogrel** (or another P2Y12 inhibitor like ticagrelor/prasugrel, but clopidogrel is the standard first-line option here).  \n\n(Note: If the original question included options, the correct choice would be the P2Y12 inhibitor listed.)  \n\n\\boxed{Clopidogrel}",
    "expected_answer": "Clopidogrel",
    "time": 1027.9573230743408,
    "answer_length": 1662,
    "retrieval_time": 0.04678606986999512,
    "generation_time": 1027.8960871696472
  },
  {
    "question": "A 37-year-old-woman presents to her primary care physician requesting a new form of birth control. She has been utilizing oral contraceptive pills (OCPs) for the past 8 years, but asks to switch to an intrauterine device (IUD). Her vital signs are: blood pressure 118/78 mm Hg, pulse 73/min and respiratory rate 16/min. She is afebrile. Physical examination is within normal limits. Which of the following past medical history statements would make copper IUD placement contraindicated in this patient?",
    "answer": "To determine the contraindication for copper IUD placement, we focus on key absolute contraindications specific to copper-containing devices:\n\n\n### Key Background  \nCopper IUDs release copper ions locally. A critical absolute contraindication is **Wilson’s disease**—a genetic disorder of copper metabolism where the body cannot properly excrete copper, leading to toxic accumulation in organs (liver, brain, eyes). Adding exogenous copper (via the IUD) would exacerbate this toxicity.\n\n\n### Other Considerations  \n- **Active PID**: Contraindication for all IUDs, but not specific to copper.  \n- **Heavy menstrual bleeding**: Relative contraindication (copper IUDs may increase flow), but not absolute.  \n- **Past ectopic pregnancy**: Not a contraindication (though failure risk for ectopic is higher if the IUD fails, it is still safe to use).  \n\n\n**Answer: A history of Wilson's disease.**",
    "expected_answer": "Active or recurrent pelvic inflammatory disease (PID)",
    "time": 15.764971017837524,
    "answer_length": 891,
    "retrieval_time": 0.013461112976074219,
    "generation_time": 15.73734188079834
  },
  {
    "question": "A 23-year-old woman comes to the physician because she is embarrassed about the appearance of her nails. She has no history of serious illness and takes no medications. She appears well. A photograph of the nails is shown. Which of the following additional findings is most likely in this patient?",
    "answer": "To address this question, we need to infer the likely nail condition based on the scenario (young woman, no serious illness, embarrassed by nail appearance) and common associations with nail abnormalities:\n\n\n### Key Inference:  \nThe most probable nail condition here is **koilonychia (spoon nails)**—a classic sign of **iron deficiency anemia**. Koilonychia presents as nails that are thin, soft, and concave (spoon-shaped), which is common in young adults with unrecognized iron deficiency (often due to menstrual blood loss in women).\n\n\n### Additional Finding:  \nThe most likely associated finding is **iron deficiency anemia**, characterized by:  \n- Microcytic, hypochromic red blood cells (on peripheral smear)  \n- Low serum ferritin (gold standard for iron deficiency)  \n- Possible symptoms like fatigue, pallor, or glossitis (inflamed tongue), though the patient may be asymptomatic early on.\n\n\n**Answer:** Iron deficiency anemia (or microcytic hypochromic anemia).  \n\n(Note: This inference is based on the most common clinical correlation for an embarrassing nail condition in a young woman with no serious illness.)\n\n\n\\boxed{Iron deficiency anemia}",
    "expected_answer": "Silvery plaques on extensor surfaces",
    "time": 22.090818166732788,
    "answer_length": 1156,
    "retrieval_time": 0.011816978454589844,
    "generation_time": 22.06229019165039
  },
  {
    "question": "A 24-year-old G2P1 woman at 39 weeks’ gestation presents to the emergency department complaining of painful contractions occurring every 10 minutes for the past 2 hours, consistent with latent labor. She says she has not experienced vaginal discharge, bleeding, or fluid leakage, and is currently taking no medications. On physical examination, her blood pressure is 110/70 mm Hg, heart rate is 86/min, and temperature is 37.6°C (99.7°F). She has had little prenatal care and uses condoms inconsistently. Her sexually transmitted infections status is unknown. As part of the patient’s workup, she undergoes a series of rapid screening tests that result in the administration of zidovudine during delivery. The infant is also given zidovudine to reduce the risk of transmission. A confirmatory test is then performed in the mother to confirm the diagnosis of HIV. Which of the following is most true about the confirmatory test?",
    "answer": "To address the question about the confirmatory test for HIV, we first recall the standard HIV testing algorithm:\n\n\n### Key Background  \nRapid screening tests (e.g., rapid antibody tests) detect antibodies to HIV but can have false positives. A **confirmatory test** is required to validate positive screening results, as it targets specific HIV components to ensure accuracy.  \n\n\n### The Confirmatory Test: Western Blot  \nThe gold-standard confirmatory test for HIV is the **Western blot assay**. Its mechanism involves:  \n1. Separating HIV proteins (e.g., p24 [core antigen], gp41 [envelope transmembrane protein], gp120/gp160 [envelope surface proteins]) via gel electrophoresis.  \n2. Transferring these proteins to a membrane.  \n3. Detecting patient antibodies that bind to **specific HIV proteins** (not just any antibody).  \n\nThis specificity distinguishes it from screening tests and confirms true HIV infection.  \n\n\n### Conclusion  \nThe most accurate statement about the confirmatory test is that it **identifies antibodies against specific HIV viral proteins** (via electrophoresis and targeted antibody detection, as in the Western blot).\n\n\n**Answer:** The confirmatory test (Western blot) detects antibodies against specific HIV proteins (e.g., p24, gp41, gp120/gp160) to confirm infection.  \n\n(Note: If this aligns with an option like \"Identifies specific HIV antibodies against viral proteins,\" that is the correct choice.)  \n\n\\boxed{Identifies specific HIV antibodies against viral proteins}  \n\n(Adjust based on exact options, but this is the core truth about the confirmatory test.)",
    "expected_answer": "It is an HIV-1/HIV2 antibody differentiation immunoassay",
    "time": 24.610984086990356,
    "answer_length": 1596,
    "retrieval_time": 0.01899576187133789,
    "generation_time": 24.584216117858887
  },
  {
    "question": "A 72-year-old man comes to the physician because of a 2-month history of fatigue and worsening abdominal pain. During this period, he also has excessive night sweats and shortness of breath on exertion. Over the past 3 months, he has had a 5.6-kg (12-lb) weight loss. He had a myocardial infarction 3 years ago. He has hypertension, diabetes mellitus, and chronic bronchitis. His medications include insulin, aspirin, lisinopril, and an albuterol inhaler. He has smoked half a pack of cigarettes for the past 45 years. Vital signs are within normal limits. The spleen is palpated 6 cm below the left costal margin. Laboratory studies show:\nHemoglobin 6.4 g/dL\nMean corpuscular volume 85 μm3\nLeukocyte count 5,200/mm3\nPlatelet count 96,000/mm3\nA blood smear is shown. Bone marrow aspiration shows extensive fibrosis and a few scattered plasma cells. A JAK 2 assay is positive. Which of the following is the most appropriate next step in management?\"",
    "answer": "To determine the most appropriate next step in management, we first establish the diagnosis based on the patient’s clinical and laboratory findings:\n\n\n### **Key Clinical & Lab Findings**  \n- 72-year-old man with systemic symptoms (fatigue, night sweats, weight loss, dyspnea), splenomegaly (6cm below costal margin), and cytopenias (anemia: Hb 6.4g/dL; thrombocytopenia: 96k/mm³).  \n- Bone marrow: Extensive fibrosis (hallmark of myelofibrosis).  \n- JAK2 mutation positive (common in myeloproliferative neoplasms like primary myelofibrosis [PMF]).  \n\n\n### **Diagnosis**  \n**Primary Myelofibrosis (PMF)**—a myeloproliferative neoplasm characterized by bone marrow fibrosis, extramedullary hematopoiesis (splenomegaly), systemic symptoms, and JAK2 mutations in ~50-60% of cases.  \n\n\n### **Next Step in Management**  \nThe patient has **symptomatic PMF** (splenomegaly, B symptoms, cytopenias). The standard of care for such patients is **JAK inhibitor therapy** (e.g., ruxolitinib, a JAK1/JAK2 inhibitor).  \n\nRuxolitinib is approved for intermediate/high-risk PMF and effectively:  \n- Reduces splenomegaly (relieves abdominal pain).  \n- Improves systemic symptoms (night sweats, weight loss, fatigue).  \n- Modulates the underlying JAK2-driven pathophysiology.  \n\nSupportive care (transfusions) addresses anemia but does not target the disease. Allogeneic stem cell transplant (curative) is not feasible in a 72-year-old patient. Hydroxyurea is less effective in fibrotic stages and may worsen cytopenias.  \n\n\n**Answer:** Initiate ruxolitinib (JAK inhibitor).  \n\n(Note: If options included ruxolitinib, this is the correct choice.)  \n\n\\boxed{Ruxolitinib}",
    "expected_answer": "Ruxolitinib",
    "time": 36.08656692504883,
    "answer_length": 1650,
    "retrieval_time": 0.02297806739807129,
    "generation_time": 36.05905818939209
  },
  {
    "question": "A 20-year-old man comes to the physician because of worsening gait unsteadiness and bilateral hearing loss for 1 month. He has had intermittent tingling sensations on both cheeks over this time period. He has no history of serious medical illness and takes no medications. Audiometry shows bilateral sensorineural hearing loss. Genetic evaluation shows a mutation of a tumor suppressor gene on chromosome 22 that encodes merlin. This patient is at increased risk for which of the following conditions?",
    "answer": "To answer this question, we first identify the patient’s condition based on the clinical and genetic findings:\n\n\n### Key Clinical & Genetic Clues  \n- 20-year-old man with bilateral sensorineural hearing loss, gait unsteadiness, and facial tingling.  \n- Genetic mutation: Tumor suppressor gene on chromosome 22 encoding **merlin** → this confirms **Neurofibromatosis Type 2 (NF2)**.  \n\n\n### NF2-Associated Conditions  \nNF2 is characterized by an increased risk of several tumors, including:  \n1. **Bilateral vestibular schwannomas** (acoustic neuromas): Explains the patient’s hearing loss and gait unsteadiness (due to vestibular dysfunction).  \n2. **Meningiomas**: Common in NF2 (multiple meningiomas may develop).  \n3. **Ependymomas**: Especially of the spinal cord.  \n4. Schwannomas of other cranial nerves (e.g., trigeminal nerve, causing facial tingling).  \n\n\n### Most Likely Answer  \nGiven the question asks for an **increased risk** (future condition), the classic NF2-associated tumor beyond the current symptoms is **meningioma** (a frequent complication of NF2).  \n\n\n**Answer: Meningioma**  \n\n(Note: If ependymoma was an option, it is also a valid NF2-associated risk, but meningioma is more commonly tested as a key NF2 complication.)\n\n\n\\boxed{Meningioma}",
    "expected_answer": "Meningioma",
    "time": 29.141767263412476,
    "answer_length": 1266,
    "retrieval_time": 0.011429786682128906,
    "generation_time": 29.11350178718567
  },
  {
    "question": "A 47-year-old executive schedules an appointment his physician for a routine medical check-up. He currently has no complaints and claims to be “as fit as a fiddle.” The physical examination findings are unremarkable, except for a mid-systolic murmur heard in the 2nd left intercostal space that radiates to the carotids on auscultation. The physician instructs the patient to stand from a supine position with the stethoscope still placed on his chest. Which of the following changes would occur with this maneuver?",
    "answer": "To answer this question, we first identify the murmur and then analyze the effect of standing on its intensity.\n\n\n### Step 1: Identify the Murmur  \nThe key findings are:  \n- **Mid-systolic murmur** at the 2nd left intercostal space.  \n- **Radiates to carotids**.  \n\nThese features are classic for **aortic stenosis (AS)**. Pulmonic stenosis (PS) also causes a mid-systolic murmur at the 2nd left intercostal space but does not radiate to carotids (it radiates to the left shoulder instead). AS is confirmed by the carotid radiation.\n\n\n### Step 2: Effect of Standing on AS Murmur  \nStanding reduces venous return (gravity pulls blood to the legs), decreasing left ventricular end-diastolic volume (LVEDV) and preload.  \n\nFor **fixed outflow obstruction (AS)**:  \n- The murmur intensity depends on flow across the stenotic valve.  \n- Lower preload → less blood available to eject through the valve → reduced flow across the valve → **murmur intensity decreases**.  \n\nIn contrast, dynamic obstruction (e.g., hypertrophic cardiomyopathy) murmur increases with standing, but this is excluded here by carotid radiation.\n\n\n**Answer: The murmur intensity decreases.**\n\n\n\\boxed{The murmur intensity decreases}",
    "expected_answer": "A reduction in diastolic filling time",
    "time": 1617.3176181316376,
    "answer_length": 1200,
    "retrieval_time": 0.015680789947509766,
    "generation_time": 1617.2909817695618
  },
  {
    "question": "A microbiologist is studying the emergence of a virulent strain of the virus. After a detailed study of the virus and its life cycle, he proposes a theory: Initially, a host cell is co-infected with 2 viruses from the same virus family. Within the host cell, concomitant production of various genome segments from both viruses occurs. Ultimately, the different genome segments from the viruses are packaged into a unique and novel virus particle. The newly formed virus particle is both stable and viable and is a new strain from the virus family that caused the outbreak of infection. Which of the following viruses is capable of undergoing the above-mentioned process?",
    "answer": "The process described in the question is **genetic reassortment**, which occurs when two viruses with segmented genomes co-infect a host cell, and their genome segments are mixed during packaging into new virus particles. This leads to novel viral strains.\n\n\n### Key Analysis:  \nReassortment is only possible for viruses with **segmented genomes**. Among common viruses:  \n- **Influenza virus** (Orthomyxovirus) has an 8-segmented negative-sense RNA genome, making it capable of reassortment. This is why new influenza strains (e.g., pandemic strains) emerge via reassortment between human, avian, or swine influenza viruses.  \n- Non-segmented viruses (e.g., HIV, measles, SARS-CoV-2) cannot undergo reassortment.  \n\n\n**Answer: Influenza virus**",
    "expected_answer": "Rotavirus",
    "time": 9.213496923446655,
    "answer_length": 745,
    "retrieval_time": 0.018427133560180664,
    "generation_time": 9.189109802246094
  },
  {
    "question": "A 59-year-old overweight woman presents to the urgent care clinic with the complaint of severe abdominal pain for the past 2 hours. She also complains of a dull pain in her back with nausea and vomiting several times. Her pain has no relation with food. Her past medical history is significant for recurrent abdominal pain due to cholelithiasis. Her father died at the age of 60 with some form of abdominal cancer. Her temperature is 37°C (98.6°F), respirations are 15/min, pulse is 67/min, and blood pressure is 122/98 mm Hg. Physical exam is unremarkable. However, a CT scan of the abdomen shows a calcified mass near her gallbladder. Which of the following diagnoses should be excluded first in this patient?",
    "answer": "To determine the diagnosis that should be excluded first, we analyze the key clinical findings and their implications:\n\n\n### **Key Clinical Details**  \n- 59yo overweight woman with history of cholelithiasis.  \n- Severe abdominal pain, back pain, nausea/vomiting.  \n- CT shows **calcified mass near gallbladder**.  \n- Family history of abdominal cancer (father, age 60).  \n\n\n### **Critical Associations**  \nA calcified mass near the gallbladder raises concern for **porcelain gallbladder** (calcification of the gallbladder wall, a complication of chronic cholelithiasis). However, porcelain gallbladder is strongly associated with **gallbladder carcinoma** (up to 10-30% risk in some studies). Given the patient’s family history of abdominal cancer and the potential for life-threatening malignancy, this is the highest-priority diagnosis to exclude first.  \n\n\n### **Conclusion**  \nThe most urgent diagnosis to exclude is **gallbladder carcinoma** due to its serious prognosis and association with calcified gallbladder pathology (porcelain gallbladder) in this patient.\n\n\n**Answer: Gallbladder carcinoma**",
    "expected_answer": "Gallbladder cancer",
    "time": 16.849931955337524,
    "answer_length": 1106,
    "retrieval_time": 0.018043041229248047,
    "generation_time": 16.824387073516846
  },
  {
    "question": "A 7-year-old boy is brought to his pediatrician’s office for a follow-up visit. He was diagnosed with asthma when he was 3 years old and has since been on treatment for the condition. He is currently on a β-agonist inhaler because of exacerbation of his symptoms. He has observed that his symptoms are more prominent in springtime, especially when the new flowers are blooming. His mother has a backyard garden and whenever he goes out to play there, he experiences chest tightness with associated shortness of breath. He has been advised to take more precaution during this seasonal change and to stay away from pollen. He is also being considered for an experimental therapy, which attenuates the activity of certain mediators which cause his asthmatic attack. The targeted mediator favors the class switching of antibodies. A reduction in this mechanism will eventually reduce the exaggerated response observed during his asthmatic attacks, even when exposed to an allergen. Which of the following mediators is described in this experimental study?",
    "answer": "To determine the correct mediator, we analyze the key clues from the question and connect them to immunological mechanisms of allergic asthma:\n\n\n### Key Clues Recap  \n- The patient has **seasonal allergic asthma** (type I hypersensitivity).  \n- The experimental therapy targets a mediator that **favors antibody class switching**, and reducing it alleviates asthma attacks.  \n\n\n### Relevant Immunology  \nAllergic asthma relies on **IgE-mediated hypersensitivity**:  \n- Th2 cells secrete cytokines that drive B cells to switch from IgM to **IgE** (the antibody responsible for type I reactions).  \n- The primary cytokine promoting this class switch to IgE is **IL-4**.  \n\n\n### Why IL-4 Is the Answer  \nIL-4 directly induces B cell class switching to IgE. Reducing IL-4 activity decreases IgE production, which in turn reduces mast cell degranulation (histamine/leukotriene release) and bronchoconstriction—core features of asthma attacks.  \n\n\n**Answer: IL-4**",
    "expected_answer": "IL-4",
    "time": 13.972421884536743,
    "answer_length": 958,
    "retrieval_time": 0.021338939666748047,
    "generation_time": 13.945236921310425
  },
  {
    "question": "A 3-month-old boy is brought the emergency department by his parents after an episode of cyanosis and muscle hypotonia that resolved after 2 minutes. Diagnostic evaluation fails to discover an exact etiology of the boy's symptoms and the episode is classified as a brief resolved unexplained event (BRUE). The risk profile for BRUE in infants remains largely unknown. The pediatrician who saw the boy in the emergency department is trying to identify risk factors for BRUE. She is aware of several confounders, including age, socioeconomic background, and family history of medical illness. She recruits 75 infants under 1 year of age with BRUE and 75 infants without BRUE of the same age, socioeconomic background, and family history of medical illness. She then compares the two groups with regard to history of feeding problems and history of recent upper respiratory infection. Which of the following methods was conducted to control confounding bias in the study?",
    "answer": "To determine the method used to control confounding bias, we analyze the study design described:\n\n\n### Key Observations from the Study  \nThe pediatrician recruited **cases** (infants with BRUE) and **controls** (infants without BRUE) that were explicitly matched on three confounding variables:  \n- Age  \n- Socioeconomic background  \n- Family history of medical illness  \n\n\n### Definition of Matching  \nMatching is a technique in case-control studies where controls are selected to have the same distribution as cases for specific confounding variables. This ensures that the confounders do not differ systematically between the two groups, thereby minimizing their impact on the observed association between the exposure (feeding problems/recent URI) and the outcome (BRUE).  \n\n\n**Answer: Matching** (specifically, individual or group matching on the identified confounders).  \n\nIf options were provided, the correct choice would be the one referring to \"matching.\" For example: \"Matching\" or \"Case-control matching.\"\n\n\n\\boxed{Matching}",
    "expected_answer": "Matching",
    "time": 13.514868021011353,
    "answer_length": 1037,
    "retrieval_time": 0.018878936767578125,
    "generation_time": 13.488394975662231
  },
  {
    "question": "A 29-year-old man presents to the emergency department due to central chest pain over the past 3 days which is constant and unrelated to exertion. The pain is sharp, severe, increases when lying down, and improves with leaning forward. The pain also radiates to his shoulders and neck. The patient has no past medical history. He has smoked 10 cigarettes per day for the past 7 years and occasionally drinks alcohol. He presents with vital signs: blood pressure 110/70 mm Hg, regular radial pulse of 95/min, and temperature 37.3°C (99.1°F). On physical exam, a scratching sound of to-and-from character is audible over the left sternal border at end-expiration with the patient leaning forward. His chest X-ray is normal and ECG is shown in the picture. Which of the following is the optimal therapy for this patient?",
    "answer": "To determine the optimal therapy, we first diagnose the patient’s condition based on clinical findings:\n\n\n### Step 1: Diagnosis  \nThe patient presents with:  \n- **Chest pain**: Sharp, constant, worse when lying down, better leaning forward (classic for pericarditis).  \n- **Pericardial friction rub**: A to-and-fro scratching sound over the left sternal border (pathognomonic for pericarditis).  \n- **Low-grade fever**: Suggests inflammation.  \n- **Normal chest X-ray**: No cardiomegaly (rules out large effusion).  \n\n**Diagnosis**: Acute idiopathic/viral pericarditis (most common in young adults with no medical history).\n\n\n### Step 2: Optimal Therapy  \nAccording to ESC guidelines for acute pericarditis:  \n- **First-line**: High-dose NSAIDs + colchicine.  \n  - NSAIDs (e.g., ibuprofen 600–800mg q8h or aspirin 750–1000mg q8h) reduce inflammation and pain.  \n  - Colchicine (0.5mg bid for 3 months) lowers recurrence risk (key adjunct to NSAIDs).  \n- **Steroids**: Reserved for contraindications to NSAIDs/colchicine (e.g., pregnancy, NSAID intolerance) or autoimmune causes (not applicable here).  \n\n\n**Answer**: High-dose NSAID (e.g., ibuprofen) plus colchicine.  \n\n(Note: If specific options were provided, the correct choice would include this combination.)  \n\n\\boxed{Ibuprofen plus colchicine} (or equivalent NSAID + colchicine)  \n(Assuming standard options, this is the optimal therapy.)",
    "expected_answer": "Ibuprofen + colchicine +/- omeprazole",
    "time": 19.048304080963135,
    "answer_length": 1396,
    "retrieval_time": 0.1307840347290039,
    "generation_time": 19.020424842834473
  },
  {
    "question": "A 46-year-old man is brought to the emergency department for evaluation of altered mental status. He was found on the floor in front of his apartment. He is somnolent but responsive when aroused. His pulse is 64/min, respiratory rate is 15/min, and blood pressure is 120/75 mm Hg. On physical examination, an alcoholic smell and slurred speech are noted. Neurological exam shows diminished deep tendon reflexes bilaterally and an ataxic gait. His pupils are normal. Blood alcohol concentration is 0.04%. An ECG shows no abnormalities. Which of the following is the most likely cause of this patient's symptoms?",
    "answer": "To determine the most likely cause of the patient’s symptoms, we analyze key findings and their associations:\n\n\n### Key Clinical Clues  \n- **Alcoholic history**: Alcoholic smell, slurred speech (consistent with chronic alcohol use).  \n- **Discrepancy**: Low blood alcohol concentration (0.04%, too low for severe intoxication) but severe neurological symptoms (somnolence, ataxia, diminished deep tendon reflexes).  \n- **No withdrawal signs**: Normal pulse (64/min), BP (120/75 mmHg), no tremors/seizures.  \n- **No Wernicke triad complete**: No ophthalmoplegia (normal pupils), but ataxia and altered mental status are present (Wernicke’s triad is often incomplete, with only 10% of patients showing all three components: confusion, ataxia, ophthalmoplegia).  \n\n\n### Critical Association  \nChronic alcohol use impairs thiamine (vitamin B1) absorption and utilization. **Wernicke encephalopathy** (acute thiamine deficiency) is a common complication in alcoholics, presenting with:  \n- Altered mental status (somnolence/confusion),  \n- Ataxia,  \n- Ophthalmoplegia (not always present).  \n\n\n### Ruling Out Other Causes  \n- **Acute alcohol intoxication**: Excluded by low BAC.  \n- **Hypoglycemia**: No mention of glucose levels, but not the primary association here.  \n- **Electrolyte abnormalities**: Hypokalemia/hypophosphatemia lack supporting signs (normal ECG, no muscle weakness).  \n\n\n**Answer: Wernicke encephalopathy (due to thiamine deficiency)**\n\n\n\\boxed{Wernicke\\ encephalopathy}",
    "expected_answer": "Benzodiazepine intoxication\n\"",
    "time": 33.17885208129883,
    "answer_length": 1487,
    "retrieval_time": 0.017132997512817383,
    "generation_time": 33.150964975357056
  },
  {
    "question": "A 77-year-old woman presents to the emergency room with the complaints of fever, malaise, and night sweats. She recently observed an enlargement of her axillary lymph nodes, which she examines on a weekly basis. She has a remote history of breast cancer in her 60s that was treated with radiation and chemotherapy. She also reports a history of extensive travel to Africa and a 30-pack-year history of smoking. On physical exam, several axillary lymph nodes are palpable with a large non-tender palpable mass in her right axilla measuring 10 x 8 cm. Fine-needle aspiration demonstrates what the pathologist describes as \"a centroblastic and immunoblastic cell presence, suspicious for non-Hodgkin’s lymphoma (NHL)–diffuse large B cell variant\". Which of the following risk factors is responsible for this patient’s condition?",
    "answer": "To determine the responsible risk factor for the patient’s diffuse large B cell lymphoma (DLBCL), we analyze her history against known risk factors for non-Hodgkin lymphoma (NHL):\n\n\n### Key Background  \nDLBCL is a common NHL subtype. Its risk factors include **previous cancer treatment (radiation/chemotherapy)**, immunodeficiency, autoimmune diseases, and certain infections.  \n\n\n### Analysis of Patient’s Risk Factors  \n1. **Previous breast cancer treatment**: Radiation and chemotherapy damage DNA, increasing the risk of secondary malignancies like NHL. The patient received both modalities for breast cancer in her 60s (now 77), a remote but well-documented cause of late-onset NHL.  \n2. **Travel to Africa**: Endemic Burkitt lymphoma (EBV-associated) is common in Africa, but this is not DLBCL. Travel to Africa is not a direct risk factor for DLBCL.  \n3. **Smoking**: Smoking is linked to lung/bladder cancer but not DLBCL.  \n\n\n**Answer**: Previous radiation and chemotherapy for breast cancer.\n\n\n\\boxed{Previous radiation and chemotherapy for breast cancer}",
    "expected_answer": "Previous radiation therapy",
    "time": 15.65044093132019,
    "answer_length": 1066,
    "retrieval_time": 0.0174560546875,
    "generation_time": 15.623806953430176
  },
  {
    "question": "A 3-month-old infant is brought to her pediatrician because she coughs and seems to have difficulty breathing while feeding. In addition, she seems to have less energy compared to other babies and appears listless throughout the day. She was born by cesarean section to a G1P1 woman with no prior medical history and had a normal APGAR score at birth. Her parents say that she has never been observed to turn blue. Physical exam reveals a high-pitched holosystolic murmur that is best heard at the lower left sternal border. The most likely cause of this patient's symptoms is associated with which of the following abnormalities?",
    "answer": "To answer this question, we first analyze the case to identify the most likely diagnosis and its associated abnormalities:\n\n\n### **Key Case Findings**  \n- **Infant age**: 3 months (symptoms appear as pulmonary vascular resistance [PVR] drops, ~2-3 months post-birth).  \n- **Symptoms**: Cough, dyspnea on feeding (exertional dyspnea), listlessness, **no cyanosis** (rules out right-to-left shunts).  \n- **Murmur**: High-pitched holosystolic murmur at the lower left sternal border (LLSB) → classic for **ventricular septal defect (VSD)**.  \n\n\n### **Diagnosis: Ventricular Septal Defect (VSD)**  \nVSD is the most common congenital heart defect. It causes a **left-to-right shunt** (since left ventricular pressure > right ventricular pressure). Early in life, high PVR limits the shunt, but as PVR decreases (2-3 months), the shunt increases, leading to:  \n- Increased pulmonary blood flow → pulmonary congestion (cough, dyspnea on feeding).  \n- Decreased systemic cardiac output → listlessness.  \n\n\n### **Associated Abnormality**  \nThe primary structural abnormality is a **ventricular septal defect** (most commonly membranous septal defect, ~80% of cases). The functional abnormality is a **left-to-right intracardiac shunt**.  \n\n\n**Answer**: Ventricular septal defect (membranous type) or left-to-right shunt.  \n\n*(Note: If options were provided, the most likely correct choice would align with these findings.)*  \n**Final Answer (most probable):** Ventricular septal defect.  \n\n\\boxed{Ventricular \\ septal \\ defect}",
    "expected_answer": "22q11 deletion",
    "time": 30.83656597137451,
    "answer_length": 1518,
    "retrieval_time": 0.015089273452758789,
    "generation_time": 30.808764934539795
  },
  {
    "question": "A 30-year-old African American woman comes to the physician for the evaluation of a dry cough and chest discomfort for the past 3 days. During this period, the patient has had headaches, muscle aches, joint pain, fever, and chills. Ten days ago, she was hiking with her family in Mississippi. The patient has asthma that is treated with an albuterol inhaler. Her mother has a lung disease treated with methotrexate. The patient has smoked one pack of cigarettes daily for the past 10 years. Her temperature is 38°C (100.4°F). Physical examination shows slight wheezes throughout both lung fields. Laboratory studies and urinalysis are positive for polysaccharide antigen. Bronchoalveolar lavage using silver/PAS-staining shows macrophages filled with a dimorphic fungus with septate hyphae. Which of the following is the most likely cause of this patient's symptoms?",
    "answer": "To determine the most likely cause of the patient’s symptoms, we analyze the key clinical and laboratory findings alongside endemic fungal patterns:\n\n\n### **Key Clinical/Laboratory Clues**  \n- **Endemic region**: Hiking in Mississippi (Ohio-Mississippi River Valley, a hotspot for *Histoplasma capsulatum*).  \n- **Dimorphic fungus**: Grows as mold (septate hyphae) in the environment and yeast in the body.  \n- **Intracellular in macrophages**: *Histoplasma* yeast (2-5 μm) are classic for residing inside macrophages (seen on BAL silver/PAS stain).  \n- **Polysaccharide antigen**: *Histoplasma* polysaccharide antigen is detectable in urine/serum (matches positive labs/UA).  \n\n\n### **Elimination of Other Options**  \n- **Blastomyces dermatitidis**: SE US endemic, but BAL shows large, thick-walled yeast with broad-based buds (not intracellular in macrophages).  \n- **Coccidioides immitis**: Southwest US endemic, forms spherules with endospores (no intracellular macrophages).  \n\n\n**Answer: Histoplasma capsulatum**\n\n\n\\boxed{Histoplasma capsulatum}",
    "expected_answer": "Histoplasma capsulatum infection",
    "time": 24.777979135513306,
    "answer_length": 1051,
    "retrieval_time": 0.019119977951049805,
    "generation_time": 24.752647876739502
  },
  {
    "question": "A 62-year-old patient has been hospitalized for a week due to a stroke. One week into the hospitalization, he develops a fever and purulent cough. His vitals include: heart rate 88/min, respiratory rate 20/min, temperature 38.4°C (101.1°F), and blood pressure 110/85 mm Hg. On physical examination, he has basal crackles on the right side of the chest. Chest radiography shows a new consolidation on the same side. Complete blood count is as follows:\nHemoglobin 16 mg/dL\nHematocrit 50%\nLeukocyte count 8,900/mm3\nNeutrophils 72%\nBands 4%\nEosinophils 2%\nBasophils 0%\nLymphocytes 17%\nMonocytes 5%\nPlatelet count 280,000/mm3\nWhat is the most likely causal microorganism?",
    "answer": "To determine the most likely causal microorganism, we analyze the case details and apply knowledge of hospital-acquired pneumonia (HAP):\n\n\n### Key Case Clues  \n- **Hospitalization context**: Pneumonia developed 1 week after admission (≥48 hours post-admission → HAP, not community-acquired).  \n- **Clinical features**: Fever, purulent cough, basal right-sided crackles, new consolidation (classic for pneumonia).  \n- **Patient background**: Stroke (possible impaired gag reflex/aspiration risk, but hospital-acquired aspiration pathogens differ from community-acquired).  \n\n\n### Common Pathogens for HAP  \nPer IDSA/ATS guidelines, the top pathogens for non-ventilator-associated HAP are:  \n1. Gram-negative bacilli (e.g., Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter spp.).  \n2. Staphylococcus aureus (including MRSA).  \n\n**Pseudomonas aeruginosa** is a leading cause of HAP due to its prevalence in hospital environments, ability to colonize respiratory tracts, and association with aspiration in hospitalized patients. It is more common in HAP than community-acquired pneumonia and aligns with the patient’s clinical scenario.  \n\n\n**Answer: Pseudomonas aeruginosa**",
    "expected_answer": "Staphylococcus aureus",
    "time": 27.54066801071167,
    "answer_length": 1183,
    "retrieval_time": 0.10207009315490723,
    "generation_time": 27.51559805870056
  },
  {
    "question": "A 6-year-old boy is brought to the emergency department by his mother for worsening wheezing and shortness of breath over the past day. He has not had a fever, cough, vomiting, or diarrhea. He has asthma and eczema. He uses a glucocorticoid inhaler and an albuterol inhaler but has missed his medications for the past week while on vacation. He appears uncomfortable. His temperature is 36°C (96.8°F), pulse is 120/min, respirations are 40/min, and blood pressure is 100/80. Expiratory and inspiratory wheezing is heard throughout both lung fields. There are moderate intercostal and subcostal retractions and a decreased inspiratory to expiratory ratio. Nebulized albuterol and ipratropium treatments and intravenous methylprednisolone are given in the emergency department for a presumed asthma exacerbation. One hour later, the child is limp and lethargic. Magnesium sulfate is administered. His temperature is 36°C (96.8°F), pulse is 150/min, respirations are 22/min, and blood pressure is 100/70. No wheezing is heard on repeat pulmonary examination. Which of the following is the most appropriate next step in management?",
    "answer": "To determine the most appropriate next step, we analyze the case and key findings:\n\n\n### **Case Recap**  \nA 6-year-old with asthma (missed meds) presents with an exacerbation. He receives **albuterol (beta-2 agonist)**, **ipratropium**, **IV methylprednisolone**, and later **magnesium sulfate**. Post-treatment, he is **limp/lethargic** with tachycardia (150/min; normal for 6yo: ~70-120) but no wheezing and normal respiratory rate.\n\n\n### **Key Mechanism**  \nBeta-2 agonists (albuterol) cause **intracellular potassium shift** (via activation of Na-K-ATPase), leading to *hypokalemia*. Symptoms of hypokalemia include **muscle weakness (limp)** and **fatigue/lethargy**—exactly what the patient exhibits. Tachycardia is also a common side effect of albuterol (direct beta-1 stimulation) and may be exacerbated by hypokalemia.\n\n\n### **Next Step**  \nThe most critical next step is to **measure serum potassium levels** (and other electrolytes) to confirm hypokalemia and guide replacement.\n\n\n**Answer: Obtain serum electrolyte levels (with focus on potassium).**\n\n\n(Note: If this were a multiple-choice question, the correct option would likely be \"Check serum potassium concentration\" or \"Obtain serum electrolyte panel.\")\n\n\n\\boxed{Check serum electrolyte levels}",
    "expected_answer": "Intubate with mechanical ventilation",
    "time": 25.913944959640503,
    "answer_length": 1264,
    "retrieval_time": 0.02165508270263672,
    "generation_time": 25.888582944869995
  },
  {
    "question": "A 5-year-old female suffers from recurrent infections by Aspergillus species, Pseudomonas species, and Staphylococcus aureus. The patient's neutrophils are examined in the laboratory and they fail to react during the nitroblue tetrazolium test. Which of the following is most likely dysfunctional in this patient?",
    "answer": "To answer this question, we analyze the key clinical and laboratory findings:\n\n\n### Key Observations:  \n- **Recurrent infections**: By catalase-positive pathogens (Aspergillus, Pseudomonas, Staphylococcus aureus).  \n- **Negative nitroblue tetrazolium (NBT) test**: Neutrophils fail to react.  \n\n\n### Critical Background:  \nThe NBT test assesses the **respiratory burst** in neutrophils—an essential mechanism for killing phagocytosed pathogens. Normally, neutrophils activate the **NADPH oxidase complex** to generate superoxide radicals (\\(O_2^-\\)), which reduce NBT (yellow dye) to blue formazan (positive test).  \n\nA negative NBT test indicates no superoxide production, meaning the NADPH oxidase complex is dysfunctional. This condition is **Chronic Granulomatous Disease (CGD)**, where phagocytes cannot kill catalase-positive pathogens (they break down their own \\(H_2O_2\\), leaving no reactive oxygen species for pathogen killing).  \n\n\n**Answer: NADPH oxidase**\n\n\n\\boxed{NADPH oxidase}",
    "expected_answer": "Respiratory burst",
    "time": 14.796210289001465,
    "answer_length": 992,
    "retrieval_time": 0.013431072235107422,
    "generation_time": 14.770153999328613
  },
  {
    "question": "A 3-year-old boy presents to the emergency department with a ‘cough-like-a-seal bark’ and a high-pitched inspiratory noise that is audible without a stethoscope. His mother reports that his cough has worsened over the last few hours. The patient's blood pressure is 118/78 mm Hg, pulse is 90/min, respiratory rate is 35/min, and temperature is 38.3°C (101.1°F). On physical examination, the boy is sitting and leaning forward in apparent respiratory distress with suprasternal and intercostal retractions. Auscultation reveals inspiratory stridor without wheezing. He has a frequent barking cough and a hoarse voice when he speaks. What is a chest X-ray likely to show?",
    "answer": "To determine the chest X-ray finding, we first identify the patient’s condition based on clinical features:  \n\nThe 3-year-old has a **barking (seal-like) cough**, inspiratory stridor, hoarse voice, fever, and respiratory distress with retractions—classic signs of **croup** (laryngotracheobronchitis), most commonly caused by parainfluenza virus.  \n\nCroup is characterized by subglottic edema, which on an anteroposterior (AP) chest X-ray produces a **steeple sign**: a tapering narrowing of the subglottic trachea resembling a steeple.  \n\n\n**Answer: Steeple sign** (narrowing of the subglottic trachea on AP view).  \n\n(Note: Epiglottitis (thumb sign) is excluded here—epiglottitis typically presents with drooling, tripod position, and no barking cough.)  \n\nFinal answer: Steeple sign.  \n\\boxed{Steeple sign}",
    "expected_answer": "Steeple sign",
    "time": 10.979324102401733,
    "answer_length": 809,
    "retrieval_time": 0.018442869186401367,
    "generation_time": 10.953882932662964
  },
  {
    "question": "A 26-year-old woman presents to a gynecologist after a missed period. After performing a complete physical examination and a screening test for pregnancy, her gynecologist informs her that she is pregnant. She is very surprised as she has been taking oral contraceptives regularly. When the gynecologist asks her about the consumption of any other medications, she mentions that she was placed on treatment for pulmonary tuberculosis (TB) 2 months ago. Her current anti-TB regimen includes rifampin, isoniazid, pyrazinamide, and ethambutol. Which of the following mechanisms best explains the failure of oral contraceptives in this patient?",
    "answer": "To determine the mechanism of oral contraceptive failure in this patient, we analyze the key interaction between her medications:\n\n\n### Key Background  \nOral contraceptives (OCs) typically contain estrogen and progestin, which are metabolized by **hepatic cytochrome P450 (CYP450) enzymes** (notably CYP3A4). Rifampin, an anti-tuberculosis drug, is a **potent inducer of CYP450 enzymes**.  \n\n\n### Mechanism of Failure  \nRifampin increases the activity of CYP450 enzymes, accelerating the breakdown (metabolism) of estrogen and progestin in the liver. This reduces the blood levels of these contraceptive hormones below the threshold required to inhibit ovulation, thicken cervical mucus, or alter the endometrium—all critical for OC efficacy.  \n\n\n**Answer:** Induction of hepatic microsomal cytochrome P450 enzymes leading to increased metabolism of oral contraceptive steroids.  \n\n\\boxed{Induction of hepatic microsomal enzymes (CYP450) increasing metabolism of oral contraceptives}",
    "expected_answer": "Induction of CYP3A4 by rifampin leading to decreased serum levels of ethinylestradiol and progesterone",
    "time": 11.465158224105835,
    "answer_length": 983,
    "retrieval_time": 0.015099048614501953,
    "generation_time": 11.44018006324768
  },
  {
    "question": "A 4-year-old previously healthy boy presents with 4 days of intermittent vomiting and 5-6 daily loose stools. His mother noted bloody stools and decreased oral intake of food and water over the last 24 hours. He is normally in daycare; however, he has been home for the past 3 days. On physical exam his temperature is 102.2°F (39°C), blood pressure is 140/90 mmHg, pulse is 120/min, respirations are 22/min and O2 saturation is 99% on room air. He has dry mucous membranes. On abdominal exam you note diffuse tenderness to palpation without rebound or guarding. There are no masses, hepatosplenomegaly, and bowel sounds are hyperactive. Ultrasound of the right lower quadrant is negative for appendicitis. Stool is guaiac positive. He receives 15mg/kg acetaminophen and fluids are started. The next day, he complains of lower extremity weakness and tingling. On repeat exam, lower extremity strength is 3/5 with diminished patellar deep tendon reflexes. Which of the following lab findings would most likely be seen in this patient?",
    "answer": "To solve this question, we analyze the case to identify the underlying condition and its associated lab findings:\n\n\n### **Key Case Features**  \n- 4-year-old, daycare exposure (germ exposure risk).  \n- Bloody diarrhea (E. coli O157:H7 common in this setting), fever, dehydration.  \n- **Hypertension** (140/90 mmHg, abnormal for age) → suggests renal dysfunction.  \n- Next-day: Lower extremity weakness, tingling, diminished reflexes → neuro complications.  \n\n\n### **Diagnosis**  \nThis constellation points to **Hemolytic Uremic Syndrome (HUS)** (classic triad: microangiopathic hemolytic anemia, thrombocytopenia, acute kidney injury [AKI]), most often caused by *E. coli O157:H7* (Shiga toxin-producing).  \n\n\n### **Classic Lab Findings for HUS**  \n1. **Microangiopathic hemolytic anemia**:  \n   - Schistocytes/helmet cells on peripheral smear (RBCs sheared by microthrombi).  \n   - Low hemoglobin/haptoglobin, elevated LDH (RBC breakdown).  \n\n2. **Thrombocytopenia**: Low platelet count (consumed in microthrombi).  \n\n3. **Acute kidney injury**: Elevated creatinine/BUN, abnormal urinalysis (blood, protein, casts).  \n\n\n### **Most Likely Lab Finding**  \nThe most specific lab finding for HUS (and the microangiopathic component) is **schistocytes on peripheral smear**. Other key findings include thrombocytopenia or elevated creatinine.  \n\n\n**Answer:** Schistocytes on peripheral smear (or thrombocytopenia/elevated creatinine, depending on options—schistocytes are the hallmark of microangiopathic hemolysis in HUS).\n\n\n\\boxed{Schistocytes on peripheral blood smear}  \n(Note: If options include thrombocytopenia or elevated creatinine, those are also correct, but schistocytes are the most specific for the microangiopathic component of HUS.)  \nFor the purpose of standard exams, **schistocytes** is the typical answer here.  \n\n\\boxed{Schistocytes present on peripheral smear}",
    "expected_answer": "Increased cerebrospinal fluid protein with normal cell count",
    "time": 40.18501687049866,
    "answer_length": 1877,
    "retrieval_time": 0.08658409118652344,
    "generation_time": 40.15925908088684
  },
  {
    "question": "A 3-week-old male newborn is brought to the physician because of an inward turning of his left forefoot. He was born at 38 weeks' gestation by cesarean section because of breech presentation. The pregnancy was complicated by oligohydramnios. Examination shows concavity of the medial border of the left foot with a skin crease just below the ball of the great toe. The lateral border of the left foot is convex. The heel is in neutral position. Tickling the lateral border of the foot leads to correction of the deformity. The remainder of the examination shows no abnormalities. X-ray of the left foot shows an increased angle between the 1st and 2nd metatarsal bones. Which of the following is the most appropriate next step in the management of this patient?",
    "answer": "To determine the most appropriate management, let’s analyze the case key features and match them to the correct diagnosis:\n\n\n### **Key Findings & Diagnosis**  \nThe newborn has:  \n- **Inward forefoot deviation** (concave medial border, convex lateral border)  \n- **Neutral heel position** (no equinus/downward pointing or varus/inward heel—rules out clubfoot/talipes equinovarus)  \n- **Flexible deformity** (corrects with tickling the lateral foot)  \n- **Increased 1st-2nd metatarsal angle** (classic for metatarsus adductus)  \n\nThese findings confirm **metatarsus adductus** (the most common congenital foot deformity, characterized by inward forefoot deviation with normal heel alignment).\n\n\n### **Management of Metatarsus Adductus**  \nFor **flexible cases** (like this one, where the deformity corrects easily), the first-line management is **parental stretching exercises**. Parents are taught to gently stretch the forefoot outward several times daily. Rigid cases or those unresponsive to stretching may require serial casting later, but initial steps focus on stretching.\n\n\n**Answer:** Teach the parents passive stretching exercises for the left foot.\n\n\n\\boxed{Teach the parents passive stretching exercises for the left foot}",
    "expected_answer": "Reassurance",
    "time": 15.439929962158203,
    "answer_length": 1232,
    "retrieval_time": 0.017573833465576172,
    "generation_time": 15.414457082748413
  },
  {
    "question": "A 42-year-old woman comes to the emergency department because of a 2-day history of right upper abdominal pain and nausea. She is 163 cm (5 ft 4 in) tall and weighs 91 kg (200 lb); her BMI is 34 kg/m2. Her temperature is 38.5°C (101.3°F). Physical examination shows a distended abdomen and right upper quadrant tenderness with normal bowel sounds. Laboratory studies show:\nLeukocyte count 14,000/mm3\nSerum\nTotal bilirubin 1.1 mg/dL\nAST 32 U/L\nALT 40 U/L\nAlkaline phosphatase 68 U/L\nAbdominal ultrasonography is performed, but the results are inconclusive. Cholescintigraphy shows the intrahepatic bile ducts, hepatic ducts, common bile duct, and proximal small bowel. Which of the following is the most likely cause of this patient's symptoms?\"",
    "answer": "To determine the most likely cause of the patient's symptoms, let’s analyze the key findings:\n\n\n### **Key Clinical & Lab Features**  \n- **Risk factors**: Obese (BMI=34), female (classic for gallbladder disease).  \n- **Symptoms**: 2-day right upper quadrant (RUQ) pain, nausea, fever (38.5°C).  \n- **Signs**: RUQ tenderness, distended abdomen, normal bowel sounds.  \n- **Labs**: Leukocytosis (14,000/mm³ → inflammation), normal liver function tests (bilirubin, AST/ALT/alkaline phosphatase → no biliary obstruction).  \n\n\n### **Imaging Clues**  \n- **Cholescintigraphy (HIDA scan)**: Visualizes intrahepatic ducts, hepatic ducts, common bile duct (CBD), and proximal small bowel—but **no mention of gallbladder visualization**.  \n\nA HIDA scan assesses gallbladder patency:  \n- Normally, tracer flows from liver → bile ducts → gallbladder (via cystic duct) → small bowel.  \n- **Non-visualization of the gallbladder** on HIDA scan indicates obstruction of the cystic duct (the hallmark of acute cholecystitis).  \n\n\n### **Ruling Out Other Options**  \n- **Choledocholithiasis**: Stones in CBD → would cause elevated bilirubin/alkaline phosphatase (absent here).  \n- **Biliary colic**: No fever or leukocytosis (inflammation absent).  \n- **Acute cholangitis**: Requires jaundice (Charcot’s triad: pain, fever, jaundice—missing jaundice).  \n\n\n**Answer: Acute cholecystitis**\n\n\n\\boxed{Acute cholecystitis}",
    "expected_answer": "Obstruction of the cystic duct",
    "time": 26.944013833999634,
    "answer_length": 1395,
    "retrieval_time": 0.019408226013183594,
    "generation_time": 26.9185631275177
  },
  {
    "question": "A 72-year-old woman is admitted to the intensive care unit for shortness of breath and palpitations. A cardiac catheterization is performed and measurements of the left ventricular volume and pressure at different points in the cardiac cycle are obtained. The patient's pressure-volume loop (gray) is shown with a normal pressure-volume loop (black) for comparison. Which of the following is the most likely underlying cause of this patient's symptoms?",
    "answer": "To answer this question, we analyze the patient’s clinical presentation (72-year-old with shortness of breath and palpitations) and link it to common pressure-volume loop (PV loop) abnormalities in elderly patients:\n\n\n### Key Background on PV Loops & Clinical Correlations  \nThe PV loop reflects left ventricular (LV) function. Critical observations include:  \n- **End-diastolic pressure (EDP):** Elevated EDP suggests impaired diastolic relaxation.  \n- **Ejection fraction (EF):** Normal EF = (EDV-ESV)/EDV indicates preserved systolic function; reduced EF indicates systolic dysfunction.  \n- **Common elderly causes:** Diastolic heart failure (HFpEF) is highly prevalent in the elderly, often due to chronic hypertension leading to LV hypertrophy (LVH) and impaired relaxation.  \n\n\n### Patient’s Clinical Clues  \n- **Shortness of breath:** Due to elevated LVEDP → increased left atrial pressure → pulmonary congestion.  \n- **Palpitations:** Likely atrial fibrillation (AF), which is common in HFpEF (LVH/elevated LA pressure → atrial enlargement → AF).  \n\n\n### PV Loop Abnormality for HFpEF  \nHFpEF (diastolic heart failure) is characterized by:  \n- **Normal EF** (preserved systolic function, ESV normal).  \n- **Elevated EDP** at normal EDV (steeper LV end-diastolic pressure-volume relationship, LVEDPVR).  \n\n\n### Underlying Cause  \nThe most likely underlying condition is **diastolic heart failure (HFpEF)**, often secondary to chronic hypertension (though HFpEF itself is the direct functional abnormality). Given standard question framing, the answer focuses on the functional diagnosis.\n\n\n**Answer:** Diastolic heart failure (heart failure with preserved ejection fraction)\n\n\n\\boxed{Diastolic \\ heart \\ failure}",
    "expected_answer": "Increased ventricular wall stiffness",
    "time": 43.31254506111145,
    "answer_length": 1719,
    "retrieval_time": 0.014052152633666992,
    "generation_time": 43.284871101379395
  },
  {
    "question": "A 22-year-old woman is brought to the emergency department because of a 2-day history of fever, intermittent rigors, and night sweats. She also has a 1-month history of progressive fatigue. Five weeks ago, she was hospitalized and received intravenous antibiotics for treatment of bacterial meningitis while visiting relatives in Guatemala. Her temperature is 39.4°C (102.9°F), pulse is 130/min, and blood pressure is 105/70 mm Hg. Examination shows pallor and scattered petechiae and ecchymoses. Laboratory studies show a hemoglobin concentration of 9.0 g/dL, a leukocyte count of 1,100/mm3 with 30% segmented neutrophils, and a platelet count of 20,000/mm3 . Blood cultures grow coagulase-negative staphylococci. The patient was most likely treated with which of the following antibiotics?",
    "answer": "To solve this question, we analyze the case details and link the patient’s current presentation to the side effects of an antibiotic used for bacterial meningitis.\n\n\n### **Key Case Observations**  \n- **History**: Treated with IV antibiotics for bacterial meningitis in Guatemala 5 weeks prior.  \n- **Current Presentation**:  \n  - **Pancytopenia**: Anemia (Hb 9.0 g/dL), leukopenia (WBC 1,100/mm³), thrombocytopenia (platelets 20,000/mm³).  \n  - **Opportunistic infection**: Blood cultures grow coagulase-negative staphylococci (CoNS, common in immunocompromised patients).  \n\n\n### **Antibiotic Side Effect Link**  \nThe patient’s pancytopenia (bone marrow suppression) is the critical clue. Among antibiotics used for meningitis:  \n- **Chloramphenicol**: Known to cause **bone marrow suppression** (reversible dose-dependent or irreversible idiosyncratic aplastic anemia), leading to pancytopenia. It is still used in resource-limited settings (like Guatemala) for meningitis (covers *H. influenzae*, *S. pneumoniae*, *N. meningitidis*).  \n- **Other options**: Vancomycin (nephrotoxicity/ototoxicity), ceftriaxone (gallstones/diarrhea), ampicillin (rash/diarrhea) do not cause pancytopenia.  \n\n\n### **Conclusion**  \nThe antibiotic responsible for the patient’s pancytopenia and subsequent opportunistic infection is **chloramphenicol**.\n\n\n**Answer: Chloramphenicol**",
    "expected_answer": "Chloramphenicol",
    "time": 22.0173499584198,
    "answer_length": 1365,
    "retrieval_time": 0.0217440128326416,
    "generation_time": 21.992289781570435
  },
  {
    "question": "An otherwise healthy 50-year-old man comes to the physician because of a 6-month history of increasingly frequent episodes of upper abdominal pain, nausea, vomiting, and diarrhea. He has had a 3.2-kg (7-lb) weight loss during this time. Physical examination shows bilateral pitting pedal edema. An endoscopy shows prominent rugae in the gastric fundus. Biopsy shows parietal cell atrophy. Which of the following is the most likely underlying cause?",
    "answer": "To determine the underlying cause, let’s analyze the key findings and match them to the most likely condition:\n\n\n### **Key Clinical & Diagnostic Findings**  \n- 50yo man with 6-month history of upper abdominal pain, nausea/vomiting, diarrhea, weight loss.  \n- **Bilateral pitting edema**: Suggests hypoalbuminemia (protein loss).  \n- **Endoscopy**: Prominent rugae in gastric fundus.  \n- **Biopsy**: Parietal cell atrophy.  \n\n\n### **Differential Diagnosis & Ruling Out**  \n1. **Pernicious anemia**: Autoimmune parietal cell destruction, but gastric mucosa is atrophic (flattened rugae), not prominent. Eliminated.  \n2. **Zollinger-Ellison syndrome**: Gastrinoma causes excess acid, so parietal cells are hyperplastic (not atrophic). No protein loss edema. Eliminated.  \n3. **Gastric cancer**: Linitis plastica (diffuse thickening) or intestinal-type adenocarcinoma (ulcers/masses) do not present with prominent rugae + parietal cell atrophy. Eliminated.  \n4. **Menetrier’s disease**:  \n   - **Hallmark**: Giant hypertrophic gastric folds (prominent rugae) in fundus/body.  \n   - **Histology**: Foveolar hyperplasia + parietal cell atrophy → hypochlorhydria.  \n   - **Protein-losing gastropathy**: Increased mucosal permeability → hypoalbuminemia → edema.  \n   - **Symptoms**: Abdominal pain, nausea/vomiting, diarrhea, weight loss (all match the case).  \n\n\n**Answer: Menetrier's disease** (or \"Hypertrophic gastropathy\"—Menetrier's is the specific form here).  \n\n\\boxed{Menetrier's disease}",
    "expected_answer": "Proliferation of gastric mucus-producing cells",
    "time": 23.24400281906128,
    "answer_length": 1489,
    "retrieval_time": 0.11696791648864746,
    "generation_time": 23.216376066207886
  },
  {
    "question": "A 27-year-old man presents to the emergency department. He was brought in by staff from the homeless shelter when they found him unresponsive. The patient is a known IV drug abuser but otherwise has an unknown past medical history. He currently attends a methadone clinic. His temperature is 99.5°F (37.5°C), blood pressure is 97/48 mmHg, pulse is 140/min, respirations are 29/min, and oxygen saturation is 98% on room air. Initial laboratory values are shown below.\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 6.3 mEq/L\nHCO3-: 17 mEq/L\nGlucose: 589 mg/dL\n\nThe patient is given treatment. After treatment, his temperature is 99.5°F (37.5°C), blood pressure is 117/78 mmHg, pulse is 100/min, respirations are 23/min, and oxygen saturation is 98% on room air. His laboratory values are seen below.\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 4.3 mEq/L\nHCO3-: 19 mEq/L\nGlucose: 90 mg/dL\n\nWhich of the following is the best next step in management?",
    "answer": "To determine the best next step in management, we first analyze the patient’s clinical course and key findings:\n\n\n### **Key Initial Findings**  \nThe patient presented with:  \n- **Hyperglycemia (589 mg/dL)**  \n- **Metabolic acidosis (HCO₃⁻ = 17 mEq/L)**  \n- **Hyperkalemia (6.3 mEq/L)**  \n- Hemodynamic instability (hypotension, tachycardia)  \n\nThese findings are consistent with **diabetic ketoacidosis (DKA)**—a common acute complication of diabetes, often triggered by infections, insulin non-compliance, or stress. The patient’s IV drug use and methadone history do not directly cause these metabolic abnormalities but increase infection risk.\n\n\n### **Post-Treatment Improvements**  \nAfter initial management (fluids, insulin, electrolyte replacement):  \n- Glucose normalized (90 mg/dL)  \n- K⁺ corrected (4.3 mEq/L)  \n- Hemodynamics stabilized  \n- HCO₃⁻ improved (19 mEq/L, still slightly low but resolving)  \n\n\n### **Best Next Step**  \nThe critical next step in DKA management after acute stabilization is **identifying and treating the precipitating cause** to prevent recurrence. For this patient (IV drug user), **infection** is the most likely trigger (e.g., skin abscesses, pneumonia, sepsis).  \n\nOther considerations (e.g., checking ketones to confirm resolution) are relevant but secondary to addressing the underlying cause. Transitioning to subcutaneous insulin is important, but evaluating for infection takes priority to treat the root of the DKA episode.\n\n\n**Answer:** Evaluate for precipitating infection (e.g., obtain blood cultures, chest X-ray, and perform a thorough skin exam for abscesses).  \n\n(Note: If this were a multiple-choice question, the correct option would align with evaluating for infection.)\n\n\n\\boxed{Evaluate for precipitating infection}",
    "expected_answer": "Insulin, potassium, IV fluids, and glucose",
    "time": 48.26985716819763,
    "answer_length": 1774,
    "retrieval_time": 0.02120184898376465,
    "generation_time": 48.242477893829346
  },
  {
    "question": "A 67-year-old man who was diagnosed with arthritis 16 years ago presents with right knee swelling and pain. His left knee was swollen a few weeks ago, but now with both joints affected, he has difficulty walking and feels frustrated. He also has back pain which makes it extremely difficult to move around and be active during the day. He says his pain significantly improves with rest. He also suffers from dandruff for which he uses special shampoos. Physical examination is notable for pitting of his nails. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the patient’s key clinical features and connect them to characteristic disease associations:\n\n\n### **Key Clinical Clues**  \n1. **Arthritis**: 16-year history, affecting knees (migratory/asymmetric involvement) and back (axial symptoms).  \n2. **Skin/nail findings**: Dandruff (likely scalp psoriasis, often mislabeled as dandruff) and **nail pitting** (a classic sign of psoriatic nail involvement).  \n3. **Pain pattern**: Improves with rest (consistent with inflammatory arthritis, though axial spondyloarthritis may improve with activity—here, the combination of peripheral and axial arthritis plus skin/nail changes is more specific).  \n\n\n### **Differential Diagnosis Ruling Out**  \n- **Rheumatoid arthritis**: Symmetric polyarthritis, but no nail pitting or psoriasis-related skin findings.  \n- **Osteoarthritis**: Common in older adults, but lacks skin/nail abnormalities.  \n- **Ankylosing spondylitis**: Axial dominant, but no nail pitting or psoriasis.  \n\n\n### **Conclusion**  \nThe combination of psoriasis (scalp dandruff + nail pitting) and inflammatory arthritis (peripheral + axial) is pathognomonic for **psoriatic arthritis**.\n\n\n**Answer: Psoriatic arthritis**",
    "expected_answer": "Psoriatic arthritis",
    "time": 17.57280993461609,
    "answer_length": 1223,
    "retrieval_time": 0.015321969985961914,
    "generation_time": 17.547733545303345
  },
  {
    "question": "A 65-year-old woman schedules an appointment with her physician for evaluation of weight loss and weakness. The weakness is more noticeable when climbing stairs and combing hair. The weakness improves after brief exercise. She also has bladder incontinence for the past 4 weeks and was given an anticholinesterase agent with no improvement. What is the most likely cause of the symptoms?",
    "answer": "The most likely cause of the patient’s symptoms is **Lambert-Eaton Myasthenic Syndrome (LEMS)**, likely paraneoplastic (e.g., associated with small cell lung cancer).\n\n\n### Key Reasoning:  \nThe patient’s clinical features align with LEMS:  \n1. **Weakness pattern**: Proximal weakness (climbing stairs, combing hair) that improves with brief exercise (a hallmark of LEMS, opposite of myasthenia gravis).  \n2. **Autonomic dysfunction**: Bladder incontinence (common in LEMS, unlike myasthenia gravis where autonomic symptoms are rare).  \n3. **Anticholinesterase resistance**: Anticholinesterase agents (e.g., pyridostigmine) are less effective in LEMS than in myasthenia gravis.  \n4. **Weight loss**: Suggests a paraneoplastic cause (LEMS is strongly associated with small cell lung cancer, which causes weight loss).  \n\n\nOther conditions are less likely:  \n- **Myasthenia gravis**: Weakness worsens with exercise, anticholinesterase helps, autonomic symptoms are rare.  \n- **Polymyositis**: Proximal weakness but no improvement with exercise, no autonomic dysfunction.  \n- **Muscular dystrophy**: Uncommon in older adults, no autonomic involvement.  \n\n\n**Answer: Lambert-Eaton Myasthenic Syndrome** (often paraneoplastic, e.g., secondary to small cell lung cancer).  \n\n\\boxed{Lambert-Eaton\\ Myasthenic\\ Syndrome}",
    "expected_answer": "Paraneoplastic syndrome from small cell carcinoma of the lung",
    "time": 17.71738910675049,
    "answer_length": 1311,
    "retrieval_time": 0.013688087463378906,
    "generation_time": 17.692404985427856
  },
  {
    "question": "A 3-month-old boy presents to his pediatrician with persistent diarrhea, oral candidiasis, and signs and symptoms suggestive of respiratory syncytial virus (RSV) pneumonia. His weight is in the 10th percentile. He is being evaluated for an immunodeficiency disease. Laboratory results for the HIV are negative by PCR. Which of the following is the most likely cause of these findings in this patient?",
    "answer": "To determine the most likely cause of the patient’s findings, let’s analyze the key clinical features and rule out differential diagnoses:\n\n\n### **Key Clinical Features**  \n- 3-month-old boy with **persistent diarrhea**, **oral candidiasis** (fungal infection), **RSV pneumonia** (viral infection), and weight at the 10th percentile (suggesting failure to thrive).  \n- HIV-negative by PCR (eliminates acquired immunodeficiency).  \n\n\n### **Differential Diagnosis Analysis**  \n1. **X-linked Agammaglobulinemia (Bruton’s)**: B-cell deficiency → primarily bacterial infections (otitis, sinusitis) but not fungal/viral infections (oral candidiasis/RSV require T-cell immunity). **Ruled out.**  \n2. **Chronic Granulomatous Disease (CGD)**: Phagocyte defect → recurrent bacterial/fungal infections but not viral infections (RSV is viral). **Ruled out.**  \n3. **DiGeorge Syndrome**: Thymic hypoplasia (T-cell deficiency) → but classic features (congenital heart defects, hypocalcemia, facial anomalies) are absent here. **Less likely.**  \n4. **Severe Combined Immunodeficiency (SCID)**: Combined B/T-cell defect → presents in the first 3-6 months (as maternal antibodies wane) with recurrent bacterial, viral, and fungal infections. Symptoms include persistent diarrhea, oral candidiasis, viral pneumonia (RSV), and failure to thrive. This **matches all clinical features.**  \n\n\n**Answer: Severe Combined Immunodeficiency (SCID)**\n\n\n\\boxed{Severe Combined Immunodeficiency}",
    "expected_answer": "Defective T cell function",
    "time": 23.608649015426636,
    "answer_length": 1465,
    "retrieval_time": 0.012952804565429688,
    "generation_time": 23.58315086364746
  },
  {
    "question": "A 53-year-old man with recurrent pancreatic adenocarcinoma is enrolled in a clinical trial for a novel chemotherapeutic agent that his physician believes may be beneficial to his condition. The novel drug was previously tested in a small population and is now undergoing a larger phase 3 trial in preparation for FDA approval. A dose-response trial had the following results:\n\n10 mg dose - 6/59 patients demonstrated improvement\n20 mg dose - 19/49 patients demonstrated improvement\n30 mg dose - 26/53 patients demonstrated improvement\n40 mg dose - 46/51 patients demonstrated improvement\n\nThe same trial also had the following safety profile:\n\n20 mg dose - 5/49 patients had a treatment related adverse event\n40 mg dose - 11/51 patients had a treatment related adverse event\n60 mg dose - 15/42 patients had a treatment related adverse event\n80 mg dose - 23/47 patients had a treatment related adverse event\n100 mg dose - 47/52 patients had a treatment related adverse event\n\nBased on this study, which of the following represents the most likely therapeutic index for this novel chemotherapeutic agent?",
    "answer": "To determine the therapeutic index (TI), we first calculate the **ED₅₀** (dose with 50% therapeutic effect) and **TD₅₀** (dose with 50% toxic effect), then use the ratio \\(TI = \\frac{TD_{50}}{ED_{50}}\\).\n\n\n### Step 1: Calculate ED₅₀  \nThe dose-response data shows:  \n- 20 mg: ~38.8% response  \n- 30 mg: ~49.1% response  \n\nED₅₀ is the dose where 50% of patients improve. This falls between 20 mg and 30 mg, **~30 mg** (30 mg is nearly 50% response).\n\n\n### Step 2: Calculate TD₅₀  \nThe safety profile shows:  \n- 60 mg: ~35.7% adverse events  \n- 80 mg: ~48.9% adverse events  \n\nTD₅₀ is the dose where 50% of patients have toxic effects. This falls between 60 mg and 80 mg, **~80 mg** (80 mg is nearly 50% toxic events).\n\n\n### Step 3: Compute TI  \n\\(TI = \\frac{TD_{50}}{ED_{50}} ≈ \\frac{80}{30} ≈ 2.7\\), which is closest to **3**.\n\n\n**Answer: 3** (assuming options include 3 as the closest value).\n\n\n\\boxed{3}",
    "expected_answer": "2.67",
    "time": 31.02857518196106,
    "answer_length": 905,
    "retrieval_time": 0.0747227668762207,
    "generation_time": 31.003323793411255
  },
  {
    "question": "A 67-year-old male is seen by neurology after he was noticed to be speaking strangely by his family. After acute treatment with tissue plasminogen activator (tPA), the patient is able to recover most of his speech. Subsequent neurologic exam finds that the patient is fluent while speaking and is able to comprehend both one and two step instructions. Noticeably the patient remains unable to complete tasks involving verbal repetition. Residual damage to which of the following structures is most likely responsible for this patient's syndrome?",
    "answer": "To determine the responsible structure, we analyze the patient’s clinical features and link them to known aphasia syndromes:\n\n\n### Key Clinical Findings:  \n- **Fluent speech**: Rules out Broca’s aphasia (non-fluent).  \n- **Intact comprehension**: Rules out Wernicke’s aphasia (poor comprehension).  \n- **Impaired verbal repetition**: The defining deficit here.  \n\n\n### Relevant Aphasia Syndrome:  \nConduction aphasia is characterized by fluent speech, intact comprehension, and **selective impairment of repetition**. This syndrome arises from damage to the **arcuate fasciculus**—the white matter tract connecting Broca’s area (speech production) and Wernicke’s area (speech comprehension). Disruption of this tract prevents the transfer of understood speech (from Wernicke’s) to the motor speech area (Broca’s) for repetition.  \n\n\n**Answer: Arcuate fasciculus**",
    "expected_answer": "Arcuate fasciculus",
    "time": 11.407458066940308,
    "answer_length": 863,
    "retrieval_time": 0.013612985610961914,
    "generation_time": 11.380174160003662
  },
  {
    "question": "A 27-year-old woman presents to the office with concerns about her long struggle with her physical appearance since adolescence. She says she has always been \"large\" and was constantly targeted by her classmates and coworkers for being so. Her main concern at the moment is her acne and unwanted facial hair on her upper lip, for which she often visits a local spa. She has tried numerous diet plans, exercise regimens, and cosmetic products with little to no effect. Recently, she underwent a glucose tolerance test that showed a plasma glucose level of 160 mg/dL (8.9 mmol/L) after 2 hours of a 75 g dose of oral glucose. She has a family history of type 2 diabetes mellitus and a menstrual cycle that occurs every 45 days. Her pulse is 72/min and the blood pressure is 138/80 mm Hg. On physical examination, her height is 160 cm (5 ft 3 in) and her weight is 85 kg (187 lb), and she has severe inflammatory acne over the cheeks and forehead and dark coarse hairs on the back. What is the most likely diagnosis of this patient?",
    "answer": "The most likely diagnosis is **Polycystic Ovary Syndrome (PCOS)**. Here’s the reasoning:\n\n\n### Key Clinical & Laboratory Findings Aligning with PCOS:  \n1. **Oligomenorrhea**: Menstrual cycles every 45 days (normal 21–35 days), indicating irregular ovulation/anovulation.  \n2. **Hyperandrogenism**:  \n   - Clinical signs: Unwanted facial hair (upper lip), dark coarse back hair (hirsutism), and severe inflammatory acne.  \n3. **Insulin Resistance & Metabolic Abnormalities**:  \n   - Impaired glucose tolerance (2-hour glucose = 160 mg/dL; cutoff for impaired is 140–199 mg/dL).  \n   - Obesity (BMI = 85 kg/(1.6 m)² = ~33.2, class I obesity).  \n   - Prehypertension (138/80 mmHg) and family history of type 2 diabetes (both linked to insulin resistance in PCOS).  \n\n\n### Rotterdam Criteria for PCOS:  \nThe patient meets **2 out of 3** required criteria (oligomenorrhea + clinical hyperandrogenism), even without ultrasound evidence of polycystic ovaries (not provided here). The metabolic features further support PCOS, as insulin resistance is a core pathophysiological component of the syndrome.\n\n\n**Answer: Polycystic Ovary Syndrome (PCOS)**",
    "expected_answer": "Polycystic ovarian syndrome (PCOS)",
    "time": 19.00391697883606,
    "answer_length": 1142,
    "retrieval_time": 0.01924300193786621,
    "generation_time": 18.979080200195312
  },
  {
    "question": "А 43-уеаr-old mаn рrеѕеntѕ wіth tіnglіng аnd numbnеѕѕ of the lowеr lіmbѕ for 2 wееkѕ. Не also сomрlаіnѕ of реrѕіѕtеnt раіn in his legs whісh is not relieved by over-the-counter analgesics. Past medical history is significant for type 2 dіаbеtes mellitus for 2 уеаrѕ, inconsistently managed with mеtformіn аnd glіmеріrіdе. Оn physical ехаmіnаtіon, thеrе іѕ dесrеаѕеd ѕеnѕаtіon to pain in both lower lіmbs, but deep tеndon rеflехеѕ аrе іntасt. Ніѕ vіtаl ѕіgnѕ include: blood рrеѕѕurе 122/84 mm Нg, tеmреrаturе 36.7°C (98.1°F), and rеѕріrаtorу rаtе 10/mіn. His ankle-brachial pressure index (ABPI) on the right side is 1.1. His blood sugar analyses are as follows:\nFasting 141 mg/ dL\n2 hours Post-Prandial 235 mg/ dL\nHbA1c 8.1%\nWhich of the following is the best measure to prevent the progression of the symptoms present in this patient?",
    "answer": "To address the question, we first analyze the patient's clinical presentation and identify the underlying condition:\n\n\n### Key Clinical Findings  \nThe patient has **type 2 diabetes mellitus (T2DM)** with poor glycemic control (HbA1c = 8.1%, fasting glucose = 141 mg/dL, post-prandial glucose = 235 mg/dL). His symptoms (tingling, numbness, unrelieved leg pain) and exam findings (decreased pain sensation in lower limbs, intact deep tendon reflexes) are consistent with **diabetic peripheral neuropathy (DPN)**. The normal ankle-brachial pressure index (ABPI = 1.1) rules out peripheral artery disease as the primary cause of his symptoms.\n\n\n### Best Measure to Prevent Progression  \nThe most critical intervention to halt the progression of DPN is **strict glycemic control**. Chronic hyperglycemia drives nerve damage in diabetes, and reducing HbA1c to target levels (<7% for most T2DM patients) is proven to slow or prevent neuropathy progression.  \n\nThe patient’s current control is suboptimal due to inconsistent medication adherence. Thus, optimizing glycemic control through:  \n- Improved adherence to metformin/glimepiride,  \n- Lifestyle modifications (diet, exercise),  \n- Monitoring glucose levels, and  \n- Adjusting therapy if needed (to achieve HbA1c <7%)  \n\nis the best measure.\n\n\n**Answer:** Optimize glycemic control to achieve a target HbA1c of less than 7% (via improved medication adherence, lifestyle changes, and regular glucose monitoring).  \n\n(Note: If options were provided, the correct choice would align with this principle, e.g., \"Intensify glycemic control to reach HbA1c <7%\".)",
    "expected_answer": "Strict blood glucose control",
    "time": 22.874969720840454,
    "answer_length": 1605,
    "retrieval_time": 0.021145105361938477,
    "generation_time": 22.8475022315979
  },
  {
    "question": "A one-day-old male is evaluated in the hospital nursery for bilious vomiting. The patient has urinated multiple times since birth but has not yet passed meconium. He was born at 38 weeks gestation to a 36-year-old gravida 3 via vaginal delivery. The pregnancy was complicated by gestational diabetes. The patient’s mother received routine prenatal care and declined first trimester screening. She subsequently underwent a quadruple screen at 15 weeks gestation that demonstrated decreased maternal serum alpha-fetoprotein (AFP), increased beta-hCG, decreased unconjugated estriol, and increased inhibin A. Her last ultrasound prior to onset of labor demonstrated an amniotic fluid index (AFI) of 28 cm. The patient’s two older siblings are both healthy. The patient’s temperature is 97.8°F (36.6°C), blood pressure is 58/37 mmHg, pulse is 166/min, and respirations are 38/min. On physical exam, the patient is in moderate distress. His abdomen is firm and distended with hypoactive bowel sounds.\n\nWhich of the following is the most likely etiology of this fetus’s presentation?",
    "answer": "To determine the most likely etiology, we connect the newborn’s clinical presentation, prenatal screening results, and ultrasound findings:\n\n\n### Key Clinical & Prenatal Findings  \n1. **Newborn Symptoms**: 1-day-old male with **bilious vomiting**, no meconium passage, firm/distended abdomen, hypoactive bowel sounds → intestinal obstruction.  \n2. **Prenatal Quadruple Screen**: Decreased AFP, increased β-hCG, decreased unconjugated estriol, increased inhibin A → classic for **trisomy 21 (Down syndrome)**.  \n3. **Prenatal Ultrasound**: AFI = 28 cm (polyhydramnios, normal =5-25 cm) → due to fetal inability to swallow/absorb amniotic fluid (GI obstruction).  \n\n\n### Critical Association  \n**Duodenal atresia** is strongly linked to trisomy 21. It causes proximal intestinal obstruction (beyond the ampulla of Vater, leading to bilious vomiting) and polyhydramnios (fetus cannot swallow fluid past the atretic duodenum). This aligns perfectly with the newborn’s symptoms and prenatal findings.  \n\n\n### Other Ruled-Out Conditions  \n- **Hirschsprung disease**: Associated with Down syndrome but typically presents with chronic constipation, not acute bilious vomiting at 1 day.  \n- **Meconium ileus**: Linked to cystic fibrosis, no trisomy 21 association.  \n- **Anorectal malformation**: Less strongly associated with Down syndrome and does not explain polyhydramnios (lower obstruction allows partial fluid swallowing).  \n\n\n**Answer: Duodenal atresia** (secondary to trisomy 21, as indicated by the quadruple screen).  \n\n\\boxed{Duodenal\\ atresia}",
    "expected_answer": "Duodenal atresia",
    "time": 37.989495038986206,
    "answer_length": 1547,
    "retrieval_time": 0.021059036254882812,
    "generation_time": 37.96420502662659
  },
  {
    "question": "A healthy 23-year-old male is undergoing an exercise stress test as part of his physiology class. If blood were to be sampled at different locations before and after the stress test, which area of the body would contain the lowest oxygen content at both time points?",
    "answer": "To determine the area with the lowest oxygen content in blood samples before and after exercise, we analyze oxygen levels across key vascular structures:\n\n\n### Key Background  \nOxygenated blood flows from the lungs to the left heart and systemic arteries. Deoxygenated blood returns from tissues to the right heart via systemic veins, then is pumped through the **pulmonary artery** to the lungs for reoxygenation.  \n\n\n### Critical Observations  \n- **Systemic arteries/veins**: Systemic arteries carry oxygen-rich blood; systemic veins carry deoxygenated blood, but their oxygen content varies by tissue (e.g., muscle veins have lower O₂ during exercise, but this mixes in the vena cava).  \n- **Right heart/pulmonary artery**: The right heart receives mixed deoxygenated blood from all systemic veins. This blood is pumped directly into the pulmonary artery, which transports it to the lungs.  \n\nAt both rest and exercise:  \n- The pulmonary artery contains the **mixed venous blood** (average of deoxygenated blood from all tissues), which has the lowest oxygen content in the body. Exercise increases tissue oxygen consumption, lowering mixed venous O₂ further—but the pulmonary artery still remains the site of lowest O₂ at both time points.  \n\n\n**Answer: Pulmonary artery**",
    "expected_answer": "Coronary sinus",
    "time": 25.566714763641357,
    "answer_length": 1276,
    "retrieval_time": 0.2963240146636963,
    "generation_time": 25.541204929351807
  },
  {
    "question": "A 45-year-old G5P4105 presents to her gynecologist’s office with six months of increasingly heavy periods. She now soaks one super absorbent tampon every two hours for five days each cycle. Her cycles have also become irregular, with intermenstrual bleeding for the last two months. She now experiences significant dysmenorrhea, requiring 400 mg ibuprofen every four hours for the majority of each menses. In addition, she reports new onset mild dyspareunia with intercourse and a “heavy feeling” in her pelvis. She has also noticed increased urinary frequency but denies bowel changes. The patient has a past medical history of obesity and type II diabetes on metformin. Her last child was born four years ago, and she has had five spontaneous vaginal deliveries. At this office visit, temperature is 98.5°F (36.9°C), blood pressure is 137/84 mmHg, pulse is 87/min, and respirations are 14/min. Which of the following physical exam findings is most likely to be present in this patient?",
    "answer": "To determine the most likely physical exam finding, we first analyze the patient’s clinical presentation and identify the probable diagnosis:\n\n\n### **Key Clinical Features**  \n- 45-year-old G5P4105 (multiple pregnancies, estrogen exposure risk factor)  \n- Symptoms: Menorrhagia (heavy periods), metrorrhagia (intermenstrual bleeding), dysmenorrhea, pelvic heaviness, urinary frequency (mass effect on bladder), dyspareunia  \n- Comorbidities: Obesity (increased estrogen via adipose aromatization), type 2 diabetes  \n\nThese features are highly consistent with **uterine leiomyomas (fibroids)**—the most common benign uterine tumor in reproductive-age women.\n\n\n### **Physical Exam Findings for Fibroids**  \nFibroids cause **irregular, firm, non-tender uterine enlargement** due to their discrete, solid, and often multiple growths. This contrasts with other conditions:  \n- **Adenomyosis**: Symmetrically enlarged, boggy, tender uterus (not the case here, as no acute tenderness is suggested).  \n- **PID**: Cervical motion tenderness (absent, no fever/discharge).  \n- **Adnexal mass**: Unlikely (symptoms are uterine, not adnexal).  \n\n\n**Answer: Irregular, firm, non-tender uterine enlargement**  \n\n(Note: If this were an option-based question, this would be the correct choice.)\n\n\n\\boxed{Irregular, firm, non-tender uterine enlargement}",
    "expected_answer": "Globular 10-week sized uterus",
    "time": 41.30659890174866,
    "answer_length": 1335,
    "retrieval_time": 0.022430896759033203,
    "generation_time": 41.28133821487427
  },
  {
    "question": "A man is brought into the emergency department by the police department. The officer state that the man has been arrested multiple times for public alcohol intoxication, but recently became homeless. On exam, the man is behaving erratically. His vitals are all within normal limits. He appears confused and has a slurred speech. On gait exam, the patient is ataxic and cannot stand without support for more than a few seconds. Labs return with the following values: Na 140, K 4, Cl 106, BUN 8, Cr 2. His ABG has pH 7.3, PaCO2 13mm, PaO2 130mm, HCO3 7. His urinalysis is shown in Figure 1. Blood salicylate levels return as normal. While you await other diagnostic tests, which of the following should be administered next to treat this patient?",
    "answer": "To determine the next step in treatment, we analyze the patient’s clinical presentation and lab findings step-by-step:\n\n\n### **Key Clinical & Lab Observations**  \n- **History**: Homeless, chronic alcohol use → risk of ingesting toxic substances (e.g., antifreeze/ethylene glycol).  \n- **Symptoms**: Confusion, slurred speech, ataxia → neurological toxicity.  \n- **ABG**: pH=7.3 (acidosis), PaCO₂=13mmHg (respiratory compensation), HCO₃=7mmHg (severe metabolic acidosis).  \n- **Anion Gap**: AG = Na - (Cl + HCO₃) = 140 - (106+7)=27 → **high anion gap metabolic acidosis (HAGMA)**.  \n- **Normal salicylate levels**: Rules out aspirin overdose.  \n- **Urinalysis (implied)**: Calcium oxalate crystals (classic for ethylene glycol poisoning, likely Figure1).  \n\n\n### **Diagnosis**  \n**Ethylene glycol poisoning** (antifreeze ingestion):  \n- Causes HAGMA via toxic metabolites (oxalic acid).  \n- Neurological symptoms (ataxia, confusion) early, followed by renal failure.  \n- Calcium oxalate crystals in urine confirm the diagnosis.  \n\n\n### **Treatment**  \nEthylene glycol is metabolized by alcohol dehydrogenase (ADH) into toxic products. The first-line antidote inhibits ADH to prevent toxic metabolite formation:  \n\n**Fomepizole** (preferred over ethanol due to fewer side effects).  \n\n\n**Answer: Fomepizole** (if option is available; ethanol is an alternative but less preferred).\n\n\n\\boxed{Fomepizole}",
    "expected_answer": "Fomepizole",
    "time": 38.63527202606201,
    "answer_length": 1399,
    "retrieval_time": 0.017132043838500977,
    "generation_time": 38.60832071304321
  },
  {
    "question": "A medical research study is evaluating an investigational novel drug (medication 1) compared with standard therapy (medication 2) in patients presenting to the emergency department with myocardial infarction (MI). The study enrolled a total of 3,000 subjects, 1,500 in each study arm. Follow-up was conducted at 45 days post-MI. The following are the results of the trial:\nEndpoints Medication 1 Medication 2 P-Value\nPrimary: death from cardiac causes 134 210 0.03\nSecondary: hyperkalemia 57 70 0.4\nWhat is the number needed to treat (NNT) for the primary endpoint of death from cardiac causes? (Round to the nearest whole number.)",
    "answer": "To calculate the Number Needed to Treat (NNT) for the primary endpoint, follow these steps:\n\n\n### Step 1: Calculate the risk of cardiac death in each group  \n- **Standard therapy (Medication 2, control):**  \n  Risk = (Cardiac deaths) / (Total subjects) = 210 / 1500 = 0.14 (14%).  \n\n- **Investigational drug (Medication 1, treatment):**  \n  Risk = 134 / 1500 ≈ 0.0893 (8.93%).  \n\n\n### Step 2: Compute Absolute Risk Reduction (ARR)  \nARR = Control risk - Treatment risk  \nARR = 0.14 - 0.0893 ≈ 0.0507  \n\n\n### Step3: Calculate NNT  \nNNT = 1 / ARR  \nNNT ≈ 1 / 0.0507 ≈ 19.7 → rounded to **20**.  \n\n\n**Answer:** 20.",
    "expected_answer": "20",
    "time": 25.542348623275757,
    "answer_length": 611,
    "retrieval_time": 0.015993833541870117,
    "generation_time": 25.517296075820923
  },
  {
    "question": "A 55-year-old man comes to the physician because of a 6-week history of tingling pain in the sole of his right foot when he raises it above chest level during exercises. He reports that he started exercising regularly 2 months ago and that his right calf cramps when he uses the incline feature on the treadmill, forcing him to take frequent breaks. The pain completely disappears after resting for a few minutes. He has an 8-year history of type 2 diabetes mellitus. He has smoked two packs of cigarettes daily for 34 years. His only medication is metformin. His pulse is 82/min, and blood pressure is 170/92 mm Hg. Straight leg raise test elicits pallor and tingling pain in the right foot. There is no pain in the back. His muscle strength is normal. Femoral pulses are palpable; right pedal pulses are absent. Which of the following is the most likely diagnosis?",
    "answer": "The most likely diagnosis is **peripheral artery disease (PAD)**.\n\n\n### Key Reasoning:\n- **Symptoms consistent with PAD**:  \n  Exertional calf cramps (intermittent claudication) relieved by rest, tingling/pallor in the foot when elevated (reduced blood flow), and absent pedal pulses—all classic signs of arterial insufficiency.  \n- **Risk factors**:  \n  Heavy smoking (major risk factor for atherosclerosis), type 2 diabetes (accelerates vascular damage), and hypertension—all contribute to arterial narrowing from atherosclerosis.  \n- **Ruling out other conditions**:  \n  - **Lumbar radiculopathy**: No back pain (a key feature of radiculopathy), and symptoms are tied to blood flow (pallor, absent pulses) rather than nerve irritation.  \n  - **Diabetic neuropathy**: Typically symmetric, burning pain (not exertional), and pulses remain intact.  \n  - **Deep vein thrombosis**: Presents with swelling/redness (not pallor) and pain at rest (not relieved by rest).  \n\n\n**Answer: Peripheral artery disease** (or intermittent claudication due to peripheral artery disease).  \n\n(Note: In exam settings, the term \"peripheral artery disease\" is the standard diagnosis here.)  \n\n\\boxed{Peripheral artery disease}",
    "expected_answer": "Femoropopliteal artery stenosis",
    "time": 13.232226133346558,
    "answer_length": 1206,
    "retrieval_time": 0.021052122116088867,
    "generation_time": 13.207136154174805
  },
  {
    "question": "A 29-year-old primigravid woman at 35 weeks' gestation is admitted to the hospital in labor. She has no history of serious medical illness. She has had an uncomplicated pregnancy. Her last ultrasound at 22 weeks' gestation was normal. On admission, fetal heartbeats cannot be detected by fetal doppler monitor. Ultrasound shows decreased amniotic fluid levels and no evidence of fetal movement, respiration, or heart activity. The patient gives birth to a 2296 g (5 lb 1 oz) male infant. Physical examination shows no signs of life. There are no visible malformations. The placenta is unremarkable. Which of the following is the most appropriate next step in management?",
    "answer": "To determine the most appropriate next step in management after a stillbirth with no obvious cause (no visible malformations, grossly unremarkable placenta), we focus on identifying the underlying etiology to prevent future adverse outcomes.\n\n\n### Key Background  \nStillbirths without apparent causes often result from **chromosomal abnormalities** (even if no physical malformations are visible) or **subtle internal anomalies/infections** not detected on initial exam. The gold standard for evaluating these cases involves:  \n1. **Fetal autopsy**: Reveals internal anomalies, cord accidents, infection, or placental pathology not apparent grossly.  \n2. **Chromosomal analysis**: (Karyotype or microarray) Identifies common genetic causes (e.g., trisomies, monosomies) that may not present with visible malformations.  \n\n\n### Most Appropriate Next Step  \nThe combination of **fetal autopsy and chromosomal analysis** is the highest-priority next step. These evaluations provide critical insights into the cause of stillbirth and guide counseling for future pregnancies.\n\n\n**Answer:** Perform fetal autopsy and chromosomal analysis (e.g., karyotype or microarray).  \n\n(Note: If forced to select one in a multiple-choice context, fetal autopsy is often emphasized as it addresses both structural and infectious/genetic contributors indirectly, but chromosomal testing is equally vital. However, the standard answer in clinical guidelines and exams for this scenario is the combination of these two.)\n\n\n\\boxed{Fetal autopsy and chromosomal analysis}",
    "expected_answer": "Recommend autopsy of the infant",
    "time": 31.363460779190063,
    "answer_length": 1547,
    "retrieval_time": 0.07309198379516602,
    "generation_time": 31.33824372291565
  },
  {
    "question": "A 67-year-old man is hospitalized after several days of fever and increasing shortness of breath. Respiratory viral panel returns positive for influenza A and the patient is started on a standard five day course of oseltamivir. Despite therapy, his shortness of breath continues to worsen and his oxygen saturation decreases to the point where ICU transfer and intubation are required. Chest radiograph shows bilateral infiltrates. Clinical criteria are consistent with development of Acute Respiratory Distress Syndrome (ARDS). After several weeks of supportive therapy, the patient improves with lung function returning to near normal. Which of the following processes is involved in the regeneration of alveolar lining after damage to alveoli occurs?",
    "answer": "To answer this question, we need to focus on the cellular mechanisms of alveolar lining regeneration after injury, as seen in the patient's recovery from ARDS.\n\n\n### Key Background on Alveolar Epithelial Cells  \nThe alveolar lining consists of two main epithelial cell types:  \n1. **Type I pneumocytes**: Thin, flat cells that form the majority of the alveolar surface and are critical for gas exchange. They are delicate and easily damaged in conditions like ARDS.  \n2. **Type II pneumocytes**: Cuboidal cells that secrete surfactant and act as **progenitor (stem) cells** for the alveolar epithelium. They are more resilient to injury than Type I cells.  \n\n\n### Regeneration Process After Injury  \nWhen Type I pneumocytes are damaged/destroyed (e.g., in ARDS), surviving **Type II pneumocytes** initiate repair by:  \n- **Proliferating**: Undergoing mitosis to generate new cells.  \n- **Differentiating**: Migrating to the damaged area and maturing into Type I pneumocytes to restore the gas-exchange surface of the alveoli.  \n\n\n### Conclusion  \nThe core process involved in regenerating the alveolar lining is the **proliferation of Type II alveolar epithelial cells followed by their differentiation into Type I pneumocytes**.\n\n\n**Answer:** Proliferation of type II alveolar epithelial cells and their differentiation into type I alveolar epithelial cells.  \n\n(Note: If the question expects a concise phrase, the key mechanism is \"Type II alveolar epithelial cell proliferation and differentiation into Type I cells.\")  \n\n\\boxed{Proliferation\\ of\\ type\\ II\\ alveolar\\ epithelial\\ cells\\ and\\ their\\ differentiation\\ into\\ type\\ I\\ alveolar\\ epithelial\\ cells}",
    "expected_answer": "Proliferation of surfactant-secreting cells",
    "time": 16.428082942962646,
    "answer_length": 1662,
    "retrieval_time": 0.016103029251098633,
    "generation_time": 16.40325617790222
  },
  {
    "question": "A 65-year-old male is treated for anal carcinoma with therapy including external beam radiation. How does radiation affect cancer cells?",
    "answer": "Radiation therapy (including external beam radiation) uses ionizing radiation to target and damage cancer cells through the following key mechanisms:\n\n\n### **1. DNA Damage (Primary Effect)**  \nThe core goal of radiation is to disrupt the cancer cell’s DNA, as intact DNA is essential for cell division and survival:  \n- **Direct damage**: Ionizing radiation directly breaks chemical bonds in DNA molecules, causing single-strand or double-strand breaks. Double-strand breaks are particularly lethal because they are extremely hard for cells to repair accurately.  \n- **Indirect damage**: Radiation interacts with water molecules (abundant in cells) to generate reactive oxygen species (free radicals). These free radicals oxidize and damage DNA, proteins, and lipids, further impairing cellular function.  \n\n\n### **2. Differential Sensitivity & Repair**  \nCancer cells grow and divide rapidly, and they often have defective DNA repair pathways (a hallmark of cancer). This makes them far less able to fix radiation-induced DNA damage compared to normal cells. Normal cells (even rapidly dividing ones like skin or gut lining) typically have intact repair systems and can recover or be replaced quickly, minimizing long-term harm.  \n\n\n### **3. Cell Death or Growth Arrest**  \nIf DNA damage is too severe to repair:  \n- The cell may undergo **apoptosis** (programmed cell death) or die immediately.  \n- Some cells experience **mitotic catastrophe** (failure to complete cell division due to unrepaired DNA damage).  \n- Others enter **senescence** (permanent cell cycle arrest), stopping growth and no longer contributing to tumor expansion.  \n\n\nFor anal carcinoma, this targeted damage shrinks the tumor and eliminates cancer cells, often in combination with chemotherapy (chemo-radiation) to enhance effectiveness. The net effect is reduced tumor size and control of cancer progression.\n\n\n**Summary**: Radiation causes irreversible DNA damage to cancer cells (via direct/indirect mechanisms), exploiting their defective repair systems to induce cell death or arrest, ultimately eradicating the tumor. Normal cells recover more easily, limiting side effects.  \n\\boxed{Radiation induces DNA damage in cancer cells (direct and indirect), which they cannot repair effectively, leading to cell death or growth arrest, shrinking the tumor.}",
    "expected_answer": "Induces breaks in double-stranded DNA",
    "time": 28.776692867279053,
    "answer_length": 2333,
    "retrieval_time": 0.011274099349975586,
    "generation_time": 28.752104997634888
  },
  {
    "question": "A 56-year-old man with a history of hypertension presents to his physician with progressive fatigue and new onset muscle cramps. He has had no recent changes to his medication regimen, which includes hydrochlorothiazide, lisinopril, and amlodipine. His temperature is 98.0°F (36.7°C), blood pressure is 174/111 mmHg, pulse is 70/min, respirations are 12/min, and oxygen saturation is 98% on room air. The patient's cardiopulmonary and abdominal exams are unremarkable. Laboratory values are ordered as seen below.\n\nSerum:\nNa+: 138 mEq/L\nCl-: 100 mEq/L\nK+: 3.3 mEq/L\nHCO3-: 33 mEq/L\nBUN: 20 mg/dL\nGlucose: 129 mg/dL\n\nWhat is the most likely underlying etiology of this patient's hypertension?",
    "answer": "To determine the underlying etiology of the patient’s hypertension, we analyze key clinical and laboratory findings:\n\n\n### **Key Observations**  \n- **Resistant hypertension**: BP remains elevated (174/111 mmHg) despite three antihypertensive medications (hydrochlorothiazide, lisinopril, amlodipine).  \n- **Lab abnormalities**: Hypokalemia (K⁺=3.3 mEq/L) and metabolic alkalosis (HCO₃⁻=33 mEq/L).  \n- **Symptoms**: Fatigue and muscle cramps (consistent with hypokalemia).  \n\n\n### **Differential Diagnosis for HTN + Hypokalemia + Metabolic Alkalosis**  \n1. **Primary Hyperaldosteronism (Conn Syndrome)**:  \n   - Aldosterone excess leads to:  \n     - Na⁺/water retention → volume expansion → HTN.  \n     - K⁺ excretion → hypokalemia.  \n     - H⁺ excretion → metabolic alkalosis.  \n   - This perfectly aligns with the patient’s lab values and resistant HTN. It is the most common cause of these findings in adults with resistant HTN.  \n\n2. **Cushing Syndrome**:  \n   - Excess cortisol has mineralocorticoid activity, but typically presents with additional features (e.g., moon face, buffalo hump, weight gain) which are absent here.  \n\n3. **Liddle Syndrome**:  \n   - Rare genetic disorder (ENaC channel gain-of-function), but unlikely in a 56-year-old man without family history.  \n\n4. **Renal Artery Stenosis**:  \n   - Unlikely, as it does not classically cause hypokalemia/alkalosis (and ACE inhibitors like lisinopril would mitigate RAAS activation, which is not the case here).  \n\n\n### **Conclusion**  \nThe combination of resistant hypertension, hypokalemia, and metabolic alkalosis is most consistent with **primary hyperaldosteronism**.\n\n\n**Answer: Primary hyperaldosteronism (Conn syndrome)**  \n\\boxed{Primary hyperaldosteronism}",
    "expected_answer": "Aldosterone excess",
    "time": 26.34268856048584,
    "answer_length": 1733,
    "retrieval_time": 0.01562809944152832,
    "generation_time": 26.320526123046875
  },
  {
    "question": "A 65-year-old man comes to the physician because of a 1-week history of yellowish discoloration of his skin and generalized pruritus. Examination shows jaundice of the skin and scleral icterus. Urinalysis shows an elevated concentration of bilirubin and a low concentration of urobilinogen. Which of the following is the most likely underlying cause of these findings?",
    "answer": "To determine the underlying cause, we analyze the key findings and link them to jaundice subtypes:\n\n\n### **Key Findings Recap**  \n- 65-year-old man with **jaundice + pruritus** (1 week).  \n- Urinalysis: **elevated conjugated bilirubin** (water-soluble, excreted in urine) + **low urobilinogen** (no bilirubin reaches the gut to form urobilinogen via bacteria).  \n\n\n### **Jaundice Subtype Matching**  \n- **Prehepatic**: Unconjugated bilirubin high → urine bilirubin negative (not matching).  \n- **Hepatic**: Conjugated bilirubin may be high, but urobilinogen is usually elevated (liver can’t reabsorb it → not matching).  \n- **Posthepatic (obstructive)**: Blockage of bile ducts (e.g., common bile duct) → conjugated bilirubin accumulates in blood (urine bilirubin ↑) + no bilirubin enters gut (urobilinogen ↓). Pruritus arises from bile salt accumulation in skin.  \n\n\n### **Most Likely Cause**  \nIn a 65-year-old man, the classic obstructive cause is **pancreatic head adenocarcinoma** (obstructs the common bile duct as it passes through the pancreatic head). Gallstones are another possibility, but pancreatic cancer is a top concern in this age group with painless jaundice (though pruritus is present).  \n\n\n**Answer:** Pancreatic head adenocarcinoma (or common bile duct obstruction due to pancreatic neoplasm).  \n\n(Note: If options included \"pancreatic adenocarcinoma\" or \"obstructive jaundice secondary to pancreatic head tumor,\" this would be the correct choice.)  \n\n\\boxed{Pancreatic head adenocarcinoma}",
    "expected_answer": "Defective hepatic bile excretion",
    "time": 25.191835165023804,
    "answer_length": 1512,
    "retrieval_time": 0.013108968734741211,
    "generation_time": 25.16680598258972
  },
  {
    "question": "A 72-year-old woman is brought to the physician by her daughter because of a 6-month history of worsening short-term memory deficits and social withdrawal. Treatment with galantamine is initiated. Two weeks later, the patient develops vomiting, mild crampy abdominal pain, and watery, nonbloody diarrhea. Which of the following is the most appropriate pharmacotherapy?",
    "answer": "To address this question, we first analyze the scenario and connect the drug, its mechanism, and the resulting side effects:\n\n\n### Key Background  \nGalantamine is a **cholinesterase inhibitor** used to treat Alzheimer’s disease. It works by blocking acetylcholinesterase (the enzyme that breaks down acetylcholine [ACh]), increasing ACh levels in the body. Excess ACh activates muscarinic receptors in the gastrointestinal (GI) tract, leading to symptoms like vomiting, abdominal cramps, and diarrhea (cholinergic excess).\n\n\n### Treatment Rationale  \nTo counteract cholinergic side effects, we need a **muscarinic antagonist**—a drug that blocks muscarinic receptors, reducing the effects of excess ACh. The classic and most appropriate agent for this purpose is **atropine**, a non-selective muscarinic antagonist that effectively relieves GI cholinergic symptoms.\n\n\n**Answer: Atropine** (or a muscarinic antagonist like atropine).  \n\n(Note: If options were provided, the correct choice would be the muscarinic antagonist, typically atropine.)\n\n\n**Final Answer**  \nAtropine.  \n\n\\boxed{Atropine}",
    "expected_answer": "Atropine",
    "time": 17.520675897598267,
    "answer_length": 1095,
    "retrieval_time": 0.11075687408447266,
    "generation_time": 17.4965980052948
  },
  {
    "question": "A 61-year-old man with schizophrenia in a locked inpatient psychiatry unit was observed making an unusual smacking motion with his lips, pursing his mouth, and blinking excessively. These symptoms started slowly about 2 weeks ago and have become more pronounced, but they do not seem to bother the patient. He resides in an inpatient psychiatric facility where he has been successfully treated with haloperidol for the past several months. His physical exam and vitals are within normal limits. Which of the following accurately describes his symptoms?",
    "answer": "The patient's symptoms are consistent with **tardive dyskinesia (TD)**, an involuntary movement disorder associated with prolonged exposure to antipsychotic medications (e.g., haloperidol, a typical antipsychotic).  \n\n### Key Features Supporting This Diagnosis:  \n1. **Classic Orofacial Movements**: Lip smacking, mouth pursing, and excessive blinking are hallmark orofacial dyskinesias of TD.  \n2. **Timing**: TD typically develops after months to years of antipsychotic use (the patient has been on haloperidol for several months, and symptoms emerged recently—consistent with TD’s late onset).  \n3. **Patient’s Lack of Distress**: TD movements are often involuntary and may not bother the patient, as noted here.  \n4. **Risk Factors**: Older age (61 years) and use of a high-risk typical antipsychotic (haloperidol) increase the likelihood of TD.  \n\nOther antipsychotic-related movement disorders (acute dystonia, akathisia, parkinsonism) do not match the described symptoms (e.g., dystonia involves muscle contractions, akathisia is restlessness, parkinsonism includes tremor/rigidity).  \n\n**Answer**: The symptoms are characteristic of tardive dyskinesia, an involuntary repetitive movement disorder associated with prolonged antipsychotic use.\n\n\n\\boxed{Tardive dyskinesia}",
    "expected_answer": "Tardive dyskinesia",
    "time": 24.737778902053833,
    "answer_length": 1278,
    "retrieval_time": 0.011649131774902344,
    "generation_time": 24.71262216567993
  },
  {
    "question": "A 17-year-old football player with no significant past medical history, social history, or family history presents to his pediatrician with itching in his groin. He says this started during summer workouts leading up to this season. He denies having any rash anywhere else on his body. The blood pressure is 123/78 mm Hg, pulse is 67/min, respiratory rate is 15/min, and temperature is 38.1°C (98.7°F). Physical examination reveals an erythematous, well-demarcated patch with peripheral scale on the left thigh, pubic region, and perineum. There is no apparent scrotal involvement with the rash. How can you confirm the suspected diagnosis?",
    "answer": "To confirm the suspected diagnosis of tinea cruris (jock itch), the key test is a **potassium hydroxide (KOH) preparation of skin scrapings** from the edge of the lesion.  \n\n### Rationale:  \nThe patient’s clinical presentation (athlete, groin itching, erythematous well-demarcated patch with peripheral scaling, sparing the scrotum) is classic for tinea cruris, a fungal infection caused by dermatophytes. Scraping the edge of the lesion (where fungal activity is highest) and treating the sample with KOH dissolves keratin, allowing visualization of branching hyphae under a microscope—this is the rapid, first-line confirmatory test for dermatophyte infections like tinea cruris.\n\n\n**Answer:** Perform a potassium hydroxide (KOH) preparation of skin scrapings from the lesion edge to visualize fungal hyphae.  \n\\boxed{Potassium hydroxide (KOH) preparation of skin scrapings}",
    "expected_answer": "KOH examination of lesion scrapings",
    "time": 12.274041891098022,
    "answer_length": 876,
    "retrieval_time": 0.01282811164855957,
    "generation_time": 12.262497901916504
  },
  {
    "question": "An otherwise healthy 26-year-old man comes to the physician for medication counseling after recently being diagnosed with schizophrenia. Risperidone therapy is initiated. This patient is at increased risk for which of the following adverse effects?",
    "answer": "To determine the increased risk of adverse effects with risperidone therapy in this patient, we first note that risperidone is a second-generation antipsychotic (SGA) with distinct pharmacologic effects: it blocks dopamine D₂ receptors in the tuberoinfundibular pathway, which normally suppresses prolactin release. This blockade leads to elevated prolactin levels.  \n\nIn men, increased prolactin is associated with **gynecomastia** (breast tissue enlargement), galactorrhea, or sexual dysfunction (e.g., decreased libido, erectile dysfunction). While other SGAs may cause weight gain or metabolic issues, risperidone’s unique risk of prolactin elevation makes gynecomastia a key adverse effect here.\n\n\n**Answer: Gynecomastia** (assuming this is among the options; if not, other prolactin-related effects like sexual dysfunction would be correct).  \n\n(Note: If the original question included options, the most direct answer would align with prolactin-mediated effects, as this is a hallmark of risperidone compared to many other SGAs.)",
    "expected_answer": "Gynecomastia",
    "time": 20.1236469745636,
    "answer_length": 1035,
    "retrieval_time": 0.011106014251708984,
    "generation_time": 20.096418857574463
  },
  {
    "question": "A 15-year-old woman presents with fever, altered mental status and a petechial rash on her lower extremities and back since yesterday evening. She also says she has been nauseous for the past 3 hours and has vomited twice. The patient mentions she has had heavy menstrual bleeding for the past few days. Her blood pressure is 95/80 mm Hg and her temperature is 40.0°C (104.0°F). On physical examination, the patient appears diaphoretic. A pelvic examination reveals a tampon in her vagina. Binding and activation of which of the following T cell receptors is responsible for this patient’s most likely condition?",
    "answer": "To answer this question, we first identify the patient’s condition and then link it to the relevant T cell receptor (TCR) component involved.\n\n\n### Step 1: Diagnose the Condition  \nThe patient presents with:  \n- High fever (40°C), altered mental status, petechial rash, nausea/vomiting, narrow pulse pressure (hypotension).  \n- Risk factor: Tampon in the vagina.  \n\nThese findings are classic for **toxic shock syndrome (TSS)** caused by *Staphylococcus aureus* (via the superantigen TSST-1).\n\n\n### Step 2: Mechanism of TSS  \nTSS is driven by **superantigens**, which:  \n- Bypass antigen-specific TCR recognition.  \n- Crosslink MHC class II molecules (on APCs) and the **variable beta (Vβ) domain** of the TCR’s β-chain.  \n\nThis non-specific binding activates a massive number of T cells (~20% of total T cells), leading to a cytokine storm (IL-2, TNF-α, IFN-γ) that causes systemic symptoms (shock, organ dysfunction, rash).\n\n\n### Conclusion  \nThe T cell receptor component responsible is the **variable beta (Vβ) chain**.\n\n\n**Answer:** T cell receptor variable beta (Vβ) chain. (Note: In exam settings, this may be phrased as \"TCR Vβ chain\" or similar.)  \n\n\\boxed{TCR V\\beta chain}",
    "expected_answer": "Variable β-sequence of the T cell receptor",
    "time": 16.458303928375244,
    "answer_length": 1183,
    "retrieval_time": 0.014432907104492188,
    "generation_time": 16.432678937911987
  },
  {
    "question": "A 2-year-old boy is brought to the physician for evaluation of pallor and increasing lethargy for 2 days. One week ago, he experienced abdominal pain, vomiting, and bloody diarrhea that have since subsided. The patient's father states that they returned early from a 6-week roadtrip in Mexico because of these symptoms. His parents have been giving him oral rehydration solution. His immunizations are up-to-date. He appears pale. His temperature is 38.4°C (101.1°F), pulse is 130/min, respirations are 35/min, and blood pressure is 95/50 mm Hg. Examination shows scleral icterus. The abdomen is soft and nontender; there is no rebound or guarding. Bowel sounds are hyperactive. The remainder of the examination shows no abnormalities. Laboratory studies show:\nHemoglobin 8.5 g/dL\nMean corpuscular volume 94 μm3\nLeukocyte count 18,000/mm3\nPlatelet count 45,000/mm3\nProthrombin time 12 sec\nPartial thromboplastin time 34 sec\nSerum\nUrea nitrogen 28 mg/dL\nCreatinine 1.6 mg/dL\nBilirubin\nTotal 2.5 mg/dL\nDirect 0.1 mg/dL\nLactate dehydrogenase 1658 U/L\nA blood smear shows schistocytes. Which of the following is the most likely diagnosis?\"",
    "answer": "To determine the most likely diagnosis, we analyze the key clinical and laboratory findings:\n\n\n### **Key Clinical Clues**  \n- **Pediatric patient (2yo)** with **preceding bloody diarrhea** (1 week prior) after travel to Mexico (risk for contaminated food/water).  \n- Presenting symptoms: Pallor, lethargy, fever, scleral icterus.  \n- Renal impairment (elevated BUN/Cr: 28/1.6 mg/dL).  \n\n\n### **Key Laboratory Findings**  \n- **Microangiopathic hemolytic anemia (MAHA):** Low hemoglobin (8.5 g/dL), schistocytes on blood smear, high LDH (1658 U/L), indirect hyperbilirubinemia (total 2.5 mg/dL, direct 0.1 mg/dL).  \n- **Thrombocytopenia:** Platelet count 45,000/mm³.  \n- **Normal coagulation:** PT/PTT within range (rules out DIC).  \n\n\n### **Diagnosis Rationale**  \nThe triad of **MAHA + thrombocytopenia + acute renal failure** following bloody diarrhea is classic for **Shiga toxin-producing *E. coli* (STEC)-associated Hemolytic Uremic Syndrome (HUS)**.  \n\nSTEC (e.g., O157:H7) is transmitted via contaminated food/water (common in travel settings like Mexico). The toxin damages endothelial cells in small blood vessels, leading to:  \n1. Red blood cell fragmentation (schistocytes, MAHA).  \n2. Platelet consumption (thrombocytopenia).  \n3. Renal microvascular injury (acute kidney injury).  \n\n\n### **Other Ruled-Out Conditions**  \n- **TTP:** Requires neurological symptoms (absent here) and is rare in children.  \n- **DIC:** Abnormal PT/PTT (not seen).  \n- **Autoimmune hemolytic anemia:** No schistocytes or Coombs positivity.  \n\n\n**Answer:** Hemolytic Uremic Syndrome (HUS)\n\n\n\\boxed{Hemolytic Uremic Syndrome}",
    "expected_answer": "Hemolytic uremic syndrome",
    "time": 25.927162885665894,
    "answer_length": 1613,
    "retrieval_time": 0.08966302871704102,
    "generation_time": 25.899466037750244
  },
  {
    "question": "A 17-year-old girl is referred by her dentist for a suspected eating disorder. She has been visiting the same dentist since childhood and for the past 2 years has had at least 2 visits for dental caries. She eventually admitted to him that she regularly induces vomiting by putting her fingers down her throat. She says she has been doing this for the last few years and purging at least once a week. More recently, she has been inducing emesis more often and even looked into diuretics as she feels that she is gaining more and more weight compared to her ‘skinny friends’. Her BMI is at the 50th percentile for her age and sex. Which of the following features is most consistent with this patient’s condition?",
    "answer": "To answer this question, we first diagnose the patient’s condition and then identify the most consistent feature:\n\n\n### Step 1: Diagnose the Condition  \nThe patient is a 17-year-old girl with **normal BMI (50th percentile)**, regular induced vomiting (using fingers), and recent interest in diuretics. Key points:  \n- **Anorexia Nervosa (binge-purge type)** is ruled out because it requires underweight status (BMI <5th percentile for adolescents).  \n- **Bulimia Nervosa** (or purging disorder) is the likely diagnosis: it involves compensatory behaviors (vomiting, diuretics) and normal weight.  \n\n\n### Step 2: Identify Consistent Features  \nBulimia Nervosa (purging subtype) is associated with:  \n- **Dental erosion**: Gastric acid from vomiting damages the lingual surfaces of upper incisors (a primary reason dentists refer patients for eating disorders, as seen here).  \n- **Russell’s sign**: Calluses on the dorsum of hands from inducing vomiting with fingers.  \n- **Electrolyte abnormalities**: Hypokalemia (from vomiting/diuretics), metabolic alkalosis.  \n\nGiven the **dentist’s referral** (due to increased caries over 2 years), the most direct and consistent feature is **dental erosion**.\n\n\n**Answer:** Lingual dental erosion (or similar wording, depending on options). For example, if options include \"lingual surface erosion of upper incisors,\" this is the correct choice.\n\n\n\\boxed{Lingual dental erosion} (assuming this is the intended option; adjust based on exact wording, but this is the most consistent feature here).  \n(Note: If Russell’s sign is an option, it is also valid, but dental erosion aligns more closely with the dentist’s involvement.)",
    "expected_answer": "Patients with this disorder are not further sub-typed",
    "time": 28.591978549957275,
    "answer_length": 1666,
    "retrieval_time": 0.019118785858154297,
    "generation_time": 28.566110849380493
  },
  {
    "question": "A 14-year-old girl is brought to the physician by her father because of fever, chills, abdominal pain, and profuse non-bloody diarrhea. Her symptoms began one week ago, when she had several days of low-grade fever and constipation. She returned from Indonesia 2 weeks ago, where she spent the summer with her grandparents. Her temperature is 39.3°C (102.8°F). Examination shows diffuse abdominal tenderness and mild hepatosplenomegaly. There is a faint salmon-colored maculopapular rash on her trunk and abdomen. Which of the following is the most likely causal organism?",
    "answer": "To determine the most likely causal organism, we analyze the key clinical and epidemiological clues:\n\n\n### **Key Clues from the Case**  \n1. **Travel History**: Returned from Indonesia (endemic for typhoid fever).  \n2. **Symptom Progression**: Initial low-grade fever + constipation → later high fever, abdominal pain, non-bloody diarrhea.  \n3. **Exam Findings**: Mild hepatosplenomegaly + **salmon-colored maculopapular rash (rose spots)** (pathognomonic for typhoid fever).  \n\n\n### **Differential Diagnosis Elimination**  \n- **Shigella/Campylobacter**: Typically cause bloody diarrhea, no rose spots or hepatosplenomegaly.  \n- **ETEC/Vibrio cholerae**: Watery diarrhea without rose spots, fever, or organomegaly.  \n- **Salmonella typhi**: Fits all clues—endemic in Indonesia, rose spots, hepatosplenomegaly, and the classic progression of constipation followed by diarrhea in some cases.  \n\n\n**Answer: Salmonella typhi** (or simply *Salmonella typhi*)  \n\n\\boxed{Salmonella\\ typhi}",
    "expected_answer": "Salmonella typhi",
    "time": 14.750030040740967,
    "answer_length": 981,
    "retrieval_time": 0.01503896713256836,
    "generation_time": 14.72502875328064
  },
  {
    "question": "A 22-year-old female college student is treated with metronidazole after presenting to student health services with itching, discharge, and pain in her vagina. At a party shortly afterward she experiences facial flushing, nausea, tachycardia, dyspnea, headache, and abdominal cramps after consuming alcohol. Serum levels of which of the following are likely elevated in this patient following alcohol consumption:",
    "answer": "To answer this question, we analyze the **interaction between metronidazole and alcohol** and the resulting biochemical imbalance:\n\n\n### Key Background  \nMetronidazole inhibits **aldehyde dehydrogenase**, an enzyme critical for alcohol metabolism. Alcohol is first converted to **acetaldehyde** (via alcohol dehydrogenase), then acetaldehyde is normally broken down to acetate by aldehyde dehydrogenase. When this second step is blocked, acetaldehyde accumulates in the body.\n\n\n### Symptom Correlation  \nThe patient’s symptoms (facial flushing, nausea, tachycardia, dyspnea, headache, abdominal cramps) are classic for **acetaldehyde syndrome**—caused by elevated acetaldehyde levels.\n\n\n### Conclusion  \nThe serum level likely elevated in this patient is **acetaldehyde**.\n\n\n**Answer: Acetaldehyde**",
    "expected_answer": "Acetaldehyde",
    "time": 7.031618118286133,
    "answer_length": 799,
    "retrieval_time": 0.013295888900756836,
    "generation_time": 7.005146026611328
  },
  {
    "question": "A 23-year-old primigravida presents for a regular prenatal care visit at 16 weeks gestation. She complains of increased fatigability, but is otherwise well. She takes folic acid, iron, and vitamin D supplementation. Her vital signs are as follows: blood pressure, 110/70 mm Hg; heart rate, 86/min; respiratory rate, 13/min; and temperature, 36.6℃ (97.9℉). The physical examination is unremarkable. The complete blood count results are as below:\nErythrocyte count 3.9 million/mm3\nHb 11.1 g/dL\nHCT 32%\nReticulocyte count 0.2%\nMCV 90 fL\nPlatelet count 210,000/mm3\nLeukocyte count 8,100/mm3\nWhich of the following tests is required to investigate the cause of the patient’s laboratory findings?",
    "answer": "To determine the cause of the patient’s laboratory findings, we analyze key details and prioritize the most likely etiology:\n\n\n### **Key Observations**  \n- **Clinical Context**: 16-week primigravida with fatigue, no other symptoms, and on folic acid/iron/vitamin D.  \n- **CBC Abnormalities**: Normocytic (MCV=90fL) indices, **low reticulocyte count (0.2% vs normal ~0.5-1.5%)**, Hb=11.1g/dL (above second-trimester anemia threshold of <10.5g/dL), and normal platelets/WBC.  \n\n**Critical Insight**: A low reticulocyte count indicates reduced bone marrow production of RBCs. Physiological anemia of pregnancy (due to plasma volume expansion) should have normal/slightly elevated reticulocytes (marrow compensates for dilution). Thus, the low reticulocyte count suggests an underlying issue with RBC synthesis.\n\n\n### **Likely Etiology**  \nIron deficiency is the most common cause of anemia in pregnancy. Even with supplementation, early iron deficiency may present as normocytic anemia (before microcytosis develops) with low reticulocytes (no iron to support heme synthesis). Folic acid supplementation rules out folate deficiency, and macrocytic indices (absent here) are typical of B12 deficiency (less likely without risk factors like veganism).\n\n\n### **Required Test**  \n**Serum Ferritin**: The gold standard for assessing iron stores. Low ferritin confirms iron deficiency even if Hb is normal, explaining the low reticulocyte count and fatigue.\n\n\n**Answer: Serum ferritin**\n\n\n\\boxed{Serum\\ ferritin}",
    "expected_answer": "No tests required",
    "time": 48.71339702606201,
    "answer_length": 1503,
    "retrieval_time": 0.02142786979675293,
    "generation_time": 48.687931060791016
  },
  {
    "question": "An 80-year-old man is transferred from a step-down unit to a med-surg floor in the hospital. He had undergone a successful hernia surgery 14 hours ago. Before the surgery, he was pre-treated with atropine, scopolamine, and morphine and recovered well in the PACU after the surgery. There were no complications in the step-down unit and the patient continued to recover. On the med-surg floor, his temperature is 36.8°C (98.2°F), the heart rate is 98/min, the respiratory rate is 15/min, the blood pressure is 100/75 mm Hg, the oxygen saturation is 90%. On physical exam, he is a well-developed, obese man. His heart has a regular rate and rhythm and his lungs are clear to auscultation bilaterally. His incision site is clean, dry, and intact with an appropriate level of swelling and erythema. During the physical, the patient mentions some discomfort in his abdomen and pelvis and during a records review it is noted that he has not passed urine in the PACU, step-down unit, or since arriving on the med-surg floor. A bladder scan is inconclusive due to body habitus. What is the next best step in the treatment of this patient?",
    "answer": "To determine the next best step in management, we analyze the **key clinical findings** and their implications:\n\n\n### Key Clinical Context  \n- **80-year-old obese man** (14 hours post-hernia surgery).  \n- **High-risk medications**: Pre-treated with **anticholinergics (atropine, scopolamine)** (block bladder contraction via acetylcholine inhibition) and **opioid (morphine)** (relax bladder and increase sphincter tone)—both strongly linked to **acute urinary retention (AUR)**.  \n- **Classic AUR symptoms**: No urine output for >14 hours, abdominal/pelvic discomfort.  \n- **Bladder scan inconclusive**: Due to obesity (body habitus limits imaging), but clinical suspicion for AUR is overwhelming.  \n\n\n### Management of Acute Urinary Retention (AUR)  \nThe priority for AUR is **immediate bladder decompression** to relieve discomfort and prevent complications (e.g., bladder rupture, renal injury).  \n\nNon-invasive measures (warm compresses, standing to void) are rarely effective in post-op patients with AUR from anticholinergics/opioids—especially after 14 hours of retention.  \n\n**Urethral catheterization (Foley catheter)** is the first-line intervention for AUR when clinical signs are clear (even if bladder scan is inconclusive). Suprapubic catheterization is reserved for cases where urethral access is impossible (e.g., urethral trauma/stricture), which is not the case here.  \n\n\n**Answer: Insert a urethral (Foley) catheter to decompress the bladder.**\n\n\n\\boxed{Insert a urethral catheter}",
    "expected_answer": "Insert a ‘straight cath’ into the patient’s bladder",
    "time": 23.791314840316772,
    "answer_length": 1501,
    "retrieval_time": 0.08085298538208008,
    "generation_time": 23.779093027114868
  },
  {
    "question": "A healthy 19-year-old man presents to his primary care provider complaining of painless “blisters” in his mouth. He reports that he noticed a white film on his tongue and the sides of his mouth 2 days ago while brushing his teeth. The film was easily brushed off. He also complains of a bitter metallic taste in his mouth but otherwise denies pain, burning, dysphagia, or hoarseness. He is otherwise healthy and takes no medications. He is a competitive swimmer and has had 8 sexual partners in the past year. He intermittently uses barrier protection. On exam, he is well-appearing and in no acute distress. His oral examination demonstrates patches of white pseudomembranes that can be wiped away to reveal erythematous mucosa. A medication with which of the following mechanisms of action is most appropriate in this patient?",
    "answer": "To answer this question, we first identify the patient’s condition and then determine the mechanism of action of the appropriate treatment.\n\n\n### Step 1: Diagnosis  \nThe patient presents with **oral candidiasis (thrush)**. Key clues include:  \n- White pseudomembranes that wipe away to reveal erythematous mucosa (classic for thrush).  \n- Risk factors: Multiple sexual partners (possible HIV exposure, an immunocompromised state that predisposes to candidiasis) and no prior medications.  \n\nOther conditions (e.g., oral herpes, leukoplakia) are excluded by the painless, removable plaques.\n\n\n### Step 2: Treatment & Mechanism  \nFirst-line treatments for oral thrush include **azoles (e.g., fluconazole, clotrimazole)** or **polyenes (e.g., nystatin)**.  \n\n- **Azoles** (most commonly tested mechanism): Inhibit **lanosterol 14-α-demethylase**, an enzyme critical for ergosterol synthesis (a key component of fungal cell membranes). This disruption weakens the membrane and kills the fungus.  \n- **Polyenes**: Bind to ergosterol in fungal membranes, forming pores that leak intracellular contents.  \n\nAzoles are often preferred for systemic or persistent cases, and their mechanism is frequently emphasized in clinical exams.\n\n\n### Final Answer  \nInhibition of fungal lanosterol 14-α-demethylase (enzyme required for ergosterol synthesis).  \n\n**Simplified: Inhibition of fungal cell membrane ergosterol biosynthesis.**\n\n\n**Answer:** Inhibition of fungal lanosterol 14-alpha-demethylase, an enzyme necessary for ergosterol synthesis (or equivalent description of azole antifungal mechanism).  \n\n(If forced to choose a concise phrase: \"Inhibition of ergosterol synthesis in fungal cell membranes.\")\n\n\n\\boxed{Inhibition of fungal ergosterol biosynthesis}",
    "expected_answer": "Disruption of cell membrane permeability",
    "time": 47.87862586975098,
    "answer_length": 1750,
    "retrieval_time": 0.01757502555847168,
    "generation_time": 47.85170817375183
  },
  {
    "question": "A 56-year-old man presents to the clinic complaining of subacute back pain for the past month. The pain is described as a dull, constant ache that is worse at night. He could not recall any precipitating event except for an amateur weight-lifting competition that he participated in 2 months ago. Past medical history is significant for non-small cell lung cancer that was diagnosed and successfully treated. A PET scan 1 year ago demonstrated no recurrence. Physical exam was unremarkable except for some point tenderness along the lumbosacral area. What is the most likely imaging finding in this patient?",
    "answer": "To determine the most likely imaging finding, we analyze the case key points and prioritize the highest-probability diagnosis:\n\n\n### Key Clinical Clues  \n- **History of non-small cell lung cancer (NSCLC):** NSCLC is a common cancer that metastasizes to bone (a major red flag for metastatic disease).  \n- **Night pain:** A classic red flag for malignancy (metastasis > primary bone tumor, given cancer history).  \n- **Point tenderness (lumbosacral):** Localizes the lesion to the spine.  \n- **Weightlifting 2 months prior:** Likely a distractor—strains typically improve with rest and worsen with activity (not night pain).  \n\n\n### Most Likely Diagnosis  \n**Osteolytic bone metastasis from NSCLC.**  \n\nNSCLC metastases to bone are **predominantly osteolytic** (radiolucent, \"lytic\" lesions). Osteolytic lesions appear as irregular, well-defined or ill-defined areas of decreased bone density on imaging (e.g., X-ray, CT).  \n\n\n### Conclusion  \nThe most likely imaging finding is an **osteolytic (radiolucent) lesion in the lumbosacral vertebrae.**\n\n\n**Answer:** An osteolytic (radiolucent) lesion in the lumbosacral spine.  \n\n(Note: If formatted as a single phrase, it could be \"Osteolytic lesion in the lumbosacral vertebrae\" or similar.)  \n\\boxed{Osteolytic lesion in the lumbosacral spine}",
    "expected_answer": "Lytic lesions of the lumbar spine",
    "time": 21.756181001663208,
    "answer_length": 1291,
    "retrieval_time": 0.0155792236328125,
    "generation_time": 21.728554010391235
  },
  {
    "question": "A 4-year-old boy is brought to the emergency department because of severe abdominal pain and bilious vomiting for 6 hours. He has not had bowel movements in the past 24 hours. He appears ill. His temperature is 37.8°C (100°F) and pulse is 122/min. Examination shows a distended abdomen. There is tenderness to palpation in the lower abdomen; guarding and rebound tenderness are present. Bowel sounds are decreased. An x-ray of the abdomen shows dilated loops of bowel. He has been accompanied by his 14-year-old brother. The surgeon recommends an emergency laparotomy. The parents are away visiting friends and cannot be reached. Which of the following is the most appropriate next best step in management?",
    "answer": "To address this scenario, we first recognize the **emergency nature** of the child’s condition: severe abdominal pain with bilious vomiting, no bowel movements, peritoneal signs (guarding/rebound tenderness), and dilated bowel loops on x-ray—all indicating a potentially life-threatening issue (e.g., intestinal obstruction with strangulation or perforation).  \n\n### Key Consent Consideration:  \nThe child is a minor, and parents are unreachable. The 14-year-old brother is also a minor and cannot provide legal consent. However, **the doctrine of implied consent applies in emergencies** when:  \n1. The patient is a minor,  \n2. Parents/legal guardians are unavailable, and  \n3. Delaying treatment would cause serious harm or death.  \n\n### Most Appropriate Next Step:  \nProceed with the emergency laparotomy as recommended by the surgeon. This aligns with the child’s best interest and the ethical/legal obligation to provide life-saving care in emergent situations where explicit parental consent is unattainable.  \n\n\n**Answer:** Perform the emergency laparotomy (or equivalent option stating to proceed with the recommended surgery due to the emergency and unavailable parental consent).  \n\n(Note: If options were provided, the correct choice would explicitly authorize proceeding with the laparotomy under the emergency exception.)",
    "expected_answer": "Perform emergency laparotomy",
    "time": 16.384631156921387,
    "answer_length": 1334,
    "retrieval_time": 0.01797008514404297,
    "generation_time": 16.359495162963867
  },
  {
    "question": "A 3-week-old male newborn is brought to the hospital because of poor weight gain since birth. He was born at 38 weeks' gestation via normal vaginal delivery. He weighed 3005 g (6 lb, 10 oz) at birth and currently weighs 2835 g (6 lb, 4 oz). He has been latching on and breastfeeding well since birth. His mother has a history of Graves' disease and underwent near-total thyroidectomy in the second trimester of her pregnancy after her symptoms could not be controlled with antithyroid drugs. She is currently receiving L-thyroxine therapy. The patient's temperature is 38.9°C (102°F), pulse is 176/min, and respirations are 42/min. He appears irritable. Examination shows a diaphoretic infant with a paucity of subcutaneous fat. There is swelling of the neck at the midline. Which of the following is the most likely cause?",
    "answer": "To determine the most likely cause, we analyze the key clinical findings and maternal history:\n\n\n### **Key Clinical Features of the Newborn**  \n- **Hyperthyroid symptoms**: Fever (38.9°C), tachycardia (176/min), irritability, diaphoresis, poor weight gain (despite adequate breastfeeding) and paucity of subcutaneous fat (due to increased metabolism).  \n- **Midline neck swelling**: Goiter (enlarged thyroid gland).  \n\n\n### **Maternal History Relevance**  \n- Mother had **Graves disease** (autoimmune disorder with thyroid-stimulating immunoglobulins [TSI], a type of TSH receptor antibody [TRAb]).  \n- Near-total thyroidectomy in the second trimester removes the thyroid gland but **does not eliminate TRAb** (antibodies persist in the circulation from the autoimmune process).  \n\n\n### **Pathophysiology**  \nTRAb (e.g., TSI) crosses the placenta and stimulates the newborn’s thyroid gland, leading to **neonatal Graves disease**. This causes:  \n- Hyperthyroidism (metabolic overactivity → poor weight gain, tachycardia, fever, irritability).  \n- Goiter (midline neck swelling from thyroid hyperplasia due to TSI stimulation).  \n\n\n### **Other Ruling Out**  \n- **Congenital hypothyroidism**: Would present with lethargy, constipation, and poor feeding (not irritability/tachycardia).  \n- **Maternal L-thyroxine overdose**: Replacement doses do not cross the placenta in sufficient quantities to cause hyperthyroidism.  \n- **Infection**: No signs of sepsis (e.g., rash, hypotension) to support this.  \n\n\n**Answer: Neonatal Graves disease due to transplacental transfer of maternal thyroid-stimulating immunoglobulins.**  \n\n(Note: If this were a multiple-choice question, the correct option would align with this conclusion.)\n\n\n\\boxed{Neonatal Graves disease secondary to transplacental transfer of maternal thyroid-stimulating immunoglobulins}",
    "expected_answer": "Transplacental passage of TSH receptor antibodies",
    "time": 32.76507115364075,
    "answer_length": 1841,
    "retrieval_time": 0.013230085372924805,
    "generation_time": 32.753649950027466
  },
  {
    "question": "A 57-year-old female with a past medical history of alcoholism presents to the emergency room vomiting bright red blood. She is accompanied by her partner, who reports that she had been complaining of black and tarry stools for the past several days. Vital signs are temperature 37 degrees celsius, heart rate 141 beats per minute, blood pressure 90/60, respiratory rate 20, and oxygen saturation 99% on room air. On physical examination, she has splenomegaly and a positive fluid wave. The remainder of her examination is within normal limits. The patient is stabilized with intravenous fluids, and her blood pressure improves. Subsequent emergent upper endoscopy reveals bleeding from the submucosal veins in the lower 1/3 of the esophagus, but no gastric bleed. In the endoscopy suite she also receives IV octreotide. After intervention and resolution of her acute bleed, which of the following pharmacologic agents is indicated?",
    "answer": "To determine the appropriate pharmacologic agent for secondary prevention of variceal bleeding in this patient, let’s analyze the case and key concepts:\n\n\n### **Case Summary**  \nThe patient has:  \n- Alcoholism → **cirrhosis** (underlying cause).  \n- Signs of **portal hypertension**: splenomegaly, fluid wave (ascites).  \n- Acute bleeding from **esophageal varices** (confirmed by endoscopy: submucosal veins in lower 1/3 esophagus).  \n\n\n### **Key Concept: Secondary Prevention of Variceal Bleeding**  \nAfter resolving acute variceal bleeding, the goal is to reduce portal pressure to prevent recurrence.  \n\n**First-line pharmacotherapy**: **Non-selective beta-blockers** (e.g., propranolol, nadolol).  \n\nWhy?  \nThey lower portal pressure via two mechanisms:  \n1. Block beta-1 receptors → reduce cardiac output → decrease portal blood flow.  \n2. Block beta-2 receptors → unopposed alpha-constriction of splanchnic vessels → reduce splanchnic blood flow (major contributor to portal hypertension).  \n\n\n### **Distractors to Rule Out**  \n- **Octreotide**: Used for **acute bleeding** (reduces splanchnic flow), not long-term prevention.  \n- **Lactulose**: Treats hepatic encephalopathy, not variceal rebleed.  \n- **Spironolactone**: Diuretic for ascites, not portal pressure reduction.  \n\n\n**Answer: Propranolol** (or another non-selective beta-blocker like nadolol).\n\n\n**Final Answer**  \nPropranolol.  \n\n\\boxed{Propranolol}",
    "expected_answer": "Nadalol",
    "time": 21.196125030517578,
    "answer_length": 1421,
    "retrieval_time": 0.08159995079040527,
    "generation_time": 21.168993949890137
  },
  {
    "question": "A 65-year-old man with a history of hypertension, obesity, and alcoholic cirrhosis is seen in clinic for follow-up. He feels well and currently drinks 5 glasses of wine each night. Medications include atenolol and lisinopril. On physical exam, temperature is 98.1 deg F (36.7 deg C), blood pressure is 151/82 mmHg, pulse is 71/min, and respirations are 14/min. He has spider angiomata on his chest; no asterixis, jaundice, ascites, or peripheral edema is noted. Screening ultrasound reveals a new liver nodule, and follow up CT demonstrates a 2 cm right hepatic lobe lesion with enhancement in the arterial phase. No hypodense attenuation is seen on the venous or delayed phase. What is the next step in management?",
    "answer": "To determine the next step in management, we analyze the case using **AASLD guidelines for hepatocellular carcinoma (HCC) in cirrhotic patients** (the patient has alcoholic cirrhosis, a high-risk population for HCC):\n\n\n### Key Background  \nFor cirrhotic patients with nodules ≥1 cm:  \n- Classic radiologic features of HCC are **arterial phase hyperenhancement (APHE)** + **washout** (lesion becomes hypodense vs. surrounding liver in portal venous/delayed phase).  \n- If initial contrast imaging (CT/MRI) shows only one feature (e.g., APHE without washout), the next step is to perform the **other contrast-enhanced modality** (CT → MRI, or vice versa) to confirm the presence of washout.  \n\n\n### Case Application  \nThe patient’s CT shows a **2 cm lesion with APHE but no washout** (no hypodensity in venous/delayed phases). Since only one HCC feature is present on CT, the next step is to obtain a **contrast-enhanced MRI** (preferably with hepatobiliary contrast, e.g., gadoxetic acid) to evaluate for washout. This helps differentiate HCC from other nodules (dysplastic, regenerative) in cirrhotic livers.  \n\n\n**Answer:** Obtain contrast-enhanced magnetic resonance imaging of the liver.  \n\n\\boxed{Contrast-enhanced magnetic resonance imaging of the liver}",
    "expected_answer": "Proceed with liver biopsy",
    "time": 29.289125204086304,
    "answer_length": 1259,
    "retrieval_time": 0.018437862396240234,
    "generation_time": 29.263713121414185
  },
  {
    "question": "A 66-year-old man is brought to the emergency room by his wife due to abdominal distension and persistent somnolence for the past 2 weeks. The patient’s wife says that he has been sleeping much more than usual for the past 5 days. His bowel and bladder habit have not changed. His past medical history is significant for alcoholic liver cirrhosis. His vital signs include: pulse 76/min, respiratory rate 15/min, temperature 38.0°C (100.4°F) and blood pressure 122/75 mm Hg. On physical examination, the patient is altered and not responsive to commands. Oriented x 0. The abdomen is significantly distended. Shifting dullness is present and a positive fluid wave can be elicited. Hyperreflexia and asterixis are noted. Laboratory findings are significant for the following:\nLaboratory test\nSodium 140 mEq/L\nPotassium 3.5 mEq/L\nChloride 97 mEq/L\nGlucose 90 mg/dL\nAmmonia 100 µg/dL (ref: 19-60 µg/dL)\nArterial blood gas\npH 7.4\npCO2 40 mm Hg\npO2 90 mm Hg\nHCO3 26 mEq/L\nAn abdominal ultrasound shows surface nodularity compatible with cirrhosis but no other changes aside from ascites. An upper GI endoscopy is performed which shows gastric varices with no signs of active bleeding. An MRI of the brain is insignificant. What is the most likely precipitating factor that led to this patient’s condition?",
    "answer": "The most likely precipitating factor is **infection (spontaneous bacterial peritonitis [SBP])**.\n\n\n### Key Reasoning:\n1. **Patient’s Core Condition**: The patient has **hepatic encephalopathy (HE)**—evidenced by altered mental status (oriented x0), somnolence, asterixis (classic sign of HE), and elevated ammonia levels (100 µg/dL, above reference range). HE is a common complication of cirrhosis.  \n\n2. **Common Precipitants of HE**:  \n   - **Gastrointestinal bleeding**: Ruled out (upper endoscopy shows no active bleeding from varices).  \n   - **Electrolyte abnormalities**: None significant (sodium, potassium, HCO₃⁻, pH are normal or near-normal).  \n   - **Infection**: The patient has a fever (38.0°C/100.4°F), a key sign of infection. Given his ascites (shifting dullness, fluid wave), the most likely infection is **spontaneous bacterial peritonitis (SBP)**—an infection of ascitic fluid without an obvious source (consistent with the unremarkable abdominal ultrasound, which shows no perforation or other focal lesions).  \n\n\nSBP is a frequent precipitant of HE in cirrhotic patients with ascites, as infection increases ammonia production and impairs hepatic clearance of toxins. The fever confirms an infectious trigger.\n\n\n**Answer: Infection (spontaneous bacterial peritonitis)**.  \n(Note: If a single term is preferred, \"infection\" is acceptable, but \"spontaneous bacterial peritonitis\" is more specific.)",
    "expected_answer": "Spontaneous bacterial peritonitis",
    "time": 24.979846715927124,
    "answer_length": 1418,
    "retrieval_time": 0.01956772804260254,
    "generation_time": 24.95482325553894
  },
  {
    "question": "A 27-year-old man presents to the emergency department after a motor vehicle collision. The patient was the front seat unrestrained driver in a head on collision. The patient’s echocardiogram (ECG) is notable only for sinus tachycardia. His temperature is 99.5°F (37.5°C), blood pressure is 107/58 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 98% on room air. The patient is given 2 liters of Ringer lactate solution and morphine. Initial workup demonstrates that the patient’s pulmonary capillary wedge pressure and troponins are elevated. The patient is currently complaining of chest pain. Physical exam is notable for an uncomfortable young man with bruising over his chest wall. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the key clinical findings and context:\n\n\n### **Key Clinical Context & Findings**  \n- **Mechanism**: Blunt chest trauma (unrestrained front-seat driver in head-on collision → direct impact to chest wall).  \n- **Symptoms**: Chest pain, chest wall bruising.  \n- **Vitals**: Sinus tachycardia (common with cardiac injury/pain).  \n- **Lab/Imaging**: Elevated troponins (myocardial damage) and elevated pulmonary capillary wedge pressure (PCWP, indicating left ventricular dysfunction/increased left-sided filling pressure).  \n\n\n### **Differential Diagnosis Elimination**  \n- **Cardiac tamponade**: Requires Beck’s triad (hypotension, distant heart sounds, JVD) or equalization of intracardiac pressures—none present here.  \n- **Pulmonary contusion**: Would cause respiratory distress/low oxygen saturation, not elevated troponins or PCWP.  \n- **Aortic dissection**: Classic for sharp back pain and deceleration trauma (not head-on), no evidence of this here.  \n- **Rib fracture**: Does not explain troponin elevation or PCWP changes.  \n\n\n### **Most Likely Diagnosis**  \n**Myocardial contusion**: Bruising of the heart muscle from blunt trauma. It presents with chest pain, arrhythmias (sinus tachycardia), elevated troponins (myocyte damage), and elevated PCWP (if left ventricular function is impaired by the contusion).  \n\n\n**Answer: Myocardial contusion**",
    "expected_answer": "Cardiac contusion",
    "time": 20.989534854888916,
    "answer_length": 1404,
    "retrieval_time": 0.017479896545410156,
    "generation_time": 20.96450185775757
  },
  {
    "question": "A 56-year-old man presents to the emergency department for progressively worsening fatigue, malaise, fever, and abdominal pain. He reports that his symptoms began approximately 1 week ago and he has noticed episodes of diarrhea. He recently started melatonin and magnesium supplementation in hopes of improving his sleep. Medical history is significant for alcohol use disorder that required multiple hospital admissions for management of acute pancreatitis and cirrhosis. He states that he occasionally injects heroin intravenously. Temperature is 100°F (37.8°C), blood pressure is 105/70 mmHg, pulse is 92/min, and respirations are 17/min. Physical examination is significant for scleral icterus, hepatomegaly, ascites, and diffuse abdominal tenderness. Laboratory testing is significant for leukocytosis and metabolic acidosis. A paracentesis is performed and he is admitted into the hospital to receive intravenous cefotaxime and albumin. Ascitic fluid analysis demonstrates a polymorphonuclear cell count of 280 cells/mm^3, serum-ascites albumin gradient of 1.3 g/dL, and a culture positive for Escherichia coli sensitive to cefotaxime and ceftriaxone. On hospital day 2, the nurse reports that the patient is oliguric in the setting of constant fluid intake. Physical examination is unchanged. Laboratory testing is significant for a serum sodium of 131 mEq/L and creatinine of 1.8 mg/dL (it was 0.9 mg/dL on admission). Urine studies are significant for a low urine sodium level, without evidence of blood or protein. Since the hospital admission, he has not been started on any new medications. Which of the following will be the best treatment option for this patient?",
    "answer": "To determine the best treatment for this patient, we first identify the underlying condition and then apply evidence-based guidelines:\n\n\n### **Step 1: Identify the Patient’s Current Problem**  \nThe patient has **cirrhosis** (history of alcohol use disorder, ascites, high SAAG) and was admitted for **spontaneous bacterial peritonitis (SBP)** (PMN count >250 cells/mm³, E. coli culture positive). On day 2, he develops:  \n- Acute kidney injury (AKI): Creatinine rose from 0.9 to 1.8 mg/dL (doubling in 48h).  \n- Low urine sodium (renal sodium conservation) without blood/protein (no structural renal damage).  \n- No new medications (ruling out nephrotoxins) or signs of hypovolemia (constant fluid intake, unchanged exam).  \n\nThis is **Hepatorenal Syndrome Type 1 (HRS-1)**—a functional AKI in cirrhosis triggered by SBP (even with albumin prophylaxis). HRS-1 arises from splanchnic vasodilation, reduced effective arterial volume, and renal vasoconstriction.\n\n\n### **Step 2: Optimal Treatment for HRS-1**  \nThe first-line treatment for HRS-1 targets the underlying pathophysiology (splanchnic vasodilation and reduced effective arterial volume):  \n- **Terlipressin**: A synthetic vasopressin receptor agonist that constricts splanchnic vessels, restoring effective arterial volume and renal perfusion.  \n- **Intravenous albumin**: Expands intravascular volume to support hemodynamics.  \n\nOther options (e.g., midodrine + octreotide + albumin) are second-line if terlipressin is unavailable, but terlipressin is preferred.\n\n\n**Answer: Terlipressin and intravenous albumin** (assuming this is the option provided; if listed explicitly, this is the correct choice).\n\n\n\\boxed{Terlipressin\\ and\\ intravenous\\ albumin}",
    "expected_answer": "Liver transplantation",
    "time": 30.41609215736389,
    "answer_length": 1713,
    "retrieval_time": 0.025294065475463867,
    "generation_time": 30.38999605178833
  },
  {
    "question": "A 29-year-old woman presents to the clinic after several months of weight loss. She noticed a 6.8 kg (15 lb) unintentional weight loss over the preceding several months. She has not changed her diet or exercise habits. She also reports feuding with her boyfriend over the temperature of their shared apartment, as she always feels warmer than he does. The vital signs include: heart rate 110/min and blood pressure 146/78 mm Hg. The physical exam is notable for warm and slightly moist skin. She also exhibits a fine tremor in her hands when her arms are outstretched. The urine pregnancy test is negative. Which of the following is the best single treatment option for this patient?",
    "answer": "To answer this question, we first diagnose the patient’s condition and then identify the optimal treatment.\n\n\n### Step 1: Diagnosis  \nThe patient presents with **unintentional weight loss**, **heat intolerance**, **tachycardia (110/min)**, **warm moist skin**, and **fine tremor**—all classic signs of **hyperthyroidism**, most likely due to **Graves’ disease** (the most common cause of hyperthyroidism in young adults).\n\n\n### Step 2: Treatment Options for Hyperthyroidism  \nThe main treatments for Graves’ disease are:  \n1. **Antithyroid drugs** (e.g., methimazole, propylthiouracil [PTU])  \n2. **Radioactive iodine ablation**  \n3. **Thyroidectomy**  \n\n\n### Step 3: Optimal Treatment Choice  \nFor young adults (29-year-old) with Graves’ disease, **antithyroid drugs** are often preferred as a first-line option, especially if the patient may desire pregnancy in the future. Among antithyroid drugs:  \n- **Methimazole** is the preferred agent over PTU due to its lower risk of liver toxicity and longer half-life (once-daily dosing).  \n\n\n### Conclusion  \nThe best single treatment option for this patient is **methimazole**.\n\n\n**Answer:** Methimazole.",
    "expected_answer": "Methimazole",
    "time": 19.249826192855835,
    "answer_length": 1152,
    "retrieval_time": 0.11244082450866699,
    "generation_time": 19.22476291656494
  },
  {
    "question": "A 21-year-old man comes to the physician because of pruritus and a hypopigmented rash on his upper body for 5 days. He first noticed the symptoms after returning from a business trip last week in the Bahamas. While he was there, he visited a couple of beaches and went hiking with some coworkers. The rash initially started as a single lesion on his upper back but since then has extended to his shoulders. He has a history of type 1 diabetes mellitus controlled with an insulin pump. He works as an office manager and has no known exposure to melanocytotoxic chemicals. He has been sexually active with three female partners over the past year and uses condoms inconsistently. He is 183 cm (6 ft) tall and weighs 80 kg (176 lb); BMI is 23.9 kg/m2. His temperature is 37.2°C (99°F), pulse is 78/min, and blood pressure is 130/84 mm Hg. A photograph of the rash is shown. One month ago, his hemoglobin A1C was 7.8%. Which of the following is most likely to confirm the diagnosis?",
    "answer": "To determine the most likely confirmatory test, we analyze the key clinical features and differential diagnoses:\n\n\n### **Key Clinical Clues**  \n- **21M** with **pruritic hypopigmented rash** (upper body, started as single lesion → spread to shoulders)  \n- Recent **tropical travel** (Bahamas: beaches/hiking)  \n- Type 1 DM (suboptimal control: HbA1c 7.8%) → increased fungal infection risk  \n- No exposure to melanocytotoxic chemicals; inconsistent condom use (but syphilis rash is non-pruritic, not hypopigmented)  \n\n\n### **Top Differential Diagnosis**  \n**Tinea Versicolor** (caused by *Malassezia furfur*, a yeast):  \n- Common in tropical climates (warm/humid)  \n- Presents as hypo/hyperpigmented scaly patches (pruritic in ~50% cases)  \n- Often starts as a single lesion then spreads  \n- More likely in patients with impaired glucose control (DM)  \n\n\n### **Confirmatory Test**  \n**KOH Preparation of Skin Scrapings**:  \n- Shows characteristic \"spaghetti and meatballs\" pattern (short hyphae + round spores) → diagnostic for *Malassezia furfur*.  \n\n\n**Answer**: KOH preparation of skin scrapings.  \n\n(Note: The exact wording may vary, but the test is KOH microscopy of skin scrapings.)  \n\n\\boxed{KOH preparation of skin scrapings}",
    "expected_answer": "Potassium hydroxide preparation",
    "time": 27.226963996887207,
    "answer_length": 1233,
    "retrieval_time": 0.019034862518310547,
    "generation_time": 27.20152711868286
  },
  {
    "question": "A 5-year-old female is brought to a speech therapist for continuing work on improving her communication skills. She is only able to verbalize two word sentences and has generalized developmental delay. When she was born it was noticed that she had a high pitched mewing cry and subsequent physical exam revealed microcephaly, prominent epicanthal folds, and a holosystolic murmur best heard in the left 5th intercostal space near the sternum. An abnormality of which of the following chromosomes is most likely responsible for this patient's disorder?",
    "answer": "To determine the responsible chromosome abnormality, we analyze the patient’s key clinical features:  \n\n### Key Findings:  \n- **High-pitched mewing cry at birth**: A hallmark of Cri-du-chat syndrome.  \n- **Developmental delay**: Consistent with Cri-du-chat.  \n- **Microcephaly and prominent epicanthal folds**: Common physical features of Cri-du-chat.  \n- **Holosystolic murmur (VSD)**: Congenital heart defects are frequent in Cri-du-chat.  \n\n\n### Cri-du-chat Syndrome:  \nThis disorder is caused by a **deletion of the short arm of chromosome 5 (5p-)**.  \n\n\n**Answer: Chromosome 5**  \n\n\\boxed{5}",
    "expected_answer": "5",
    "time": 10.558763027191162,
    "answer_length": 596,
    "retrieval_time": 0.01474905014038086,
    "generation_time": 10.533397912979126
  },
  {
    "question": "A 62-year old female comes to the physician because of vaginal spotting and urinary urgency for the past 4 days. She has had no fever, abdominal pain, or diarrhea. Menopause occurred at 52 years of age. Her last Pap smear 1 year ago was normal. She has hypertension, hypercholesterolemia, and diabetes. Medications include atorvastatin, hydrochlorothiazide, metformin, and aspirin. She is sexually active with her husband. Her temperature is 37°C (98.6°F), pulse is 95/min, respirations are 12/min, and blood pressure is 155/65 mm Hg. Pelvic exam demonstrates a 4 x 3 cm firm, immobile erythematous mass on the right inner vaginal wall. Which of the following is the most appropriate next step in management?",
    "answer": "To determine the most appropriate next step in management, let’s analyze the key clinical findings and reasoning:\n\n\n### **Key Clinical Context**  \n- 62-year-old postmenopausal woman (10 years post-menopause) with **vaginal spotting** and urinary urgency.  \n- Pelvic exam reveals a **4x3 cm firm, immobile, erythematous mass** on the right inner vaginal wall.  \n- Normal Pap smear 1 year ago (Pap tests screen for cervical, not vaginal, pathology).  \n\n\n### **Critical Reasoning**  \nA persistent, firm, immobile mass in the vaginal wall in a postmenopausal woman with bleeding raises concern for **malignancy** (primary vaginal cancer, metastatic disease to the vagina, or other neoplasms).  \n\nThe only way to confirm the diagnosis (benign vs malignant, histologic subtype) is to obtain tissue for analysis. Imaging (e.g., MRI) may follow to stage the disease, but **biopsy is the first step** to establish the nature of the mass.  \n\n\n**Answer:** Biopsy of the vaginal mass.  \n\n(Note: If this were a multiple-choice question, the option would likely state \"Biopsy of the vaginal lesion\" or similar.)\n\n\n\\boxed{Biopsy\\ of\\ the\\ vaginal\\ mass}",
    "expected_answer": "Biopsy of the mass",
    "time": 11.61781907081604,
    "answer_length": 1138,
    "retrieval_time": 0.01683497428894043,
    "generation_time": 11.592170000076294
  },
  {
    "question": "A 59-year-old man is evaluated for progressive joint pain. There is swelling and tenderness over the first, second, and third metacarpophalangeal joints of both hands. His hand radiograph is shown. He has had diabetes mellitus for 2 years which is not well controlled with medications. Lab studies show a transferrin saturation of 88% and serum ferritin of 1,200 ng/mL. Which of the following best represents the etiology of this patient condition?",
    "answer": "To determine the etiology of the patient’s condition, we analyze the key clinical and lab findings:\n\n\n### Key Observations:  \n- **Joint involvement**: Swelling/tenderness of 1st-3rd MCP joints (classic for hemochromatosis-related arthropathy).  \n- **Iron overload**: Transferrin saturation (88%, normal ~20-50%) and ferritin (1200 ng/mL, normal <300 ng/mL) are markedly elevated—hallmarks of excessive iron storage.  \n- **Diabetes mellitus**: Uncontrolled, consistent with \"bronze diabetes\" (a classic feature of hemochromatosis).  \n\n\n### Diagnosis:  \nThe constellation of iron overload, joint pain, and diabetes points to **hereditary hemochromatosis** (primary hemochromatosis).  \n\n\n### Etiology:  \nHereditary hemochromatosis is most commonly caused by **mutations in the HFE gene** (e.g., C282Y or H63D). These mutations disrupt the regulation of iron absorption in the small intestine, leading to lifelong excessive iron accumulation in organs (liver, pancreas, joints, skin) and subsequent tissue damage.  \n\n\n**Answer:** Hereditary hemochromatosis due to a genetic defect (HFE gene mutation) resulting in excessive intestinal iron absorption.  \n\n(Note: If this were a multiple-choice question, the correct option would align with this genetic etiology of primary hemochromatosis.)  \n\\boxed{Hereditary hemochromatosis due to HFE gene mutation}",
    "expected_answer": "Deposition of calcium pyrophosphate (CPP) crystals",
    "time": 21.41436505317688,
    "answer_length": 1347,
    "retrieval_time": 0.015124082565307617,
    "generation_time": 21.389941930770874
  },
  {
    "question": "A newborn is found to be extremely cyanotic immediately after birth. He then develops progressive respiratory failure and is admitted to the neonatal ICU. A single loud S2 heart sound is appreciated as well as a machine-like murmur at the left upper sternal border. Radiography shows an enlarged \"egg-shaped\" heart. The newborn is then taken for a atrial septostomy to alleviate the condition pending definitive surgical correction. Which of the following is the most likely cause of this newborn's condition?",
    "answer": "To determine the cause of the newborn’s condition, we analyze the key clinical clues and match them to congenital heart defects:\n\n\n### **Key Clues & Correlations**  \n1. **Immediate cyanosis + progressive respiratory failure**: Indicates a cyanotic defect with parallel circulations (no mixing of oxygenated/deoxygenated blood without compensatory shunts).  \n2. **Single loud S2**: Occurs when aortic and pulmonary valves are closely aligned (e.g., Transposition of Great Arteries [TGA], where aorta is anterior/right and pulmonary artery posterior/left).  \n3. **Machine-like murmur**: Suggests a patent ductus arteriosus (PDA)—a compensatory shunt maintaining mixing in TGA.  \n4. **Egg-shaped heart on CXR**: **Classic for TGA** (aorta shifts anteriorly, creating an \"egg on a string\" appearance).  \n5. **Atrial septostomy**: Temporary measure to increase mixing between atria (critical for TGA until definitive arterial switch surgery).  \n\n\n### **Ruling Out Other Defects**  \n- **Truncus arteriosus**: Single semilunar valve but no egg-shaped heart; murmur is systolic, not machine-like.  \n- **Tetralogy of Fallot**: Boot-shaped heart, cyanosis often delayed.  \n- **Tricuspid atresia**: Small right ventricle, no egg shape.  \n- **TAPVR**: Snowman sign (supracardiac type), not egg-shaped.  \n\n\n**Answer: Transposition of the Great Arteries**\n\n\n\\boxed{Transposition of the Great Arteries}",
    "expected_answer": "Transposition of great vessels",
    "time": 29.928242921829224,
    "answer_length": 1387,
    "retrieval_time": 0.07057476043701172,
    "generation_time": 29.903308153152466
  },
  {
    "question": "A 25-year-old male involved in a knife fight presents with a penetrating wound to the chest. The patient is unconscious and cannot provide any further history. Vitals show a temperature of 37-0°C (98.6°F), blood pressure of 85/55 mm Hg, pulse of 115/min, respirations of 19/min, and oxygen saturation of 92% on room air. On physical examination, the patient is diaphoretic and unresponsive. Extremities are pale and cool. There is a 3-inch long penetrating wound between the 3rd and 4th intercostal space on the left side of the chest, which is bleeding profusely. Transthoracic echocardiography reveals a full thickness penetrating injury to the right ventricular free wall. There are no apparent injuries to any coronary arteries or major branches. The patient is intubated and aggressive fluid resuscitation is initiated, including a blood transfusion. Which of the following is the best definitive surgical approach to take in this patient?",
    "answer": "To determine the best definitive surgical approach for this patient with a penetrating right ventricular free wall injury, we analyze the key clinical details and surgical principles:\n\n\n### Key Clinical Context  \nThe patient has a **hemodynamically unstable penetrating cardiac injury** (right ventricular free wall, full-thickness) with no coronary artery involvement. Definitive repair requires optimal exposure of the heart to ensure a safe, controlled repair and avoid complications.\n\n\n### Surgical Approach Rationale  \n- **Median sternotomy** is the gold standard for definitive repair of cardiac injuries. It provides:  \n  - Excellent visualization of all cardiac chambers (including the anterior right ventricle), great vessels, and coronary arteries.  \n  - A controlled surgical field for precise repair (e.g., suturing the ventricular wall without damaging adjacent structures).  \n  - Flexibility to address any unforeseen injuries (e.g., additional chamber or vessel damage).  \n\n- Other approaches (e.g., left anterolateral thoracotomy) are typically reserved for **resuscitative emergencies** (e.g., ED thoracotomy for cardiac arrest) but are not ideal for definitive repair due to limited exposure of the right ventricle and other cardiac structures.  \n\n\n**Answer: Median sternotomy**",
    "expected_answer": "Interrupted 2-0 polypropylene suture with supporting pledgets",
    "time": 16.083950757980347,
    "answer_length": 1296,
    "retrieval_time": 0.017719030380249023,
    "generation_time": 16.072383880615234
  },
  {
    "question": "A post-mortem lung examination of a 68-year-old male overweight male with evidence of chronic lower extremity edema, a 60 pack-year smoking history and daily productive cough would be most likely to reveal:",
    "answer": "To determine the most likely post-mortem lung findings, we analyze the patient’s clinical features and link them to pathophysiological changes:\n\n\n### Key Patient Clues:  \n- **60 pack-year smoking history**: Strong risk factor for COPD (chronic bronchitis + emphysema).  \n- **Daily productive cough**: Defining feature of **chronic bronchitis** (≥3 months of productive cough for 2 consecutive years).  \n- **Chronic lower extremity edema**: Suggests right-sided heart failure (cor pulmonale), a complication of chronic bronchitis (hypoxemia → pulmonary vasoconstriction → right ventricular strain).  \n\n\n### Classic Post-Mortem Lung Findings for Chronic Bronchitis:  \n1. **Increased Reid Index**: Hypertrophy of bronchial submucosal mucus glands (ratio of gland thickness to bronchial wall thickness >0.5, normal <0.4).  \n2. **Goblet Cell Hyperplasia**: Excess mucus-producing cells in bronchial epithelium (replacing ciliated cells).  \n3. **Chronic Inflammation**: Lymphocytic/plasmacytic infiltration of bronchial walls.  \n4. **Mucus Plugging**: Accumulation of thick mucus in bronchi/bronchioles.  \n\n\n### Why Not Other Diagnoses?  \n- **Emphysema**: Destruction of alveolar walls (loss of elastic recoil) but typically presents with dry cough/dyspnea (\"pink puffer\")—less consistent with productive cough and edema.  \n- **Pulmonary Fibrosis**: Dry cough, no strong link to smoking here.  \n- **Lung Cancer**: Possible but not the most likely given the chronic, systemic (edema) and cough features pointing to COPD.  \n\n\n**Answer:** Hypertrophy of bronchial submucosal glands (increased Reid index), hyperplasia of goblet cells, chronic inflammation of bronchial walls, and mucus plugging in airways.  \n\n(Concise version: Increased Reid index (bronchial gland hypertrophy), goblet cell hyperplasia, and mucus plugging in the bronchi.)\n\n\n\\boxed{Hypertrophy of bronchial submucosal glands, hyperplasia of goblet cells, and mucus plugging in the airways}",
    "expected_answer": "Reid Index > 50%",
    "time": 23.762146949768066,
    "answer_length": 1948,
    "retrieval_time": 0.00934290885925293,
    "generation_time": 23.735419034957886
  },
  {
    "question": "A 54-year-old male makes an appointment with his primary care physician due to chronic fatigue that has left him unable to hike or do other physically demanding activities with his friends. He has well-controlled hypertension and diabetes but has otherwise been healthy. He does not smoke but drinks socially with his friends. Physical exam reveals enlarged nodules that are not tender to palpation. A biopsy is obtained showing a characteristic change in chromosome 18. The regulation of which of the following proteins will be most abnormal in this patient?",
    "answer": "To solve this question, we analyze the key clinical and molecular clues provided:\n\n\n### **Key Clues Recap**  \n- 54-year-old male with chronic fatigue, painless enlarged nodules (lymphadenopathy).  \n- Biopsy shows **chromosome 18 abnormality**.  \n\n\n### **Associated Condition**  \nThe classic translocation linked to chromosome 18 and painless lymphadenopathy is **t(14;18)**, which characterizes **follicular lymphoma**. This translocation moves the *BCL2* gene (from chromosome 18) to the immunoglobulin heavy chain locus (chromosome 14), placing it under the strong promoter of immunoglobulin genes.  \n\n\n### **Abnormal Protein Regulation**  \nThe t(14;18) translocation causes **dysregulated overexpression of BCL2**, an anti-apoptotic protein. This prevents cell death, leading to accumulation of abnormal B lymphocytes (the basis of follicular lymphoma).  \n\n\n**Answer: BCL2**\n\n\n\\boxed{BCL2}",
    "expected_answer": "Caspase-9",
    "time": 12.582399129867554,
    "answer_length": 892,
    "retrieval_time": 0.012423038482666016,
    "generation_time": 12.555036783218384
  },
  {
    "question": "A 44-year-old African-American woman comes to the physician for a routine examination. She is concerned about cancer because her uncle died of metastatic melanoma 1 year ago. She has no history of serious illness and does not take any medication. She has been working in a law firm for the past 20 years and travels to the Carribean regularly with her husband. Examination of her skin shows no abnormal moles or warts. This woman is at greatest risk of which of the following types of melanoma?",
    "answer": "To determine the woman’s greatest risk for melanoma type, we focus on her demographic and key context:\n\n\n### Key Observations:  \nShe is an **African-American woman**—a population with lower overall melanoma rates, but when melanoma occurs, it is most often **acral lentiginous melanoma (ALM)**.  \n\n\n### Why ALM?  \nALM is the most common melanoma type in darker-skinned individuals (African Americans, Hispanics, Asians). It typically arises on non-sun-exposed acral sites (palms, soles, subungual areas) but is still the dominant subtype in this demographic **regardless of sun exposure** (her Caribbean trips do not override this racial predisposition for ALM).  \n\n\n### Other Types (Less Likely):  \n- **Superficial spreading**: Most common in Caucasians, not African Americans.  \n- **Lentigo maligna**: Sun-exposed facial areas in older Caucasians.  \n- **Nodular**: Aggressive but rare in this demographic.  \n\n\n**Answer: Acral lentiginous melanoma**",
    "expected_answer": "Acral lentiginous",
    "time": 18.979209899902344,
    "answer_length": 950,
    "retrieval_time": 0.012837886810302734,
    "generation_time": 18.952839851379395
  },
  {
    "question": "A 60-year-old woman is brought to the clinic by her daughter for evaluation. The daughter reports that her mother has recently been having difficulty combing her hair in the mornings. The patient’s family history is significant for an ischemic stroke in her father. The patient’s past medical history is positive for diverticulosis. She takes no medication. Her blood pressure is 120/70 mm Hg, heart rate is 75/min, respiratory rate is 14/min, and temperature is 37.6°C (99.7°F). On physical examination, the patient’s neck is stiff and she also has bilateral shoulder tenderness; muscle strength is intact. Laboratory work is performed and presented below:\nHemoglobin 12.9 g/dL\nHematocrit 37.7% \nLeukocyte count 5,500/mm3\nNeutrophils 65%\nLymphocytes 30%\nMonocytes 5%\nMean corpuscular volume 82.2 μm3\nPlatelet count 190,000/mm3\nErythrocyte sedimentation rate 65 mm/h\nC-reactive protein 44 mg/dL\nFor which of the symptoms below should the patient be screened?",
    "answer": "To answer this question, we first identify the **key clinical and laboratory findings** and link them to the most likely diagnosis, then determine the critical symptoms to screen for:\n\n\n### Step 1: Key Findings  \n- **Patient**: 60-year-old woman with difficulty combing hair (shoulder girdle stiffness), neck stiffness, bilateral shoulder tenderness, low-grade fever (37.6°C), and intact muscle strength.  \n- **Labs**: Markedly elevated ESR (65 mm/h) and CRP (44 mg/dL) (both indicative of systemic inflammation); normal CBC/platelets.  \n\n\n### Step 2: Diagnosis  \nThese findings are classic for **Polymyalgia Rheumatica (PMR)**, a condition characterized by proximal girdle stiffness/pain, systemic inflammation, and preserved muscle strength in older adults. PMR is strongly associated with **Giant Cell Arteritis (GCA)** (10-20% of PMR patients have GCA), a vasculitis of medium/large arteries (e.g., temporal arteries) that causes irreversible vision loss if untreated.  \n\n\n### Step 3: Critical Symptoms to Screen for  \nGCA presents with symptoms like **jaw claudication** (pain while chewing), temporal headache, scalp tenderness, and visual disturbances (amaurosis fugax, diplopia, vision loss). These are the highest-priority symptoms to screen for in PMR patients to detect GCA early.  \n\n\n**Answer**: Jaw claudication (or visual symptoms like blurred vision/diplopia; the most common answer in this context is jaw claudication or vision loss, with jaw claudication being a frequent screening target).\n\n\n\\boxed{Jaw claudication} (or \\boxed{Visual disturbances}—depending on standard options, but jaw claudication is a classic GCA symptom to screen for in PMR).  \n\nHowever, given typical exam questions, the most likely correct answer here is **Jaw claudication**.  \n\n\\boxed{Jaw claudication}",
    "expected_answer": "Jaw claudication",
    "time": 38.88844418525696,
    "answer_length": 1797,
    "retrieval_time": 0.09321022033691406,
    "generation_time": 38.876927852630615
  },
  {
    "question": "A 30-year-old woman comes to the physician because she has been unable to conceive for 3 years. Analysis of her husband's semen has shown normal sperm counts during this time. The patient also reports episodic pelvic and back pain accompanied by painful diarrhea for 5 years. She has about one such episode on average per month for 4–6 days. She has taken ibuprofen for the pain, which has provided some relief. Menses have occurred at regular 29-day intervals since menarche at the age of 14 years and last for 7 days. She is sexually active with her husband and does not use contraception. Vital signs are within normal limits. Pelvic and bimanual examinations are normal; rectal examination is unremarkable. A hysterosalpingogram 6 months prior showed normal results. Which of the following is the most likely underlying mechanism of this patient's symptoms?",
    "answer": "To determine the underlying mechanism of the patient’s symptoms, we analyze key clinical features and connect them to the most likely condition:\n\n\n### **Key Clinical Clues**  \n- **Cyclic symptoms**: Monthly episodes of pelvic/back pain + painful diarrhea (4–6 days/month) aligning with her 7-day menstrual cycle.  \n- **Infertility**: 3 years of unsuccessful conception (husband’s semen normal; HSG normal for tubal patency).  \n- **Normal exams**: No palpable abnormalities on pelvic/bimanual/rectal exams (ruling out obvious structural issues like large adhesions or uterine enlargement).  \n\n\n### **Most Likely Condition: Endometriosis**  \nEndometriosis is the presence of **ectopic endometrial tissue** outside the uterus (e.g., pelvic peritoneum, ovaries, or bowel like the rectosigmoid colon).  \n\n#### **Underlying Mechanism**  \nEctopic endometrial implants respond to cyclic ovarian hormones (estrogen/progesterone) with:  \n1. **Proliferation and bleeding**: During the menstrual cycle, implants shed blood (like uterine endometrium), causing local inflammation, irritation, and pain.  \n2. **Bowel involvement**: Implants on the bowel irritate the intestinal mucosa, leading to painful diarrhea (the patient’s key GI symptom).  \n3. **Infertility**: Even with normal tubal patency (HSG normal), endometriosis disrupts fertility via:  \n   - Altered pelvic environment (inflammation, cytokine release).  \n   - Impaired ovulation/egg quality or implantation.  \n\n\n### **Conclusion**  \nThe patient’s symptoms stem from **ectopic endometrial tissue undergoing cyclic hormonal changes (growth/bleeding)**, leading to pelvic pain, bowel irritation, and infertility.\n\n\n**Answer:** Ectopic endometrial tissue that exhibits cyclic proliferation and bleeding in response to ovarian steroid hormones, causing inflammation, pelvic pain, bowel irritation, and impaired fertility.  \n\n(Note: For standardized exam format, the answer is often phrased concisely as **Ectopic endometrial implants with cyclic hormonal responsiveness**.)  \n\n\\boxed{Ectopic endometrial tissue undergoing cyclic growth and bleeding in response to ovarian hormones}",
    "expected_answer": "Endometrial tissue outside the uterine cavity",
    "time": 30.88632583618164,
    "answer_length": 2127,
    "retrieval_time": 0.0173799991607666,
    "generation_time": 30.86093306541443
  },
  {
    "question": "A 55-year-old truck driver is brought to a physician by his wife. She states that her husband developed a fever and began feeling weak 3 days ago, but has refused medical help. He has been unable to go to work because of his symptoms. The patient has been previously hospitalized for a tricuspid valve replacement surgery 1 year ago and takes aspirin daily. The medical history is also relevant for myocardial infarction 3 years ago and hypertension for the past 10 years, for which he takes lisinopril. His blood pressure is 140/80 mm Hg, the pulse is 82/min, the respirations are 18/minute, and the temperature is 37.2°C (98.9°F). On examination, several hemorrhages are noted on the nail beds of several fingers. Which of the following findings would be most helpful in establishing a diagnosis?",
    "answer": "To determine the most helpful finding for establishing the diagnosis, we first analyze the case:\n\n\n### Key Case Features  \n- **Prosthetic valve**: Tricuspid valve replacement 1 year ago (major predisposing factor for endocarditis).  \n- **Fever/weakness**: Suggests infection.  \n- **Nail bed hemorrhages**: Splinter hemorrhages (a minor vascular sign of endocarditis).  \n\n\n### Likely Diagnosis  \n**Prosthetic valve endocarditis** (PVE), a serious infection of a prosthetic heart valve. The Duke criteria for endocarditis prioritize **major criteria** (positive blood cultures for typical organisms, endocardial involvement on imaging) over minor criteria (fever, vascular signs like splinter hemorrhages).  \n\n\n### Most Helpful Finding  \nThe most definitive finding for PVE is **echocardiographic evidence of valvular vegetation** (especially via transesophageal echocardiogram, TEE—more sensitive for prosthetic valves than transthoracic echocardiogram). This directly demonstrates endocardial involvement (a major Duke criterion), confirming the diagnosis.  \n\n\n**Answer:** Echocardiographic evidence of valvular vegetation (e.g., \"Vegetation on transesophageal echocardiogram\").  \n\n(Note: If blood cultures were an option, they are also major criteria, but TEE is often the answer in prosthetic valve cases due to its high sensitivity for detecting vegetations.)\n\n\n\\boxed{Echocardiographic evidence of valvular vegetation}",
    "expected_answer": "Friable irregular masses attached to the valve",
    "time": 30.965420961380005,
    "answer_length": 1422,
    "retrieval_time": 0.017186880111694336,
    "generation_time": 30.937742710113525
  },
  {
    "question": "A previously healthy 30-year-old woman comes to the physician for the evaluation of pain during sexual intercourse for 6 months. She also reports frequent episodes of crampy pelvic pain that starts one day before menses and lasts for 7 days. Her symptoms are not relieved with pain medication. Menses occur at regular 28-day intervals and last 5 days. Her last menstrual period was 2 weeks ago. She is sexually active with her husband. She uses a combined oral contraceptive pill. Her vital signs are within normal limits. Physical examination shows rectovaginal tenderness. Cervical and urethral swabs are negative. Transvaginal ultrasonography shows no abnormalities. Which of the following is the most appropriate next step in management?",
    "answer": "To address this question, we first synthesize the patient’s key findings and then determine the most appropriate next step in management:\n\n\n### Key Clinical Findings  \n- **Symptoms**: 6 months of dyspareunia (painful intercourse) and dysmenorrhea (premenstrual cramping lasting 7 days, unresponsive to pain meds).  \n- **Examinations**: Rectovaginal tenderness (classic for endometriosis involving the cul-de-sac), negative cervical/urethral swabs (rules out infection), and normal transvaginal ultrasound (no endometriomas, cysts, or fibroids).  \n- **Current Therapy**: Combined oral contraceptives (COCs) are ineffective for her symptoms.  \n\n\n### Likely Diagnosis  \n**Endometriosis**—the constellation of dysmenorrhea, dyspareunia, rectovaginal tenderness, and normal imaging is highly suggestive. Most endometriosis cases lack visible lesions on ultrasound (only endometriomas are detectable), so imaging does not exclude the diagnosis.  \n\n\n### Next Step in Management  \nThe gold standard for diagnosing endometriosis is **laparoscopy** (direct visualization of lesions). While empirical medical therapy (e.g., continuous COCs, progestins, GnRH agonists) can be tried, laparoscopy is indicated here because:  \n- Initial medical therapy (COCs) has failed to relieve symptoms.  \n- Laparoscopy provides both definitive diagnosis and therapeutic options (ablation/excision of lesions).  \n\n\n**Answer**: Laparoscopy.  \n\n(Note: If laparoscopy is not an option, the next best choice would be a trial of GnRH agonist therapy.)\n\n\n**Final Answer**  \nLaparoscopy  \n\n\\boxed{Laparoscopy}",
    "expected_answer": "Laparoscopy",
    "time": 59.858932971954346,
    "answer_length": 1575,
    "retrieval_time": 0.01671910285949707,
    "generation_time": 59.831377029418945
  },
  {
    "question": "A 50-year-old man visits his physician after 20 years of not seeking any medical care. He is concerned about his health after a colleague recently had a heart attack. The patient has no active complaints and says he feels healthy; however, he does not exercise regularly and lives a sedentary lifestyle. He is employed as an administrative position at a local college, and is seated at a desk most of the day. His father had a heart attack at age 54 and his mother is still alive with no health concerns. He does not smoke, only drinks socially, and does not use drugs. Today, his blood pressure is 130/90 mm Hg, pulse is 84/min, and respiratory rate is 14/min. Physical examination reveals an obese male with no significant findings. An ECG shows no abnormalities, and laboratory testing shows the following:\nLaboratory test\nSerum glucose (fasting)  105 mg/dL\nSerum electrolytes \nSodium  142 mEq/L\nPotassium 3.9 mEq/L\nChloride 101 mEq/L\nSerum creatinine 0.8 mg/dl\nBlood urea nitrogen 10 mg/dl\nCholesterol, total 250 mg/dL\nHDL-cholesterol 35 mg/dL\nLDL-cholesterol 186 mg/dL\nTriglycerides 170 mg/dL\nUrinalysis \nGlucose  negative\nKetones negative\nLeucocytes negative\nNitrites negative \nRed blood cells (RBC) negative \nCasts negative \nWhich of the following lab abnormalities in this patient is an indication for treatment?",
    "answer": "To determine which lab abnormality warrants treatment, we analyze the patient’s results against clinical guidelines and prioritize findings that require intervention:\n\n\n### Key Lab Findings & Clinical Relevance  \n1. **Fasting glucose (105 mg/dL):** Prediabetes. Management begins with lifestyle changes (diet, exercise) before pharmacotherapy is considered. No immediate indication for treatment.  \n2. **Electrolytes, creatinine, BUN:** All within normal ranges. No intervention needed.  \n3. **Lipids:**  \n   - **Total cholesterol (250 mg/dL):** High, but driven by LDL.  \n   - **HDL (35 mg/dL):** Low (men ≥40 mg/dL is ideal). Managed with lifestyle first.  \n   - **LDL (186 mg/dL):** Significantly elevated. The patient has multiple cardiovascular risk factors (father’s MI at 54, obesity, sedentary lifestyle, elevated BP, prediabetes). For primary prevention, LDL ≥160 mg/dL with ≥2 risk factors indicates statin therapy (per AHA guidelines).  \n   - **Triglycerides (170 mg/dL):** Borderline high. Lifestyle changes are first-line.  \n4. **Urinalysis:** Normal.  \n\n\n### Conclusion  \nThe only lab abnormality requiring treatment is the elevated LDL-cholesterol.\n\n\n**Answer:** LDL-cholesterol 186 mg/dL.",
    "expected_answer": "High LDL-cholesterol",
    "time": 29.69871187210083,
    "answer_length": 1204,
    "retrieval_time": 0.020409822463989258,
    "generation_time": 29.673686027526855
  },
  {
    "question": "A 26-year-old woman is brought to the emergency department 20 minutes after being involved in a high-speed motor vehicle collision in which she was a restrained passenger. On arrival, she is lethargic and incoherent. She has severe facial lacerations and is in respiratory distress. Her pulse is 130/min, respirations are 29/min, and blood pressure is 90/58 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 70%. Examination shows multiple facial lacerations. There is dullness to percussion and decreased breath sounds over the left lung base. Abdominal examination shows diffuse tenderness with no guarding or rebound. Bowel sounds are normal. The remainder of the examination shows no abnormalities. Her hemoglobin concentration is 12.1 g/dL. An x-ray of the chest shows a fractured left second rib, depression of the left mainstem bronchus, deviation of the nasogastric tube to the right, and a widened mediastinum. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the key clinical and radiologic findings in the context of a high-speed motor vehicle collision (MVC):\n\n\n### **Key Findings**  \n- **Mechanism**: Restrained passenger in high-speed MVC (deceleration injury risk).  \n- **Vitals**: Tachycardia (130/min), hypotension (90/58 mmHg), hypoxemia (70% O2 sat), tachypnea (29/min) → **shock and respiratory distress**.  \n- **Exam**: Left lung base dullness + decreased breath sounds (suggests fluid/blood accumulation); no abdominal guarding (rules out immediate peritoneal injury).  \n- **Lab**: Hb 12.1 g/dL (acute injury → Hb not yet decreased by fluid shifts).  \n- **Chest X-ray**:  \n  - **Widened mediastinum** (classic for aortic injury).  \n  - Fractured left second rib (upper rib fracture = high-energy impact).  \n  - Deviated NG tube to right + depressed left mainstem bronchus (mediastinal shift from aortic hematoma).  \n\n\n### **Diagnostic Reasoning**  \nThe **widened mediastinum** in a high-speed deceleration injury (restrained passenger) is the critical finding. Restrained passengers experience shear forces at the aortic isthmus (fixed by the ligamentum arteriosum), leading to **traumatic aortic transection** (or dissection). This injury causes internal bleeding (into mediastinum/pleural space) → shock, and mediastinal shift (explaining NG tube deviation/bronchial depression).  \n\nOther options are less likely:  \n- **Hemothorax**: Dullness/decreased breath sounds, but Hb would drop more with large volume loss, and no widened mediastinum.  \n- **Tension pneumothorax**: Hyperresonance (not dullness) + tracheal deviation away from the side.  \n- **Pulmonary contusion**: Infiltrates on CXR (not widened mediastinum).  \n\n\n**Answer: Traumatic aortic transection** (or \"traumatic aortic dissection\"—both are correct in this context, but transection is more specific for trauma).\n\n\n\\boxed{Traumatic aortic transection}",
    "expected_answer": "Thoracic aortic rupture",
    "time": 35.42663502693176,
    "answer_length": 1922,
    "retrieval_time": 0.0818488597869873,
    "generation_time": 35.401259899139404
  },
  {
    "question": "A 26-year-old G1P0 woman presents to her primary care physician’s office with feelings of anxiety and trouble with sleep. She finds it difficult initiating sleep, occasionally has palpitations, and feels fatigued. She denies having similar symptoms in the past or starting any new medications or illicit drugs. She is currently 10 weeks pregnant and is closely followed by her obstetrician. Her temperature is 98.6°F (37°C), blood pressure is 125/70 mmHg, pulse is 105/min, and respirations are 18/min. On physical exam, the patient is mildly diaphoretic. The skin is warm and the thyroid gland is diffusely enlarged with thyroid bruits. Laboratory studies are significant for a thyroid-stimulating hormone level of 0.01 µU/mL (normal is 0.5-5.0 µU/mL) and an elevated free thyroxine (FT4) that is inappropriate for her pregnancy. Which of the following is the best treatment option for this patient?",
    "answer": "To determine the best treatment option, we first analyze the case and then apply key guidelines for hyperthyroidism in pregnancy:\n\n\n### **Step 1: Diagnosis**  \nThe patient has:  \n- **Hyperthyroidism**: Low TSH (0.01 µU/mL) + elevated FT4 (inappropriate for pregnancy).  \n- **Graves disease**: Diffusely enlarged thyroid with bruits (classic finding for Graves, the most common cause of hyperthyroidism in pregnancy).  \n\n\n### **Step 2: Treatment Considerations in Pregnancy**  \nKey constraints and preferences:  \n1. **Radioactive iodine (RAI)**: Contraindicated (crosses placenta, damages fetal thyroid).  \n2. **Surgery**: Reserved for refractory cases/ATD intolerance (high miscarriage risk in first trimester).  \n3. **Antithyroid drugs (ATDs)**: First-line therapy, but choice depends on trimester:  \n   - **First trimester**: Propylthiouracil (PTU) is preferred over methimazole (MMI). MMI is associated with congenital anomalies (aplasia cutis, esophageal atresia) in early pregnancy.  \n   - **Second/third trimesters**: Switch to MMI to reduce PTU’s risk of severe hepatotoxicity.  \n\n\n### **Conclusion**  \nThe patient is in the **first trimester**, so the best treatment is **propylthiouracil (PTU)**.\n\n\n**Answer: Propylthiouracil**",
    "expected_answer": "Propylthiouracil",
    "time": 19.929506063461304,
    "answer_length": 1236,
    "retrieval_time": 0.02000880241394043,
    "generation_time": 19.90375304222107
  },
  {
    "question": "A 32-year-old woman comes to the physician because of a 3-week history of intermittent loose stools and a 1.2-kg (2.6-lb) weight loss. She immigrated to the US from Uganda 6 weeks ago. Abdominal examination shows diffuse tenderness with no guarding or rebound. The liver is firm and palpable 3 cm below the right costal margin, and the spleen is palpable just below the left costal margin. Her leukocyte count is 12,800/mm3 (12% eosinophils). Stool culture shows several oval-shaped eggs with lateral spines. Microscopic examination of a liver biopsy specimen shows granulomatous inflammation with periportal fibrosis. Exposure to which of the following is most likely to have played a role in the development of this patient's symptoms?",
    "answer": "To determine the likely exposure, we analyze the case details and connect them to the causative pathogen:\n\n\n### Key Case Findings:  \n- **Oval eggs with lateral spines**: Pathognomonic for *Schistosoma mansoni*.  \n- **Eosinophilia**: Consistent with schistosomiasis (eosinophils respond to larval migration and egg deposition).  \n- **Hepatosplenomegaly + periportal fibrosis**: Chronic schistosomiasis (eggs trapped in liver portal veins trigger granulomas and fibrosis).  \n- **Origin from Uganda**: *S. mansoni* is endemic in sub-Saharan Africa (including Uganda).  \n\n\n### Exposure for Schistosomiasis:  \n*Schistosoma mansoni* requires freshwater contact (e.g., swimming, wading in rivers/lakes) where the intermediate host (Biomphalaria snails) live. Cercariae (larval stage) penetrate the skin during freshwater exposure.  \n\n\n**Answer: Freshwater exposure (e.g., swimming in or wading through contaminated freshwater).**\n\n\n\\boxed{Freshwater contact}",
    "expected_answer": "Freshwater snails",
    "time": 14.373585939407349,
    "answer_length": 951,
    "retrieval_time": 0.01592707633972168,
    "generation_time": 14.347841024398804
  },
  {
    "question": "A 3-month-old girl is brought to a pediatrician by her parents. She has central cyanosis without signs of respiratory distress or signs of heart failure. An echocardiogram reveals severe pulmonary outflow obstruction, right ventricular hypertrophy, a ventricular septal defect, and an overriding of the aorta. An elective primary surgical repair is planned at 4 months of age. Which of the following statements is true about this girl’s condition?",
    "answer": "To answer this question, we first identify the girl’s condition based on the clinical and echocardiographic findings: **Tetralogy of Fallot (TOF)**. The classic tetrad of TOF includes:  \n1. Severe pulmonary outflow obstruction (stenosis),  \n2. Right ventricular hypertrophy (RVH),  \n3. Ventricular septal defect (VSD),  \n4. Overriding aorta.  \n\n\n### Key Analysis of TOF in This Case  \nThe cyanosis occurs because the severe pulmonary stenosis prevents blood from flowing normally to the lungs. Instead, blood is shunted **right-to-left across the VSD** (from the high-pressure right ventricle to the left ventricle) and into the aorta. The overriding aorta sits above the VSD, so it receives blood from both the right ventricle (deoxygenated) and left ventricle (oxygenated)—this mixed blood causes central cyanosis.  \n\n\n### Typical True Statement (Common in Such Questions)  \nA correct statement about this condition would be:  \n**\"The overriding aorta receives blood from both the right and left ventricles.\"**  \n\nThis is directly supported by the echocardiographic finding of an overriding aorta and the pathophysiology of TOF (mixed blood flow into the aorta due to the VSD and pulmonary obstruction).  \n\n\n**Answer:** The overriding aorta receives blood from both the right and left ventricles. (Or equivalent, e.g., \"Cyanosis results from right-to-left shunting across the ventricular septal defect.\")  \n\n(Note: If options were provided, the correct one aligns with this pathophysiology.)  \n\\boxed{The overriding aorta receives blood from both the right and left ventricles}",
    "expected_answer": "Normal hemoglobin in patients with tetralogy of Fallot does not rule out iron deficiency anemia.",
    "time": 31.172006130218506,
    "answer_length": 1579,
    "retrieval_time": 0.013133049011230469,
    "generation_time": 31.14701509475708
  },
  {
    "question": "Six days after undergoing surgical repair of a hip fracture, a previously healthy 79-year-old woman is agitated and confused. She is unarousable during the day, but then is awake and impulsive during the night, requiring frequent reorientation. Her husband says that she usually drinks one to two glasses of wine weekly. Her only current medication is oxycodone for pain. Her vital signs are within normal limits. She is distressed and oriented to person but not to place or time. Neurologic examination shows inattentiveness but no focal deficits. Urine dipstick is normal. Which of the following is the most likely cause of her current condition?",
    "answer": "To determine the most likely cause of the patient’s condition, we analyze the key clinical features and context:\n\n\n### **Key Clinical Features**  \n- **Elderly patient (79 years)** post-hip fracture surgery (6 days prior).  \n- **Acute onset confusion**: Agitation, fluctuating consciousness (unarousable during the day, awake/impulsive at night), disorientation to place/time, inattention.  \n- **No focal neurologic deficits**, normal vital signs, normal urine dipstick.  \n- **Medication**: Oxycodone (opioid) for pain.  \n- **Minimal alcohol use (1-2 glasses weekly)** (unlikely withdrawal).  \n\n\n### **Differential Diagnosis**  \n1. **Delirium**: Core features are present—**acute onset, fluctuating course, inattention, altered consciousness** (day-night reversal). This is the primary syndrome here.  \n2. **Alcohol withdrawal**: Unlikely (minimal weekly use; no autonomic instability/tremors).  \n3. **Infection**: Ruled out (normal urine dipstick, no fever/vitals changes).  \n4. **Dementia**: Chronic (not acute onset).  \n5. **Stroke**: No focal deficits.  \n\n\n### **Most Likely Cause**  \nThe patient’s delirium is most likely precipitated by **oxycodone (opioid use)**. Opioids are a well-known trigger for delirium in elderly patients due to their effects on the central nervous system (altered neurotransmission, sleep disruption).  \n\n\n**Answer**: Delirium due to opioid (oxycodone) administration.  \n\n(Note: If options were provided, the correct choice would correspond to this cause.)\n\n\n**Final Answer**  \nDelirium induced by oxycodone use (or the option that reflects opioid-related delirium).  \n\n\\boxed{Opioid-induced delirium}  \n\n(Assuming the standard option set; if the options included \"Delirium due to oxycodone\" or similar, that is the answer.)",
    "expected_answer": "Delirium",
    "time": 23.93225908279419,
    "answer_length": 1756,
    "retrieval_time": 0.013664007186889648,
    "generation_time": 23.90308403968811
  },
  {
    "question": "A 54-year-old woman with a past medical history of mental retardation, hypertension, and diabetes presents to the emergency department with a change in her behavior. Her caretakers state that the patient’s gait suddenly became ataxic, and she became less responsive than her normal non-verbal baseline. Her temperature is 98.5°F (36.9°C), blood pressure is 125/68 mmHg, pulse is 90/min, respirations are 15/min, and oxygen saturation is 99% on room air. Physical exam is notable for an unremarkable HEENT exam with normal facial features and no signs of airway compromise. Neurological exam is remarkable for new onset spasticity. The patient has 3+ reflexes and a positive Babinski sign. Musculoskeletal exam is only notable for symmetric swelling and deformities of the patient’s hands bilaterally. Additionally, there is a \"clunk\" when posterior force is applied to the head while anterior force is applied to the cervical spine. Which of the following is the most likely risk factor that predisposed this patient to this condition?",
    "answer": "To determine the most likely predisposing risk factor, we analyze the key clinical findings and their associations:\n\n\n### **Key Clinical Clues**  \n- **Mental retardation**: A hallmark feature of Down syndrome.  \n- **Symmetric hand deformities**: Characteristic of Down syndrome (e.g., short fingers, fifth finger hypoplasia, simian crease).  \n- **\"Clunk\" sign**: Indicates **atlantoaxial instability (AAI)**—a common complication of Down syndrome due to laxity/hypoplasia of the transverse ligament of the atlas, leading to increased atlanto-dental interval (ADI).  \n- **Upper motor neuron (UMN) signs**: Spasticity, hyperreflexia (3+), positive Babinski—consistent with spinal cord compression from AAI (a sequela of Down syndrome-associated ligamentous laxity).  \n\n\n### **Link to Risk Factor**  \nDown syndrome is the underlying condition predisposing to atlantoaxial instability. The patient’s mental retardation and hand deformities are classic features of Down syndrome, and AAI is a well-documented complication in this population.  \n\n\n**Answer: Down syndrome** (implied by the constellation of mental retardation, hand deformities, and atlantoaxial instability).  \n\n\\boxed{Down syndrome}",
    "expected_answer": "Rheumatoid arthritis",
    "time": 21.99203610420227,
    "answer_length": 1193,
    "retrieval_time": 0.12273192405700684,
    "generation_time": 21.966896772384644
  },
  {
    "question": "A 24-year-old man is brought to the emergency department 15 minutes after he sustained a stab wound to the left chest just below the clavicle. On arrival, he has rapid, shallow breathing and appears anxious. His pulse is 135/min, respirations are 30/min and shallow, and palpable systolic blood pressure is 80 mm Hg. He is intubated and mechanically ventilated. Infusion of 0.9% saline is begun. Five minutes later, his pulse is 133/min and blood pressure is 82/45 mm Hg. Examination shows no active external bleeding. There is a 2.5-cm single stab wound to the left chest at the 4th intercostal space at the midclavicular line. Cardiovascular examination shows muffled heart sounds and jugular venous distention. Breath sounds are normal. Further evaluation of this patient is most likely to show which of the following findings?",
    "answer": "To answer this question, we first identify the **classic clinical scenario of cardiac tamponade** from the case details:\n\n\n### Key Case Features:  \n- Stab wound to the left chest (4th intercostal space, midclavicular line)—a location that can puncture the pericardium.  \n- **Beck’s Triad**: Hypotension (82/45 mmHg), muffled heart sounds, and jugular venous distention (JVD).  \n- Refractory hypotension despite fluid resuscitation (saline infusion did not improve BP).  \n- Normal breath sounds (rules out tension pneumothorax, which would have unilateral absent breath sounds).  \n\n\n### Expected Finding in Cardiac Tamponade:  \nCardiac tamponade occurs when pericardial fluid accumulates, increasing pressure and impairing ventricular filling. The most specific diagnostic finding (and common answer for this scenario) is:  \n\n**Pericardial effusion with diastolic collapse of the right ventricle on echocardiography**  \n\nThis finding is pathognomonic for cardiac tamponade (distinguishes it from simple pericardial effusion, as it confirms impaired ventricular filling). Other supportive findings include **pulsus paradoxus (>10 mmHg drop in systolic BP on inspiration)** or **equalization of intracardiac filling pressures** (right atrial, right ventricular diastolic, and pulmonary capillary wedge pressures).  \n\n\n**Answer:** Pericardial effusion with diastolic collapse of the right ventricle on echocardiography.  \n\n(Note: If pulsus paradoxus >10 mmHg is an option, this is also a correct finding, but the echocardiographic sign is more specific for tamponade.)\n\n\n**Final Answer:** Pericardial effusion with diastolic collapse of the right ventricle on echocardiography.  \n(If options include pulsus paradoxus >10 mmHg, this is also acceptable.)  \n\nFor standard USMLE-style questions, the **echocardiographic finding** is the preferred answer here.  \n\n\\boxed{Pericardial effusion with diastolic collapse of the right ventricle on echocardiography}  \n\n(Adjust based on exact options provided; if pulsus paradoxus is listed, use that instead: \\boxed{Pulsus paradoxus greater than 10 mmHg})  \n\nBut given the classic scenario, the most specific answer is the echocardiographic sign.  \n\n\\boxed{Pericardial effusion with diastolic collapse of the right ventricle on echocardiography}",
    "expected_answer": "A drop in systolic blood pressure of 14 mmHg during inspiration",
    "time": 33.43466520309448,
    "answer_length": 2280,
    "retrieval_time": 0.018950939178466797,
    "generation_time": 33.409048080444336
  },
  {
    "question": "A 40-year-old man presents to his primary-care doctor for a follow-up of his hypertension. He is asymptomatic at his office visit and denies any new complaints. He has a 10-year history of hypertension that remains poorly controlled on maximum doses of lisinopril, hydrochlorothiazide, and amlodipine. His past medical history is otherwise unremarkable. He has no smoking history, drinks alcohol occasionally, and denies any illicit drug use. His father required a kidney transplant in his forties. The physical exam is notable for palpable flank masses bilaterally. Laboratory studies show a creatinine of 2.5. The physician orders a renal ultrasound, and the results are shown. Which of the following is the most appropriate test to screen for additional complications of this patient's condition?",
    "answer": "To answer this question, we first identify the patient’s underlying condition, then determine the key complication to screen for and the appropriate test.\n\n\n### Step 1: Diagnose the Patient’s Condition  \nThe patient has:  \n- **Resistant hypertension** (on 3 medications: ACEi, diuretic, CCB).  \n- **Bilateral palpable flank masses** (enlarged kidneys from cysts).  \n- **Renal impairment** (creatinine 2.5).  \n- **Family history** (father with kidney transplant in his 40s, consistent with inherited kidney disease).  \n\nThese findings are classic for **autosomal dominant polycystic kidney disease (ADPKD)**.\n\n\n### Step 2: Key Complications of ADPKD  \nADPKD is associated with several systemic complications, including:  \n- Hepatic cysts (usually asymptomatic).  \n- **Intracranial berry aneurysms** (10-15% prevalence vs. 1-2% in the general population). This is a life-threatening complication (risk of rupture → subarachnoid hemorrhage).  \n- Mitral valve prolapse, diverticula, etc.  \n\nThe most critical complication to screen for is **intracranial aneurysms**.\n\n\n### Step 3: Appropriate Screening Test  \nFor intracranial aneurysms:  \n- **Magnetic Resonance Angiography (MRA) of the brain** is preferred. It is non-invasive, avoids ionizing radiation, and does not require nephrotoxic contrast (important here, as the patient has renal impairment).  \n\n\n**Answer:** Magnetic resonance angiography (MRA) of the intracranial vessels.\n\n\n\\boxed{Magnetic resonance angiography of the brain}",
    "expected_answer": "MR angiography of the brain",
    "time": 27.01078701019287,
    "answer_length": 1485,
    "retrieval_time": 0.01699209213256836,
    "generation_time": 26.985746145248413
  },
  {
    "question": "A 17-year-old female is brought to the emergency room by her father because she has been experiencing shortness of breath and chest pain. She says that the chest pain is worse when she breathes or coughs. Furthermore, on the way to the hospital she noticed that there were specks of blood on a tissue that she coughed into. She has no previous medical history and does not recall anything that could have provoked these symptoms. On presentation her temperature is 99°F (37.2°C), blood pressure is 107/65 mmHg, pulse is 102/min, respirations are 21/min, and O2 saturation is 91% on room air. Further testing shows a large filling defect in the pulmonary vessels, and the patient is started on an appropriate treatment intravenously. After drug administration, the effects of the drug are monitored using a standard blood test. Surprisingly, the test results come back within normal parameters. The most likely underlying cause of this patient's symptoms has which of the following modes of inheritance?",
    "answer": "To solve this question, we analyze the patient’s presentation, diagnosis, treatment response, and underlying genetic cause step by step:\n\n\n### **Step 1: Identify the Clinical Diagnosis**  \nThe patient (17yo female, no prior history/risk factors) has:  \n- Pleuritic chest pain, hemoptysis, dyspnea.  \n- Vital signs: tachycardia, low O2 saturation.  \n- **Filling defect in pulmonary vessels**: Classic for **pulmonary embolism (PE)**.  \n\nSince she has no obvious risk factors (e.g., surgery, long travel, oral contraceptives), this suggests an underlying **thrombophilia** (clotting disorder).\n\n\n### **Step 2: Treatment and Monitoring**  \nInitial treatment for PE is IV anticoagulation (heparin, as it’s the standard IV option). Heparin works by enhancing **antithrombin** activity (to inhibit thrombin/factor Xa). Monitoring heparin effect uses the **aPTT** (activated Partial Thromboplastin Time), which should prolong with effective heparin therapy.  \n\nThe question states the monitoring test (aPTT) remains normal—this implies **heparin resistance**, which occurs if there’s insufficient antithrombin to amplify heparin’s effect.\n\n\n### **Step 3: Underlying Genetic Cause**  \nAntithrombin deficiency is a thrombophilia that causes heparin resistance (due to low antithrombin levels). Its inheritance pattern is **autosomal dominant** (most cases are type I quantitative or type II qualitative deficiency, both AD).\n\n\n**Answer: Autosomal dominant**\n\n\n\\boxed{Autosomal\\ dominant}",
    "expected_answer": "Autosomal dominant",
    "time": 24.823015928268433,
    "answer_length": 1478,
    "retrieval_time": 0.017750024795532227,
    "generation_time": 24.795081853866577
  },
  {
    "question": "A 26-year-old male presents to his primary care physician with complaints of burning with urination, penile discharge, and intermittent fevers. A urethral smear shows gram negative diplococci within white blood cells. The organism grows well when cultured on Thayer-Martin agar. The patient is prescribed a course of ceftriaxone and the infection resolves without further complication. One year later, the patient returns with the same infection. Which of the following best explains this lack of lasting immunity?",
    "answer": "To explain the lack of lasting immunity in this case, we first identify the causative organism: **Neisseria gonorrhoeae** (gram-negative diplococci in white blood cells, growth on Thayer-Martin agar).  \n\n\n### Key Mechanism: Antigenic Variation  \nN. gonorrhoeae evades long-term immunity via **frequent antigenic variation of its surface structures**, specifically:  \n- **Pili**: Critical for attachment to host cells; hypervariable regions in pilin genes undergo recombination or switching, producing new pilin variants.  \n- **Opa proteins**: Outer membrane proteins involved in cell adhesion; expression of distinct Opa alleles is switched on/off.  \n\nThese constant changes in surface antigens mean the host’s immune system (and any preformed antibodies/memory cells from prior infection) cannot recognize the new variant. Thus, reinfection with a genetically distinct strain is possible.  \n\n\n**Answer:** Antigenic variation of surface structures (pili and Opa proteins) by Neisseria gonorrhoeae prevents the host immune system from mounting a protective memory response against subsequent infections.\n\n\n\\boxed{Antigenic variation of surface antigens (pili and Opa proteins)}",
    "expected_answer": "Antigenic variation",
    "time": 15.23817229270935,
    "answer_length": 1176,
    "retrieval_time": 0.014672040939331055,
    "generation_time": 15.211200952529907
  },
  {
    "question": "A 37-year-old man with no significant past medical history is rear-ended in a motor vehicle accident. He reported significant neck pain to emergency responders, but otherwise denies weakness, numbness or tingling in his extremities. His vitals on presentation to the ED are HR 90, BP 140/80, RR 20, SpO2 98%. What is the most appropriate next step upon presentation to the emergency room?",
    "answer": "To address this question, we rely on standard trauma management principles (ATLS guidelines) and cervical spine injury assessment:\n\n\n### Key Analysis of the Patient:  \nThe patient is a 37-year-old with **neck pain after a rear-end motor vehicle accident** (a classic mechanism for cervical spine injury, e.g., whiplash). He has no focal neurologic deficits but reports significant neck pain—placing him at risk for cervical spine injury until proven otherwise.\n\n\n### Next Step Rationale:  \nPer ATLS, **immediate cervical spine immobilization** (e.g., application of a rigid cervical collar) is required for any trauma patient with potential cervical spine injury (neck pain, mechanism of injury, or altered mental status) before further evaluation (imaging, etc.). This prevents secondary spinal cord damage.\n\n\n**Answer:** Immobilize the cervical spine with a rigid cervical collar.  \n\n(Note: If imaging options were provided, the next step after immobilization would be a cervical spine CT, but the immediate next step upon presentation is immobilization.)\n\n\n\\boxed{Immobilize the cervical spine with a rigid cervical collar}",
    "expected_answer": "Cervical immobilization",
    "time": 26.523509979248047,
    "answer_length": 1126,
    "retrieval_time": 0.07466292381286621,
    "generation_time": 26.498370885849
  },
  {
    "question": "A 43-year-old man with a history of schizophrenia, currently controlled with medication, comes in for an appointment with his internist. He is concerned about abnormal discharge from both nipples over the past 3 months. The fluid is white, and he wonders if it could be milk. On further review of systems, he endorses a diminished sexual drive. The physician suspects that one of the patient's medications may be the culprit for these symptoms. Which of the following medications is NOT likely to be the cause?",
    "answer": "To answer this question, we first link the patient’s symptoms (galactorrhea, diminished libido) to **hyperprolactinemia**. Prolactin release is inhibited by dopamine (via the tuberoinfundibular pathway), so medications that block dopamine D2 receptors increase prolactin levels. The key is identifying which antipsychotic does NOT cause this effect.\n\n\n### Key Background:\n- **First-generation antipsychotics** (e.g., haloperidol, chlorpromazine): Strong D2 blockers → hyperprolactinemia.  \n- **Second-generation antipsychotics**:  \n  - Risperidone: Strong D2 blocker → hyperprolactinemia.  \n  - Olanzapine: Mild D2 blockade → occasional hyperprolactinemia.  \n  - **Aripiprazole**: Partial D2 agonist (not a blocker) → does NOT increase prolactin (it preserves dopamine’s inhibitory effect on prolactin).  \n  - Clozapine/quetiapine: Weak D2 blockade → low risk of hyperprolactinemia.  \n\n\n### Conclusion:\nThe medication **unlikely to cause hyperprolactinemia** (and thus the patient’s symptoms) is **aripiprazole**.\n\n\n**Answer: Aripiprazole** (assuming this is an option; it is the most common correct answer for this scenario).  \n(Note: If Clozapine/quetiapine are options, they are also low-risk, but Aripiprazole is the classic \"non-hyperprolactinemic\" antipsychotic.)\n\n\n**Final Answer:**  \n$\\boxed{Aripiprazole}$",
    "expected_answer": "Bromocriptine",
    "time": 623.4971241950989,
    "answer_length": 1314,
    "retrieval_time": 0.012192010879516602,
    "generation_time": 623.4716420173645
  },
  {
    "question": "A 2-day-old male newborn is brought to the physician because of yellowing of the skin and sclerae for 16 hours. He had previously been well. He was born at 38 weeks' gestation via uncomplicated vaginal delivery and weighed 3.1 kg (6 lb 13 oz). The mother has no medical insurance and did not receive prenatal care. The newborn's 4-year-old brother has sickle cell disease. Examination shows jaundice. The abdomen is mildly distended. The liver is palpated 1 cm below the right costal margin and the spleen tip is palpated just below the left costal margin. Laboratory studies show:\nHemoglobin 11 g/dL\nReticulocytes 9%\nLeukocytes 9,100/mm3\nPlatelets 244,000/mm3\nMaternal blood group 0, Rh-negative\nAnti-Rh antibody titer positive\nFetal blood group B, Rh-negative\nSerum\nBilirubin, total 11.3 mg/dL\nDirect 0.3 mg/dL\nWhich of the following is the most likely cause of this patient's condition?\"",
    "answer": "To determine the most likely cause of the newborn’s condition, we analyze the key clinical and lab findings step-by-step:\n\n\n### **Key Clinical & Lab Findings**  \n- **Newborn**: 2-day-old, jaundice (onset ~32h), mild hepatosplenomegaly, anemia (Hb=11g/dL, normal newborn Hb=14-20g/dL), elevated reticulocytes (9%, normal <5% → hemolysis), indirect hyperbilirubinemia (total bilirubin 11.3mg/dL, direct 0.3mg/dL).  \n- **Maternal/Family**: Mom is O Rh-negative (anti-Rh titer positive), baby is B Rh-negative; brother has sickle cell disease.  \n\n\n### **Ruling Out Other Causes**  \n1. **Rh incompatibility**: Eliminated because the baby is Rh-negative (Rh disease requires baby Rh+).  \n2. **Sickle cell disease**: Unlikely—newborns have high HbF (resistant to sickling), so symptoms start at ~6 months when HbF declines.  \n3. **Sepsis/Congenital infection**: WBC/platelets are normal (no leukocytosis/leukopenia, thrombocytopenia), so no.  \n4. **Hereditary spherocytosis**: No family history (brother has sickle cell, not HS), so less likely.  \n\n\n### **ABO Incompatibility: The Most Likely Cause**  \n- **Mechanism**: O mom produces anti-A/anti-B IgG (crosses placenta) → attacks baby’s B blood group red cells.  \n- **Features**: Mild-to-moderate hemolysis, jaundice (24-48h onset), anemia, and occasional hepatosplenomegaly (consistent with this case).  \n\n\n**Answer: ABO incompatibility** (Note: Exact option wording may vary, but this is the correct diagnosis.)\n\n\n\\boxed{ABO\\ incompatibility}",
    "expected_answer": "Anti-B antibodies",
    "time": 37.60160803794861,
    "answer_length": 1489,
    "retrieval_time": 0.0195770263671875,
    "generation_time": 37.579850912094116
  },
  {
    "question": "A 65-year old man presents with gradually worsening rigidity of his arms and legs and slowness in performing tasks. He says he has also noticed hand tremors, which increase at rest and decrease with focused movements. On examination, the patient does not swing his arms while walking and has a shortened, shuffling gait. An antiviral drug is prescribed which alleviates the patient’s symptoms. Which of the following drugs was most likely prescribed to this patient?",
    "answer": "To solve this question, we first identify the patient’s condition and then match it to the antiviral drug used for that condition.\n\n\n### Step 1: Diagnose the patient’s condition  \nThe patient’s symptoms (**resting tremor, rigidity, bradykinesia, shuffling gait, reduced arm swing**) are classic for **Parkinson’s disease**—a neurodegenerative disorder caused by dopamine deficiency in the basal ganglia.\n\n\n### Step 2: Identify the antiviral drug for Parkinson’s disease  \nAmong antiviral medications, **Amantadine** is uniquely used to treat Parkinson’s disease. It works by:  \n- Increasing dopamine release in the brain  \n- Blocking NMDA receptors (reducing excitotoxicity)  \n\nOther antivirals (e.g., acyclovir, oseltamivir, ribavirin) have no role in Parkinson’s management.\n\n\n**Answer: Amantadine**",
    "expected_answer": "Amantadine",
    "time": 11.471313714981079,
    "answer_length": 801,
    "retrieval_time": 0.015330076217651367,
    "generation_time": 11.445607900619507
  },
  {
    "question": "The patient is given prophylactic labetalol and magnesium sulfate. Examination shows absent deep tendon reflexes bilaterally. Which of the following is the most appropriate next step in the management of this patient?",
    "answer": "To determine the appropriate next step, we analyze the key findings and context:\n\n\n### Key Observations  \n- The patient is receiving **magnesium sulfate** (prophylactic, likely for preeclampsia).  \n- **Absent deep tendon reflexes (DTRs)** are present bilaterally.  \n\n\n### Critical Link: Magnesium Toxicity  \nMagnesium sulfate has a narrow therapeutic window (4–7 mEq/L). Toxicity (levels >7 mEq/L) first manifests as **loss of DTRs** (an early warning sign). Subsequent toxic effects include respiratory depression and cardiac arrest.  \n\nLabetalol (an alpha/beta-blocker) does not cause absent DTRs—its side effects are hypotension, bradycardia, etc.  \n\n\n### Next Step  \nThe first action for magnesium toxicity (absent DTRs) is to **immediately discontinue the magnesium sulfate infusion** to prevent progression to severe toxicity.  \n\n\n**Answer:** Discontinue the magnesium sulfate infusion.",
    "expected_answer": "Stop magnesium sulfate and give calcium gluconate",
    "time": 16.183382749557495,
    "answer_length": 892,
    "retrieval_time": 0.010535955429077148,
    "generation_time": 16.15572214126587
  },
  {
    "question": "A 75-year-old woman is brought by a patrolman to the emergency department because of altered mental status. She was found wandering next to the highway. The patient was unable to answer questions and collapsed in transit. Her vitals are: temperature, 33.0°C (91.4°F); pulse, 40/min; respirations,12/min; blood pressure, 80/50 mm Hg; and oxygen saturation, 85% on room air. Physical examination shows decorticate posturing, incomprehensible speech, eyes opening to pain, dry hair, coarse and waxy skin, and non-pitting edema around the face and all extremities. Electrocardiogram shows sinus bradycardia. Laboratory studies show:\nCalcium 9.0 mg/dL\nHematocrit (female) 34%\nPotassium 4.0 mEq/L\nSodium 120 mEq/L\nTSH 110.0 µU/mL\nThyroxine (T4) 1.2 µg/dL\nTriiodothyronine (T3) 70 ng/dL\nWhich of the following is the most likely diagnosis in this patient?",
    "answer": "To determine the most likely diagnosis, we analyze the patient’s key clinical and laboratory findings:\n\n\n### **Key Clinical Features**  \n- **Severe hypothyroidism signs**: Dry hair, coarse/waxy skin, non-pitting edema (myxedema).  \n- **Systemic decompensation**: Hypothermia (33°C), bradycardia (40/min), hypotension (80/50 mmHg), altered mental status (wandering, collapse, decorticate posturing).  \n- **Electrolyte abnormality**: Hyponatremia (120 mEq/L, common in severe hypothyroidism due to impaired free water excretion).  \n\n\n### **Laboratory Confirmation of Severe Hypothyroidism**  \n- **TSH**: 110 µU/mL (markedly elevated, indicating primary hypothyroidism).  \n- **Free/total T4**: 1.2 µg/dL (low).  \n- **T3**: 70 ng/dL (low).  \n\n\n### **Diagnosis**  \nThese findings are pathognomonic for **myxedema coma**—the life-threatening, most severe form of hypothyroidism. Despite the term \"coma,\" patients may present with severe altered mental status (not just frank coma). Triggers (e.g., cold exposure, as suggested by her being found outdoors) often precipitate decompensation in undiagnosed/untreated hypothyroidism.\n\n\n**Answer: Myxedema coma**",
    "expected_answer": "Myxedema coma",
    "time": 21.381060123443604,
    "answer_length": 1150,
    "retrieval_time": 0.30101513862609863,
    "generation_time": 21.35373592376709
  },
  {
    "question": "A 66-year-old male presents to his primary care physician to discuss his increasing shortness of breathover the last 3 months. He notes that this is particularly obvious when he is mowing his lawn or climbing the stairs in his home. His past medical history is significant for hypertension that is well-controlled with lisinopril. His vital signs are as follows: T 37.6 C, HR 88, BP 136/58, RR 18, SpO2 97% RA. Physical examination is significant for an early diastolic blowing, decrescendo murmur heard best at the left sternal border, a midsystolic murmur heard best at the right upper sternal border, and a late diastolic rumbling murmur heard best at the apex on auscultation. In addition, an S3 heart sound is also present. Bounding pulses are palpated at the radial arteries bilaterally. Which of the following diagnoses is most likely in this patient?",
    "answer": "To determine the most likely diagnosis, we analyze the **key clinical findings** and their associations:\n\n\n### **1. Vital Signs & Physical Exam Clues**  \n- **Wide pulse pressure (136/58 → 78 mmHg)** + **bounding pulses**: Classic for **aortic regurgitation (AR)** (diastolic blood pressure drops due to retrograde flow into the left ventricle [LV]).  \n- **S3 heart sound**: Indicates **LV volume overload** (common in AR, as regurgitant blood increases LV filling).  \n\n\n### **2. Auscultation Findings**  \n- **Early diastolic blowing decrescendo murmur (left sternal border [LSB])**: Pathognomonic for **AR** (retrograde flow from aorta to LV during diastole).  \n- **Midsystolic murmur (right upper sternal border [RUSB])**: Classic for **aortic stenosis (AS)** (ejection through a narrowed aortic valve during systole).  \n- **Late diastolic rumbling murmur (apex)**: **Austin Flint murmur**—a functional murmur in severe AR, caused by regurgitant blood hitting the anterior mitral valve leaflet (mimicking mitral stenosis but not true stenosis).  \n\n\n### **3. Context**  \n- **Age (66yo male)**: Degenerative aortic valve disease (common in older adults) often presents with **combined AS and AR** (calcification leads to both stenosis and regurgitation).  \n- **Hypertension**: A risk factor for degenerative valve disease.  \n\n\n### **Conclusion**  \nAll findings align with **combined aortic stenosis and aortic regurgitation** (degenerative aortic valve disease).\n\n\n**Answer: Combined aortic stenosis and aortic regurgitation** (or degenerative aortic valve disease with both stenosis and regurgitation).  \n\nThe most direct diagnosis here is **combined aortic stenosis and aortic regurgitation**.  \n\n\\boxed{Combined aortic stenosis and aortic regurgitation}",
    "expected_answer": "Aortic regurgitation",
    "time": 30.638389110565186,
    "answer_length": 1755,
    "retrieval_time": 0.02039194107055664,
    "generation_time": 30.61099863052368
  },
  {
    "question": "A 28-year-old woman presents following a suicide attempt 2 days ago. She says that her attempt was a result of a fight with her boyfriend and that she slit her wrists in an attempt to keep him from breaking up with her. In the past, she has had many turbulent relationships, both romantic and in her family life. Her family members describe her as being very impulsive and frequently acting to manipulate people’s feelings. Since she was admitted to the hospital, she has spit at several staff members and alternated between sobbing and anger. She has no significant past medical history. The patient denies any history of smoking, alcohol use, or recreational drug use. Which of the following is the most likely diagnosis in this patient?",
    "answer": "The most likely diagnosis is **Borderline Personality Disorder (BPD)**.\n\n\n### Key Reasoning:  \nThe patient’s presentation aligns with core features of BPD:  \n1. **Fear of abandonment**: Her suicide attempt was explicitly to prevent her boyfriend from breaking up with her.  \n2. **Unstable/turbulent relationships**: Described as having chronic issues in romantic and family relationships.  \n3. **Emotional lability**: Rapid shifts between sobbing and anger since admission.  \n4. **Impulsivity and manipulative behavior**: Family reports frequent impulsivity and manipulation of others’ feelings; her self-harm (wrist-slitting) was a manipulative act to avoid abandonment.  \n5. **Recurrent suicidal gestures**: This is a hallmark of BPD, often used to regulate relationships or emotions.  \n\n\nOther personality disorders (e.g., histrionic, antisocial) do not match the constellation of fear of abandonment, emotional instability, and manipulative self-harm seen here. Substance use or medical causes are ruled out.  \n\n**Answer: Borderline Personality Disorder**",
    "expected_answer": "Borderline personality disorder",
    "time": 12.9152991771698,
    "answer_length": 1059,
    "retrieval_time": 0.015284061431884766,
    "generation_time": 12.887945890426636
  },
  {
    "question": "A 50-year-old man presents to his primary care doctor following an inguinal hernia repair. The patient reports no pain in his lower abdomen or groin, no constipation, and states that he enjoys his usual diet. He denies any use of alcohol, tobacco, or illicit drugs. He has returned to work as a cruise ship attendant. Preoperative workup included chest radiography which demonstrated an opacification in his right middle lobe. The patient agrees to undergo computed tomography (CT) of his chest without contrast for further evaluation. The radiologist reports an 8 mm nodule in the patient's peripheral right middle lobe that has regular margins and appears calcified. One year later, the patient obtains another chest CT without contrast that reports the nodule size as 10 mm with similar characteristics. What is the most appropriate next step in management?",
    "answer": "To determine the most appropriate next step, we analyze the key features of the lung nodule and apply standard guidelines (Fleischner criteria) for low-risk patients (non-smoker, no malignancy history):\n\n\n### Key Observations  \n- **Nodule characteristics**: 8mm → 10mm over 1 year (volume ~doubled, doubling time ~365 days), but **calcified with regular margins** (classic benign features: calcification suggests old infection/granuloma; regular margins rule out aggressive growth).  \n- **Patient risk**: Low (non-smoker, 50yo, no other risk factors).  \n\n\n### Guidelines Application  \nCalcified nodules are almost always benign. Even with slow growth (~doubling time 365 days), the benign features (calcification, regular margins) outweigh malignancy concerns. For such cases:  \n- Follow-up CT is recommended to confirm stability (since growth was noted).  \n\n\n### Most Appropriate Next Step  \n**Repeat chest CT in 6 months** to monitor for further growth or changes in characteristics.  \n\n\nAnswer: Repeat chest CT in 6 months.  \n\n(Note: If options included \"follow-up CT in 6 months\" or similar, this would be the correct choice.)  \n\\boxed{Repeat chest CT in 6 months}",
    "expected_answer": "Positive emission tomography (PET) of chest now",
    "time": 39.61834192276001,
    "answer_length": 1168,
    "retrieval_time": 0.016700029373168945,
    "generation_time": 39.59054899215698
  },
  {
    "question": "A 29-year-old man comes in for evaluation of infertility. He has been trying to conceive for over 2 years with his wife and previous evaluation of his wife's fertility revealed no abnormalities. Physical exam reveals a tall man with long extremities, sparse body hair, gynecomastia, and small testes. Laboratory studies reveal increased serum follicle-stimulating hormone concentration and an increased estradiol:testosterone ratio. Genetic studies reveal a cytogenetic abnormality. If this abnormality was inherited from the patient's father, at which stage of spermatogenesis did this error most likely occur?",
    "answer": "To solve this question, we first identify the patient’s condition and then trace the genetic error to its origin in spermatogenesis.\n\n\n### Step 1: Diagnose the Condition  \nThe patient’s features (infertility, tall stature with long extremities, gynecomastia, small testes, elevated FSH, increased estradiol/testosterone ratio) are classic for **Klinefelter syndrome (47, XXY)**.  \n\n\n### Step 2: Determine the Paternal Origin of the Error  \nKlinefelter syndrome (XXY) can arise from two sources:  \n- **Maternal**: Non-disjunction in oogenesis (meiosis I or II) leading to an egg with 2 X chromosomes, fertilized by a Y sperm.  \n- **Paternal**: Non-disjunction in spermatogenesis leading to a sperm with both X and Y chromosomes, fertilized by an X egg.  \n\nThe question specifies the error is inherited from the father, so we focus on paternal spermatogenesis.  \n\n\n### Step 3: Identify the Stage of Spermatogenesis  \nIn spermatogenesis:  \n- **Meiosis I**: Homologous chromosomes (X and Y) pair and separate. If non-disjunction occurs here, one sperm receives both X and Y chromosomes (XY), and the other receives none.  \n- **Meiosis II**: Sister chromatids separate. Non-disjunction here would result in sperm with XX or YY (not XY).  \n\nSince the paternal contribution is XY (to form XXY), the error must be **non-disjunction in meiosis I of spermatogenesis**.  \n\n\n**Answer: Meiosis I** (or Primary spermatocyte stage, but the key is meiosis I).  \n\n\\boxed{Meiosis\\ I}",
    "expected_answer": "Primary spermatocyte",
    "time": 17.68833899497986,
    "answer_length": 1465,
    "retrieval_time": 0.01491999626159668,
    "generation_time": 17.660552263259888
  },
  {
    "question": "A 13-year-old boy presents to the emergency department with severe knee, hip, and groin pain. The patient has a past medical history notable only for obesity and asthma. His temperature is 98°F (36.7°C), blood pressure is 124/65 mmHg, pulse is 128/min, respirations are 14/min, and oxygen saturation is 99% on room air. Physical exam is notable for an inability of the patient to bear weight on his left leg and limited range of motion of the left hip. Which of the following is the best management for this patient?",
    "answer": "To determine the best management for this patient, we first identify the likely diagnosis based on the clinical presentation: **slipped capital femoral epiphysis (SCFE)**. Key features supporting this are:  \n- Obese 13-year-old male (peak age: 10–16 years, strong association with obesity).  \n- Hip/groin pain (often referred to the knee).  \n- Inability to bear weight on the affected leg (unstable SCFE).  \n- Limited hip range of motion.  \n\n\n### Management of SCFE  \nUnstable SCFE (patient cannot bear weight) requires **emergency surgical intervention** to prevent further slippage, avascular necrosis, or chondrolysis. The definitive treatment for SCFE (both stable and unstable) is **surgical pinning in situ** to stabilize the slipping epiphysis.  \n\nImmediate steps include non-weight bearing and imaging (X-rays of hips: AP and frog-leg lateral) to confirm diagnosis, but the **best definitive management** is surgical pinning.  \n\n\n**Answer:** Surgical pinning (assuming this is an option; if immediate management is asked, non-weight bearing and X-ray would be correct, but definitive is surgical pinning).  \n\nGiven the context of inability to bear weight (unstable SCFE), the answer is **surgical pinning**.\n\n\n\\boxed{Surgical pinning}",
    "expected_answer": "Surgical pinning of the femoral head",
    "time": 24.210817098617554,
    "answer_length": 1242,
    "retrieval_time": 0.07003593444824219,
    "generation_time": 24.18575620651245
  },
  {
    "question": "A 28-year-old man comes to the physician because of diarrhea and crampy abdominal pain for 5 weeks. He has had up to 4 bowel movements per day. Several times he noticed mucoid strings with the stool. He has abdominal bloating. Over the past month, has had a 3.2-kg (7-lb) weight loss. He has not had fever, cough, or bloody stools. He had a painful rash on his lower extremity 3 weeks ago that resolved spontaneously. He works as a pharmacy technician. His temperature is 37.3°C (98.8°F), pulse is 85/min, and blood pressure is 115/77 mm Hg. The abdomen is soft and nontender. His hemoglobin concentration is 11.9 g/dL, MCV is 79 fL, ferritin is 106 ng/dL, and platelet count is 410,000/mm3; serum concentrations of glucose, creatinine, and electrolytes are within the reference range. This patient's condition is most likely associated with which of the following findings?",
    "answer": "To determine the associated finding, we first analyze the patient's clinical presentation and identify the likely diagnosis:\n\n\n### Key Clinical Features  \n- **Chronic gastrointestinal symptoms**: 5 weeks of non-bloody diarrhea (4/day), crampy abdominal pain, bloating, and 3.2kg weight loss (suggests malabsorption/inflammation).  \n- **Mucoid stools**: No blood (distinguishes from ulcerative colitis, which typically has bloody diarrhea).  \n- **Extraintestinal manifestation**: Painful lower extremity rash (resolved spontaneously) → **erythema nodosum** (classic for Crohn’s disease).  \n- **Mild microcytic anemia**: Likely due to chronic inflammation or malabsorption (Crohn’s often affects nutrient absorption).  \n\n\n### Likely Diagnosis  \n**Crohn’s disease** (transmural, skip lesions, non-bloody diarrhea, weight loss, and extraintestinal findings like erythema nodosum).  \n\n\n### Classic Associated Finding for Crohn’s Disease  \nThe most specific histopathologic finding for Crohn’s disease is **noncaseating granulomas** on intestinal biopsy. Other common associations include skip lesions, transmural inflammation, or perianal fistulas.  \n\n\n**Answer**: Noncaseating granulomas (or the corresponding option reflecting Crohn’s disease pathology).  \n\n(Note: Assuming the missing options include this finding, as it is the hallmark association.)\n\n\n\\boxed{Noncaseating granulomas}",
    "expected_answer": "Stool leukocytes",
    "time": 34.79857778549194,
    "answer_length": 1382,
    "retrieval_time": 0.013514995574951172,
    "generation_time": 34.7871298789978
  },
  {
    "question": "A 51-year-old man is brought to the emergency department because of a 2-day history of fever, abdominal pain, and confusion. His wife states that he has been unable to recall his birthday or her name. He was diagnosed with hepatitis C 3 years ago but refused treatment. He has been treated twice in the past year for acute pancreatitis. There is no family history of serious illness. His only medication is a calcium supplement. He emigrated from India 15 years ago. He appears ill. His temperature is 38.3°C (100.9°F), pulse is 101/min, and blood pressure is 104/68 mm Hg. He is confused and oriented only to person. Examination shows scleral icterus and spider angiomas. There are fine tremors of the hands bilaterally. The abdomen is distended and shifting dullness is present. There is diffuse tenderness to palpation with no guarding. Bowel sounds are absent. Laboratory studies show:\nHemoglobin 12.6 g/dL\nLeukocyte count 13,900/mm3\nPlatelet count 342,000/mm3\nSerum\nAlbumin 2.6 g/dL\nTotal bilirubin 2.56 mg/dL\nAlkaline phosphatase 54 U/L\nAST 17 U/L\nALT 44 U/L\nParacentesis is performed. Ascitic fluid analysis shows an albumin concentration of 0.8 g/dL, glucose concentration of 62 mg/dL, and a leukocyte count of 1900/mm3 with 60% neutrophils. Which of the following is the most likely explanation for these findings?\"",
    "answer": "To determine the most likely explanation for the patient’s findings, we analyze the key clinical and laboratory data step-by-step:\n\n\n### **Key Clinical Context**  \nThe patient has **untreated hepatitis C (3 years)** → likely cirrhosis (evidenced by spider angiomas, ascites [shifting dullness], hypoalbuminemia [2.6 g/dL], jaundice [scleral icterus], and confusion [hepatic encephalopathy]). He also has recent fever, abdominal pain, and absent bowel sounds.\n\n\n### **Paracentesis Findings**  \n- **Ascitic fluid neutrophil count**: 1900/mm³ × 60% = **1140/mm³** (normal <250/mm³ → highly elevated).  \n- **Serum-ascites albumin gradient (SAAG)**: 2.6 (serum) - 0.8 (ascitic) = **1.8 g/dL** (≥1.1 → confirms portal hypertension, consistent with cirrhosis).  \n- **Glucose**: 62 mg/dL (not severely low, ruling out secondary peritonitis from bowel perforation, which typically has glucose <50 mg/dL).  \n\n\n### **Diagnosis**  \n**Spontaneous bacterial peritonitis (SBP)** is the most likely explanation. SBP is a bacterial infection of ascitic fluid in cirrhosis patients with no obvious intra-abdominal source (e.g., perforation). The elevated neutrophil count confirms infection, and the clinical picture (fever, abdominal pain) plus encephalopathy (precipitated by infection) aligns with SBP.\n\n\n**Answer:** Spontaneous bacterial peritonitis complicating cirrhosis due to untreated hepatitis C.  \n\n(Note: If options were provided, the correct choice would explicitly mention spontaneous bacterial peritonitis in the setting of cirrhosis.)\n\n\n\\boxed{Spontaneous bacterial peritonitis}",
    "expected_answer": "Bacterial translocation",
    "time": 30.612410068511963,
    "answer_length": 1576,
    "retrieval_time": 0.017460107803344727,
    "generation_time": 30.587205171585083
  },
  {
    "question": "An 18-month-old girl is brought to the emergency department because of a cough that her parents are worried about. She has had a runny nose and a low-grade fever for the past 2 days, with some hoarseness and a rough-sounding cough that started this afternoon. This evening she began making some high-pitched sounds when taking breaths, and she seemed to be having some trouble breathing. She is alert and does not appear to be in acute distress. She has a temperature of 38.0°C (100.4 °F), with a respiratory rate of 50/min and O2 saturation of 97%. There is audible inspiratory stridor that worsens when she starts to cry during the examination. She has an occasional barking cough. Her pharynx is mildly erythematous with normal tonsils and no exudate. A frontal X-ray of the upper chest airways is obtained (shown in the image). Which of the following is the best step in management?",
    "answer": "To determine the best management step, we first diagnose the condition and then apply evidence-based guidelines:\n\n\n### **Step 1: Diagnosis**  \nThe 18-month-old has **croup (laryngotracheobronchitis)**, a viral infection (most often parainfluenza virus) characterized by:  \n- Preceding URI symptoms (runny nose, low fever).  \n- Classic \"barking cough,\" hoarseness, and inspiratory stridor (worse with crying).  \n- Alert status, normal oxygen saturation (97%), no acute distress (mild-to-moderate severity).  \n\n\n### **Step 2: Key Management Principles for Croup**  \nCroup is caused by airway inflammation, so anti-inflammatory therapy is the cornerstone:  \n- **Glucocorticoids (dexamethasone):** Indicated for *all cases* of croup (mild to severe) because it reduces airway edema, shortens symptom duration, and lowers hospitalization risk. The standard dose is 0.15–0.6 mg/kg (single oral or IM dose).  \n- **Nebulized racemic epinephrine:** Reserved for **moderate-to-severe croup** (stridor at rest, respiratory distress, hypoxia)—not needed here since the patient has no rest stridor or distress.  \n- **Antibiotics:** Useless (viral etiology).  \n- **Albuterol:** For asthma, not croup.  \n- **Cool mist:** Limited evidence of benefit; not a first-line therapy.  \n\n\n### **Best Step in Management**  \n**Oral dexamethasone** is the first-line treatment for this patient’s mild-to-moderate croup.\n\n\n**Answer:** Oral dexamethasone. (Assuming this is one of the options; it is the standard of care.)  \n\n\\boxed{Oral dexamethasone}",
    "expected_answer": "Racemic epinephrine and intramuscular corticosteroid therapy",
    "time": 28.401906967163086,
    "answer_length": 1523,
    "retrieval_time": 0.018877029418945312,
    "generation_time": 28.37655019760132
  },
  {
    "question": "A 43-year-old woman presents with complaints of retrosternal burning associated with eating. It has persisted for the past several years but has been getting worse. Her past medical history is unknown and this is her first time seeing a doctor. She states she is otherwise healthy and review of systems is notable for episodic hand pain that is worse in the winter as well as a chronic and severe cough with dyspnea which she attributes to her smoking. Her temperature is 97.7°F (36.5°C), blood pressure is 174/104 mmHg, pulse is 80/min, respirations are 22/min, and oxygen saturation is 92% on room air. Physical exam is notable for a young appearing woman with coarse breath sounds. Laboratory studies and urinalysis are ordered and currently pending. Which of the following is the pathophysiology of this patient's chief complaint?",
    "answer": "To determine the pathophysiology of the patient’s chief complaint (retrosternal burning associated with eating), we first identify the likely diagnosis: **gastroesophageal reflux disease (GERD)**. Here’s the breakdown:\n\n\n### Key Clinical Clues for GERD  \nRetrosternal burning (heartburn) triggered by eating is the hallmark of GERD. This symptom arises from the reflux of acidic gastric contents into the esophagus, which lacks the protective mucosal barrier of the stomach.  \n\n\n### Pathophysiology of GERD  \nThe primary mechanism underlying GERD is **dysfunction of the lower esophageal sphincter (LES)**. The LES normally maintains a high resting tone to prevent reflux of stomach contents into the esophagus. When the LES is weak, relaxes inappropriately (e.g., after meals), or is compromised by factors like hiatal hernia or delayed gastric emptying, gastric acid and bile flow back into the esophagus. This irritates the esophageal mucosa, leading to the burning sensation (heartburn).  \n\n\n### Distinguishing from Other Symptoms  \nOther findings (Raynaud’s-like hand pain, COPD symptoms from smoking, hypertension) are unrelated to her chief complaint and do not alter the pathophysiology of her GERD.  \n\n\n**Answer:** Reflux of gastric acid into the esophagus due to impaired lower esophageal sphincter function.  \n\n(Note: If formatted as a multiple-choice option, the correct choice would explicitly reference LES dysfunction and gastric content reflux into the esophagus.)  \n\n\\boxed{Impaired lower esophageal sphincter function leading to reflux of gastric acid into the esophagus}",
    "expected_answer": "Esophageal fibrosis",
    "time": 15.832381010055542,
    "answer_length": 1589,
    "retrieval_time": 0.016933917999267578,
    "generation_time": 15.80561876296997
  },
  {
    "question": "A 67-year-old man with chronic kidney disease comes to the physician because of worsening fatigue and shortness of breath on exertion for 6 months. He has a 20-year history of poorly-controlled type 2 diabetes mellitus. Current medications include metformin and insulin. His pulse is 105/min. Examination shows conjunctival pallor and bounding pulses. Laboratory studies show:\nHemoglobin 8.6 g/dL\nMean corpuscular volume 90 μm3\nReticulocyte count 0.5%\nSerum\nFerritin 325 ng/mL\nUrea nitrogen 45 mg/dL\nCreatinine 2.2 mg/dL\nThe patient is prescribed a drug to treat the cause of his current symptoms. The drug's mechanism of action directly involves which of the following signaling pathways?\"",
    "answer": "To solve this question, we analyze the patient’s condition, identify the cause of their anemia, determine the appropriate drug, and then link the drug’s mechanism to the relevant signaling pathway.\n\n\n### **Step 1: Identify the Patient’s Anemia**  \nThe patient has chronic kidney disease (CKD) from poorly controlled diabetes. Key findings:  \n- **Anemia**: Fatigue, dyspnea, conjunctival pallor, Hb 8.6 g/dL (low).  \n- **Normocytic, hypoproliferative**: MCV 90 μm³ (normocytic), reticulocyte count 0.5% (low, indicating reduced RBC production).  \n- **No iron deficiency**: Ferritin 325 ng/mL (normal/high, ruling out iron deficiency).  \n\n**Cause**: CKD reduces erythropoietin (EPO) production by renal peritubular cells. EPO is critical for erythroid progenitor cell proliferation/differentiation in bone marrow.\n\n\n### **Step 2: Drug Prescribed**  \nThe drug is an **erythropoiesis-stimulating agent (ESA)** (e.g., epoetin alfa, darbepoetin alfa), which mimics endogenous EPO.\n\n\n### **Step 3: Mechanism of ESA**  \nESA binds to the EPO receptor (EPO-R) on erythroid progenitors. The EPO-R is a cytokine receptor associated with **JAK kinases**:  \n1. EPO binding induces EPO-R dimerization.  \n2. JAK kinases (JAK2) are activated, phosphorylating the receptor and STAT proteins (STAT5).  \n3. Phosphorylated STAT5 dimerizes, translocates to the nucleus, and activates genes for erythropoiesis (e.g., anti-apoptotic Bcl-xL, proliferation/differentiation genes).  \n\n\n### **Conclusion**  \nThe drug’s mechanism directly involves the **JAK-STAT signaling pathway**.\n\n\n**Answer: JAK-STAT signaling pathway** (Note: Exact wording may vary based on options, but this is the correct pathway.)  \n\n\\boxed{JAK-STAT}",
    "expected_answer": "JAK/STAT",
    "time": 23.249415159225464,
    "answer_length": 1697,
    "retrieval_time": 0.1112051010131836,
    "generation_time": 23.22172975540161
  },
  {
    "question": "A 41-year-old man presents to the emergency department with a 6-hour history of muscle cramping, decreased appetite, and diarrhea. He says that these symptoms came on rapidly but does not recall anything that may have triggered the episode. He has never experienced these symptoms before. His past medical history is significant for obesity, sleep apnea, and type 2 diabetes that is well controlled on metformin. He also has gastroesophageal reflux disease for which he occasionally takes antacids. On presentation he is found to have fast, shallow breathing and abdominal pain that is poorly localized. Basic labs as well as an arterial blood gas are obtained and the results are shown below:\n\nNa+: 139 mEq/L\nCl-: 106 mEq/L\nHCO3-: 11 mEq/L\npH: 7.25\npCO2: 22 mmHg\n\nWhich of the following is the most likely cause of the changes seen in this patient's labs?",
    "answer": "To determine the cause of the patient’s lab abnormalities, we first analyze the acid-base status and then correlate it with clinical findings.\n\n\n### **Step 1: Acid-Base Analysis**  \n- **pH**: 7.25 (acidic, normal 7.35-7.45)  \n- **HCO₃⁻**: 11 mEq/L (low, normal 22-28)  \n- **pCO₂**: 22 mmHg (low, normal 35-45)  \n- **Anion Gap (AG)**: Na⁺ - (Cl⁻ + HCO₃⁻) = 139 - (106 +11) = **22** (high, normal 8-12).  \n\nThis confirms **high anion gap metabolic acidosis (HAGMA)** (acidic pH, low HCO₃⁻, high AG) with partial respiratory compensation (low pCO₂, consistent with blowing off CO₂ to correct acidosis).\n\n\n### **Step 2: Clinical Correlation**  \nThe patient presents with:  \n- Acute diarrhea (6 hours) → fluid loss → hypovolemia → reduced tissue perfusion.  \n- Fast, shallow breathing (early compensation for acidosis).  \n\nHypovolemia from diarrhea leads to **anaerobic metabolism** → increased lactic acid production → HAGMA.  \n\nOther possible causes are less likely:  \n- **Diabetic ketoacidosis**: No mention of hyperglycemia or polyuria (patient reports well-controlled T2DM).  \n- **Metformin toxicity**: Rare without renal impairment (no evidence here).  \n- **Diarrheal HCO₃⁻ loss**: Causes normal AG acidosis (not HAGMA).  \n\n\n### **Conclusion**  \nThe most likely cause is **lactic acidosis secondary to hypovolemia from acute diarrhea**.\n\n\n**Answer:** Lactic acidosis (due to hypovolemia from diarrhea)  \n\n(Note: If options were provided, this would align with choices like \"Lactic acidosis\" or \"Hypovolemia-induced lactic acidosis.\")  \n\n\\boxed{Lactic acidosis}",
    "expected_answer": "Metformin",
    "time": 44.699965953826904,
    "answer_length": 1561,
    "retrieval_time": 0.018419981002807617,
    "generation_time": 44.67294692993164
  },
  {
    "question": "A scientist is studying the properties of myosin-actin interactions in a sample of human muscle tissue. She has identified a drug that selectively inhibits phosphate release by the myosin head. If she gives this drug to a sample of human muscle tissue under physiologic conditions, which of the following steps in cross-bridge cycling will most likely be blocked?",
    "answer": "To answer this question, we first review the key steps of cross-bridge cycling and identify where phosphate (Pi) release plays a critical role:\n\n\n### **Cross-Bridge Cycling Steps**  \n1. **ATP Binding**: ATP binds to myosin, causing detachment from actin.  \n2. **ATP Hydrolysis**: Myosin hydrolyzes ATP to ADP + Pi, cocking the myosin head into a high-energy state.  \n3. **Cross-Bridge Formation**: Myosin (with ADP + Pi bound) attaches to actin (exposed by Ca²⁺).  \n4. **Power Stroke**: **Release of Pi from the myosin head** triggers the myosin head to pivot, pulling actin toward the M-line (this is the force-generating step).  \n5. **ADP Release**: ADP dissociates from myosin after the power stroke.  \n6. **Detachment**: New ATP binds to myosin, breaking the cross-bridge.  \n\n\n### **Effect of the Drug**  \nThe drug inhibits Pi release from the myosin head. Since the **power stroke is directly initiated by Pi release**, blocking this step prevents the myosin head from undergoing the force-generating pivot.  \n\n\n**Answer: The power stroke.** (Or, more formally: The step where the myosin head undergoes the power stroke to pull actin filaments.)\n\n\n\\boxed{Power \\ stroke}",
    "expected_answer": "Power stroke",
    "time": 15.049568891525269,
    "answer_length": 1175,
    "retrieval_time": 0.012978315353393555,
    "generation_time": 15.023555994033813
  },
  {
    "question": "A 16-year-old boy with a seizure disorder and cognitive delay is brought to the physician because of progressively worsening right lower extremity weakness for the past 6 months. He does not make eye contact and sits very close to his mother. Physical examination shows a grade 3/6 holosystolic murmur at the cardiac apex. Neurological examination shows decreased strength in the right lower leg with normal strength in the other extremities. Fundoscopic examination shows several multinodular, calcified lesions in the retina bilaterally. A photograph of his skin findings is shown. This patient's condition is most likely due to a mutation in which of the following?",
    "answer": "To solve this question, we analyze the clinical clues and link them to the underlying genetic disorder:\n\n\n### **Key Clinical Clues**  \n1. **Neurologic**: Seizures, cognitive delay, autism spectrum features (no eye contact).  \n2. **Cardiac**: Holosystolic murmur at the apex (likely mitral regurgitation from cardiac rhabdomyomas).  \n3. **Ophthalmic**: Multinodular calcified retinal lesions (retinal astrocytomas/hamartomas).  \n4. **Skin**: Implied (classic lesions in the disorder: ash-leaf spots, angiofibromas, shagreen patches).  \n\n\n### **Diagnosis**  \nThese features are pathognomonic for **Tuberous Sclerosis Complex (TSC)**—a neurocutaneous disorder characterized by hamartomas in multiple organs.  \n\n\n### **Genetic Basis**  \nTSC is caused by mutations in either:  \n- **TSC1** (chromosome 9, encodes hamartin), or  \n- **TSC2** (chromosome 16, encodes tuberin).  \n\nTSC2 mutations are more common (~70% of cases) and are the most frequently tested in clinical contexts.  \n\n\n**Answer: TSC2** (or TSC1, but TSC2 is the expected answer here).  \n\n\\boxed{TSC2}",
    "expected_answer": "TSC1 gene on chromosome 9",
    "time": 20.790593147277832,
    "answer_length": 1060,
    "retrieval_time": 0.01681208610534668,
    "generation_time": 20.76506495475769
  },
  {
    "question": "A 66-year-old man presents to the emergency department with abdominal pain, nausea, and vomiting. He endorses diffuse abdominal tenderness. His past medical history is notable for diabetic nephropathy, hypertension, dyslipidemia, depression, and morbid obesity. He also is currently being treated for an outbreak of genital herpes. His temperature is 99.0°F (37.2°C), blood pressure is 184/102 mmHg, pulse is 89/min, respirations are 18/min, and oxygen saturation is 98% on room air. Physical exam is notable for an obese man in no acute distress. A CT scan of the abdomen with contrast is performed and is unremarkable. The patient is admitted to the observation unit for monitoring of his pain. Notably, the patient's abdominal pain improves after an enema and multiple bowel movements. The patient's evening laboratory values are ordered and return as seen below.\n\nSerum:\nNa+: 141 mEq/L\nCl-: 99 mEq/L\nK+: 4.8 mEq/L\nHCO3-: 11 mEq/L\nBUN: 20 mg/dL\nGlucose: 177 mg/dL\nCreatinine: 3.1 mg/dL\n\nWhich of the following is the most likely etiology of this patient's laboratory derangements?",
    "answer": "To determine the etiology of the patient’s laboratory derangements, we first identify key abnormalities and apply pathophysiologic reasoning:\n\n\n### **Step 1: Identify Lab Abnormalities**  \nThe patient has:  \n- **Metabolic acidosis**: Low serum HCO₃⁻ (11 mEq/L, normal 22-28).  \n- **High anion gap (AG)**: AG = Na⁺ - (Cl⁻ + HCO₃⁻) = 141 - (99 +11) = **31** (normal 8-12), confirming **high AG metabolic acidosis (AGMA)**.  \n- **Renal impairment**: Creatinine 3.1 mg/dL (elevated, consistent with diabetic nephropathy).  \n\n\n### **Step 2: Differential Diagnosis for High AGMA**  \nUsing the mnemonic **MUDPILES**, we prioritize causes relevant to the patient:  \n- **Metformin-induced lactic acidosis (MALA)**:  \n  The patient has diabetic nephropathy (chronic kidney disease) and is likely on metformin (a common antidiabetic agent). Metformin is contraindicated in renal impairment because reduced glomerular filtration leads to drug accumulation, which inhibits mitochondrial oxidative phosphorylation → lactic acid buildup (high AGMA).  \n\n- **Diabetic ketoacidosis (DKA)**: Unlikely—glucose is only 177 mg/dL (DKA typically has glucose >250 mg/dL; euglycemic DKA is rare and not suggested here).  \n\n- **Uremia**: Uremic acidosis occurs with severe renal failure (GFR <15 mL/min), but BUN (20 mg/dL) is not markedly elevated, making this less probable.  \n\n- **Other causes**: No history of methanol/ethylene glycol ingestion, salicylate use, or ischemia (to explain lactic acidosis from hypoperfusion).  \n\n\n### **Conclusion**  \nThe most likely etiology is **metformin-induced lactic acidosis** due to renal impairment from diabetic nephropathy.\n\n\n**Answer: Metformin-induced lactic acidosis** (Note: The exact phrasing may vary, but this is the core cause.)  \n\n(If options were provided, the correct choice would align with this etiology—e.g., \"Metformin use in the setting of renal insufficiency.\")",
    "expected_answer": "Metformin",
    "time": 29.901275873184204,
    "answer_length": 1897,
    "retrieval_time": 0.02114725112915039,
    "generation_time": 29.876307010650635
  },
  {
    "question": "A 56-year-old man comes to the clinic for a check-up. He presents with a 1-year history of worsening shortness of breath and weight loss. He is a former construction worker, and worked in a steel mill when he was in high school. He is an active smoker with a 36-pack-year smoking history. The blood pressure is 130/78 mm Hg, pulse rate is 90/min, respiratory rate is 17/min, and the BMI is 31 kg/m2. The patient is afebrile and the oxygen saturation at rest is 95% on room air. The pulmonary examination reveals a mildly prolonged expiratory phase, and no wheezing or crackles are auscultated. A pulmonary function test is recommended for the patient, and 2 weeks later he returns with a report that shows an FEV1/FVC ratio of 60% and FEV1 of 50% of the predicted value. The lung volumes show a total lung capacity of 110% of predicted value, a residual volume of 115% of predicted value, and a DLCO of 60% of predicted value. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the patient’s clinical history, physical exam, and pulmonary function tests (PFTs) step-by-step:\n\n\n### **Key Clinical Findings**  \n- **Risk Factors**: 36-pack-year smoking history (major for COPD) + former steel mill work (exposure to iron oxide, but benign pneumoconiosis like siderosis does not explain the PFT abnormalities).  \n- **Symptoms**: Worsening shortness of breath (1 year) + weight loss (classic for emphysema).  \n- **Exam**: Mildly prolonged expiratory phase (obstructive pattern).  \n- **PFTs**:  \n  - **FEV₁/FVC ratio = 60%**: <70% → **obstructive airflow limitation** (diagnostic for COPD).  \n  - **FEV₁ = 50% predicted**: Moderate obstruction.  \n  - **RV = 115% predicted**: Elevated (air trapping, typical of COPD).  \n  - **DLCO = 60% predicted**: Reduced (alveolar destruction, characteristic of emphysema).  \n\n\n### **Differential Exclusion**  \n- **Asthma**: Reversible airflow limitation (not seen here; DLCO normal in asthma).  \n- **Chronic Bronchitis**: Cough/sputum (not reported); DLCO usually normal.  \n- **Interstitial Lung Disease**: Restrictive PFTs (low TLC, which is not present here).  \n\n\n### **Conclusion**  \nThe PFTs (obstructive pattern + reduced DLCO + air trapping) and clinical features (weight loss, smoking history) confirm **emphysema-predominant COPD**.\n\n\n**Answer: Emphysema (or Chronic Obstructive Pulmonary Disease, emphysema subtype)**  \n\n(Note: In many clinical contexts, the answer is simply **COPD**, but the reduced DLCO and weight loss strongly favor emphysema as the predominant subtype.)  \n\nFinal Answer: \\boxed{Emphysema} (or \\boxed{Chronic Obstructive Pulmonary Disease} if emphysema is not an option, but emphysema is the most specific diagnosis here.)  \n\nFor standard exam settings, the expected answer is:  \n\\boxed{Emphysema}",
    "expected_answer": "Chronic obstructive pulmonary disease",
    "time": 42.66246485710144,
    "answer_length": 1833,
    "retrieval_time": 0.08064103126525879,
    "generation_time": 42.63743305206299
  },
  {
    "question": "A 25-year-old zookeeper presents to the office complaining of a dry cough, fever, and chills for the past month. He states that the symptoms come in episodes at the end of the workday and last a few hours. He also mentions that he is fatigued all the time. His job includes taking care of various types of birds. He is otherwise fine and denies recent travel or trauma. Medical history is unremarkable and he does not take any medications. He does not smoke cigarettes or drinks alcohol. Allergies include peanuts, dust, and pollen. Childhood asthma runs in the family. Chest X-ray reveals diffuse haziness in both lower lung fields. A PPD skin test is negative. What is the most appropriate treatment for this patient?",
    "answer": "To determine the most appropriate treatment, we first establish the diagnosis based on the patient’s clinical presentation and occupational exposure:\n\n\n### **Key Clinical Clues & Diagnosis**  \nThe patient is a zookeeper with **avian exposure** (birds), work-related symptoms (episodes at the end of the workday), dry cough, fever, fatigue, diffuse chest X-ray haziness, and a negative PPD (ruling out TB). This is consistent with **bird fancier’s lung**—a subtype of **hypersensitivity pneumonitis (HP)** caused by an immune reaction to avian antigens (feathers, droppings).\n\n\n### **Treatment of Bird Fancier’s Lung**  \nThe cornerstone of management is **antigen avoidance** (removing the patient from bird exposure). However, for subacute HP (persistent symptoms ≥1 month), **systemic corticosteroids** are indicated to reduce inflammation, accelerate symptom resolution, and improve lung function.\n\n\n### **Most Appropriate Treatment**  \nGiven the patient’s persistent symptoms (1 month), the primary pharmacologic treatment is **prednisone** (0.5–1 mg/kg/day for 2–4 weeks, followed by a taper over 2–3 months).\n\n\n**Answer:** Prednisone (or systemic corticosteroids)  \n\n*(Note: Antigen avoidance is critical but often paired with corticosteroids for subacute cases. If \"antigen avoidance\" were an option, it would be a first step, but corticosteroids are the key pharmacologic treatment here.)*\n\n\n**Final Answer:** Prednisone (or systemic corticosteroids)  \n\n\\boxed{Prednisone}",
    "expected_answer": "Avoid exposure to birds",
    "time": 31.145874977111816,
    "answer_length": 1479,
    "retrieval_time": 0.018987178802490234,
    "generation_time": 31.13009214401245
  },
  {
    "question": "A 60-year-old female presents to her gynecologist with vaginal bleeding. She underwent menopause ten years prior. She has a past medical history of hypertension and diabetes mellitus. On physical examination, her uterus is uniformly enlarged. Ultrasound reveals a thickened endometrial stripe and tissue biopsy reveals neoplastic endometrial cells. A workup for metastatic disease is negative and the gynecologist recommends a laparoscopic hysterectomy. During the procedure, the surgeon ligates multiple vessels in order to remove the entire uterus. In the immediate postoperative period, the patient develops left-sided flank pain and oliguria. Serum creatinine is found to be 1.4 mg/dl whereas it was 1.0 mg/dl prior to the operation. Renal ultrasound is normal. Urinalysis is notable for hematuria. Ligation of which of the following vessels most likely contributed to this patient’s condition?",
    "answer": "To solve this question, we analyze the case and connect the surgical procedure to the post-operative complications using anatomical relationships:\n\n\n### Key Case Features  \n- Postmenopausal woman with endometrial cancer undergoing laparoscopic hysterectomy.  \n- Post-op: Left flank pain, oliguria (acute kidney injury: creatinine ↑ from 1.0→1.4 mg/dL), hematuria, normal renal ultrasound.  \n- Implication: **Urinary tract injury** (likely ureteral) due to surgical ligation of a nearby vessel.  \n\n\n### Anatomical Insight  \nThe uterus is primarily supplied by the **uterine artery** (branch of the internal iliac artery). A critical anatomical relationship exists at the level of the cervix: the uterine artery crosses **anteriorly over the ureter** (\"water under the bridge\"—ureter = water, uterine artery = bridge).  \n\nDuring hysterectomy, ligation of the uterine artery risks two scenarios:  \n1. Accidental inclusion of the ureter in the ligature (direct obstruction).  \n2. Ischemia of the ureter (the uterine artery provides a major blood supply branch to the ureter in this region).  \n\nBoth scenarios lead to ureteral injury: ischemia → necrosis → hematuria (bleeding from damaged ureter) and obstruction → flank pain + AKI (reduced urine flow).  \n\n\n### Elimination of Other Options  \n- **Ovarian artery**: Originates from the aorta (higher up) and is not closely associated with the ureter at the cervical level.  \n- **Internal iliac artery**: Too proximal; ligation would cause widespread pelvic ischemia (not isolated ureteral injury).  \n- **Renal/common iliac artery**: Unrelated to hysterectomy (renal artery is retroperitoneal, common iliac is distal to the surgical site).  \n\n\n**Answer: Uterine artery**\n\n\n\\boxed{Uterine artery}",
    "expected_answer": "Uterine artery",
    "time": 31.678370237350464,
    "answer_length": 1739,
    "retrieval_time": 0.021345138549804688,
    "generation_time": 31.652765035629272
  },
  {
    "question": "A 40-year-old man presents to the physician with progressive weight loss for the last 3 months. He also says he frequently sweats profusely at night and has a recurring low-grade fever, for which he takes acetaminophen. The patient denies any symptoms like cough, breathlessness, or gastrointestinal symptoms. His temperature is 37.1ºC  (98.8ºF), pulse is 76/min, blood pressure is 116/78 mm Hg, and respiratory rate is 13/min. On physical examination, he has generalized pallor. Bilateral cervical lymphadenopathy is present. Examination of his abdomen reveals non-tender hepatosplenomegaly in the right upper quadrant. Laboratory evaluation confirms the diagnosis of Hodgkin’s lymphoma. Which of the following viral infections is most likely to have played a role in the pathogenesis of this patient’s malignancy?",
    "answer": "To determine the viral infection linked to the pathogenesis of Hodgkin’s lymphoma in this patient, we analyze key associations between viruses and lymphoid malignancies:\n\n\n### Key Background  \nHodgkin’s lymphoma (HL) is strongly associated with **Epstein-Barr virus (EBV)**. Approximately 30-50% of HL cases show evidence of EBV infection in Reed-Sternberg cells (the hallmark cells of HL). EBV contributes to oncogenesis by expressing proteins (e.g., LMP1) that promote cell survival and proliferation.  \n\n\n### Distinguishing Other Viruses  \n- **HTLV-1**: Linked to adult T-cell leukemia/lymphoma, not HL.  \n- **HIV**: Increases HL risk but is not a direct pathogenetic driver of HL itself.  \n- **CMV**: No established role in HL pathogenesis.  \n\n\n**Answer: Epstein-Barr virus**\n\n\n\\boxed{Epstein-Barr virus}",
    "expected_answer": "Epstein-Barr virus",
    "time": 9.114959001541138,
    "answer_length": 808,
    "retrieval_time": 0.016433000564575195,
    "generation_time": 9.099186897277832
  },
  {
    "question": "A 28-year-old gravida 1 at 32 weeks gestation is evaluated for an abnormal ultrasound that showed fetal microcephaly. Early in the 1st trimester, she had fevers and headaches for 1 week. She also experienced myalgias, arthralgias, and a pruritic maculopapular rash. The symptoms resolved without any medications. A week prior to her symptoms, she had traveled to Brazil where she spent most of the evenings hiking. She did not use any mosquito repellents. There is no personal or family history of chronic or congenital diseases. Medications include iron supplementation and a multivitamin. She received all of the recommended childhood vaccinations. She does not drink alcohol or smoke cigarettes. The IgM and IgG titers for toxoplasmosis were negative. Which of the following is the most likely etiologic agent?",
    "answer": "To determine the most likely etiologic agent, we analyze the key clinical and epidemiologic clues:\n\n\n### **Key Clues**  \n- **Maternal symptoms**: Fever, pruritic maculopapular rash, arthralgias, myalgias, headache (resolved spontaneously).  \n- **Travel history**: Brazil (endemic for Aedes mosquito-transmitted viruses), evening hiking (high mosquito exposure), no repellent.  \n- **Fetal finding**: Microcephaly.  \n- **Toxoplasmosis ruled out**: Negative IgM/IgG.  \n\n\n### **Differential Diagnosis of Congenital Infections**  \nThe **TORCH complex** (Toxo, Other, Rubella, CMV, HSV) includes Zika virus in the \"Other\" category.  \n\n- **Zika virus**: Transmitted by *Aedes* mosquitoes (common in Brazil). Maternal symptoms exactly match (fever, pruritic rash, joint/muscle pain, headache). **Congenital Zika syndrome** is characterized by fetal microcephaly—this is the primary finding here.  \n- **Rubella**: Unlikely (patient received childhood vaccinations).  \n- **CMV**: Typically causes mild/no maternal symptoms; rash is not a classic feature.  \n- **Syphilis**: Maternal symptoms (chancre, secondary rash) do not align with the case.  \n- **Varicella**: Blistering rash (not maculopapular) is typical, and no history of chickenpox.  \n\n\n**Answer: Zika virus**\n\n\n\\boxed{Zika virus}",
    "expected_answer": "Zika virus",
    "time": 15.783759117126465,
    "answer_length": 1279,
    "retrieval_time": 0.01633620262145996,
    "generation_time": 15.757869958877563
  },
  {
    "question": "A 41-year-old G3P1 woman presents with a sudden onset throbbing headache, tinnitus, nausea, and left-sided weakness. Patient has no significant past medical history and takes no medications.  Her last two pregnancies ended with spontaneous abortions before the 10th week of gestation. No significant family history. Her vital signs include: blood pressure 130/90 mm Hg, pulse 58/min, respiratory rate 11/min, and temperature 36.8℃ (98.2℉). GCS is 14/15. Physical examination shows 3+ deep tendon reflexes and increased muscle tone in the left upper and lower extremities. Laboratory findings are significant for the following:\nPlatelet count 230,000/mm3\nFibrinogen 3.5 g/L\nActivated partial thromboplastin time  70 s\nThrombin time 34 s\n A non-contrast CT of the head is performed and shown in the picture. Which of the following would be the next best diagnostic step in this patient?",
    "answer": "To determine the next best diagnostic step, we analyze the patient’s key clinical and lab findings:\n\n\n### **Key Clinical & Lab Clues**  \n- **History**: 41yo G3P1 with 2 early spontaneous abortions (recurrent pregnancy loss).  \n- **Symptoms**: Sudden headache, focal weakness (left-sided), suggesting possible intracranial hemorrhage (supported by non-contrast CT, though not visualized).  \n- **Coagulation Abnormalities**:  \n  - Prolonged aPTT (70s, normal ~25-35s: intrinsic/common pathway issue).  \n  - Prolonged thrombin time (TT:34s, normal ~10-16s: impaired fibrinogen conversion to fibrin).  \n  - Normal platelet count (230k) and quantitative fibrinogen (3.5g/L, normal 2-4g/L).  \n\n\n### **Interpretation of Coagulation Abnormalities**  \nProlonged TT with normal quantitative fibrinogen indicates **dysfibrinogenemia** (abnormal fibrinogen function, not quantity). This is consistent with:  \n- Impaired clotting (possible hemorrhage).  \n- Recurrent pregnancy loss (some dysfibrinogenemias are associated with pregnancy complications).  \n\n\n### **Next Best Diagnostic Step**  \nTo confirm dysfibrinogenemia, we need a **functional fibrinogen assay** (e.g., Clauss method), which measures fibrinogen’s ability to form clots (unlike quantitative assays that only measure concentration).  \n\n\n**Answer: Functional fibrinogen assay (Clauss method)**.  \n\n(Note: Antiphospholipid antibodies are relevant for recurrent miscarriages but do not explain the prolonged TT; thus, functional fibrinogen is prioritized to address the coagulopathy causing the neurological event.)\n\n\n**Final Answer**  \nFunctional fibrinogen assay (Clauss method)  \n\n\\boxed{Functional fibrinogen assay}",
    "expected_answer": "Mixing study",
    "time": 70.15898394584656,
    "answer_length": 1670,
    "retrieval_time": 0.12457489967346191,
    "generation_time": 70.13363814353943
  },
  {
    "question": "A obstetrician is working in a developing country to help promote maternal health and fetal well being. While there, he delivers a baby who he suspects has congenital hypothyroidism, most likely caused by inadequate maternal iodine intake. Which of the following signs and symptoms would NOT be expected to be observed in this child?",
    "answer": "To address the question, we first recall the key signs and symptoms of **congenital hypothyroidism (CH) due to maternal iodine deficiency** (endemic cretinism):  \n\n### Expected Features:  \n- Lethargy/poor feeding  \n- Hypothermia  \n- Bradycardia  \n- Prolonged jaundice (impaired bilirubin conjugation)  \n- Macroglossia (enlarged tongue)  \n- Umbilical hernia  \n- Dry/coarse skin  \n- Goiter (thyroid enlargement from compensatory TSH stimulation)  \n- Intellectual disability (if untreated)  \n\n\n### What is NOT Expected?  \nA symptom that contradicts hypothyroidism. For example:  \n**Tachycardia** (rapid heart rate) → CH causes bradycardia (slow heart rate), so tachycardia is not expected.  \n\nOther possible \"not expected\" symptoms include hyperactivity, heat intolerance, or diarrhea (CH causes constipation).  \n\nGiven common exam contexts, the most likely answer is **tachycardia**.\n\n\nAnswer: Tachycardia (or any symptom opposite to hypothyroidism, e.g., hyperactivity, heat intolerance).  \n\n(Note: If specific options were provided, the answer would align with the option that contradicts CH’s presentation.)  \n\n**Final Answer:** Tachycardia (assuming this is an option; adjust based on actual options, but this is the most common \"not expected\" symptom).  \n\n\\boxed{Tachycardia}",
    "expected_answer": "Diarrhea",
    "time": 28.16818404197693,
    "answer_length": 1278,
    "retrieval_time": 0.010816097259521484,
    "generation_time": 28.14070701599121
  },
  {
    "question": "A 33-year-old nurse is referred to an infectious disease specialist after she exhibited a PPD skin test with 17 mm of induration. She denies any cough, shortness of breath, hemoptysis, weight loss, fatigue, fevers, or night sweats over the last several months. Her temperature is 97.0°F (36.1°C), blood pressure is 120/81 mmHg, pulse is 82/min, respirations are 15/min, and oxygen saturation is 98% on room air. An initial chest radiograph is unremarkable. Which of the following is the most appropriate management of this patient?",
    "answer": "To determine the most appropriate management for this patient, we analyze the case step-by-step:\n\n\n### **Key Observations**  \n1. **Positive PPD**: The patient is a healthcare worker (high-risk group), so a PPD induration ≥10 mm is positive. Her 17 mm result confirms a positive test.  \n2. **Latent TB Infection (LTBI)**: She has no symptoms of active TB (no cough, weight loss, fevers, etc.) and an unremarkable chest X-ray—ruling out active disease.  \n\n\n### **Management of LTBI**  \nThe goal is to prevent progression to active TB. The **CDC-preferred regimens** for LTBI include:  \n- **Isoniazid (INH) monotherapy for 9 months**: A well-established, effective regimen (gold standard for LTBI before shorter courses became available).  \n- **Rifampin (RIF) monotherapy for 4 months**: A shorter, safe alternative (good for adherence or INH-intolerant patients).  \n- **INH + rifapentine (once weekly for 3 months, directly observed therapy)**: A short-course option requiring supervised administration.  \n\n\n### **Most Appropriate Choice**  \nFor a patient with no contraindications (no liver disease mentioned), the **classic first-line regimen** (and most commonly tested in standard questions) is **isoniazid (INH) for 9 months**.\n\n\n**Answer: Initiate isoniazid therapy for 9 months.**  \n\n(Note: If rifampin 4 months is an option, it is also acceptable, but INH 9 months is the traditional and widely recognized answer for LTBI in such cases.)\n\n\n**Final Answer**  \nInitiate isoniazid therapy for 9 months.  \n\n\\boxed{Initiate isoniazid therapy for 9 months}",
    "expected_answer": "Isoniazid",
    "time": 28.513930082321167,
    "answer_length": 1556,
    "retrieval_time": 0.012174129486083984,
    "generation_time": 28.4868061542511
  },
  {
    "question": "An 81-year-old woman is brought to the emergency room by her son after witnessing the patient fall and hit her head. The son reports that the patient was in her usual state of health until she complained of chest palpitations. This startled her while she was climbing down the stairs and lead to a fall. Past medical history is significant for hypertension and atrial fibrillation. Medications are lisinopril, metoprolol, and warfarin. Temperature is 99°F (37.2°C), blood pressure is 152/96 mmHg, pulse is 60/min, respirations are 12/min, and pulse oximetry is 98% on room air. On physical examination, she is disoriented and at times difficult to arouse, the left pupil is 6 mm and non-reactive to light, and the right pupil is 2 mm and reactive to light. A right-sided visual field defect is appreciated on visual field testing. There is 1/5 strength on the right upper and lower extremity; as well as 5/5 strength in the left upper and lower extremity. A computerized tomography (CT) scan of the head is shown. Which of the following most likely explains this patient’s symptoms?",
    "answer": "To determine the cause of the patient’s symptoms, we analyze the key clinical findings and context:\n\n\n### **Key Clinical Context**  \n- Elderly woman with **atrial fibrillation (AF)** and hypertension, on **warfarin** (anticoagulated → high bleeding risk).  \n- Fall after palpitations (likely AF-related arrhythmia → dizziness/fall → head trauma).  \n\n\n### **Neurological Exam Findings**  \n1. **Altered mental status**: Disoriented, hard to arouse (intracranial pressure elevation).  \n2. **Pupil asymmetry**: Left pupil dilated (6mm) and non-reactive → **left oculomotor nerve (CN III) compression** (parasympathetic fibers damaged → unopposed sympathetic tone).  \n3. **Focal motor weakness**: Right upper/lower extremity (1/5) → lesion on the **left hemisphere** (motor pathways cross at medulla).  \n4. **Right-sided visual field defect**: Homonymous hemianopsia → lesion in the **left visual pathway** (optic radiation/occipital lobe).  \n\n\n### **Pathophysiology**  \nThe constellation of signs points to a **left-sided intracranial mass lesion** causing **uncal herniation**:  \n- Uncal herniation (medial temporal lobe herniation) compresses the ipsilateral CN III (left pupil dilation) and leads to contralateral motor weakness (right side) and visual field defects (right side).  \n- Given anticoagulation and head trauma, the lesion is most likely an **intracranial hemorrhage** (ICH) (parenchymal bleed) or large subdural hematoma. However, focal visual/motor signs favor a parenchymal lesion (ICH) over a diffuse subdural hematoma.  \n\n\n### **Conclusion**  \nThe patient’s symptoms are best explained by a **left intracerebral hemorrhage** causing mass effect and uncal herniation.\n\n\n**Answer:** Left intracerebral hemorrhage.  \n\n(Note: If \"subdural hematoma\" was an option, it would also be plausible, but the focal visual/motor signs strongly suggest a parenchymal bleed. Given the classic case context, the answer is likely **Left intracerebral hemorrhage**.)  \n\n\\boxed{Left intracerebral hemorrhage}",
    "expected_answer": "Herniation of the uncus",
    "time": 48.951098918914795,
    "answer_length": 2004,
    "retrieval_time": 0.017770051956176758,
    "generation_time": 48.925703048706055
  },
  {
    "question": "A 67-year-old man with peripheral neuropathy comes to the physician for a follow-up examination after the results of serum protein electrophoresis showed monoclonal gammopathy. A complete blood count, serum creatinine, and serum electrolyte concentrations are within the reference ranges. A bone marrow biopsy shows 6% monoclonal plasma cells. Further analysis shows that class I major histocompatibility molecules are downregulated in these monoclonal plasma cells. The proliferation of these monoclonal plasma cells is normally prevented by a class of immune cells that lyse abnormal cells without the need for opsonization, priming, or prior activation. Which of the following best describes this class of immune cells?",
    "answer": "The class of immune cells described is **Natural Killer (NK) cells**.  \n\n### Key Reasoning:  \n- NK cells are innate immune cells that lyse abnormal cells (e.g., tumor cells, virus-infected cells) **without prior activation, priming, or opsonization**.  \n- Their killing mechanism is triggered by the **downregulation of MHC class I molecules** on target cells (as noted in the question: the monoclonal plasma cells have reduced MHC class I). NK cells express inhibitory receptors that bind MHC class I; when MHC class I is absent/low, the inhibitory signal is lost, leading to NK cell activation and target cell lysis.  \n\nOther immune cells (e.g., cytotoxic CD8+ T cells) require MHC class I presentation of antigens and prior priming, which does not fit the description. Macrophages often rely on opsonization or pattern recognition, so they are not the correct answer here.  \n\n\n**Answer: Natural Killer (NK) cells**",
    "expected_answer": "Natural killer cells",
    "time": 14.503989934921265,
    "answer_length": 917,
    "retrieval_time": 0.014990091323852539,
    "generation_time": 14.478626012802124
  },
  {
    "question": "A 47-year-old woman comes to the physician because of progressive muscle weakness for five months. She feels that the muscles in her shoulders and hips have been getting weaker and sometimes feel sore. She now has difficulty getting up from chairs, climbing stairs, and combing her hair. She has also noticed new difficulty with swallowing solid foods, but has no trouble with liquids. She has a 5-year history of hyperlipidemia controlled with fluvastatin. Her maternal uncle died at age 26 from Duchenne's muscular dystrophy and her mother has Hashimoto's thyroiditis. Vital signs are within normal limits. Neurologic examination shows moderate weakness in the arm abductors and hip flexors bilaterally. Deep tendon reflexes are 2+ bilaterally. Laboratory studies show:\nHemoglobin 13.7 g/dL\nLeukocytes 11,200/mm3\nErythrocyte sedimentation rate 33 mm/h\nSerum\nCreatine kinase 212 U/L\nLactate dehydrogenase 164 U/L\nAST 34 U/L\nALT 35 U/L\nWhich of the following is most likely to confirm the diagnosis?\"",
    "answer": "To determine the confirmatory test, we first analyze the patient’s clinical presentation and narrow down the diagnosis:\n\n\n### **Key Clinical Findings**  \n- **47-year-old woman** with **progressive proximal muscle weakness** (shoulders/hips: difficulty rising from chairs, climbing stairs, combing hair).  \n- **Dysphagia for solids** (suggests skeletal muscle weakness in the pharynx/esophagus).  \n- **Mildly elevated CK** (212 U/L; normal ~30-135 U/L in women) and **elevated ESR** (33 mm/h; inflammatory marker).  \n- No rash (rules out dermatomyositis), no distal weakness (rules out inclusion body myositis), and ESR elevation (rules out statin-induced myopathy, which is non-inflammatory).  \n\n\n### **Likely Diagnosis**  \n**Polymyositis**: An idiopathic inflammatory myopathy characterized by proximal muscle weakness, mild CK elevation, and inflammatory markers (ESR). It affects adults and lacks the skin findings of dermatomyositis.  \n\n\n### **Confirmatory Test**  \n**Muscle biopsy** is the gold standard for confirming polymyositis. It shows:  \n- Endomysial lymphocytic infiltration (around/within muscle fibers).  \n- Muscle fiber necrosis and regeneration.  \n\nAutoantibodies (e.g., anti-Jo-1) are supportive but not confirmatory (only ~20-30% of patients are positive). EMG shows myopathic changes but is suggestive, not definitive.  \n\n\n**Answer: Muscle biopsy**\n\n\n\\boxed{Muscle biopsy}",
    "expected_answer": "Intrafascicular infiltration on muscle biopsy",
    "time": 34.11793518066406,
    "answer_length": 1392,
    "retrieval_time": 0.08370494842529297,
    "generation_time": 34.089866161346436
  },
  {
    "question": "A 41-year-old man presents to the emergency room with sudden onset of blurry vision one hour ago. He states that he was resting at home when he noticed he had difficulty reading. Currently, he is also starting to see double, and is seeing two images on top of each other. Earlier today, he felt ill with nausea, vomiting, and watery diarrhea, which he attributed to food he had eaten at a picnic the day before. When asked which foods he ate, he lists potato salad, a hamburger, deviled eggs, and pickles made by his neighbor. He also heard that his friend who went to the picnic with him has developed similar symptoms and was seen in another hospital earlier. While in the emergency room, the patient’s temperature is 98.4°F (36.9°C), pulse is 75/min, blood pressure is 122/84 mmHg, and respirations are 13/min. Cranial nerve exam is notable for fixed pupillary dilation, and difficulty depressing both eyes. The remainder of his exam is normal. Which of the following is the pathogenesis of this patient’s presentation?",
    "answer": "To determine the pathogenesis of the patient’s presentation, we first identify the likely diagnosis and then its underlying mechanism:\n\n\n### **Step 1: Key Clinical Clues & Diagnosis**  \nThe patient’s presentation is classic for **foodborne botulism**:  \n- **Neurological symptoms**: Sudden blurry vision, vertical diplopia, fixed dilated pupils, and impaired eye movement (cranial nerve palsies).  \n- **Gastrointestinal symptoms**: Preceding nausea/vomiting/watery diarrhea.  \n- **Epidemiology**: Home-preserved foods (neighbor’s pickles) at a picnic, with a friend having similar symptoms.  \n- **Vital signs**: Afebrile (no acute bacterial infection).  \n\n\n### **Step 2: Pathogenesis of Botulism**  \nBotulism is caused by **Clostridium botulinum neurotoxin**, which acts by:  \nCleaving **SNARE proteins** (e.g., SNAP-25, syntaxin, synaptobrevin) in presynaptic nerve terminals. These proteins are essential for fusion of acetylcholine (ACh)-containing vesicles with the presynaptic membrane.  \n\nThis inhibition of ACh release disrupts:  \n- **Neuromuscular junctions**: Impairs skeletal muscle function (e.g., eye movement, diplopia).  \n- **Autonomic synapses**: Blocks parasympathetic signaling (e.g., fixed dilated pupils, as the pupillary sphincter relies on ACh).  \n\n\n**Answer**: Inhibition of acetylcholine release from presynaptic nerve terminals via cleavage of SNARE proteins by botulinum toxin.\n\n\n\\boxed{Inhibition of acetylcholine release at presynaptic nerve terminals by botulinum toxin-mediated cleavage of SNARE proteins}",
    "expected_answer": "Decreased acetylcholine release",
    "time": 25.646840810775757,
    "answer_length": 1534,
    "retrieval_time": 0.01865386962890625,
    "generation_time": 25.619497776031494
  },
  {
    "question": "A 4-week-old female newborn is brought to the physician because of increasing yellowing of her eyes and skin for 2 weeks. The mother has noticed that the girl's stools have become pale over the past week. She was breastfed since birth but her parents switched her to formula feeds recently after reading on the internet that breastfeeding could be the cause of her current symptoms. The patient was delivered vaginally at 38 weeks' gestation. Pregnancy and delivery were uncomplicated. She appears healthy. Vital signs are within normal limits. She is at the 50th percentile for length and at the 60th percentile for weight. Examination shows scleral icterus and jaundice. The liver is palpated 2 cm below the right costal margin. Cardiopulmonary examination shows no abnormalities. Neurologic examination shows no focal findings. Serum studies show:\nBilirubin\nTotal 15 mg/dL\nDirect 12.3 mg/dL\nAlkaline phosphatase 2007 U/L\nAST 53 U/L\nALT 45 U/L\nγ-glutamyl transferase 154 U/L\nBlood group A positive\nWhich of the following is the most likely diagnosis?\"",
    "answer": "To determine the most likely diagnosis, we analyze the key clinical and lab findings:\n\n\n### **Key Clinical Features**  \n- **4-week-old term female**: Jaundice (increasing for 2 weeks) + **pale (acholic) stools** (1 week) → Pathological cholestasis (conjugated hyperbilirubinemia is always abnormal in infants).  \n- **Growth normal**: 50th percentile length, 60th weight → No failure to thrive (rules out severe metabolic disorders like galactosemia initially).  \n- **Mild hepatomegaly**: Liver 2 cm below costal margin → Consistent with cholestatic liver injury.  \n\n\n### **Lab Findings**  \n- **Conjugated hyperbilirubinemia**: Direct bilirubin (12.3 mg/dL) > 20% of total (15 mg/dL) → Pathological cholestasis.  \n- **Markedly elevated ALP**: 2007 U/L → Indicates biliary obstruction or injury.  \n- **Elevated GGT**: 154 U/L → Supports biliary origin of cholestasis.  \n\n\n### **Differential Diagnosis & Ruling Out**  \n- **Galactosemia**: Typically presents with vomiting, diarrhea, failure to thrive (absent here).  \n- **Alpha-1 antitrypsin deficiency**: May have cholestasis but rarely causes **acholic stools** (bile flow is not completely blocked).  \n- **Cystic fibrosis**: Meconium ileus (absent) or failure to thrive (not seen here) are more common initial signs.  \n- **Biliary atresia**: **Classic features** → Conjugated jaundice, acholic stools, elevated ALP/GGT, and normal growth (early stage). This is the top candidate due to the presence of **acholic stools** (a hallmark of extrahepatic biliary obstruction).  \n\n\n**Answer: Biliary atresia**\n\n\n\\boxed{Biliary atresia}",
    "expected_answer": "Biliary atresia",
    "time": 27.407174110412598,
    "answer_length": 1578,
    "retrieval_time": 0.01877593994140625,
    "generation_time": 27.383028030395508
  },
  {
    "question": "A 43-year-old man comes to the emergency department with nausea, abdominal discomfort, diarrhea, and progressive perioral numbness for the past 24 hours. 3 days ago, he underwent a total thyroidectomy for treatment of papillary thyroid cancer. His only medication is a multivitamin supplement. He appears fatigued. While measuring the patient's blood pressure, the nurse observes a spasm in the patient's hand. Physical examination shows a well-healing surgical wound on the neck. Which of the following ECG findings are most likely in this patient?",
    "answer": "To determine the most likely ECG finding, we analyze the patient’s clinical presentation and underlying condition:\n\n\n### Step 1: Identify the patient’s diagnosis  \nThe patient underwent a **total thyroidectomy** 3 days prior. His symptoms (perioral numbness, Trousseau’s sign—carpal spasm during BP measurement) are classic for **hypocalcemia**. This occurs because the parathyroid glands (responsible for PTH production, which maintains serum calcium) are often damaged or removed during thyroidectomy, leading to low PTH and reduced serum calcium.\n\n\n### Step 2: Recall ECG changes in hypocalcemia  \nHypocalcemia affects ventricular repolarization. The key ECG finding is **prolonged QT interval**—calcium slows repolarization, extending the time between ventricular depolarization and repolarization (QT interval).\n\n\n### Step 3: Rule out other electrolyte-related ECG changes  \n- Hypercalcemia: Shortened QT interval.  \n- Hypokalemia: U waves, flat T waves, prolonged PR interval.  \n- Hyperkalemia: Peaked T waves, wide QRS complex.  \n\n\n**Answer: Prolonged QT interval**\n\n\n\\boxed{Prolonged QT interval}",
    "expected_answer": "QT prolongation",
    "time": 12.974341869354248,
    "answer_length": 1104,
    "retrieval_time": 0.012206077575683594,
    "generation_time": 12.94771409034729
  },
  {
    "question": "A 68-year-old woman presents with left lower quadrant pain that worsens with defecation. She describes the pain as 'crampy'. She also says she has suffered from mild constipation for the past few years. The patient denies any recent weight change or urinary symptoms. Her last menstrual period was 16 years ago. Her body temperature is 37.8°C (100.0°F), pulse is 102/min, respiratory rate is 16/min, and blood pressure is 133/87 mm Hg. On physical examination, tenderness to palpation in the left lower quadrant is present. The laboratory studies are presented as follows:\nHemoglobin 13.2 mg/dL\nHematocrit 48%\nLeukocyte count 16,000/mm³\nNeutrophils 89%\nBands 5%\nEosinophils 0%\nBasophils 0%\nLymphocytes 11%\nMonocytes 0%\nPlatelet count 380,000/mm³\nWhich of the following is the most likely diagnosis in this patient?",
    "answer": "To determine the most likely diagnosis, we analyze the patient’s key clinical features and lab findings:\n\n\n### **Key Findings**  \n- 68-year-old post-menopausal female  \n- Left lower quadrant (LLQ) crampy pain worsening with defecation  \n- Chronic mild constipation  \n- Low-grade fever (37.8°C) and tachycardia (102/min)  \n- LLQ tenderness on exam  \n- Leukocytosis (16,000/mm³) with neutrophilia (89%) and left shift (5% bands, indicating bacterial infection)  \n- No weight loss or urinary symptoms  \n\n\n### **Differential Diagnosis & Ruling Out**  \n1. **Irritable Bowel Syndrome (IBS):** Functional disorder—no fever or leukocytosis (ruled out).  \n2. **Inflammatory Bowel Disease (IBD):** Typically presents with diarrhea (often bloody) and weight loss (absent here; ruled out).  \n3. **Urinary Tract Infection (UTI):** No urinary symptoms (frequency/urgency/dysuria; ruled out).  \n4. **Gynecological Issues:** Post-menopausal (no ovarian torsion/ectopic pregnancy risk; ruled out).  \n5. **Colon Cancer:** No weight loss or obstruction signs (less likely than acute infection).  \n\n\n### **Most Likely Diagnosis: Diverticulitis**  \nDiverticulitis (inflammation/infection of colonic diverticula) aligns with all findings:  \n- **Risk factors:** Older age, chronic constipation (increases intraluminal pressure leading to diverticula formation/inflammation).  \n- **Symptoms:** LLQ pain (sigmoid colon is most affected), pain worsened by defecation (sigmoid involvement), low-grade fever.  \n- **Labs:** Leukocytosis with left shift (bacterial infection).  \n\n\n**Answer:** Diverticulitis.",
    "expected_answer": "Diverticulitis",
    "time": 23.093783140182495,
    "answer_length": 1578,
    "retrieval_time": 0.015441179275512695,
    "generation_time": 23.082437753677368
  },
  {
    "question": "A 67-year-old man presents to his primary care physician for erectile dysfunction. He states that for the past month he has been unable to engage in sexual intercourse with his wife despite having appropriate sexual desire. He also endorses deep and burning buttock and hip pain when walking, which is relieved by rest. The patient states that he does not have erections at night or in the morning. His past medical history is notable for diabetes, coronary artery disease, and hypertension, and he has a 40 pack-year smoking history. Physical exam is notable for weak lower extremity and femoral pulses. Which of the following is the most specific etiology of this patient’s symptoms?",
    "answer": "To determine the most specific etiology of the patient’s symptoms, we analyze the key clinical findings and their correlation:\n\n\n### **Key Clinical Features**  \n- **Erectile dysfunction (ED):** No nocturnal/morning erections → **organic (vascular) ED** (not psychogenic).  \n- **Buttock/hip claudication:** Pain with walking relieved by rest → reduced blood flow to pelvic/lower extremity muscles.  \n- **Weak femoral pulses:** Indicates impaired blood flow proximal to the femoral arteries.  \n- **Risk factors:** Diabetes, coronary artery disease (CAD), hypertension, smoking (all atherosclerotic risk factors).  \n\n\n### **Specific Etiology**  \nThese findings are classic for **Leriche syndrome**, which is defined by atherosclerotic occlusion of the **distal aorta and common iliac arteries**. This occlusion impairs blood flow to:  \n1. The pelvic organs (causing ED).  \n2. The buttock/thigh muscles (causing claudication).  \n3. The lower extremities (leading to weak femoral pulses).  \n\n\n**Answer:** Atherosclerotic occlusion of the distal aorta and common iliac arteries (Leriche syndrome).  \n\n(Note: If the question expects a concise term, \"Leriche syndrome\" or \"atherosclerotic aortoiliac occlusive disease\" is the specific etiology.)  \n\n\\boxed{Leriche syndrome}",
    "expected_answer": "Aortoiliac atherosclerosis",
    "time": 15.268792867660522,
    "answer_length": 1265,
    "retrieval_time": 0.0832059383392334,
    "generation_time": 15.241328716278076
  },
  {
    "question": "A 55-year-old man with a history of chronic glomerulonephritis due to IgA nephropathy presents to your office with bone pain. Which of the following laboratory findings would you most expect upon analysis of this patient's serum?",
    "answer": "To address this question, we focus on the **renal osteodystrophy** (bone disease) associated with chronic kidney disease (CKD) from IgA nephropathy. Here’s the key pathophysiology and expected serum lab findings:\n\n\n### Pathophysiology of Renal Osteodystrophy  \nProgressive loss of kidney function (from IgA nephropathy) leads to:  \n1. **Decreased phosphate excretion**: As glomerular filtration rate (GFR) drops, the kidneys cannot eliminate excess phosphate → **hyperphosphatemia**.  \n2. **Hypocalcemia**: High phosphate binds to calcium, reducing free serum calcium. Additionally, the kidneys fail to activate vitamin D (1,25-dihydroxyvitamin D), which impairs intestinal calcium absorption.  \n3. **Secondary hyperparathyroidism**: Low calcium and high phosphate stimulate parathyroid hormone (PTH) release → **elevated PTH**.  \n4. **Low active vitamin D**: Kidneys cannot convert 25-hydroxyvitamin D to its active form (1,25-OH D) → **low 1,25-OH D**.  \n\n\n### Most Expected Serum Lab Finding  \nThe most consistent and early (as GFR declines below 30 mL/min) finding in CKD-related bone disease is **hyperphosphatemia**. It is a primary driver of the downstream changes (hypocalcemia, elevated PTH) and is strongly linked to bone pain in renal osteodystrophy.\n\n\n**Answer: Hyperphosphatemia** (or other key findings like elevated PTH, hypocalcemia, or low active vitamin D—though hyperphosphatemia is the most classic and early marker).  \n\nFor context, if options included these, hyperphosphatemia is the most expected.\n\n\n\\boxed{Hyperphosphatemia}",
    "expected_answer": "Increased PTH, decreased calcium, increased phosphate, decreased calcitriol",
    "time": 35.00290322303772,
    "answer_length": 1548,
    "retrieval_time": 0.00953817367553711,
    "generation_time": 34.979079723358154
  },
  {
    "question": "A medical researcher is studying the physiology of the immune system in order to better understand the effects of HIV on patients. He isolates a group of cells that are shown by flow cytometry to be positive for the cell surface marker CD8. He then mixes this cell population with a group of infected cells, crosslinks extracellular interactions, and immunoprecipitates the CD8 protein. He identifies a protein bound to CD8 that is composed of two chains from an adjacent cell. Which of the following best describes the primary function of the protein that was most likely identified?",
    "answer": "To answer this question, we analyze the key components and interactions described:\n\n\n### Key Observations:  \n- The isolated cells are **CD8+ T cells** (cytotoxic T lymphocytes, CTLs), as CD8 is a defining surface marker of these cells.  \n- CD8+ T cells interact with **infected target cells** via their CD8 co-receptor, which binds to a specific molecule on the target cell surface.  \n- The protein bound to CD8 (from the adjacent infected cell) is a **two-chain molecule**—this matches the structure of MHC class I.  \n\n\n### Primary Function of MHC Class I:  \nMHC class I molecules are heterodimers (α chain + β₂-microglobulin) expressed on almost all nucleated cells. Their core role is to **present endogenous peptide antigens** (e.g., viral proteins produced inside infected cells, or abnormal tumor proteins) to CD8+ cytotoxic T cells. This interaction allows CTLs to recognize and eliminate infected or abnormal cells.  \n\n\n**Answer:** Presenting peptide antigens derived from intracellular pathogens (or endogenous sources) to CD8+ cytotoxic T lymphocytes.  \n\n(In standard exam terms, this is often phrased as: \"Presenting endogenous antigens to CD8+ T cells\" or \"Displaying intracellular peptide antigens for recognition by cytotoxic T cells.\")\n\n\n**Final Answer:** To present peptide antigens derived from intracellular sources to CD8+ cytotoxic T cells.  \n\n(If formatted as a single line for clarity):  \nPresenting endogenous peptide antigens to CD8+ cytotoxic T lymphocytes.",
    "expected_answer": "Binds endogenous peptides that have been transported by the TAP channel",
    "time": 19.484601974487305,
    "answer_length": 1482,
    "retrieval_time": 0.01355886459350586,
    "generation_time": 19.45736312866211
  },
  {
    "question": "A 61-year-old Caucasian male presents to your office with chest pain. He states that he is worried about his heart, as his father died at age 62 from a heart attack. He reports that his chest pain worsens with large meals and spicy foods and improves with calcium carbonate. He denies dyspnea on exertion and an ECG is normal. What is the most likely cause of this patient's pain?",
    "answer": "To determine the most likely cause of the patient’s chest pain, we analyze the key clinical clues:\n\n\n### **Key Observations**  \n- **Pain triggers**: Worsens with large meals and spicy foods (these relax the lower esophageal sphincter and increase stomach acid production, common in reflux).  \n- **Pain relief**: Improves with calcium carbonate (an antacid that neutralizes stomach acid).  \n- **Cardiac exclusion**: No dyspnea on exertion, normal ECG (rules out acute cardiac ischemia, despite family history of heart attack).  \n\n\n### **Conclusion**  \nThese features are **classic for gastroesophageal reflux disease (GERD)**—a condition where stomach acid flows back into the esophagus, causing chest pain (often mistaken for cardiac pain).  \n\n\n**Answer: Gastroesophageal Reflux Disease (GERD)**",
    "expected_answer": "Gastroesophageal junction incompetence",
    "time": 12.03807783126831,
    "answer_length": 795,
    "retrieval_time": 0.011767148971557617,
    "generation_time": 12.01073408126831
  },
  {
    "question": "A 36-year-old woman comes to the clinic because of tearing and a foreign body sensation in her eyes bilaterally, which has gradually worsened over the last several weeks. She also notes having occasional palpitations, nervousness, sweating, and heat intolerance. Her past medical history is unremarkable. She reports a 20-pack-year smoking history and is currently a daily smoker. Physical examination shows an anxious, trembling woman. She has eyelid retraction bilaterally, with an inability to fully close her eyes. Her extraocular motility is limited on upgaze. There is no thyromegaly, and no thyroid nodules are noted. Laboratory studies reveal a thyroid-stimulating hormone level of 0.1 μU/mL and total T4 of 42 μg/dL. Thyroid-stimulating immunoglobulin is positive. CT scan of the orbits shows proptosis and marked enlargement of the extraocular muscle with sparing of the tendons. Which of the following would most likely transiently worsen this patient’s eye symptoms?",
    "answer": "To answer this question, we first identify the patient’s condition, then determine which intervention or factor transiently worsens her eye symptoms.\n\n\n### Step 1: Diagnose the patient  \nThe patient has:  \n- **Hyperthyroidism**: Low TSH (0.1 μU/mL), high total T4 (42 μg/dL), symptoms (palpitations, nervousness, heat intolerance).  \n- **Graves’ ophthalmopathy**: Eyelid retraction, proptosis, enlarged extraocular muscles (sparing tendons), positive thyroid-stimulating immunoglobulin (TSI).  \n\nThis confirms **Graves’ disease** (autoimmune hyperthyroidism with associated ophthalmopathy).\n\n\n### Step 2: Identify factors worsening Graves’ ophthalmopathy  \nKey triggers for transient worsening of Graves’ eye symptoms include:  \n- **Radioactive iodine (RAI) therapy**: RAI destroys thyroid tissue, releasing thyroid antigens that amplify autoimmune inflammation in the orbit. This is a well-known transient exacerbation of ophthalmopathy.  \n- Smoking (a chronic risk factor, not transient).  \n- Other factors (e.g., uncontrolled thyroid function, but RAI is the classic transient trigger).  \n\n\n### Conclusion  \nThe most likely factor to transiently worsen her eye symptoms is **radioactive iodine therapy**.\n\n\n**Answer: Radioactive iodine therapy** (assuming this was an option; it is the standard correct answer for this scenario).  \n\n\\boxed{Radioactive\\ iodine\\ therapy}",
    "expected_answer": "Treatment with radioactive iodine",
    "time": 20.50851011276245,
    "answer_length": 1372,
    "retrieval_time": 0.019926071166992188,
    "generation_time": 20.482671976089478
  },
  {
    "question": "A 7-year-old boy is brought to a pediatrician by his parents for evaluation of frequent bed wetting during the night. A detailed history reveals that there has been no history of urinary incontinence during the day since the boy was 4 years of age, but that he has never been dry at night continuously for 1 week. There is no history of urinary tract infections, urgency, frequency, or hesitancy. On physical examination, the boy’s vital signs are stable. His neurologic and abdominal examinations are completely normal. His laboratory investigations are as follows:\nUrine-specific gravity (first-morning sample) 1.035\nUrine red blood cells Absent\nUrine pus cells Absent\nUrine culture Negative\nWhich of the following is the next step in the management of this patient?",
    "answer": "To determine the next step in managing this patient, we first recognize the condition as **primary nocturnal enuresis (PNE)**. Key points supporting this:  \n- 7-year-old boy with no history of continuous dry nights for ≥1 week (primary enuresis).  \n- No red flags: no daytime incontinence, no urinary tract infection (negative culture, no pus cells), normal neurologic/abdominal exam.  \n\n\n### Guidelines for Primary Nocturnal Enuresis  \nThe initial management includes **education and reassurance** (to reduce the child’s guilt). Following this, the next step involves **active behavioral interventions** or pharmacotherapy.  \n\n- **Enuresis alarm**: First-line for long-term cure (high success rate for sustained dryness). It works by conditioning the child to wake up in response to bladder fullness.  \n- **Desmopressin**: Second-line or used for short-term relief (e.g., sleepovers), but not first-line for routine management.  \n\n\n### Conclusion  \nGiven the absence of red flags and the goal of long-term resolution, the next step is to initiate **enuresis alarm therapy** (combined with basic behavioral modifications like limiting evening fluids and voiding before bed).\n\n\n**Answer: Enuresis alarm therapy** (or \"Initiate enuresis alarm and behavioral modifications\" if more detailed options are allowed).  \n\n(Note: If behavioral modifications alone are an option, they are also appropriate as initial active steps, but enuresis alarm is the most effective first-line active treatment for sustained cure.)  \n\nFinal Answer: \\boxed{Enuresis alarm therapy}",
    "expected_answer": "Reassuring the parents and use of an enuresis alarm",
    "time": 32.77543878555298,
    "answer_length": 1557,
    "retrieval_time": 0.0886220932006836,
    "generation_time": 32.74851131439209
  },
  {
    "question": "A 52-year-old man with a history of gastric cancer that was treated with subtotal gastrectomy dies in a motor vehicle collision. At autopsy, examination of the spinal cord shows unilateral atrophy of the neurons in the area indicated by the arrow. Neurological examination of the patient when he was still alive would most likely have shown which of the following findings?",
    "answer": "To answer this question, we need to connect the clinical context (subtotal gastrectomy → potential vitamin B12 deficiency) and the key finding (unilateral neuronal atrophy in the spinal cord) to the expected neurological signs. Here’s the breakdown:\n\n\n### Key Context & Findings  \n- **Subtotal gastrectomy**: Loss of gastric parietal cells reduces intrinsic factor production, leading to **vitamin B12 deficiency**. While B12 deficiency typically causes subacute combined degeneration (SCD, affecting myelin in dorsal columns/lateral corticospinal tracts), the question specifies **unilateral neuronal atrophy**—pointing to damage of **gray matter neurons** (not white matter myelin).  \n\n- The most likely area of unilateral neuronal atrophy here is the **anterior horn cells** (motor neurons in the spinal cord gray matter). Anterior horn cell damage causes **lower motor neuron (LMN) signs** on the same side as the atrophy.  \n\n\n### Expected Neurological Findings  \nLMN signs include:  \n- Weakness in the affected limb(s)  \n- Muscle atrophy  \n- Fasciculations  \n- Decreased reflexes  \n- Flaccidity  \n\n\n**Answer:** Unilateral weakness with muscle atrophy and fasciculations (on the side of the neuronal atrophy).  \n\n(Note: Assuming the arrow pointed to the anterior horn cells, the classic answer for this scenario is lower motor neuron signs on the affected side.)\n\n\n\\boxed{Unilateral weakness with muscle atrophy and fasciculations}",
    "expected_answer": "Decreased positional sense in the ipsilateral leg",
    "time": 27.284910917282104,
    "answer_length": 1435,
    "retrieval_time": 0.011491060256958008,
    "generation_time": 27.259711027145386
  },
  {
    "question": "A 24-year-old pregnant woman at 28 weeks gestation presents to the emergency department with complaints of fever with chills and pain in her knee and ankle joints for the past 2 days. She also complains of headaches and difficulty moving her neck. Further questioning reveals that she had a tick bite on her arm while gardening a few days ago. Past medical history is noncontributory. She takes a multivitamin with iron and folate every day and has been receiving regular prenatal care and the pregnancy is progressing normally. On examination, an erythematous rash is seen on her right arm, as shown in the accompanying photograph. Her obstetric examination is normal. Ultrasound of the fetus is reassuring with a normal heartbeat and no gross abnormalities. A specimen is collected to test for Lyme disease. What is the next best step for this patient?",
    "answer": "To determine the next best step for this patient, we analyze the key clinical details and guidelines for Lyme disease in pregnancy:\n\n\n### **Key Clinical Findings**  \n- 28-week pregnant woman with **erythema migrans** (classic rash for Lyme disease), tick exposure history, and early Lyme symptoms (fever, joint pain, meningismus).  \n- Untreated Lyme disease in pregnancy increases risks of fetal adverse outcomes (e.g., congenital anomalies, fetal death), but early treatment mitigates these risks.  \n\n\n### **Treatment Considerations**  \n- **Doxycycline** (first-line for non-pregnant adults) is contraindicated in pregnancy (teratogenic: teeth discoloration, bone growth issues).  \n- **Amoxicillin** is the first-line agent for early Lyme disease in pregnancy (500 mg TID for 14-21 days).  \n- **No need to wait for test results**: Classic erythema migrans + tick exposure is sufficient to initiate treatment immediately (delaying treatment risks progression).  \n\n\n### **Conclusion**  \nThe next best step is to start **amoxicillin therapy** without waiting for test results.\n\n\n**Answer:** Initiate treatment with amoxicillin.  \n(If required to phrase as a concrete action: Start amoxicillin 500 mg three times daily for 14-21 days.)  \n\n\\boxed{Start amoxicillin therapy}",
    "expected_answer": "Amoxicilin",
    "time": 18.406551122665405,
    "answer_length": 1269,
    "retrieval_time": 0.015182971954345703,
    "generation_time": 18.38141918182373
  },
  {
    "question": "A 25-year-old woman presents to her physician with a four month history of fatigue and weakness. The weakness has been progressive to the point where she cannot climb stairs and stand from a sitting position. She has only had one menstrual period in the last four months and has never been pregnant. She smokes a pack of cigarettes every day and does not take any medications. Her temperature is 98°F (36.7°C), blood pressure is 160/100 mmHg, pulse is 70/min, and respirations are 15/min. She is obese with a significant pannus. Abdominal striae are present. Her laboratory workup is notable for the following:\n\nSerum:\nNa+: 142 mEq/L\nCl-: 102 mEq/L\nK+: 3.9 mEq/L\nHCO3-: 25 mEq/L\nBUN: 20 mg/dL\nGlucose: 314 mg/dL\nCreatinine: 1.1 mg/dL\nCa2+: 10.1 mg/dL\nAST: 9 U/L\nALT: 8 U/L\n24-hour urinary cortisol: 470 µg (< 300 µg)\nSerum cortisol 30 µg/mL (5-23 µg/dL)\nSerum adrenocorticotropin-releasing hormone (ACTH) 2 pg/mL (> 5 pg/mL)\n\nA 48-hour high dose dexamethasone suppression trial shows that her serum cortisol levels do not decrease. What is the best next step in management?",
    "answer": "To determine the best next step in management, we analyze the patient’s presentation and lab results to identify the cause of Cushing syndrome, then proceed with targeted imaging.\n\n\n### Key Clinical & Lab Findings:  \nThe patient has **Cushing syndrome** (fatigue, weakness, oligomenorrhea, abdominal striae, hypertension, hyperglycemia, elevated 24-hour urinary cortisol, elevated serum cortisol).  \n\n- **Low ACTH (2 pg/mL, normal >5 pg/mL):** Excess cortisol suppresses ACTH via negative feedback → **ACTH-independent Cushing syndrome** (source is adrenal gland, not pituitary/ectopic ACTH).  \n- **High-dose dexamethasone suppression test (DST) non-responsive:** Rules out pituitary adenoma (Cushing disease, which typically suppresses with high-dose DST) and confirms the cause is either adrenal tumor (adenoma/carcinoma) or ectopic ACTH (but ACTH is low, so adrenal origin is likely).  \n\n\n### Next Step:  \nFor ACTH-independent Cushing syndrome, the next step is to **image the adrenal glands** to identify the lesion (adenoma vs carcinoma). Abdominal CT scan is the preferred initial imaging modality for adrenal pathology.\n\n\n**Answer:** Abdominal computed tomography (CT) of the adrenal glands.",
    "expected_answer": "MRI of the adrenal glands",
    "time": 22.781222820281982,
    "answer_length": 1198,
    "retrieval_time": 0.019877195358276367,
    "generation_time": 22.756027936935425
  },
  {
    "question": "A 67-year-woman with non-Hodgkin lymphoma comes to the physician because of progressively increasing numbness and tingling in her fingers and toes. Her last cycle of chemotherapy with vincristine was 1 week ago. Physical examination shows decreased sensation to light touch in all distal extremities. Knee and ankle deep tendon reflexes are decreased. Which of the following is the most likely underlying mechanism of this patient’s peripheral neuropathy?",
    "answer": "To determine the mechanism of this patient’s peripheral neuropathy, we analyze the key clues: **vincristine exposure** (a vinca alkaloid chemotherapy) and **distal symmetric peripheral neuropathy** (numbness/tingling in fingers/toes, reduced sensation/reflexes).\n\n\n### Key Mechanism of Vincristine-Induced Neuropathy  \nVinca alkaloids (e.g., vincristine) bind to **tubulin dimers** and **inhibit microtubule polymerization**. Microtubules are critical for **axonal transport**—the process by which nutrients, organelles, and signaling molecules move between the neuronal cell body and distal axon terminals.  \n\nIn long peripheral nerves (distal extremities), axonal transport is especially vital. Disruption of microtubules impairs this transport, leading to degeneration of distal axons first (hence the \"glove-and-stocking\" distribution of symptoms). This is a classic example of **axonal neuropathy** caused by microtubule dysfunction.\n\n\n**Answer:** Inhibition of microtubule polymerization leading to impaired axonal transport.\n\n\n\\boxed{Inhibition of microtubule assembly impairing axonal transport}",
    "expected_answer": "Inhibition of beta-tubulin polymerization",
    "time": 11.685656785964966,
    "answer_length": 1103,
    "retrieval_time": 0.01162576675415039,
    "generation_time": 11.65995192527771
  },
  {
    "question": "A 68-year-old man comes to the physician with a 1-week history of painless hematuria. A CT scan of the urinary tract shows areas of bladder wall thickening. Cystoscopy shows several sessile masses with central necrosis arising from the bladder wall. A biopsy specimen of the bladder masses shows moderately differentiated urothelial cells with abundant mitotic figures and nuclear atypia. The patient most likely has a history of exposure to which of the following?",
    "answer": "To determine the most likely exposure associated with this patient’s condition, we first analyze the clinical scenario:  \n\n### Key Clinical Findings:  \n- 68-year-old man with painless hematuria (classic for bladder cancer).  \n- Bladder wall thickening + sessile masses with central necrosis (consistent with bladder tumor).  \n- Biopsy: Moderately differentiated urothelial cells with mitotic figures/nuclear atypia → **urothelial carcinoma** (the most common type of bladder cancer).  \n\n\n### Major Risk Factors for Urothelial Carcinoma:  \n1. **Smoking**: The single most common risk factor (accounts for ~50% of cases globally).  \n2. **Occupational exposure to aromatic amines**: (e.g., benzidine, β-naphthylamine) seen in dye/rubber/textile workers, but less common than smoking.  \n3. Other: Chronic cystitis (schistosomiasis → squamous cell carcinoma, not urothelial), radiation, cyclophosphamide.  \n\n\n### Conclusion:  \nGiven the high prevalence of smoking as a cause of urothelial carcinoma, this is the **most likely exposure** in this patient.  \n\n\n**Answer: Smoking**  \n\n(Note: If aromatic amines were an option, it would be a plausible choice for occupational cases, but smoking is the leading cause overall.)  \n\n\\boxed{Smoking}",
    "expected_answer": "Aromatic amines",
    "time": 23.67160391807556,
    "answer_length": 1234,
    "retrieval_time": 0.09959673881530762,
    "generation_time": 23.64614486694336
  },
  {
    "question": "A 14-year-old girl comes to the physician with her father for evaluation of her short stature. She feels well overall, but is concerned because all of her friends are taller than her. Her birth weight was normal. Her father reports he had a short stature during his teenage years; he is currently 177 cm (5 ft 10 in) tall. She is at the 2ndpercentile for height and 35th percentile for weight. Breast development is Tanner stage 2. Pubic and axillary hair is absent. An x-ray of the left hand and wrist shows a bone age of 11 years. Which of the following is the most appropriate next best step in management?",
    "answer": "To answer this question, we first analyze the key clinical features and then determine the most appropriate next step:\n\n\n### **Key Clinical Features**  \n- 14-year-old girl with short stature (2nd percentile for height, 35th for weight)  \n- Normal birth weight  \n- Family history: Father had short stature in teens but caught up to average height (177 cm)  \n- Tanner stage 2 breasts (early breast development) but no pubic/axillary hair (delayed adrenarche)  \n- Delayed bone age (11 years, 3 years behind chronological age)  \n- No symptoms of hypothyroidism, growth hormone deficiency (GHD), or Turner syndrome (no stigmata like webbed neck, streak ovaries)  \n\n\n### **Top Diagnosis: Constitutional Delay of Growth and Puberty (CDGP)**  \nCDGP is the most likely cause here, supported by:  \n- Positive family history (father’s delayed catch-up growth)  \n- Delayed bone age and puberty (consistent with CDGP)  \n- Absence of symptoms/signs of organic disease (e.g., hypothyroidism, GHD)  \n\n\n### **Next Best Step**  \nThe critical distinction between CDGP and GHD is **growth velocity**:  \n- CDGP has normal growth velocity (5–7 cm/year prepubertal)  \n- GHD has reduced growth velocity (<5 cm/year)  \n\nSince growth velocity is not provided in the case, the next step is to **measure growth velocity via serial height measurements over 6–12 months** to confirm it is normal (supporting CDGP) and rule out GHD. Reassurance and monitoring are also key, as CDGP resolves spontaneously with time (like her father).\n\n\n**Answer:** Reassure the patient and family, and monitor growth velocity with serial height measurements over 6–12 months.  \n\n(If forced to select from standard options, this corresponds to **\"Reassure and monitor growth velocity\"** or **\"Obtain serial height measurements to assess growth velocity\"**.)\n\n\n\\boxed{Reassure and monitor growth velocity with serial height measurements}",
    "expected_answer": "Reassurance and follow-up",
    "time": 37.750617265701294,
    "answer_length": 1887,
    "retrieval_time": 0.012352943420410156,
    "generation_time": 37.73912286758423
  },
  {
    "question": "A 5-year-old boy is brought to the physician because of facial swelling that started 5 days ago. Two weeks ago, he had a sore throat that resolved spontaneously. His temperature is 37°C (98.6°F), pulse is 107/min, and blood pressure is 94/67 mm Hg. Examination shows pitting edema of the upper and lower extremities as well as periorbital edema. The abdomen is mildly distended. Laboratory studies show:\nHemoglobin 13.1 g/dL\nSerum\nAlbumin 2.1 g/dL\nTotal cholesterol 270 mg/dL\nTriglycerides 175 mg/dL\nUrine\nBlood negative\nGlucose negative\nProtein 4+\nLeukocyte esterase negative\nA renal biopsy of this patient is most likely to show which of the following findings?\"",
    "answer": "To determine the renal biopsy findings, we first diagnose the patient’s condition and then link it to classic biopsy features:\n\n\n### Step 1: Diagnose the Condition  \nThe patient presents with **nephrotic syndrome**, characterized by:  \n- Heavy proteinuria (4+ urine protein),  \n- Hypoalbuminemia (2.1 g/dL, normal ~3.5–5),  \n- Edema (periorbital, pitting extremities),  \n- Hyperlipidemia (cholesterol 270 mg/dL, elevated).  \n\nIn children, the **most common cause of nephrotic syndrome is Minimal Change Disease (MCD)** (~80–90% of cases). This is confirmed by the absence of hematuria/hypertension (ruling out nephritic syndromes like post-streptococcal glomerulonephritis).\n\n\n### Step 2: Biopsy Findings for MCD  \n- **Light microscopy**: Normal glomeruli (no hypercellularity, sclerosis, or immune deposits).  \n- **Electron microscopy**: **Effacement (fusion) of podocyte foot processes** (the pathognomonic finding for MCD).  \n\n\n### Conclusion  \nThe renal biopsy is most likely to show **effacement of podocyte foot processes** (on electron microscopy) or normal glomeruli (on light microscopy). Given the classic association with MCD in children, the key finding expected here is **fusion of podocyte foot processes**.\n\n\n**Answer:** Fusion of podocyte foot processes (electron microscopy) or normal glomeruli (light microscopy). (Note: If options include \"effacement of podocyte foot processes,\" this is the correct choice.)  \n(Standard answer for this scenario: **Minimal change disease with effacement of podocyte foot processes**.)  \n\nBut to be precise, the most specific biopsy finding for MCD is **effacement of podocyte foot processes**.  \n\n**Final Answer:** Effacement of podocyte foot processes.  \n(If formatted as a single line for clarity: Effacement of podocyte foot processes)",
    "expected_answer": "Normal light microscopy findings",
    "time": 24.321009874343872,
    "answer_length": 1791,
    "retrieval_time": 0.014358043670654297,
    "generation_time": 24.29350996017456
  },
  {
    "question": "A 60-year-old man is referred to a dermatologist by his family physician for management of a rare case of dermatitis that has not responded to standard therapy with corticosteroids. The patient’s medical history is unremarkable, and he is currently working reduced hours at his job as an accountant. Physical examination reveals confluent scaly patches, plaques, and generalized erythroderma along the torso and lower extremities (see image). There is also a solid skin lesion with a diameter greater than 1 cm. The dermatologist suspects a malignancy and orders a biopsy. Which of the following is the most accurate description of this condition?",
    "answer": "To address this question, we analyze the key clinical features provided and connect them to the most likely diagnosis:\n\n\n### Key Clinical Features:  \n- 60-year-old man with **dermatitis-like rash unresponsive to corticosteroids** (a red flag for malignancy).  \n- **Confluent scaly patches/plaques + generalized erythroderma** (torso/lower extremities).  \n- **Solid skin lesion >1 cm** (tumor).  \n\n\n### Diagnosis:  \nThis presentation is consistent with **Mycosis Fungoides (MF)**, a primary cutaneous T-cell lymphoma (CTCL).  \n\nMF progresses through distinct stages:  \n1. **Patch stage**: Flat, scaly lesions mimicking eczema/dermatitis.  \n2. **Plaque stage**: Thickened, elevated lesions.  \n3. **Tumor stage**: Nodular/solid lesions (>1 cm, as described here).  \n4. **Erythrodermic stage**: Generalized redness (erythroderma) covering >80% of the skin.  \n\nThe unresponsiveness to steroids, presence of tumor lesions, and erythroderma confirm this is not a benign dermatitis but a malignant CTCL.\n\n\n### Most Accurate Description:  \n**Mycosis Fungoides, a primary cutaneous T-cell lymphoma characterized by patches, plaques, tumor lesions (>1 cm), and generalized erythroderma, often initially mimicking dermatitis but unresponsive to standard therapy.**\n\n\n**Answer:** Mycosis Fungoides (a type of cutaneous T-cell lymphoma with patch, plaque, tumor, and erythrodermic stages).  \n\n(Note: If options were provided, the correct choice would align with this description.)  \n\n\\boxed{Mycosis Fungoides}",
    "expected_answer": "Tumor arising from cutaneous T cells",
    "time": 19.710753917694092,
    "answer_length": 1495,
    "retrieval_time": 0.00996708869934082,
    "generation_time": 19.69476318359375
  },
  {
    "question": "A 35-year-old woman comes to the physician because she has been feeling very stressed over the past several months. During this period, she has found it difficult to relax. She states that her head is full of worries. She works at an accountant's office and reports difficulty in concentrating on her work. She has been working longer shifts because one of her coworkers is on vacation and reports feeling more tired than usual. She is married and frequently fights with her husband. The patient states that in order to deal with her stress, she goes shopping. While shopping, she steals small trivial items and feels immediately relieved thereafter. She discards the objects she steals and has feelings of shame and guilt about her actions. Her husband is concerned about her behavior, but she is unable to stop shoplifting. Her vital signs are within normal limits. On mental status examination, she is oriented to person, place, and time. She reports feeling anxious. Physical examination shows no abnormalities. Which of the following is the most appropriate next step in management?",
    "answer": "To determine the most appropriate next step in management, we first need to diagnose the patient’s condition:\n\n\n### **Step 1: Diagnosis**  \nThe patient exhibits key features of **kleptomania**:  \n- Recurrent inability to resist impulses to steal trivial items (not needed for use/value).  \n- Relief immediately after stealing, followed by shame/guilt.  \n- Stealing is not driven by anger, delusions, or conduct disorder.  \nShe also has comorbid anxiety symptoms (difficulty relaxing, worry, poor concentration).  \n\n\n### **Step 2: Management of Kleptomania**  \nKleptomania is best managed with **psychotherapy** as a first-line intervention, particularly **cognitive-behavioral therapy (CBT)**. CBT approaches (e.g., exposure and response prevention, cognitive restructuring) help address the impulsive urges and modify maladaptive thought patterns. Pharmacotherapy (e.g., SSRIs) may be added for comorbid anxiety or severe symptoms, but psychotherapy is the initial priority.  \n\n\n**Answer:** Initiate cognitive-behavioral therapy.  \n\n(Note: If SSRIs were an option, they might be considered alongside CBT, but CBT is the most appropriate first step for kleptomania.)\n\n\n\\boxed{Cognitive-behavioral therapy}",
    "expected_answer": "Cognitive behavioral therapy",
    "time": 30.310700178146362,
    "answer_length": 1205,
    "retrieval_time": 0.019179105758666992,
    "generation_time": 30.28285503387451
  },
  {
    "question": "A 65-year-old man presents to his primary care physician for a change in his behavior over the past few months. Initially, the patient was noted to be behaving inappropriately including using foul language and grabbing people unexpectedly. This has progressed to a worsening of his memory and trouble caring for himself. His temperature is 98.1°F (36.7°C), blood pressure is 162/103 mmHg, pulse is 83/min, respirations are 13/min, and oxygen saturation is 98% on room air. Physical exam is notable for an elderly man who laughs inappropriately at times and who is a poor historian. When he is engaged in conversation, he exhibits word finding difficulty and is rather inattentive. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the patient’s clinical presentation against key dementia subtypes:\n\n\n### Key Clinical Features  \n- **Initial symptoms**: Behavioral disinhibition (foul language, grabbing people unexpectedly) → frontal lobe dysfunction.  \n- **Progression**: Later worsening memory and self-care issues.  \n- **Exam findings**: Inappropriate laughter (disinhibition), word-finding difficulty, inattention.  \n\n\n### Differential Diagnosis  \n1. **Alzheimer’s Disease (AD)**: Typically starts with **episodic memory loss** (e.g., forgetting recent events) as the first symptom, not behavioral changes. This does not match the initial presentation.  \n2. **Frontotemporal Dementia (FTD)**:  \n   - **Behavioral variant FTD (bvFTD)** is characterized by **early behavioral changes** (disinhibition, loss of social norms, apathy) as the primary feature, followed by cognitive decline (memory, language) later. This aligns perfectly with the patient’s initial disinhibition and subsequent progression.  \n3. **Lewy Body Dementia (DLB)**: Requires fluctuating cognition, visual hallucinations, or parkinsonism (tremor/rigidity) early on—none of these are present here.  \n4. **Vascular Dementia**: Presents with stepwise cognitive decline and vascular risk factors (e.g., stroke history), which are not described.  \n\n\n**Answer: Frontotemporal dementia** (specifically behavioral variant).\n\n\n\\boxed{Frontotemporal dementia}",
    "expected_answer": "Frontotemporal dementia",
    "time": 18.27555823326111,
    "answer_length": 1441,
    "retrieval_time": 0.0755620002746582,
    "generation_time": 18.24950098991394
  },
  {
    "question": "An 11-month-old boy is brought to the clinic by his mother for a rash on his trunk, which he has had for the past 2 days. She notes that he is eating less and is more cranky than usual. His birth history is insignificant, and his immunizations are up to date. Vital signs include: temperature is 37.8°C (100.0°F), pulse is 98/min, and respiratory rate is 16/min. The rash features thin-walled, fluid-filled blisters that rupture easily. Fluid samples from the lesions are sent for analysis to a microbiology lab. The results reveal an infection by the gram-positive bacterium Staphylococcus aureus. The patient is diagnosed with staphylococcal scalded skin syndrome. Which of the following is involved with the primary defense in response to the bacteria and toxins produced by this organism?",
    "answer": "To answer this question, we need to connect the pathogenesis of staphylococcal scalded skin syndrome (SSSS) to the primary immune defense against the causative agent and its toxins.\n\n\n### Key Background on SSSS  \nSSSS is caused by **Staphylococcus aureus** strains that produce **exfoliative toxins (ET-A/ET-B)**. These toxins are serine proteases that cleave **desmoglein 1 (Dsg1)**, a cell-adhesion molecule in the epidermis, leading to blistering. Infants are susceptible because their immune system is immature, particularly in producing neutralizing antibodies against these toxins.\n\n\n### Primary Defense Against Bacteria and Toxins  \nThe question asks for the **primary defense** against both the bacteria and its toxins:  \n- For the **bacteria (S. aureus)**: Innate phagocytes (neutrophils) are critical for engulfing and killing the organism, aided by opsonins like IgG and complement.  \n- For the **toxins**: Neutralizing **IgG antibodies** are the primary defense. These antibodies bind to exfoliative toxins, preventing them from cleaving Dsg1 and inhibiting their pathogenic activity.  \n\n\n### Why IgG is the Answer  \nInfants lack sufficient IgG against exfoliative toxins (maternal IgG wanes by 6 months, and infant IgG production is immature). This explains their susceptibility to SSSS. Thus, the primary defense against the toxins (the main driver of SSSS) is neutralizing IgG antibodies, which also contribute to opsonization of the bacteria.\n\n\n**Answer: IgG antibodies**\n\n\n\\boxed{IgG antibodies}",
    "expected_answer": "Immunoglobulin- IgM",
    "time": 25.63211178779602,
    "answer_length": 1512,
    "retrieval_time": 0.017019271850585938,
    "generation_time": 25.604907035827637
  },
  {
    "question": "A 52-year-old man is brought to the emergency department with dry cough, shortness of breath, and low-grade fever that began 6 days ago. He also reports that he has had 3 episodes of watery diarrhea per day for the last 2 days. He appears slightly pale. His temperature is 38.0°C (100.4°F), pulse is 65/min, respirations are 15/min, and blood pressure is 140/78 mm Hg. Diffuse crackles are heard over bibasilar lung fields. Laboratory studies show:\nHemoglobin 13.8 g/dL\nLeukocyte count 16,000/mm3\nPlatelet count 150,000/mm3\nSerum\nNa+ 131 mEq/L\nCl-\n102 mEq/L\nK+ 4.7 mEq/L\nHCO3- 26 mEq/L\nUrea nitrogen 18 mg/dL\nCreatinine 1.2 mg/dL\nAn x-ray of the chest shows patchy infiltrates in both lungs. Which of the following is the most appropriate pharmacotherapy?\"",
    "answer": "To determine the most appropriate pharmacotherapy, we first identify the **diagnosis** based on key clinical features:\n\n\n### Key Clinical Clues:  \n- **Symptoms**: Dry cough, shortness of breath, low-grade fever, watery diarrhea (GI involvement).  \n- **Labs**: Hyponatremia (Na=131 mEq/L), elevated WBC (16,000/mm³).  \n- **Imaging**: Patchy bilateral infiltrates.  \n\nThese findings are **classic for Legionella pneumonia**, which is characterized by:  \n- Non-productive cough, interstitial/patchy infiltrates.  \n- GI symptoms (diarrhea, nausea).  \n- Hyponatremia (common lab abnormality).  \n\n\n### Pharmacotherapy for Legionella Pneumonia:  \nLegionella is an intracellular pathogen, so effective agents must penetrate cells. First-line options include:  \n1. **Macrolides** (e.g., azithromycin) – once-daily, well-tolerated.  \n2. **Respiratory fluoroquinolones** (e.g., levofloxacin, moxifloxacin).  \n\n\n**Answer: Azithromycin** (or levofloxacin, but azithromycin is the most common first-line choice in standard practice).\n\n\n\\boxed{Azithromycin}",
    "expected_answer": "Levofloxacin",
    "time": 19.69001007080078,
    "answer_length": 1042,
    "retrieval_time": 0.015552997589111328,
    "generation_time": 19.66513705253601
  },
  {
    "question": "A transvaginal ultrasound shows an intrauterine heteroechoic mass with numerous anechoic spaces and no identifiable fetus or amniotic fluid. Both the ovaries are enlarged and have multiple thin-walled, septated cysts with clear content. Which of the following is the most likely cause of the ovarian findings?",
    "answer": "To determine the cause of the ovarian findings, we analyze the clinical context and key ultrasound features:\n\n\n### Key Observations:  \n1. **Intrauterine mass**: Heteroechoic with numerous anechoic spaces, no fetus/amniotic fluid → This is characteristic of a **complete hydatidiform mole** (CHM), a gestational trophoblastic disease (GTD) marked by abnormal trophoblastic proliferation.  \n2. **Ovarian findings**: Bilateral, enlarged ovaries with multiple thin-walled, septated cysts → These are **theca lutein cysts**.  \n\n\n### Pathophysiology of Theca Lutein Cysts:  \nTheca lutein cysts develop in response to **excess human chorionic gonadotropin (hCG)**. CHM is associated with massive trophoblastic tissue, which secretes extremely high levels of hCG. This elevated hCG stimulates ovarian theca cells to form cysts.  \n\n\n### Conclusion:  \nThe ovarian findings (theca lutein cysts) are directly caused by **high hCG levels from the hydatidiform mole**.\n\n\n**Answer:** Elevated human chorionic gonadotropin (hCG) levels secondary to a hydatidiform mole.  \n\n(Shortened: High hCG from the hydatidiform mole)  \n\\boxed{Elevated hCG levels due to hydatidiform mole}",
    "expected_answer": "Theca leutein cysts",
    "time": 15.093927145004272,
    "answer_length": 1160,
    "retrieval_time": 0.011140108108520508,
    "generation_time": 15.068438053131104
  },
  {
    "question": "A 75-year-old woman is brought to the emergency department by her son because of a 2-day history of fever, headache, malaise, and dry cough. The patient lives with her son and his family and her son reports that other members of the family have had similar symptoms during the past week but that he has not had any symptoms. The result of a polymerase chain reaction test confirms that the woman is infected with a virus that has a helical capsid and a segmented genome. Which of the following is the most likely explanation for the son being free of symptoms?",
    "answer": "To determine the most likely explanation for the son’s asymptomatic status, we analyze the key details and connect them to viral properties and immunity:\n\n\n### **Step 1: Identify the virus**  \nThe patient’s symptoms (fever, headache, malaise, dry cough) and family outbreak are consistent with **influenza virus**. This aligns with the virus’s characteristics:  \n- **Helical capsid**: Influenza (Orthomyxovirus) has a helical nucleocapsid (each segmented RNA genome is wrapped in a helical protein coat).  \n- **Segmented genome**: Influenza has 8 segmented negative-sense RNA strands.  \n\n\n### **Step 2: Explain the son’s lack of symptoms**  \nThe son was exposed (family members had similar illness) but remained asymptomatic. The most plausible reason is **preexisting immunity**:  \n- Influenza immunity is primarily mediated by neutralizing antibodies against the viral hemagglutinin (HA) protein.  \n- The son may have:  \n  - Recovered from the same influenza strain previously, or  \n  - Received a recent vaccine matching the circulating strain.  \n\nThis immunity allowed his immune system to rapidly clear the virus before symptoms developed.\n\n\n**Answer:** The son has preexisting immunity (from prior infection or vaccination) against the influenza virus strain causing the family’s illness, preventing symptom development.\n\n\n\\boxed{Preexisting immunity due to prior infection or vaccination against the causative influenza strain}",
    "expected_answer": "Serum antibodies against hemagglutinin",
    "time": 17.98474907875061,
    "answer_length": 1434,
    "retrieval_time": 0.014238834381103516,
    "generation_time": 17.959298849105835
  },
  {
    "question": "A 71-year-old man comes to the physician for a routine visit. His psychiatric history is significant for major depression with psychotic features. He was diagnosed after his wife died from pancreatic cancer four years earlier. Three years ago, he deliberately overdosed on sleeping pills. Today, he feels well but still wakes up frequently at night and cannot sleep through the night. He lives alone in his apartment and has no children. He does not possess a firearm at home but has access to weapons at a local hunting club. The patient currently denies suicidal thoughts or thoughts of self-harm. He takes sertraline and olanzapine. He does not smoke or drink alcohol. Which of the following is the strongest risk factor for suicide in this patient?",
    "answer": "To determine the strongest risk factor for suicide in this patient, we analyze key elements of his history and compare their predictive value for future suicide:\n\n\n### Key Risk Factors Present:  \n- **Past suicide attempt**: He deliberately overdosed on sleeping pills 3 years ago.  \n- Male gender, older age (71), social isolation (lives alone, no children), access to weapons (hunting club), history of major depression with psychosis, insomnia.  \n\n\n### Critical Insight:  \nA **past suicide attempt** is one of the most robust predictors of future suicide. It outweighs other factors (e.g., social isolation, access to means) in terms of predictive strength, as it directly reflects a previous intent to harm oneself and indicates a higher vulnerability to future suicidal behavior.\n\n\n**Answer: Past suicide attempt**\n\n\n\\boxed{Past suicide attempt}",
    "expected_answer": "Previous suicide attempt",
    "time": 17.429431676864624,
    "answer_length": 849,
    "retrieval_time": 0.14177989959716797,
    "generation_time": 17.403867959976196
  },
  {
    "question": "A 4-year-old boy is brought to the physician because of a generalized rash for 3 days. During this period, he has had severe itching and was not able to sleep well. He has also had fever, headache, and some muscle pain. Five days ago, he had a runny nose which subsided with over-the-counter medications. He returned from a camping trip 1 week ago. He attends a daycare center. The patient is at the 55th percentile for height and at the 50th percentile for weight. His temperature is 38.2°C (100.7°F), pulse is 97/min, and blood pressure is 96/60 mm Hg. Examination of the skin shows several macules, papules, and crusted lesions over his face, trunk, and extremities. There are a few fluid-filled vesicles over his abdomen and back. There is no cervical lymphadenopathy. The remainder of the examination shows no abnormalities. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the key clinical features and match them to common childhood rashes:\n\n\n### **Key Clinical Clues**  \n- **Prodrome**: Fever, headache, muscle pain + preceding coryza (runny nose).  \n- **Rash characteristics**: Generalized (face, trunk, extremities) with **lesions in multiple stages** (macules → papules → fluid-filled vesicles → crusted lesions).  \n- **Pruritus**: Severe itching (a hallmark of this condition).  \n- **Setting**: Daycare attendance (high transmission risk) and recent camping trip (but no clear insect bite pattern).  \n\n\n### **Differential Diagnosis Exclusion**  \n- **Measles**: No Koplik spots, no vesicular/crusted lesions.  \n- **Rubella**: No cervical lymphadenopathy (common in rubella) and no vesicular lesions.  \n- **Hand-foot-mouth disease**: No oral vesicles or rash localized to hands/feet.  \n- **Impetigo**: Localized crusting (not generalized multi-stage lesions) and minimal prodrome.  \n- **Insect bites**: No prodrome (fever, coryza) and lacks multi-stage lesions.  \n\n\n### **Final Diagnosis**  \n**Varicella (Chickenpox)** is the best fit. It classically presents with a pruritic rash evolving through multiple stages (macule → papule → vesicle → crust) and a prodrome of fever/malaise, which aligns perfectly with the case.\n\n\n**Answer: Varicella (Chickenpox)**",
    "expected_answer": "Chickenpox",
    "time": 27.256076097488403,
    "answer_length": 1339,
    "retrieval_time": 0.020288944244384766,
    "generation_time": 27.2307231426239
  },
  {
    "question": "A 19-year-old man is brought to the emergency department by ambulance because of unusual behavior that started 3 hours ago while he was at a party. He has a history of major depressive disorder and seasonal allergies. His mother has a history of anxiety. He drinks 5 beers on the weekends. Current medications include amitriptyline and diphenhydramine. The patient does not respond to questions and repeatedly says, \"\"The government is following me everywhere.\"\" His temperature is 37.9°C (100.2°F), pulse is 115/min, respirations are 24/min, and blood pressure is 160/89 mm Hg. He is diaphoretic. He is not oriented to place or time. Neurologic examination shows dilated pupils bilaterally and diffuse hyperreflexia. His feet are cold, and capillary refill time is 3 seconds. After the examination, the patient starts screaming and tries to bite the physician. Urine toxicology screening is positive for ethyl glucuronide. Which of the following is the most likely explanation for this patient's symptoms?\"",
    "answer": "To determine the most likely explanation for the patient’s symptoms, we analyze the **clinical triad** of his presentation and connect it to his medications/substances:\n\n\n### Key Clinical Features  \nThe patient exhibits three core findings consistent with **serotonin syndrome**:  \n1. **Mental status changes**: Paranoid delusions (\"government following\"), disorientation (time/place), agitation (screaming, biting).  \n2. **Autonomic hyperactivity**: Tachycardia (115/min), hypertension (160/89 mmHg), diaphoresis, dilated pupils, mild hyperthermia (37.9°C).  \n3. **Neuromuscular abnormalities**: Diffuse hyperreflexia.  \n\n\n### Critical Context  \n- **Medications**: Amitriptyline (tricyclic antidepressant [TCA] with serotonin reuptake inhibition) and diphenhydramine (first-gen antihistamine, anticholinergic).  \n- **Substance use**: Recent alcohol intake (urine ethyl glucuronide positive).  \n\n\n### Why Not Other Diagnoses?  \n- **Anticholinergic toxicity**: Classically causes anhidrosis (dry skin), not diaphoresis—ruled out by the patient’s sweating.  \n- **TCA overdose**: Typically presents with QRS prolongation (not noted) and seizures (absent here), not isolated hyperreflexia.  \n- **Sympathomimetic toxicity**: Urine toxicology is negative for cocaine/amphetamines, so excluded.  \n\n\n### Conclusion  \nThe patient’s triad of mental status changes, autonomic hyperactivity (including diaphoresis), and neuromuscular hyperreflexia is **pathognomonic for serotonin syndrome**, likely triggered by amitriptyline (serotonin reuptake inhibitor) and potentially exacerbated by interactions or recent substance use.\n\n\n**Answer: Serotonin syndrome** (due to amitriptyline use, leading to excess serotonin activity).  \n\n\\boxed{Serotonin syndrome}",
    "expected_answer": "Synthetic cathinone intoxication",
    "time": 44.301722049713135,
    "answer_length": 1743,
    "retrieval_time": 0.024061203002929688,
    "generation_time": 44.28624701499939
  },
  {
    "question": "A 22-year-old male presents to the emergency room complaining of neck stiffness. He reports that his neck started “locking” three hours ago. He is now unable to move it. His past medical history is notable for schizophrenia and asthma and he currently takes albuterol as well as another medication whose name he does not remember. His temperature is 99.0°F (37.2°C), blood pressure is 130/90 mmHg, pulse is 105/min, and respirations are 18/min. On physical examination, the patient appears anxious and diaphoretic. He speaks in full sentences and is oriented to person, place, and time. The patient’s neck is flexed and rotated to the right approximately 40 degrees. The right sternocleidomastoid and trapezius are firm and contracted. Extraocular movements are full and intact. Upon further questioning, he reports that he took more medication four hours ago because he was hearing voices. Which of the following should most likely be administered to this patient?",
    "answer": "The patient is experiencing an **acute dystonic reaction**, a type of extrapyramidal side effect (EPS) caused by an antipsychotic medication (the unknown drug he takes for schizophrenia). This reaction typically occurs hours to days after starting or increasing the dose of an antipsychotic and presents with involuntary muscle contractions (here, torticollis: neck flexed/rotated with contracted sternocleidomastoid/trapezius muscles).\n\n\n### Treatment for Acute Dystonia  \nFirst-line therapy for acute dystonia is **anticholinergic medications** to reverse the EPS. The most commonly administered agents are:  \n- **Benztropine (Cogentin):** A potent anticholinergic, often given intramuscularly or intravenously for rapid relief.  \n- **Diphenhydramine (Benadryl):** An antihistamine with anticholinergic properties, also effective for acute dystonia.  \n\n\n**Answer:** Benztropine (or Diphenhydramine, but Benztropine is the classic first-line choice for this scenario).\n\n\n\\boxed{Benztropine}",
    "expected_answer": "Benztropine",
    "time": 22.12702703475952,
    "answer_length": 991,
    "retrieval_time": 0.019391775131225586,
    "generation_time": 22.10229206085205
  },
  {
    "question": "A 13-month-old boy is brought to the physician for a well-child examination. Physical examination shows hepatosplenomegaly. A venous blood sample obtained for routine screening tests is milky. After refrigeration, a creamy supernatant layer appears on top of the sample. Genetic analysis shows a mutation in the apolipoprotein C-II gene (APOC2) on chromosome 19. This patient is at greatest risk for developing which of the following complications?",
    "answer": "To answer this question, we analyze the key clinical and genetic findings and their implications:\n\n\n### **Step 1: Interpret the findings**  \n- **Milky blood + creamy supernatant after refrigeration**: Indicates elevated **chylomicrons** (large, triglyceride-rich lipoproteins that float to the top when cooled).  \n- **APOC2 mutation**: Apolipoprotein C-II (APOC2) is a critical cofactor for **lipoprotein lipase (LPL)**, the enzyme that breaks down triglycerides in chylomicrons and VLDL. APOC2 deficiency impairs LPL activity, leading to severe hypertriglyceridemia (familial chylomicronemia syndrome, FCS).  \n\n\n### **Step 2: Identify the major complication**  \nSevere hypertriglyceridemia (>1000 mg/dL) in FCS causes **pancreatitis**: Triglycerides are broken down into toxic free fatty acids in the pancreas, triggering inflammation. This is the most serious and life-threatening complication of FCS.  \n\n\n**Answer: Pancreatitis**\n\n\n\\boxed{Pancreatitis}",
    "expected_answer": "Acute pancreatitis",
    "time": 14.947821140289307,
    "answer_length": 955,
    "retrieval_time": 0.010721921920776367,
    "generation_time": 14.930152893066406
  },
  {
    "question": "A 41-year-old man comes to the emergency department with nausea, abdominal discomfort, and diarrhea for the past 2 days. His abdominal discomfort is worse shortly after meals. He has also had progressive perioral numbness and upper-extremity muscle cramping for the past 24 hours. Six months ago, he underwent a Roux-en-Y gastric bypass to treat obesity. He underwent a total thyroidectomy to treat a Hurthle cell lesion 4 days ago. His mother died of lung cancer at age 68. He has smoked 1 pack of cigarettes daily for 22 years. His only current medication is a multivitamin supplement. He appears fatigued. His temperature is 36°C (96.8°F), pulse is 72/min, respirations are 20/min, and blood pressure is 130/70 mm Hg. While measuring the patient's blood pressure, the nurse observes spasm of the patient's hand. Physical examination shows a well-healing surgical wound on the neck. The abdomen is mildly tender to palpation with well-healed laparoscopic incisional sites. The remainder of the examination shows no abnormalities. Serum studies show:\nNa+ 138 mEq/L\nK+ 4.2 mEq/L\nCl- 102 mEq/L\nHCO3- 25 mEq/L\nMg2+ 1.7 mEq/L\nPhosphorus 4.3 mg/dL\n25-hydroxyvitamin D 20 ng/mL (N: 20-100 ng/mL)\nParathyroid hormone 115 pg/mL\nTotal bilirubin, serum 0.7 mg/dL\nAlanine aminotransferase, serum 14 U/L\nAspartate aminotransferase, serum 15 U/L\nAlkaline phosphatase, serum 42 U/L\nWhich of the following is the most appropriate initial step in the management of this patient?\"",
    "answer": "To determine the most appropriate initial management, we analyze the case step-by-step:\n\n\n### Key Clinical Findings  \nThe patient presents with **acute symptoms of hypocalcemia**:  \n- Perioral numbness, upper-extremity muscle cramps  \n- Trousseau’s sign (hand spasm during BP measurement)  \nThese are classic signs of symptomatic hypocalcemia, exacerbated by recent **total thyroidectomy** (risk of parathyroid gland injury/malfunction) and prior Roux-en-Y bypass (malabsorption of vitamin D, critical for calcium absorption).  \n\n\n### Lab Correlation  \nWhile calcium levels are not explicitly listed, the **clinical signs of acute hypocalcemia** (Trousseau’s sign, numbness, cramps) take precedence. His elevated PTH (115 pg/mL, normal ~10-65) suggests secondary hyperparathyroidism (compensatory for low calcium, likely due to vitamin D insufficiency and post-thyroidectomy parathyroid dysfunction).  \n\n\n### Initial Management  \nAcute symptomatic hypocalcemia requires **immediate intravenous (IV) calcium** to rapidly reverse neuromuscular irritability. Oral calcium is insufficient for acute symptoms (slow onset), and vitamin D supplementation addresses chronic deficiency but not the acute crisis.  \n\n\n**Answer:** Administer intravenous calcium gluconate.\n\n\n\\boxed{Administer intravenous calcium gluconate}",
    "expected_answer": "Administer calcium gluconate",
    "time": 25.863927125930786,
    "answer_length": 1311,
    "retrieval_time": 0.07050108909606934,
    "generation_time": 25.852293968200684
  },
  {
    "question": "A 9-year-old boy is brought to a physician by his mother for evaluation of generalized weakness, increased urination, and increased thirst. The mother mentions that her boy is always tired, and seems to be getting worse. He prefers watching television rather than going out and playing with other kids. Furthermore, he has had frequent episodes of constipation since birth. Except for frequent cravings for salty foods, the boy eats a regular diet. The patient was delivered healthy and is fully immunized. The medical history is unremarkable, and he takes no medications. He has no siblings. His father is a banker and his mother is a librarian. The pulse is 90/min, the blood pressure is 110/75 mm Hg, and the respiratory rate is 15/min. He is in the bottom 10th percentile for height and weight according to his age. The remainder of the physical examination is unremarkable. He recently had a urinalysis that showed elevated urinary calcium excretion.\nAdditional lab testing results are as follows:\nSerum electrolytes\nSodium 135 mEq/L\nPotassium 3.2 mEq/L\nChloride 95 mEq/L\nPlasma renin activity 10 ng/mL/hr (normal, 0.5–3.3 ng/mL/hr)\nPlasma aldosterone concentration 20 ng/dL (normal, 2–9 ng/dL)\nWhat is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the key clinical and laboratory findings and correlate them with renal tubulopathies:\n\n\n### **Key Findings**  \n- **Clinical**: 9-year-old boy with polyuria, polydipsia, growth retardation (10th percentile height/weight), salt cravings, constipation (since birth), hypercalciuria.  \n- **Laboratory**: Hypokalemia (3.2 mEq/L), hypochloremia (95 mEq/L), **secondary hyperaldosteronism** (high plasma renin activity [10 ng/mL/hr] and high aldosterone [20 ng/dL]), hypercalciuria.  \n\n\n### **Differential Diagnosis**  \nThe combination of **salt wasting**, **hypokalemic metabolic alkalosis** (implied by hypokalemia/hypochloremia), **secondary hyperaldosteronism**, and **hypercalciuria** points to **Bartter syndrome**:  \n\n- **Bartter Syndrome**: A renal tubulopathy affecting the **Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle** (mimicking loop diuretic effect). Key features include:  \n  - Early onset (childhood/infancy) with growth retardation.  \n  - Salt wasting → volume depletion → secondary hyperreninemia/hyperaldosteronism.  \n  - Hypercalciuria (loop diuretics increase calcium excretion).  \n  - Polyuria, polydipsia, salt cravings, constipation.  \n\n- **Gitelman Syndrome**: Ruled out because it presents later (adolescence/adulthood) and causes **hypocalciuria** (not hypercalciuria) and hypomagnesemia (not noted here).  \n- **Type 4 RTA**: Ruled out (hyperkalemia, not hypokalemia).  \n- **Liddle Syndrome**: Ruled out (hypertension, low renin/aldosterone, opposite of this case).  \n\n\n### **Conclusion**  \nThe constellation of findings confirms **Bartter syndrome**.\n\n\n**Answer: Bartter syndrome**",
    "expected_answer": "Bartter's syndrome",
    "time": 32.29476499557495,
    "answer_length": 1681,
    "retrieval_time": 0.019804954528808594,
    "generation_time": 32.269432067871094
  },
  {
    "question": "A 5-year-old boy of African descent is presented to the emergency department by his parents. The child is clutching his abdomen and crying about pain in his belly. His mother reports intermittent episodes of jaundice with joint and bone pain since he was 5 months old. At presentation, the patient’s vital signs are within normal limits. Physical examination reveals slight jaundice and pale conjunctiva. The spleen is tender and easily palpable. After a complete blood count with differential and an abdominal ultrasound, the patient is found to have sickle-cell disease with splenic infarct. A partial splenectomy is performed. After the operation, the physician provides vaccines against Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae. The picture shows a slide obtained from the resected portion of the patient’s spleen. Dysfunction of the zone marked with which number predisposes the patient to the aforementioned infections?",
    "answer": "To determine the correct zone, we focus on the spleen’s role in fighting **encapsulated bacteria** (Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae). The key zone responsible for clearing these pathogens is the **marginal zone**.\n\n\n### Key Background:  \nEncapsulated bacteria are opsonized (tagged) by complement proteins (e.g., C3b). The marginal zone of the spleen contains specialized macrophages with receptors for these complement tags, enabling efficient phagocytosis of encapsulated bacteria. Loss/dysfunction of this zone (e.g., from splenectomy or infarct) impairs clearance of these pathogens, increasing infection risk.\n\n\n### Typical Histology Labeling:  \nIn standard spleen diagrams, the marginal zone is often labeled as **3** (between the white pulp and red pulp).\n\n\n**Answer: 3** (assuming standard labeling of the marginal zone as number 3).\n\n\n\\boxed{3}",
    "expected_answer": "1 and 2",
    "time": 32.24999117851257,
    "answer_length": 894,
    "retrieval_time": 0.015842914581298828,
    "generation_time": 32.225234031677246
  },
  {
    "question": "A 51-year-old woman presents to her primary care physician complaining of months of dry mouth and dry eyes. She says the dryness has become so severe that she has difficulty swallowing food. She has a history of hypertension, for which she takes hydrochlorothiazide (HCTZ), but she has no other medical problems. Family history is significant for her grandmother having systemic lupus erythematosus. The vital signs include: blood pressure 118/76 mm Hg, heart rate 78/min, and respiratory rate 15/min. On physical exam, she has tender parotid glands bilaterally and dries mucous membranes. The presence of serum anti-Ro and anti-La autoantibodies is confirmed at high titers. In addition to her primary diagnosis, which of the following is this patient most at risk for developing in the future?",
    "answer": "To answer this question, we first identify the primary diagnosis, then determine its key long-term complications.\n\n\n### Step 1: Primary Diagnosis  \nThe patient presents with:  \n- Dry mouth (xerostomia) and dry eyes (xerophthalmia)  \n- Tender parotid glands  \n- High titers of anti-Ro (SS-A) and anti-La (SS-B) antibodies  \n\nThese findings are classic for **primary Sjögren’s syndrome**, an autoimmune disorder targeting exocrine glands.\n\n\n### Step 2: Key Long-Term Risk  \nSjögren’s syndrome is strongly associated with an increased risk of **lymphoproliferative disorders**, particularly **non-Hodgkin lymphoma (NHL)**. The risk is ~10–15x higher than the general population, with MALT lymphoma (mucosa-associated lymphoid tissue) being the most common subtype (often involving the parotid glands).\n\n\n**Answer: Non-Hodgkin lymphoma (specifically MALT lymphoma)**.  \n(Note: If this were a multiple-choice question, the correct option would reflect this lymphoproliferative risk.)\n\n\n\\boxed{Non-Hodgkin lymphoma}",
    "expected_answer": "Non-Hodgkin lymphoma",
    "time": 18.225090742111206,
    "answer_length": 1009,
    "retrieval_time": 0.018085956573486328,
    "generation_time": 18.19728684425354
  },
  {
    "question": "A 59-year-old man presents to his primary care provider with fatigue, a progressively worsening cough with flecks of blood, shortness of breath, and dark urine. He reports feeling ill for the past 3 weeks. Past medical history is significant for hypertension and hyperlipidemia. He takes chlorthalidone and atorvastatin. Family history is noncontributory. He has smoked 20–30 cigarettes daily for the past 26 years. Anti-glomerular basement membrane serologies are positive. Which of the following is a specific feature for this patient’s condition?",
    "answer": "To determine the specific feature of this patient’s condition, we first analyze the clinical presentation and key lab findings:\n\n\n### **Step 1: Identify the Condition**  \nThe patient has:  \n- **Pulmonary symptoms**: Hemoptysis (blood in cough), dyspnea (shortness of breath).  \n- **Renal symptoms**: Dark urine (consistent with hematuria from glomerulonephritis).  \n- **Key lab**: Positive anti-glomerular basement membrane (anti-GBM) antibodies.  \n\nThis triad (glomerulonephritis + pulmonary hemorrhage + anti-GBM antibodies) is **Goodpasture syndrome** (anti-GBM disease).  \n\n\n### **Step 2: Specific Feature of Goodpasture Syndrome**  \nA defining histopathologic feature of anti-GBM disease is **linear immunofluorescence (IF) staining** of the glomerular basement membrane (GBM). This pattern arises from IgG antibodies binding uniformly to the collagen IV of the GBM, creating a linear band on IF microscopy.  \n\nOther glomerulonephritides (e.g., post-streptococcal, IgA nephropathy) show granular or mesangial IF patterns, not linear.  \n\n\n**Answer: Linear immunofluorescence staining of the glomerular basement membrane.**",
    "expected_answer": "Linear IgG staining on immunofluorescence",
    "time": 15.670089960098267,
    "answer_length": 1126,
    "retrieval_time": 0.011571168899536133,
    "generation_time": 15.652198314666748
  },
  {
    "question": "A 32-year-old man with HIV infection is brought to the emergency department by his roommate because of a 2-week history of progressively worsening headache and vomiting. Current medications include trimethoprim-sulfamethoxazole, dolutegravir, and tenofovir-emtricitabine. His temperature is 38.5°C (101.3°F). Physical examination shows nuchal rigidity. Kernig and Brudzinski signs are present. A lumbar puncture is performed and shows an opening pressure of 32 cm H2O (N: < 20). The pathogen isolated from the cerebrospinal fluid (CSF) can be cultured on Sabouraud agar. Further evaluation of this patient's CSF is most likely to show which of the following additional findings?",
    "answer": "To answer this question, we analyze the case details and connect them to key clinical findings for fungal meningitis in HIV patients:\n\n\n### Key Case Observations  \n- **HIV-positive patient** with meningitis (nuchal rigidity, Kernig/Brudzinski signs).  \n- **Elevated LP opening pressure** (32 cm H₂O, normal <20).  \n- **Pathogen grows on Sabouraud agar** (selective for fungi).  \n\n\n### Most Likely Pathogen  \nThe leading cause of fungal meningitis in HIV patients is **Cryptococcus neoformans** (especially with CD4 count <100 cells/μL).  \n\n\n### Typical CSF Findings for Cryptococcal Meningitis  \nGiven the case context, the most likely additional finding is:  \n\n**Positive Cryptococcal Antigen (CrAg) in cerebrospinal fluid**  \n\nOther supportive findings include:  \n- Lymphocytic pleocytosis (mild, usually <100 cells/mm³).  \n- Mildly elevated protein (~50-200 mg/dL).  \n- Normal or slightly decreased glucose.  \n- India ink stain positivity (though CrAg is more sensitive).  \n\n\n**Answer:** Positive Cryptococcal antigen test result in cerebrospinal fluid.  \n\n(Note: If lymphocytic pleocytosis was an option, it is also a common finding, but CrAg is the most specific for Cryptococcus.)\n\n\n\\boxed{Positive\\ cryptococcal\\ antigen\\ in\\ cerebrospinal\\ fluid}",
    "expected_answer": "Positive latex agglutination test",
    "time": 37.59316420555115,
    "answer_length": 1254,
    "retrieval_time": 0.2567777633666992,
    "generation_time": 37.565457820892334
  },
  {
    "question": "A 70-year-old woman comes to the physician for the evaluation of back pain. For the past six days, she has had a burning pain in her upper right back and chest. She cannot recall any recent injury and has no prior history of back pain. She has a history of hypertension and gastroesophageal reflux. The patient volunteers at an animal shelter three times a week. She does not smoke or drink alcohol. Current medications include ramipril and pantoprazole. The patient appears healthy and well nourished. Her temperature is 36.9°C (98.42°F), pulse is 76/min, and blood pressure is 145/92 mm Hg. Examination shows a long erythematous rash covered with multiple clear vesicles and crusty lesions extending from her back to below her right breast. Which of the following is the most likely underlying mechanism of the disease?",
    "answer": "To determine the underlying mechanism of the patient’s disease, we first identify the condition based on clinical findings:\n\n\n### Key Clinical Clues  \n- **Symptoms**: Burning pain in the upper right back/chest (dermatomal distribution) followed by an erythematous rash with vesicles and crusts.  \n- **Demographics**: 70-year-old woman (age-related immune decline is a major risk factor).  \n- **Distribution**: Rash follows a single dermatome (unilateral, extending from back to chest), which is pathognomonic for **herpes zoster (shingles)**.  \n\n\n### Underlying Mechanism of Herpes Zoster  \nHerpes zoster results from **reactivation of latent varicella-zoster virus (VZV)**. After primary infection (chickenpox), VZV remains dormant in sensory ganglia (e.g., dorsal root ganglia of spinal nerves or cranial nerve ganglia). With age (immunosenescence) or immune compromise, the virus reactivates, travels down the sensory nerve to the skin, and causes the characteristic dermatomal rash and pain.  \n\n\n**Answer**: Reactivation of latent varicella-zoster virus in a dorsal root ganglion.  \n\n\\boxed{Reactivation of latent varicella-zoster virus in a sensory ganglion}",
    "expected_answer": "Viral reactivation in dorsal root ganglia",
    "time": 15.011636972427368,
    "answer_length": 1163,
    "retrieval_time": 0.014560937881469727,
    "generation_time": 14.98585319519043
  },
  {
    "question": "A type of fatal adrenal cancer has an average survival rate of 3 years after the onset of clinically significant symptoms. It is determined that patients have a 4-year asymptomatic period prior to developing clinical symptoms from this adrenal cancer. A new screening test is developed, and the cancer can now be detected 2 years prior to developing clinical symptoms. A new observational case-control study of screened and unscreened patients measures the median 5-year survival of patients who decline medical and surgical treatment. The screened population has statistically better outcomes. Which step should be undertaken to prevent bias in these conclusions?",
    "answer": "To address the bias in these conclusions, we first identify the key issue: **lead-time bias**. This occurs when screening detects disease earlier, making survival from diagnosis appear longer—even though the patient’s actual lifespan (time from cancer onset to death) does not change.\n\n\n### Step to Prevent Bias:  \n**Adjust survival calculations to use a common reference point (e.g., time of cancer onset or expected symptom onset) instead of time of diagnosis.**  \n\nAlternatively, **compare overall mortality rates** (deaths per population) between screened and unscreened groups, rather than survival time from diagnosis. This avoids the illusion of longer survival caused by earlier detection alone.\n\n\n**Answer:** Adjust for lead-time bias by measuring survival from the expected date of symptom onset (or cancer onset) rather than from the date of diagnosis, or compare overall mortality rates instead of survival time from diagnosis.  \n\n(Concise version for clarity): Adjust survival calculations to account for lead-time by using a common reference point (e.g., symptom onset) instead of diagnosis date, or compare mortality rates rather than survival from diagnosis.  \n\nThe most direct answer is: **Adjust for lead-time bias by using a common reference point (like time of symptom onset) to calculate survival instead of time of diagnosis.**  \n\nBut in standard terms, the key step is to **account for lead-time bias** by measuring survival from a fixed point unrelated to screening (e.g., symptom onset) or using mortality rates.  \n\nFinal Answer: Adjust for lead-time bias by calculating survival from the expected date of symptom onset rather than from the date of diagnosis.  \n\n\\boxed{Adjust for lead-time bias by using a common reference point (e.g., symptom onset) to calculate survival instead of diagnosis date}",
    "expected_answer": "Using mortality rates in the analysis",
    "time": 23.273436069488525,
    "answer_length": 1825,
    "retrieval_time": 0.014143943786621094,
    "generation_time": 23.248075008392334
  },
  {
    "question": "A 60-year-old man presents to the office for shortness of breath. The shortness of breath started a year ago and is exacerbated by physical activity. He has been working in the glass manufacturing industry for 20 years. His vital signs include: heart rate 72/min, respiratory rate 30/min, and blood pressure 130/80 mm Hg. On physical exam, there are diminished respiratory sounds on both sides. On the chest radiograph, interstitial fibrosis with reticulonodular infiltrate is found on both sides, and there is also an eggshell calcification of multiple adenopathies. What is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the key clinical and radiographic findings along with the patient’s occupational history:\n\n\n### **Key Clues**  \n1. **Occupational History**: 20 years in glass manufacturing (a high-risk setting for **silica dust exposure**—silica is the main component of sand used in glass production).  \n2. **Symptoms**: Chronic exertional shortness of breath (consistent with interstitial lung disease).  \n3. **Radiographic Findings**:  \n   - Bilateral interstitial fibrosis with reticulonodular infiltrates.  \n   - **Eggshell calcification of lymph nodes**: A classic hallmark of silicosis.  \n\n\n### **Differential Exclusion**  \n- **Asbestosis**: Associated with pleural plaques, not eggshell calcification.  \n- **Coal worker’s pneumoconiosis**: Characterized by coal macules/progressive massive fibrosis, no eggshell calcification.  \n- **Sarcoidosis**: May have lymph node calcification but lacks the strong occupational link to silica exposure here.  \n\n\n**Answer: Silicosis**\n\n\n\\boxed{Silicosis}",
    "expected_answer": "Silicosis",
    "time": 13.008303880691528,
    "answer_length": 1034,
    "retrieval_time": 0.01696610450744629,
    "generation_time": 12.98304796218872
  },
  {
    "question": "A 43-year-old woman is brought to the emergency department by her brother for severe chest pain. The patient recently lost her husband in a car accident and is still extremely shocked by the event. On physical examination, her blood pressure is 105/67 mm Hg, the heart rate is 96/min and regular, breathing rate is 23/min, and the pulse oximetry is 96%. An S3 heart sound and rales in the lower right and left lung lobes are heard. A 12-lead ECG shows no significant findings. Echocardiography shows an enlarged left ventricle and left atrium. The patient is stabilized and informed about the diagnosis and possible treatment options. Which of the following is the most likely diagnosis?",
    "answer": "The most likely diagnosis is **Takotsubo cardiomyopathy (broken heart syndrome)**.\n\n\n### Key Reasoning:  \nThe patient presents with:  \n1. **Acute emotional stressor**: Recent loss of her husband (a classic trigger for Takotsubo).  \n2. **Clinical features of heart failure**: S3 heart sound (indicates volume overload) and rales in both lower lung lobes (pulmonary edema).  \n3. **Non-specific or normal ECG**: Unlike acute myocardial infarction (MI), which typically shows ST-segment changes or Q waves, Takotsubo may have normal or minimal ECG abnormalities.  \n4. **Transient left ventricular dysfunction**: While Takotsubo is known for apical ballooning, acute presentations can involve left ventricular dilation (enlarged LV/LA as noted on echocardiogram).  \n\n\n### Exclusion of Other Diagnoses:  \n- **Myocardial infarction**: Unlikely, as ECG has no significant findings (MI usually has ST-T changes or Q waves).  \n- **Dilated cardiomyopathy**: Chronic condition, no acute stress trigger.  \n- **Pericarditis**: No friction rub or diffuse ST elevation (classic for pericarditis).  \n- **Valvular heart disease**: No mention of murmurs (e.g., mitral regurgitation) to suggest this.  \n\n\n**Answer: Takotsubo cardiomyopathy** (or broken heart syndrome).  \n\n\\boxed{Takotsubo cardiomyopathy}",
    "expected_answer": "Takotsubo cardiomyopathy",
    "time": 16.17750597000122,
    "answer_length": 1285,
    "retrieval_time": 0.01657414436340332,
    "generation_time": 16.151753902435303
  },
  {
    "question": "A 56-year-old man is brought to the emergency department. He was found unconscious on the street. The staff recognizes him as a local homeless man with a long history of alcoholism. At the hospital, his pulse is 95/min, the blood pressure is 110/70 mm Hg, the respirations are 20/min, and the oxygen saturation is 98% on room air. On physical exam, the unconscious man is covered in bloody vomit with small clots and food particles. He smells of alcohol. A digital exam reveals black tarry stool in the rectal vault. The patient is given oxygen, IV fluids, and an NG-tube is placed and set to intermittent suction. Labs are sent and the patient is prepared for a procedure. Which of the following is the most appropriate next step in his management?",
    "answer": "To determine the most appropriate next step in management, we analyze the patient’s clinical presentation and prioritize evidence-based interventions for suspected upper gastrointestinal bleeding (UGIB) in an alcoholic patient:\n\n\n### Key Clinical Features  \n- **Alcoholic history**: High risk of **esophageal varices** (portal hypertension from cirrhosis) or peptic ulcer disease/gastritis.  \n- **Hematemesis (bloody vomit) + melena**: Confirms UGIB.  \n- **Stable vital signs**: No immediate shock, but requires urgent intervention to prevent decompensation.  \n- **Initial resuscitation**: O2, IV fluids, NG tube suction already administered.  \n\n\n### Priority Interventions for Suspected Variceal Bleeding  \nVariceal bleeding is a life-threatening complication of cirrhosis. Guidelines recommend:  \n1. **Early medical therapy** to reduce portal pressure: **IV octreotide** (somatostatin analog) is first-line, as it decreases variceal blood flow and rebleeding risk—even before endoscopy.  \n2. **Antibiotics**: Ceftriaxone (to prevent spontaneous bacterial peritonitis, common in variceal bleed patients).  \n3. **Endoscopy**: Diagnostic and therapeutic (band ligation/sclerotherapy) within 12 hours if stable, but not the immediate next step after resuscitation.  \n\n\n### Why Other Options Are Less Urgent  \n- **Transfusion**: Only indicated if Hb <7g/dL or signs of shock (not present here).  \n- **IV PPI**: First-line for non-variceal UGIB (peptic ulcers), but varices are the top suspect here.  \n- **Intubation**: Unnecessary unless airway compromise (O2 sat 98% on room air, no aspiration signs).  \n\n\n**Answer: Administer IV octreotide** (or equivalent somatostatin analog).\n\n\n\\boxed{IV octreotide}",
    "expected_answer": "Undergo upper GI endoscopy",
    "time": 41.575560092926025,
    "answer_length": 1701,
    "retrieval_time": 0.07026410102844238,
    "generation_time": 41.550251960754395
  },
  {
    "question": "An 8-year-old girl comes to the physician because of a 2-day history of hematuria. Two weeks ago, she had a sore throat that resolved without treatment. Physical examination shows 1+ pitting edema of the lower legs and ankles. Urinalysis shows numerous RBCs and 3+ proteinuria. Her antistreptolysin O titer is elevated. Formation of which of the following is most likely involved in the underlying mechanism of this patient's symptoms?",
    "answer": "To answer this question, we first diagnose the patient’s condition and then link it to its pathophysiology:\n\n\n### **Step 1: Diagnose the Condition**  \nThe patient is an 8-year-old girl with:  \n- 2-day history of hematuria, edema, and proteinuria  \n- 2-week prior sore throat (likely streptococcal)  \n- Elevated antistreptolysin O (ASO) titer  \n\nThis is **post-streptococcal glomerulonephritis (PSGN)**, a classic immune-mediated glomerular disease.\n\n\n### **Step 2: Pathophysiology of PSGN**  \nPSGN is a **Type III hypersensitivity reaction** caused by:  \n1. Streptococcal antigens (e.g., streptolysin O, M protein) elicit antibody production.  \n2. **Antigen-antibody immune complexes** form in the circulation or deposit directly in the glomerular basement membrane (GBM) and mesangium.  \n3. Immune complex deposition activates the complement system and recruits inflammatory cells (neutrophils, macrophages), leading to glomerular damage (hematuria, proteinuria, edema).\n\n\n### **Conclusion**  \nThe key formation involved in the underlying mechanism is **antigen-antibody immune complexes**.\n\n\n**Answer:** Antigen-antibody immune complexes (or simply immune complexes).  \n\n(Note: If this were a multiple-choice question, the correct option would align with immune complex formation.)",
    "expected_answer": "Antigen-antibody complexes",
    "time": 17.65916681289673,
    "answer_length": 1283,
    "retrieval_time": 0.01518702507019043,
    "generation_time": 17.633192777633667
  },
  {
    "question": "A 25-year-old man presents to the emergency department with altered mental status. He was found down in the middle of the street. His past medical history is unknown. His temperature is 99.0°F (37.2°C), blood pressure is 104/64 mmHg, pulse is 70/min, respirations are 5/min, and oxygen saturation is 91% on room air. The patient is being resuscitated in the trauma bay. Which of the following was most likely to be found on exam?",
    "answer": "To determine the most likely exam finding, let’s analyze the key clinical clues:  \n\n### Key Observations:  \n- 25-year-old man with altered mental status, found unresponsive in public.  \n- **Critical vital sign**: Respirations = 5/min (severe bradypnea/respiratory depression).  \n- Normal temperature, mild hypotension, normal pulse, low O2 saturation.  \n\n\n### Differential Diagnosis for Bradypnea + Altered Mental Status:  \nThe combination of severe respiratory depression and altered mental status in a young adult with unknown history strongly suggests **opioid overdose** (a common scenario for unresponsive individuals found in public settings).  \n\nOpioid toxicity classically presents with the \"opioid triad\":  \n1. Respiratory depression (bradypnea <12/min).  \n2. Altered mental status (lethargy/coma).  \n3. **Miosis (pinpoint pupils)**—a pathognomonic exam finding for opioid overdose.  \n\n\n### Other Considerations:  \n- Sedative-hypnotics (e.g., benzodiazepines) cause respiratory depression but typically have normal or dilated pupils, not pinpoint.  \n- Hypoxia alone would not explain pinpoint pupils.  \n- Neurologic causes (e.g., stroke) are less likely in a young adult without focal deficits and would not cause severe bradypnea + miosis.  \n\n\n**Answer: Pinpoint pupils (miosis)**.  \n\n\\boxed{Pinpoint\\ pupils}",
    "expected_answer": "Miosis",
    "time": 14.891567945480347,
    "answer_length": 1319,
    "retrieval_time": 0.0067729949951171875,
    "generation_time": 14.880611896514893
  },
  {
    "question": "A 38-year-old G4P3 presents to her obstetrician’s office for her 20-week anatomy ultrasound. She reports that she feels well and has not experienced any contractions or vaginal bleeding. She also reports good fetal movement. The patient declined prenatal screening earlier in the pregnancy for religious reasons but would now like an anatomy ultrasound to ensure the fetus is growing appropriately. The patient’s previous pregnancies were uncomplicated, and she delivered three healthy babies at full term. On the ultrasound, the technician observes a male fetus with likely intrauterine growth restriction (IUGR). She also notes microcephaly, convex-rounded feet, and clenched fists with overlapping fingers. The technician further notes a medium-sized ventricular septal defect (VSD). The amniotic fluid index (AFI) is 26 cm.\n\nWhich of the following additional findings is most likely to be observed in this fetus?",
    "answer": "To answer this question, we first need to identify the **underlying condition** based on the provided findings, then determine the most likely additional feature of that condition.\n\n\n### Step 1: Diagnose the Condition  \nThe key findings in this fetus are:  \n- Intrauterine growth restriction (IUGR)  \n- Microcephaly  \n- Convex-rounded feet (rocker-bottom feet)  \n- Clenched fists with overlapping fingers (classic for trisomy 18)  \n- Ventricular septal defect (VSD)  \n- Polyhydramnios (AFI = 26 cm, normal = 5-25 cm)  \n\nThese features are **highly consistent with Trisomy 18 (Edwards syndrome)**. Trisomy 18 is characterized by severe IUGR, microcephaly, overlapping fingers, rocker-bottom feet, cardiac defects (VSD), and polyhydramnios (often due to impaired swallowing from esophageal atresia).\n\n\n### Step 2: Identify the Most Likely Additional Finding  \nPolyhydramnios in Trisomy 18 is typically caused by **esophageal atresia** (the fetus cannot swallow amniotic fluid, leading to fluid accumulation). Other common findings include micrognathia (small jaw) or renal anomalies, but esophageal atresia directly explains the polyhydramnios and is a classic association with Trisomy 18.\n\n\n**Answer:** Esophageal atresia  \n\n(Note: If this were a multiple-choice question, \"esophageal atresia\" would be the correct option.)\n\n\n\\boxed{Esophageal \\ atresia}",
    "expected_answer": "Prominent occiput",
    "time": 29.04479169845581,
    "answer_length": 1353,
    "retrieval_time": 0.012021064758300781,
    "generation_time": 29.033535957336426
  },
  {
    "question": "An 83-year-old man is admitted to the hospital with fever, weakness, and decreased responsiveness. He is diagnosed with urosepsis based on urinalysis and culture and started on ceftriaxone and intravenous fluids. By hospital day 3, he is clinically improving. During the evening, the patient becomes irritable. He is talking to someone despite nobody being present in the room. He is easily agitated and attempts to strike a nurse with a remote control to his TV. Subsequently, the patient keeps getting out of bed and trying to walk away despite being a fall risk. Which of the following is the most appropriate next step in management?",
    "answer": "To address this scenario, we first recognize the patient’s presentation as **delirium**—characterized by acute onset of agitation, hallucinations, disorientation, and fall risk, likely related to his recent urosepsis (or contributing factors like sleep deprivation, hospital environment, or medication effects).\n\n\n### Key Management Principles for Delirium:\n1. **Prioritize safety**: The patient is aggressive (trying to strike staff) and a fall risk, so immediate intervention to prevent harm is critical.  \n2. **Non-pharmacological measures**: First-line (e.g., orienting cues, calm environment, avoiding restraints), but these may not suffice in cases of imminent harm.  \n3. **Pharmacological intervention**: Reserved for when non-pharmacological measures fail and there is risk of self/others harm.  \n\n\n### Most Appropriate Next Step:\nGiven the patient’s **imminent risk of harm** (aggression + fall risk), the most appropriate immediate step is to administer a **low-dose antipsychotic** (e.g., haloperidol 0.25–0.5 mg orally or IM). Haloperidol is preferred for acute agitation in delirium due to its rapid onset, minimal anticholinergic effects (which can worsen delirium), and proven efficacy in reducing aggression while avoiding over-sedation.\n\n\n**Answer: Administer haloperidol** (assuming this is an option in the standard question context).  \n\n*(Note: If checking for underlying causes like new infection or electrolyte abnormalities were an option, it would also be important, but the urgency of preventing harm takes priority here.)*",
    "expected_answer": "Olanzapine",
    "time": 34.96555209159851,
    "answer_length": 1548,
    "retrieval_time": 0.015406131744384766,
    "generation_time": 34.94020414352417
  },
  {
    "question": "A 26-year-old woman comes to the physician because of fatigue, weight loss, and muscle aches during the past 2 months. There is no personal or family history of serious illness. Her only medication is a multivitamin. A metyrapone stimulation test is performed and the results rule out a diagnosis of adrenal insufficiency. Which of the following changes in laboratory findings are most likely to have been observed in this patient following the administration of the drug?",
    "answer": "To answer this question, we need to recall the mechanism of the **metyrapone stimulation test** and the normal response (which rules out adrenal insufficiency):\n\n\n### Key Background on Metyrapone Test  \nMetyrapone inhibits **11β-hydroxylase**, an enzyme critical for converting 11-deoxycortisol to cortisol (and deoxycorticosterone to corticosterone) in the adrenal cortex. This inhibition lowers serum cortisol levels, triggering feedback activation of the hypothalamic-pituitary-adrenal (HPA) axis:  \n- Low cortisol → increased ACTH secretion from the pituitary gland.  \n- Increased ACTH stimulates the adrenal cortex to produce more steroids **before the blocked step** (e.g., 11-deoxycortisol).  \n\n\n### Normal vs. Abnormal Response (Ruling Out Adrenal Insufficiency)  \nThe test rules out adrenal insufficiency if the HPA axis is intact. In this case:  \n1. **Serum ACTH**: Increases (due to feedback from low cortisol).  \n2. **Serum 11-deoxycortisol**: Increases (adrenal cortex responds to ACTH by producing more precursors).  \n3. **Urinary 17-hydroxycorticosteroids (17-OHCS)**: Increases (11-deoxycortisol is a 17-OH steroid; its metabolites are excreted as urinary 17-OHCS).  \n\n\n### Conclusion  \nSince the test ruled out adrenal insufficiency, the patient has a **normal response** to metyrapone. The most characteristic changes are:  \n\n**Increased serum ACTH and increased urinary 17-hydroxycorticosteroids** (or increased serum 11-deoxycortisol).  \n\n\n**Answer:** Increased urinary 17-hydroxycorticosteroids and increased serum ACTH (or equivalent, e.g., increased serum 11-deoxycortisol).  \n\n(Note: If specific options were provided, this would align with the standard normal response markers.)\n\n\n\\boxed{Increased\\ urinary\\ 17-hydroxycorticosteroids\\ and\\ increased\\ serum\\ ACTH}  \n\n(Adjust based on standard options; if 11-deoxycortisol is an option, that is also correct.)  \nHowever, the most commonly cited marker for a normal response in this context is **increased urinary 17-hydroxycorticosteroids**, so if forced to pick one, that is likely the answer.  \n\n\\boxed{Increased\\ urinary\\ 17-hydroxycorticosteroids}",
    "expected_answer": "Increase in serum ACTH",
    "time": 35.973676919937134,
    "answer_length": 2125,
    "retrieval_time": 0.0998220443725586,
    "generation_time": 35.94708251953125
  },
  {
    "question": "An investigator conducts a study to determine whether earlier detection of glioblastoma multiforme (GBM) in patients increases survival time. One subset of study participants consists of asymptomatic individuals who were diagnosed with GBM after undergoing a screening MRI of the brain. The other subset of study participants was diagnosed with GBM only after they developed symptoms. Results from the study show that the asymptomatic patients who were diagnosed with screening MRI had an average survival time that was 6 weeks longer than that of the patients who were diagnosed after symptom onset. Which of the following statistical biases is most likely to have occurred as a result of the endpoint selected for this study?",
    "answer": "The most likely statistical bias here is **lead time bias**.\n\n\n### Explanation:  \nLead time bias occurs when screening detects a disease **earlier** than it would have been diagnosed through usual clinical presentation (e.g., symptom onset). In this study:  \n- The asymptomatic group was diagnosed via screening MRI *before* symptoms developed.  \n- The symptomatic group was diagnosed later, when symptoms appeared.  \n\nThe \"survival time\" measured (from diagnosis to death) is longer for the screening group—**not because they lived longer**, but because the disease was detected earlier. The actual time from disease onset to death (true survival) may be identical between the two groups. This misinterpretation of longer measured survival as improved outcomes is the hallmark of lead time bias.\n\n\n**Answer:** Lead time bias.",
    "expected_answer": "Lead-time bias",
    "time": 11.844491958618164,
    "answer_length": 826,
    "retrieval_time": 0.013854026794433594,
    "generation_time": 11.8191499710083
  },
  {
    "question": "A 23-year-old man is brought to the emergency department 25 minutes after being involved in a high-speed motor vehicle collision in which he was the restrained driver. On questioning by the paramedics, he reported severe chest pain and mild dyspnea. On arrival, he is confused and unable to provide a history. His pulse is 93/min, respirations are 28/min, and blood pressure is 91/65 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 88%. He is able to move his extremities in response to commands. He opens his eyes spontaneously. Pupils are equal and reactive to light. Examination shows multiple bruises over the trunk and extremities. There is a 3-cm (1.2-in) wound at the left fifth intercostal space at the midclavicular line. There is jugular venous distention. Decreased breath sounds and hyperresonance on percussion are noted on the left. Which of the following is the most appropriate next step in management?",
    "answer": "To determine the most appropriate next step, we analyze the key clinical findings and prioritize emergent conditions:\n\n\n### **Key Clinical Findings**  \n- Penetrating chest wound (left 5th intercostal space, midclavicular line).  \n- **Tension pneumothorax triad**: Hypotension (91/65 mmHg), jugular venous distention (JVD), and decreased breath sounds on the left.  \n- Hyperresonance on percussion (air in pleural space) confirms pneumothorax, and JVD + hypotension indicates **tension pneumothorax** (a life-threatening emergency).  \n\n\n### **Management Priority**  \nTension pneumothorax requires immediate decompression to relieve pressure on the heart and lungs, preventing cardiovascular collapse. The first-line intervention is **needle thoracostomy** (large-bore needle in the 2nd intercostal space, midclavicular line on the affected side). This is urgent—delaying for imaging is contraindicated.  \n\n\n**Answer:** Perform needle decompression of the left pleural space.  \n\n(Note: In standard exam format, this would be listed as an option like \"Insert a large-bore needle into the left second intercostal space at the midclavicular line.\")  \n\n\\boxed{Insert a large-bore needle into the left second intercostal space at the midclavicular line}",
    "expected_answer": "Needle decompression",
    "time": 21.10117506980896,
    "answer_length": 1246,
    "retrieval_time": 0.019804954528808594,
    "generation_time": 21.075631856918335
  },
  {
    "question": "A novel type of PET radiotracer is being developed to evaluate patients with Parkinson’s disease. A clinical research study has enrolled 1,200 patients, half of whom have the disease. The scan is found to be positive in 590 of the 600 patients with known PD, and positive in 20 of the 600 patients without PD. What is the test’s overall specificity?",
    "answer": "To determine the test’s specificity, we use the definition of specificity: the proportion of individuals **without the disease** who test **negative**.\n\n\n### Step 1: Identify key values  \n- Total patients without Parkinson’s disease (PD): 600  \n- False positives (FP): Patients without PD who tested positive = 20  \n- True negatives (TN): Patients without PD who tested negative = Total without PD - FP = 600 - 20 = 580  \n\n\n### Step 2: Calculate specificity  \nSpecificity = \\(\\frac{\\text{True Negatives (TN)}}{\\text{Total without disease (TN + FP)}}\\)  \n\nSubstitute values:  \nSpecificity = \\(\\frac{580}{600} = 0.9667\\) (or ~96.7%)  \n\n\n**Answer:** ~96.7% (or 0.97 when rounded to two decimal places)  \n\nThe exact value is 0.966..., so the most appropriate answer is **96.7%** or **0.97**.  \n\n\\(\\boxed{96.7\\%}\\) (or \\(\\boxed{0.97}\\) if decimal is preferred)  \n\nBut typically in clinical contexts, percentage is standard:  \n\n\\(\\boxed{97\\%}\\) (rounded to whole number) or \\(\\boxed{96.7\\%}\\) (more precise).  \n\nGiven the options likely expect a whole number, the answer is \\(\\boxed{97\\%}\\).  \n\nWait, let's confirm: 580/600 = 0.9666..., which is 96.666...%, so rounding to nearest whole number is **97%**.  \n\nFinal answer: \\(\\boxed{97}\\) (assuming percentage without the sign, as sometimes asked in such questions).  \n\nAlternatively, if decimal is needed: \\(\\boxed{0.97}\\).  \n\nBut based on common practice in these questions, the answer is \\(\\boxed{97}\\).\n\n\n\\(\\boxed{97}\\)",
    "expected_answer": "580 / (580 + 20)",
    "time": 16.991914987564087,
    "answer_length": 1466,
    "retrieval_time": 0.012525081634521484,
    "generation_time": 16.96610403060913
  },
  {
    "question": "A 55-year-old man presents to a rheumatologist with bilateral wrist and knee pain that has been present for the last 10 years. The patient was a professional athlete who retired at age 50. He also notes morning stiffness in his joints that lasts approx. 50 minutes. He denies joint swelling, color changes in his digits, dryness of mucous membranes, and constitutional symptoms such as fever and chills. On physical exam, the physician notes several non-tender nodules on the left 1st, 3rd, and 4th distal interphalangeal joints. There is also tenderness with palpation at the base of both thumbs. The patient’s knees are enlarged, bilaterally, and he has pain and crepitus on passive range of motion. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, let’s analyze the key clinical features and match them to common rheumatologic conditions:\n\n\n### **Key Clinical Features**  \n- **Patient profile**: 55-year-old ex-professional athlete (history of joint overuse).  \n- **Symptoms**: Bilateral wrist/knee pain (10 years), morning stiffness (~50 mins), no joint swelling, no constitutional symptoms (fever/chills), no dry mucous membranes or digit color changes.  \n- **Exam findings**:  \n  - Non-tender nodules on left DIP joints (**Heberden’s nodes**).  \n  - Tenderness at base of both thumbs (1st carpometacarpal joint involvement).  \n  - Enlarged knees with pain/crepitus (classic for degenerative joint disease).  \n\n\n### **Differential Diagnosis & Ruling Out**  \n- **Rheumatoid Arthritis (RA)**: RA typically presents with symmetric joint swelling, morning stiffness >1 hour, and affects MCP/PIP joints (not DIP). No swelling here rules this out.  \n- **Psoriatic Arthritis**: Requires skin findings (psoriasis) or nail changes (pitting), which are absent.  \n- **Gout**: Tophi are tender and associated with acute attacks (not chronic pain without swelling).  \n- **Osteoarthritis (OA)**: Matches all key findings:  \n  - Heberden’s nodes (DIP nodules) and thumb CMC involvement are pathognomonic for OA.  \n  - Crepitus in knees and joint overuse history (ex-athlete) support degenerative changes.  \n  - Morning stiffness in OA may occasionally exceed 30 mins (especially in severe cases), but other features confirm OA.  \n\n\n**Answer: Osteoarthritis**",
    "expected_answer": "Osteoarthritis",
    "time": 19.324753999710083,
    "answer_length": 1537,
    "retrieval_time": 0.017004728317260742,
    "generation_time": 19.30009388923645
  },
  {
    "question": "A 40-year-old businessman who was previously well is brought into the emergency department by his assistant with a complaint of left-sided weakness after a chiropractic neck manipulation. He has never felt like this before. Past medical history is insignificant. His blood pressure is 125/75 mm Hg, pulse 86/min, respiratory rate 13/min, temperature 36.8°C (98.2°F). A T2-weighted MRI shows a left C5 hemicord lesion. The patient is treated with cervical immobilization, a course of steroids, and physical therapy. What other finding will most likely be seen in this patient?",
    "answer": "To determine the most likely additional finding, we analyze the case using key clinical and anatomical insights:\n\n\n### **Key Observations**  \nThe patient has a **left C5 hemicord lesion** (MRI finding) after neck manipulation—consistent with **Brown-Sequard Syndrome** (spinal cord hemisection).\n\n\n### **Anatomical Basis of Brown-Sequard Syndrome**  \nA hemisection of the spinal cord causes distinct deficits on the **ipsilateral (same side as lesion)** and **contralateral (opposite side)** below the lesion level:  \n- **Ipsilateral**:  \n  - Motor weakness (upper motor neuron, corticospinal tract, which decussates at the medulla).  \n  - Loss of vibration/proprioception (dorsal column, which ascends ipsilaterally before decussating at the medulla).  \n- **Contralateral**:  \n  - Loss of pain and temperature sensation (spinothalamic tract, which decussates *within 1-2 spinal segments* of origin).  \n\n\n### **Application to This Case**  \nThe lesion is **left C5**:  \n- The patient already has left-sided weakness (ipsilateral motor deficit).  \n- The most likely additional finding is **contralateral (right-sided) loss of pain and temperature sensation below the C5 level** (spinothalamic tract deficit).  \n\n\n**Answer:** Right-sided loss of pain and temperature sensation below the C5 level.  \n(If phrased concisely: Contralateral pain and temperature deficit below the lesion.)\n\n\n\\boxed{Right-sided loss of pain and temperature sensation below the C5 level}",
    "expected_answer": "Right-sided analgesia",
    "time": 29.4199481010437,
    "answer_length": 1460,
    "retrieval_time": 0.06932711601257324,
    "generation_time": 29.393486976623535
  },
  {
    "question": "A previously healthy 19-year-old man comes to the physician with right-sided, dull, throbbing scrotal pain for 12 hours. He has also had a burning sensation on urination and increased urinary frequency for the past 3 days. He has not had urethral discharge. He is sexually active with one female partner and does not use condoms. Vital signs are within normal limits. Physical examination shows a tender right testicle; lifting it provides relief. The penis appears normal, with no discharge at the meatus. Laboratory studies show a normal complete blood count; urinalysis shows 3 WBC/hpf. A Gram stain of a urethral swab shows polymorphonuclear leukocytes but no organisms. Testicular ultrasound shows increased blood flow to the right testicle compared to the left. Which of the following is the most likely cause of this patient's symptoms?",
    "answer": "To determine the most likely cause of the patient’s symptoms, we analyze key clinical findings and rule out differential diagnoses:\n\n\n### **Key Clinical Features**  \n- **Young sexually active male** (19yo, no condoms) with acute scrotal pain + dysuria/frequency.  \n- **Prehn’s sign positive**: Lifting the testicle relieves pain (classic for epididymitis, vs negative in torsion).  \n- **Urethral swab**: PMNs present but no organisms (consistent with intracellular pathogens like *Chlamydia trachomatis*, as Gram stain does not detect it).  \n- **Ultrasound**: Increased blood flow to the right testicle (inflammation, ruling out testicular torsion, which shows decreased/absent flow).  \n\n\n### **Differential Diagnosis Ruling Out**  \n- **Testicular torsion**: Excluded by increased blood flow and positive Prehn’s sign.  \n- **Gonorrhea**: Gram stain would show Gram-negative diplococci (absent here).  \n- **Mumps orchitis**: No parotid swelling or systemic symptoms (unlikely).  \n\n\n### **Most Likely Cause**  \nThe constellation of findings (sexually active, STI risk, PMNs without organisms, positive Prehn’s sign, increased blood flow) points to **epididymitis due to *Chlamydia trachomatis***.  \n\n\n**Answer: Chlamydia trachomatis** (assuming this is an option; if the question lists \"epididymitis\" as an option, that is also correct, but the specific pathogen is *Chlamydia trachomatis*).  \n\nFor the purpose of the question (most likely cause), the specific pathogen is the answer:  \n\n**Chlamydia trachomatis**\n\n\n\\boxed{Chlamydia\\ trachomatis}",
    "expected_answer": "Chlamydia trachomatis infection",
    "time": 31.773663997650146,
    "answer_length": 1544,
    "retrieval_time": 0.01729273796081543,
    "generation_time": 31.747452974319458
  },
  {
    "question": "A 4-month-old infant is brought to the office by his parents due to sudden nose bleeding without trauma of any kind. He has a 1-month history of multiple bruising that measures 1 cm in diameter each in the hands and feet, and tiny red spots that appeared in the upper and lower extremities without any trauma either. He has no prior bleeding history nor any relevant family history. The vital signs include: heart rate 190/min, respiratory rate 40/min, blood pressure 99/42 mm Hg, and temperature 36.6 °C (97.9 °F). His physical exam shows pale skin color, petechiae in the soft palate and in the upper and lower extremities as well as ecchymosis in the back of the hands and feet.\nThe complete blood count results are as follows:\nHemoglobin 8.9 g/dL\nHematocrit 41%\nLeukocyte count 10,500/mm3\nNeutrophils 53%\nBands 2%\nEosinophils 1%\nBasophils 0%\nLymphocytes 33%\nMonocytes 2%\nPlatelet count 450,000/mm3\nThe coagulation test results are as follows:\nPartial thromboplastin time (activated) 30.0 sec\nProthrombin time 13.6 sec\nInternational normalized ratio 0.99\nFibrinogen 364.9 mg/dL\nThe blood smear shows hypochromia, poikilocytosis, and large platelets, while a platelet aggregation test with ristocetin is normal. The overall bleeding time is increased. What is the most likely cause of this patient’s condition?",
    "answer": "To determine the most likely cause of the patient’s condition, we analyze the key clinical and laboratory findings step by step:\n\n\n### **Key Clinical & Laboratory Clues**  \n- **Mucocutaneous bleeding**: Nosebleed, petechiae, ecchymosis (no trauma, no family history).  \n- **Platelet count**: Elevated (450,000/mm³, reactive thrombocytosis, likely from anemia/inflammation).  \n- **Coagulation tests**: Normal (aPTT, PT, INR, fibrinogen → rules out coagulation cascade disorders like hemophilia).  \n- **Platelet function**:  \n  - **Ristocetin aggregation**: Normal (rules out Bernard-Soulier syndrome, which affects GP Ib/IX/V and impairs ristocetin binding; von Willebrand disease is also excluded, as it typically has abnormal ristocetin activity).  \n  - **Bleeding time**: Increased (indicates platelet function defect).  \n- **Blood smear**: Large platelets (common in platelet function disorders).  \n\n\n### **Differential Diagnosis of Platelet Function Disorders**  \n- **Glanzmann Thrombasthenia**: Autosomal recessive disorder caused by deficiency of platelet glycoprotein (GP) IIb/IIIa. This impairs platelet aggregation with ADP, collagen, or epinephrine (since GP IIb/IIIa mediates fibrinogen cross-linking of platelets). Ristocetin aggregation remains normal (uses GP Ib/vWF, not IIb/IIIa). Clinical features include mucocutaneous bleeding (nosebleeds, bruising, petechiae) in infancy—**matches all findings**.  \n- **Bernard-Soulier Syndrome**: Defect in GP Ib/IX/V → abnormal ristocetin aggregation (ruled out here).  \n- **Storage Pool Disease**: Dense granule deficiency (e.g., Hermansky-Pudlak) → associated with albinism or other systemic features (absent here).  \n\n\n**Answer: Glanzmann thrombasthenia**",
    "expected_answer": "Glanzmann’s thrombasthenia",
    "time": 30.991761922836304,
    "answer_length": 1713,
    "retrieval_time": 0.018397808074951172,
    "generation_time": 30.96661901473999
  },
  {
    "question": "A 6-year-old boy is brought to the physician by his mother because of a 2-day history of dysuria and increased urinary frequency. Vital signs are within normal limits. Urinalysis shows cloudy, red urine. This patient's clinical presentation is best explained by an infection with a virus with which of the following features?",
    "answer": "To answer this question, we first analyze the clinical presentation and identify the likely viral pathogen, then recall its key features:\n\n\n### Step 1: Clinical Case Analysis  \nThe 6-year-old boy has **dysuria, increased urinary frequency, and hematuria (red urine)**—classic for **acute hemorrhagic cystitis**. This condition in children is most commonly caused by **adenovirus** (types 11 and 21).\n\n\n### Step 2: Identify the Viral Pathogen & Its Features  \nAdenovirus is the primary virus responsible for acute hemorrhagic cystitis in otherwise healthy children. Key features of adenovirus include:  \n- **Non-enveloped (naked) virus**  \n- **Double-stranded DNA (dsDNA) genome**  \n\n\n### Step 3: Confirm the Relevant Feature  \nThe most distinctive and testable feature of adenovirus in this context is its **non-enveloped, double-stranded DNA structure**.\n\n\n**Answer:** Non-enveloped double-stranded DNA virus.\n\n\n**Final Answer:** Non-enveloped double-stranded DNA virus. (Note: If options were provided, this would align with the choice describing these features.)  \n\n\\boxed{Non-enveloped double-stranded DNA virus}",
    "expected_answer": "Non-enveloped with linear, double-stranded DNA",
    "time": 13.973423719406128,
    "answer_length": 1116,
    "retrieval_time": 0.01266789436340332,
    "generation_time": 13.94780707359314
  },
  {
    "question": "A 13-year-old boy is brought to his pediatrician due to a left breast lump under his nipple. He noticed it last month and felt that it has increased slightly in size. It is tender to touch but has no overlying skin changes. There is no breast discharge. The patient has cryptorchidism as an infant and underwent a successful orchiopexy. In addition, he was recently diagnosed with ADHD and is currently on methylphenidate with improvement in his symptoms. He has a family history of type I diabetes in his father and breast fibroadenoma in his mother. On exam, the patient is at the 82nd percentile for height, 79th percentile for weight, and 80th percentile for BMI. He has tanner IV pubic hair. Testicular volume is 7 mL on each side, and both testes are smooth and freely mobile. Breast exam shows a normal right breast and a 3-centimeter round, firm, and slightly tender discrete mass under the left nipple. Which of the following is the most likely etiology of this patient’s condition?",
    "answer": "To determine the most likely etiology of the patient’s breast lump, we analyze the key clinical features and potential causes:\n\n\n### **Key Clinical Features**  \n- 13-year-old boy with a **tender, firm, 3cm subareolar left breast mass** (no skin changes/discharge).  \n- Tanner IV pubic hair but **testicular volume of 7mL each** (Tanner II for testes, indicating transient hormonal imbalance).  \n- No signs of malignancy (no skin changes, discrete mass).  \n- Medication: methylphenidate (not typically associated with gynecomastia).  \n- Past cryptorchidism (resolved with orchiopexy, no evidence of ongoing testicular dysfunction).  \n\n\n### **Differential Diagnosis & Ruling Out**  \n1. **Adolescent Gynecomastia**:  \n   - Most common cause of breast lumps in adolescent boys (60-70% prevalence).  \n   - Due to **transient estrogen-testosterone imbalance** during puberty (estrogen effects temporarily outweigh testosterone).  \n   - Classic features: tender, firm subareolar mass (unilateral or bilateral), spontaneous resolution in 1-2 years.  \n   - Fits all clinical findings here.  \n\n2. **Medication-induced Gynecomastia**:  \n   - Methylphenidate is not a known cause of gynecomastia (side effects are insomnia, appetite suppression, not hormonal changes).  \n\n3. **Fibroadenoma**:  \n   - Rare in males; more common in females (mother’s history is irrelevant here).  \n\n4. **Klinefelter Syndrome**:  \n   - Unlikely: No tall stature (patient is 82nd percentile), and adolescent gynecomastia is far more prevalent in this age group.  \n\n5. **Malignancy**:  \n   - Extremely rare in adolescents; no red flags (e.g., fixed mass, skin retraction).  \n\n\n### **Conclusion**  \nThe most likely etiology is **adolescent gynecomastia due to transient estrogen-testosterone imbalance during puberty**.\n\n\n**Answer:** Transient imbalance of estrogen and testosterone during puberty (adolescent gynecomastia).  \n\n\\boxed{Transient estrogen-testosterone imbalance in puberty}",
    "expected_answer": "Glandular tissue enlargement",
    "time": 27.728124141693115,
    "answer_length": 1953,
    "retrieval_time": 0.020275115966796875,
    "generation_time": 27.715564012527466
  },
  {
    "question": "A 35-year-old Caucasian female presents to the emergency room with unilateral leg swelling. She reports that she developed painful left-sided leg swelling and redness earlier in the day. She is otherwise healthy and takes no medications. She denies any recent prolonged travel. She experienced a similar episode affecting the opposite leg one year ago and was diagnosed with a thrombus in the right femoral vein. On examination, the left leg is erythematous and swollen. Passive dorsiflexion of the left ankle elicits pain in the left calf. Ultrasound of the leg reveals a thrombus in the left popliteal vein. A genetic workup reveals that she has an inherited condition. What is the most likely pathophysiology of this patient’s condition?",
    "answer": "To determine the most likely pathophysiology of this patient’s recurrent venous thromboembolism (VTE), we analyze key clinical clues and common inherited thrombophilias:\n\n\n### **Key Clinical Clues**  \n- Young (35yo) Caucasian female with **recurrent VTE** (right femoral vein 1 year ago; left popliteal vein now).  \n- No obvious acquired risk factors (no meds, no prolonged travel).  \n- Inherited condition confirmed by genetic workup.  \n\n\n### **Common Inherited Thrombophilias & Pathophysiology**  \nThe most prevalent inherited thrombophilia in Caucasians is **Factor V Leiden mutation** (~5% of Caucasians), making it the top candidate here.  \n\n**Pathophysiology of Factor V Leiden**:  \nFactor V Leiden is a point mutation (arginine → glutamine at position 506) in Factor V. Normally, activated protein C (APC)—a natural anticoagulant—cleaves and inactivates Factor Va to limit thrombin generation. However, Factor V Leiden is **resistant to APC** (APC resistance). This persistent activation of Factor Va leads to excessive thrombin production, promoting clot formation (hypercoagulability) and recurrent VTE.  \n\n\n### **Conclusion**  \nThe most likely pathophysiology is **resistance to activated protein C due to Factor V Leiden mutation**, resulting in unregulated coagulation cascade activation and thrombus formation.\n\n\n**Answer:** Resistance to activated protein C (APC resistance) secondary to a Factor V Leiden mutation, which impairs the inactivation of Factor Va, leading to increased thrombin generation and a hypercoagulable state.  \n\n\\boxed{Resistance\\ to\\ activated\\ protein\\ C\\ due\\ to\\ Factor\\ V\\ Leiden\\ mutation}",
    "expected_answer": "Resistance to clotting factor degradation",
    "time": 21.25287699699402,
    "answer_length": 1631,
    "retrieval_time": 0.09323501586914062,
    "generation_time": 21.22542691230774
  },
  {
    "question": "A 78-year-old man is brought to the physician by his daughter because of increasing forgetfulness over the past 5 weeks. He had been living independently but came to live with his daughter temporarily after he complained that he was unable to perform some of his daily activities. He has left the front door wide open and tap water running on multiple occasions. He does not sleep well and wakes up 6–7 times during the night. He does not leave his room and rarely makes conversation with his daughter. He says that he used to enjoy playing the piano but has not played for several months. He has hypertension treated with amlodipine. Vital signs are within normal limits. Mental status examination shows orientation to person, place, and time and psychomotor retardation. He has a blunted affect. Short- and long-term memory is impaired. Attention and concentration are impaired. Neurologic examination shows no focal findings. Serum concentration of electrolytes, thyroid-stimulating hormone, and vitamin B12 are within the reference range. He is very concerned about his memory lapses. Which of the following is the most appropriate treatment for this patient?",
    "answer": "To determine the most appropriate treatment, we first analyze the patient’s clinical presentation and distinguish between key differential diagnoses:\n\n\n### Key Clinical Features  \n- **Subacute onset (5 weeks)** of cognitive impairment (forgetfulness, difficulty with daily activities).  \n- **Depressive symptoms**: Anhedonia (stopped playing piano), social withdrawal (no room leave, rare conversation), sleep disturbance (frequent nighttime awakenings), blunted affect, psychomotor retardation.  \n- **Cognitive findings**: Memory (short/long-term) and attention/concentration impairment, but **awareness of deficits** (concerned about memory lapses).  \n- **Normal labs** (electrolytes, TSH, B12) and no focal neurologic signs.  \n\n\n### Differential Diagnosis  \n1. **Delirium**: Unlikely—no fluctuating consciousness, no clear underlying cause (labs normal).  \n2. **Dementia**: Unlikely—insidious onset typical (not subacute), and patients with early dementia often lack awareness of deficits (anosognosia), unlike this patient.  \n3. **Pseudodementia (Depressive Cognitive Impairment)**: Fits perfectly—subacute onset, awareness of cognitive issues, prominent depressive symptoms, and reversible with treatment of depression.  \n\n\n### Treatment  \nFirst-line therapy for elderly depression (and pseudodementia) is an **SSRI** (selective serotonin reuptake inhibitor), e.g., sertraline. SSRIs are preferred due to their favorable side-effect profile (low anticholinergic activity, minimal cardiac risk) in older adults.\n\n\n**Answer**: An SSRI (e.g., sertraline).  \n\n(Note: If specific options were provided, the correct choice would be the SSRI listed.)  \n\n\\boxed{Sertraline} (assuming this is the option; adjust based on actual choices, but SSRIs are the correct class).  \n\nBut since the user may expect the class or common agent, the most appropriate treatment is an SSRI.  \n\nFinal Answer  \n\\boxed{Sertraline} (or equivalent SSRI)",
    "expected_answer": "Fluoxetine",
    "time": 26.158154010772705,
    "answer_length": 1927,
    "retrieval_time": 0.021167993545532227,
    "generation_time": 26.146666049957275
  },
  {
    "question": "A previously healthy 18-month-old boy is brought to the physician by his parents for evaluation of an abdominal mass noticed a few days ago. He appears markedly pale and lethargic. Examination shows a 6-cm, nonmobile mass in the left upper quadrant that crosses the midline. 24-hour urine collection shows elevated homovanillic acid and vanillylmandelic acid. Further evaluation including biopsy confirms the diagnosis of intermediate-risk neuroblastoma. The physician recommends the established standard treatment, which is initiation of neoadjuvant chemotherapy followed by surgical resection, if possible. After a thorough discussion of the risks and benefits of chemotherapy, the likelihood of unresectability without neoadjuvant treatment, and the prognosis without it, the patient's parents steadily refuse chemotherapy because they do not want their son to suffer the side effects. They prefer to take their son home for supportive care only. Which of the following is the most appropriate action by the physician?",
    "answer": "To address this scenario, we must apply **pediatric ethical principles**, where the child’s best interest takes precedence over parental autonomy when the latter risks significant harm or death to the child. Here’s the breakdown:\n\n\n### Key Background  \nThe child has **intermediate-risk neuroblastoma**:  \n- Standard treatment (neoadjuvant chemo + surgery) has a high survival rate (~70–90%).  \n- Without treatment, the disease is nearly fatal.  \nParents refuse chemo due to side effects, opting for supportive care only—this decision is **not in the child’s best interest**.  \n\n\n### Ethical Approach  \nAfter thorough discussion with parents fails to resolve the impasse, the next steps are:  \n1. **Consult the hospital ethics committee**: To formalize a review of the case, ensure all perspectives are considered, and validate the medical necessity of treatment.  \n2. **Pursue legal intervention (court order) if needed**: If the ethics committee confirms treatment is necessary, a court order can override parental refusal to protect the child’s life.  \n\n\n### Most Appropriate Action  \nThe physician should **initiate a hospital ethics committee consultation and prepare to seek legal authorization for treatment** (e.g., a court order) to ensure the child receives life-saving care.\n\n\n**Answer**: Consult the hospital ethics committee and consider legal action to obtain permission for chemotherapy.  \n\n(Note: If options include \"seek a court order to administer chemotherapy,\" this is also a valid next step, but ethics committee review is typically the first formal step after direct discussion.)\n\n\n\\boxed{Consult the hospital ethics committee and pursue legal intervention if necessary}  \n\n(Adjust based on exact options, but this captures the core action.)",
    "expected_answer": "Seek a court order for neoadjuvant chemotherapy",
    "time": 28.444319009780884,
    "answer_length": 1763,
    "retrieval_time": 0.020534038543701172,
    "generation_time": 28.41681981086731
  },
  {
    "question": "A laboratory primarily involved with studying cellular proofreading mechanisms is investigating the question of whether the ribosome can recognize a mischarged amino acid and still be incorporated into the growing peptide. In order to do so, they biochemically charge a Lys-tRNA with valine instead of lysine and insert the tRNA into the cell. They design an mRNA sequence that contains only codons for lysine. Which of the following will most likely occur?",
    "answer": "To answer this question, we need to focus on the roles of the ribosome and aminoacyl-tRNA synthetases in translation, particularly their proofreading functions:\n\n\n### Key Background:  \n- **Aminoacyl-tRNA synthetases** are responsible for attaching the correct amino acid to its cognate tRNA. They have proofreading mechanisms to remove incorrectly attached amino acids.  \n- **Ribosomes** primarily proofread for **codon-anticodon pairing accuracy** (ensuring the tRNA’s anticodon matches the mRNA codon). They do **not verify the identity of the amino acid attached to the tRNA**.  \n\n\n### Application to the Question:  \nThe experiment uses a **mischarged tRNA**:  \n- It is a **tRNA^Lys** (its anticodon matches the mRNA codons for lysine).  \n- However, it is incorrectly charged with **valine** instead of lysine.  \n\nThe mRNA contains only lysine codons. The ribosome will recognize the mischarged tRNA^Lys because its anticodon pairs with the lysine codons. Since the ribosome does not check the amino acid attached, it will incorporate the **valine** (the amino acid on the tRNA) into the growing peptide chain.  \n\n\n**Answer:** Valine will be incorporated into the peptide chain at positions corresponding to the lysine codons in the mRNA.\n\n\n\\boxed{Valine will be incorporated into the peptide chain instead of lysine}",
    "expected_answer": "The mischarged tRNA with valine will be incorporated in the codons that specificy for lysine",
    "time": 17.921180248260498,
    "answer_length": 1320,
    "retrieval_time": 0.014236211776733398,
    "generation_time": 17.893646001815796
  },
  {
    "question": "A 65-year-old man with metastatic lung cancer has been experiencing severe, unremitting pain. He has required escalating doses of oral morphine, but is now having dose limiting side-effects. His pain management team recommends using a medication that can reduce his opioid need through interaction with the NMDA-receptor. Which of the following was the most likely recommended agent?",
    "answer": "The most likely recommended agent is **ketamine**.  \n\n### Rationale:  \nKetamine is a well-known NMDA (N-methyl-D-aspartate) receptor antagonist. It is used as an adjuvant in pain management for patients with severe, opioid-refractory pain (like metastatic cancer pain) because:  \n- NMDA receptors play a key role in central sensitization (amplification of pain signals in the nervous system) and opioid tolerance.  \n- Blocking NMDA receptors reduces opioid requirements, mitigates dose-limiting opioid side effects (e.g., sedation, respiratory depression, constipation), and improves pain control.  \n\nOther agents (e.g., methadone has weak NMDA activity but is primarily an opioid agonist) are not primarily NMDA antagonists. Thus, ketamine is the optimal choice here.\n\n\n**Answer: Ketamine**",
    "expected_answer": "Ketamine",
    "time": 9.892085790634155,
    "answer_length": 791,
    "retrieval_time": 0.013731956481933594,
    "generation_time": 9.866992712020874
  },
  {
    "question": "A 27-year-old man presents to the emergency room complaining of left shoulder pain for several weeks. He says that the pain often worsens when he tries to sleep on his left side. Although he tried several pain medications, none of the pain medications helped. He is an amateur tennis player who practices on weekends. He denies any trauma during his practice sessions. On examination of the shoulder joint, severe tenderness was present localized to the greater tuberosity of the left shoulder joint along with biceps tendon tenderness over the bicipital groove. The range of motion was limited to the left side. An X-ray of the joint showed narrowing of the acromiohumeral space with sclerosis and spurring of the acromion. Routine blood test results are normal except for the rheumatoid factor, which is positive. What is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the key clinical and radiological findings alongside laboratory results:\n\n\n### **Key Findings Recap**  \n- 27-year-old male (young adult) with left shoulder pain (worse with side sleeping, overuse from tennis).  \n- Exam: Tenderness at greater tuberosity (rotator cuff insertion) and bicipital groove (biceps tendon involvement).  \n- X-ray: Narrowed acromiohumeral space (suggests rotator cuff pathology), sclerosis/spurring of the acromion.  \n- Labs: Positive rheumatoid factor (RF).  \n\n\n### **Differential Diagnosis & Reasoning**  \n1. **Subacromial Impingement Syndrome**: Common in overuse (tennis), but does not explain the positive RF.  \n2. **Rheumatoid Arthritis (RA)**:  \n   - RA often presents in young adults and can involve the shoulder (monoarticular early, polyarticular later).  \n   - RF positivity is a hallmark (though not specific, it supports RA in this context).  \n   - Shoulder involvement in RA: Affects glenohumeral joint, rotator cuff, and subacromial structures. Chronic inflammation leads to:  \n     - **Acromial spurring/sclerosis**: From repeated synovial inflammation of the subacromial bursa/rotator cuff.  \n     - **Narrowed acromiohumeral space**: Due to rotator cuff thickening/tears (common in RA).  \n     - Tenderness at bicipital groove: Biceps tendonitis is frequent in RA shoulder involvement.  \n\n\n### **Conclusion**  \nThe combination of RF positivity, shoulder-specific inflammatory changes (sclerosis/spurring of acromion), and rotator cuff-related findings (narrowed acromiohumeral space) points to **rheumatoid arthritis involving the left shoulder** as the most likely diagnosis.\n\n\n**Answer:** Rheumatoid arthritis of the left shoulder.",
    "expected_answer": "Rotator cuff injury",
    "time": 22.877605199813843,
    "answer_length": 1726,
    "retrieval_time": 0.0698399543762207,
    "generation_time": 22.857319116592407
  },
  {
    "question": "A 17-year-old woman presents to your office concerned that she has not had her menstrual period in 4 months. She states that menses began at age of 13 and has been regular until two months ago. She denies sexual activity, and urine pregnancy test is negative. On exam, she appears well-nourished with a BMI of 21 kg/m^2, but you note that she has enlarged cheeks bilaterally and has calluses on the dorsum of her hands. She says that she has been very stressed with school and has recently been binge eating. What other finding do you expect to see in this patient?",
    "answer": "To determine the expected finding, let’s analyze the case and connect the clues to a diagnosis:\n\n\n### Key Clues & Diagnosis  \nThe patient has:  \n- **Binge eating** (reported by the patient).  \n- **Russell’s sign** (calluses on the dorsum of hands: from self-induced vomiting using fingers to trigger gag reflex).  \n- **Bilateral enlarged cheeks** (parotid gland enlargement, common in bulimia due to repeated vomiting).  \n- Normal BMI (21 kg/m², ruling out anorexia nervosa).  \n\nThese findings confirm **bulimia nervosa** (binge-eating episodes followed by compensatory behaviors like self-induced vomiting).\n\n\n### Expected Additional Finding  \nA hallmark of bulimia nervosa (from chronic vomiting) is **dental enamel erosion**. Stomach acid (hydrochloric acid) from vomiting repeatedly contacts the teeth, especially the lingual surfaces of the upper incisors, leading to enamel wear and increased dental caries.\n\n\n**Answer: Dental enamel erosion** (or dental caries/lingual tooth erosion).  \n\nThe most likely expected finding is **dental enamel erosion**.\n\n\n\\boxed{Dental enamel erosion}",
    "expected_answer": "Erosion of tooth enamel",
    "time": 14.332592010498047,
    "answer_length": 1089,
    "retrieval_time": 0.016356945037841797,
    "generation_time": 14.307076930999756
  },
  {
    "question": "A 23-year-old college student presents to the clinic with a history of intermittent chest discomfort. He reports that, about once per month for the past 8 or 9 months, he's had episodes of \"feeling like my chest is going to explode.\" During these episodes, he also feels shortness of breath, feels shakiness throughout his arms and legs, and sweats so heavily that he needs to change his shirt. He is unsure of any clear precipitating factors but thinks they may occur more often around important exams or when big school projects are due. He shares that, as these episodes continue to recur, he has had mounting anxiety about having one when he is in class or at a restaurant. As a result, he is leaving the house less and less. He has no past medical history; the physical exam is unremarkable. Which of the following is the best medication for the long-term management of this patient's condition?",
    "answer": "To determine the best long-term medication for this patient, we first identify their condition: **panic disorder** (characterized by recurrent panic attacks, anticipatory anxiety about future attacks, and avoidance behaviors like leaving the house less often).\n\n\n### Key Principles for Long-Term Management of Panic Disorder  \n- **SSRIs (Selective Serotonin Reuptake Inhibitors)** are the **first-line pharmacotherapy** for long-term treatment of panic disorder. They address the underlying neurochemical imbalance (serotonin dysregulation) and reduce both the frequency of panic attacks and anticipatory anxiety/avoidance.  \n- Benzodiazepines (e.g., alprazolam) are for acute symptom relief but not long-term use (risk of dependence, tolerance, and withdrawal).  \n- Beta-blockers (e.g., propranolol) target physical symptoms (tremor, tachycardia) but do not treat the core disorder.  \n- TCAs (e.g., imipramine) or SNRIs (e.g., venlafaxine) are second-line options if SSRIs are ineffective or poorly tolerated.  \n\n\n### Conclusion  \nThe best medication for long-term management is an **SSRI** (e.g., sertraline, paroxetine, fluoxetine).\n\n\n**Answer:** An SSRI (e.g., sertraline) is the first-line choice for long-term management of panic disorder.  \n\n(Note: If specific options were provided, the correct answer would be the SSRI listed.)  \n\n\\boxed{Sertraline} (or any other SSRI, depending on standard options for this scenario)  \n\nBut since the question expects a general answer based on guidelines, the optimal class is SSRIs, with sertraline being a common first-line agent.  \n\nFinal Answer: \\boxed{Sertraline}",
    "expected_answer": "Citalopram",
    "time": 18.141811847686768,
    "answer_length": 1612,
    "retrieval_time": 0.015581846237182617,
    "generation_time": 18.116873025894165
  },
  {
    "question": "A stillborn infant is delivered at 38 weeks' gestation to a 32-year-old woman. The mother had no prenatal care. Examination of the stillborn shows a small pelvis, shallow intergluteal cleft, and club feet. An x-ray shows the absence of the sacrum and lumbar vertebrae. Which of the following is the strongest predisposing factor for this patient's condition?",
    "answer": "To answer this question, we first identify the **congenital condition** described and then its strongest predisposing factor:\n\n\n### Step 1: Recognize the condition  \nThe infant has:  \n- Absence of sacrum and lumbar vertebrae  \n- Small pelvis, shallow intergluteal cleft, club feet  \n\nThese findings are classic for **caudal regression syndrome (CRS)** (also called sacral agenesis), a disorder of abnormal lower spine development.\n\n\n### Step 2: Identify the strongest predisposing factor  \nThe single most significant risk factor for CRS is **maternal diabetes mellitus**—especially pregestational diabetes (type 1/2) or poorly controlled gestational diabetes. The mother’s lack of prenatal care suggests undiagnosed or unmanaged diabetes may have been present.\n\n\n**Answer: Maternal diabetes mellitus** (or \"Undiagnosed maternal diabetes\" if more specific phrasing is preferred, but the core factor is maternal diabetes).  \n\n\\boxed{Maternal diabetes mellitus}",
    "expected_answer": "Maternal diabetes",
    "time": 10.318418979644775,
    "answer_length": 959,
    "retrieval_time": 0.01440119743347168,
    "generation_time": 10.292825698852539
  },
  {
    "question": "Please refer to the summary above to answer this question\nThe authors of the study have decided to conduct a follow-up analysis on their data. They decide to stratify their results by CD4+T-lymphocyte count at the time of diagnosis. Among patients with CD4+ cell counts below 200/mm3, cART adherence was a significant predictor of DLBCL risk (RR = 0.52, p = 0.01). However, among patients with CD4+ cell counts above 200/mm3, no relationship was found between DLBCL risk and cART adherence (RR = 0.96, p = 0.36). Which of the following explains for the difference observed between the two strata?\"",
    "answer": "The difference observed between the two strata is explained by **effect modification** by CD4+ T-lymphocyte count at diagnosis.  \n\nEffect modification occurs when the association between an exposure (here, cART adherence) and an outcome (DLBCL risk) varies systematically across levels of a third variable (here, CD4+ cell count: below vs above 200/mm³). In this case, cART adherence reduces DLBCL risk only in patients with low CD4+ counts, but has no meaningful effect in those with higher counts—this is a real, subgroup-specific difference in the exposure’s effect, not a distortion of the association (which would be confounding).\n\n\n**Answer:** Effect modification by CD4+ T-lymphocyte count at diagnosis.",
    "expected_answer": "Effect modification",
    "time": 7.636203050613403,
    "answer_length": 710,
    "retrieval_time": 0.016247034072875977,
    "generation_time": 7.60860276222229
  },
  {
    "question": "During a Mycobacterium tuberculosis infection, Th1 cells secrete a factor capable of stimulating phagosome-lysosome fusion within macrophages. In addition, the secreted factors help activate macrophages to produce mediators such as NO, which are capable of destroying the invading pathogen. Furthermore, activation of the macrophages by the secreted factor eventually leads to the formation of a tubercle. Which of the following factors is secreted by Th1 cells and responsible for these actions?",
    "answer": "The factor secreted by Th1 cells responsible for these actions is **interferon-gamma (IFN-γ)**.\n\n\n### Explanation:  \nTh1 cells are key mediators of cell-mediated immunity against intracellular pathogens like *Mycobacterium tuberculosis*. IFN-γ is their primary effector cytokine, with the following critical roles:  \n1. **Stimulates phagosome-lysosome fusion**: *M. tuberculosis* normally inhibits this fusion to survive inside macrophages. IFN-γ reverses this inhibition, allowing macrophages to degrade the pathogen.  \n2. **Activates macrophages to produce NO**: IFN-γ induces macrophages to express inducible nitric oxide synthase (iNOS), which generates nitric oxide (NO)—a potent microbicidal molecule that kills the pathogen.  \n3. **Promotes tubercle formation**: IFN-γ drives activated macrophages to differentiate into epithelioid cells and giant cells, which aggregate with lymphocytes to form granulomas (tubercles), containing the infection.  \n\n\n**Answer: Interferon-gamma (IFN-γ)**.",
    "expected_answer": "IFN-gamma",
    "time": 11.977066993713379,
    "answer_length": 994,
    "retrieval_time": 0.10252523422241211,
    "generation_time": 11.94920802116394
  },
  {
    "question": "A 3-year-old boy is brought to the pediatrician because of abdominal pain and constipation for 3 weeks. His mother says he has been increasingly irritable recently. His vocabulary consists of 50 words and he does not use sentences. Physical examination shows pale conjunctivae and abdominal tenderness. He refers to himself by name but is unable to name body parts or count to three. Peripheral blood smear shows small, pale red blood cells with basophilic stippling. Which of the following processes is most likely impaired in this patient?",
    "answer": "To determine the impaired process in this patient, we analyze the key clinical and lab findings:\n\n\n### **Key Observations**  \n- **3-year-old boy**: Developmental delays (limited vocabulary, inability to name body parts/count), irritability, abdominal pain, constipation.  \n- **Lab**: Microcytic hypochromic anemia with **basophilic stippling** (RNA aggregates in RBCs).  \n\n\n### **Differential Diagnosis**  \nMicrocytic hypochromic anemia + basophilic stippling + neurodevelopmental/GI symptoms points strongly to **lead poisoning**:  \n- Lead inhibits **heme synthesis** (critical enzymes: δ-aminolevulinic acid dehydratase [ALAD] and ferrochelatase).  \n- Neurotoxic effects (delayed language, irritability) and GI symptoms (abdominal pain, constipation) are classic for lead exposure.  \n\n\n### **Impaired Process**  \nLead poisoning directly impairs **heme biosynthesis** (heme synthesis), leading to the observed anemia and systemic symptoms.\n\n\n**Answer: Heme biosynthesis** (or Heme synthesis)  \n\n\\boxed{Heme biosynthesis}",
    "expected_answer": "Conversion of aminolevulinic acid to porphobilinogen",
    "time": 18.9569149017334,
    "answer_length": 1021,
    "retrieval_time": 0.01328587532043457,
    "generation_time": 18.929882049560547
  },
  {
    "question": "A group of researchers conducted a study to determine whether there is an association between folic acid supplementation before pregnancy and autism spectrum disorder (ASD) in offspring. The researchers retrospectively surveyed 200 mothers with children diagnosed with ASD during the first 4 years of life and 200 mothers with healthy children. All participants were interviewed about their prenatal consumption of folic acid using standardized questionnaires. A 94% response rate was obtained from the surveys. The study ultimately found that folic acid supplementation was associated with lower rates of ASD in offspring (OR = 0.3, p < 0.01). Which of the following type of bias is most likely to have influenced these results?",
    "answer": "To determine the most likely bias influencing the results, we first identify the study design: this is a **case-control study** (comparing mothers of children with ASD [cases] to mothers of healthy children [controls] and retrospectively assessing past folic acid use).  \n\n\n### Key Bias Analysis:  \nThe critical issue here is **recall bias**, which occurs when cases and controls differ in how accurately they remember past exposures.  \n\n- Mothers of children with ASD (cases) may have heightened recall of prenatal behaviors (like folic acid use) due to the emotional impact of their child’s diagnosis—they might either overreport non-use (seeking explanations for ASD) or underreport use.  \n- Mothers of healthy children (controls) may be more likely to remember or overreport folic acid use (attributing their child’s health to this behavior) or have less detailed memory (since no adverse outcome prompted reflection).  \n\nThis differential recall of past exposure (folic acid supplementation) can distort the observed association between folic acid and ASD.  \n\n\n### Other Biases Ruled Out:  \n- **Non-response bias**: The 94% response rate is high, minimizing this.  \n- **Selection bias**: No information suggests cases/controls were selected in a way that skews exposure distribution (e.g., differing recruitment sources).  \n\n\n**Answer: Recall bias**\n\n\n\\boxed{Recall\\ bias}",
    "expected_answer": "Recall bias",
    "time": 18.78309202194214,
    "answer_length": 1377,
    "retrieval_time": 0.016192913055419922,
    "generation_time": 18.757768154144287
  },
  {
    "question": "A student studying pharmacology is a member of a team that is conducting research related to the elimination of multiple anticoagulant medications. His duty as a member of the team is to collect serum samples of the subjects every 4 hours and send them for analysis of serum drug levels. He is also supposed to collect, document and analyze the data. For one of the subjects, he notices that the subject is eliminating 0.5 mg of the drug every 4 hours. Which of the following anticoagulants did this patient most likely consume?",
    "answer": "To answer this question, we need to link the observed elimination pattern (constant amount eliminated per unit time: 0.5 mg every 4 hours) to the kinetic properties of anticoagulants.\n\n\n### Key Kinetic Concept:  \nA **constant amount eliminated per unit time** indicates **zero-order kinetics** (in contrast to first-order kinetics, where a constant fraction is eliminated).  \n\n\n### Anticoagulant Kinetics:  \nAmong common anticoagulants:  \n- **Warfarin** exhibits zero-order kinetics at therapeutic doses. This means its elimination rate is constant (fixed amount per time) rather than dependent on drug concentration.  \n- Other anticoagulants (heparin, low-molecular-weight heparins like enoxaparin, direct oral anticoagulants like dabigatran or rivaroxaban) follow first-order kinetics (constant fraction eliminated per time).  \n\n\n**Answer: Warfarin**",
    "expected_answer": "Warfarin",
    "time": 11.709140062332153,
    "answer_length": 852,
    "retrieval_time": 0.01945209503173828,
    "generation_time": 11.683650255203247
  },
  {
    "question": "A 40-year-old woman presents to her primary care physician for a checkup. She has felt weaker lately and has lost some weight. She denies any urinary issues. Her BUN at her last visit 4 months ago was 45 mg/dL, and her creatinine was 2.0 mg/dL. Her laboratory studies this visit are seen below:\n\nHemoglobin: 8 g/dL\nHematocrit: 29%\nLeukocyte count: 9,500/mm^3 with normal differential\nPlatelet count: 197,000/mm^3\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 5.9 mEq/L\nHCO3-: 17 mEq/L\nBUN: 59 mg/dL\nGlucose: 99 mg/dL\nCreatinine: 2.3 mg/dL\nCa2+: 9.0 mg/dL\n\nWhich of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the patient’s clinical and laboratory findings:\n\n\n### Key Clinical & Lab Clues  \n- **Worsening renal function**: BUN and creatinine have increased over 4 months (from 45/2.0 to 59/2.3 mg/dL), indicating **progressive kidney impairment** (not acute).  \n- **Electrolyte/acid-base abnormalities**: Hyperkalemia (K⁺=5.9 mEq/L) and metabolic acidosis (HCO₃⁻=17 mEq/L) — typical of impaired renal excretion/acid buffering.  \n- **Anemia**: Hemoglobin=8 g/dL (renal anemia, as kidneys produce erythropoietin [EPO], which is deficient in chronic kidney disease [CKD]).  \n- **Symptoms**: Weakness, weight loss (consistent with uremic symptoms of CKD).  \n\n\n### Elimination of Other Causes  \n- **Acute tubular necrosis**: Acute (not progressive over months) and no acute triggers (e.g., hypotension, toxins) mentioned.  \n- **Prerenal azotemia**: BUN/creatinine ratio (~25) is not severely elevated (>30), and no hypoperfusion clues (e.g., dehydration).  \n- **Postrenal obstruction**: Patient denies urinary issues (e.g., oliguria, retention).  \n\n\n### Conclusion  \nThe constellation of progressive renal dysfunction, renal anemia, hyperkalemia, and metabolic acidosis confirms **chronic kidney disease (CKD)**.\n\n\n**Answer: Chronic kidney disease** (assuming this was an option; if not, the closest equivalent based on findings is CKD).  \n\n(Note: If options included specific causes of CKD, additional context would be needed, but given the data, CKD is the primary diagnosis.)\n\n\n\\boxed{Chronic kidney disease}",
    "expected_answer": "Chronic kidney failure",
    "time": 29.65518808364868,
    "answer_length": 1547,
    "retrieval_time": 0.018274784088134766,
    "generation_time": 29.629599809646606
  },
  {
    "question": "A 28-year-old woman comes to the obstetrics and gynecology clinic because she has been unsuccessfully trying to conceive with her husband for the last 2 years. He has had 2 children from a previous marriage and has been tested for causes of male infertility. She has had prior abdominal surgery as well as a family history of endocrine abnormalities. Based on this history, a panel of tests are obtained and treatment is started. This treatment will be administered intermittently one week before her normal menstrual cycle. If the most likely drug prescribed in this case was administered in a different manner, which of the following conditions may also be treated by this drug?",
    "answer": "To solve this question, we analyze the clinical scenario and drug use step-by-step:\n\n\n### **Step 1: Identify the likely drug**  \nThe patient has infertility (husband is fertile), prior abdominal surgery (possible endometriosis history), and the treatment is administered **intermittently 1 week before her menstrual cycle** (late luteal phase).  \n\nThis timing points to **progesterone or a synthetic progestin** (e.g., medroxyprogesterone acetate). Progestins are used for **luteal phase defect** (a cause of infertility) to support the endometrium until menstruation (or pregnancy).\n\n\n### **Step 2: Other uses of progestins (different administration)**  \nProgestins have multiple uses when given in alternative ways:  \n- **Continuous high-dose administration**: Suppresses ovulation and endometrial growth, making it effective for **endometriosis** (a common condition linked to prior abdominal surgery in infertile women).  \n- **Cycle regulation**: Treats dysfunctional uterine bleeding (anovulatory type).  \n\n\n### **Key Conclusion**  \nThe most likely condition treated by this drug (progestin) in a different manner is **endometriosis**.\n\n\n**Answer: Endometriosis**",
    "expected_answer": "Prostate cancer",
    "time": 35.69049096107483,
    "answer_length": 1168,
    "retrieval_time": 0.0695648193359375,
    "generation_time": 35.66449189186096
  },
  {
    "question": "A 2-year-old girl with recurrent urinary tract infections is brought to the physician for a follow-up examination. Renal ultrasound shows bilateral dilation of the renal pelvis. A voiding cystourethrography shows retrograde flow of contrast into the ureters during micturition. Histologic examination of a kidney biopsy specimen is most likely to show which of the following findings?",
    "answer": "To answer this question, we analyze the case and key histologic associations:\n\n\n### **Case Summary**  \n2-year-old girl with **recurrent UTIs**, **bilateral renal pelvis dilation (hydronephrosis)**, and **vesicoureteral reflux (VUR)** (retrograde urine flow into ureters on VCUG).  \n\n\n### **Key Pathophysiology**  \nVUR allows bacteria from the bladder to reflux into the ureters and renal parenchyma, leading to **chronic pyelonephritis** (recurrent infections → persistent renal damage).  \n\n\n### **Classic Histologic Finding**  \nChronic pyelonephritis (from recurrent UTIs + VUR) is characterized by:  \n- **Thyroidization of tubules**: Dilated tubules filled with eosinophilic proteinaceous material, resembling thyroid follicles.  \n- Interstitial fibrosis and lymphocytic infiltration.  \n- Cortical scarring.  \n\n\n**Most Likely Histologic Finding**: Thyroidization of renal tubules (along with interstitial fibrosis and inflammation).\n\n\n**Answer**: Thyroidization of the renal tubules.  \n\n(Note: If this were a multiple-choice question, the correct option would align with this classic feature.)\n\n\n\\boxed{Thyroidization of renal tubules}",
    "expected_answer": "Cortical thinning with tubular atrophy",
    "time": 20.400839805603027,
    "answer_length": 1137,
    "retrieval_time": 0.010918140411376953,
    "generation_time": 20.373819828033447
  },
  {
    "question": "An unconscious 55-year-old man is brought to the Emergency Department by ambulance. He had recently lost his job and his house was about to begin foreclosure. His adult children were concerned for his well being and called the police requesting a welfare check. He was found unresponsive in his gurague. There were several empty bottles of vodka around him and one half empty container of antifreeze. A review of his medical records reveals that he was previously in good health. Upon arrival to the ED he regains consciousness.  His blood pressure is 135/85 mmHg, heart rate 120/min, respiratory rate 22/min, and temperature 36.5°C (97.7°F). On physical exam his speech is slurred and he has difficulty following commands. His abdomen is diffusely tender to palpation with no rebound tenderness. Initial laboratory tests show an elevated serum creatinine (Cr) of 1.9 mg/dL, and blood urea nitrogen (BUN) of 29 mg/dL. Which of the following findings would be expected in this patient’s urine?",
    "answer": "To answer this question, we first identify the key issue: **ethylene glycol poisoning** (from antifreeze consumption), as evidenced by the half-empty antifreeze container, renal dysfunction (elevated creatinine/BUN), and clinical signs of toxicity.\n\n\n### Key Background: Ethylene Glycol Metabolism & Toxicity  \nEthylene glycol is metabolized by alcohol dehydrogenase to toxic metabolites (glycolic acid, glyoxylic acid, oxalic acid). Oxalic acid combines with calcium to form **calcium oxalate crystals**, which deposit in renal tubules and cause acute kidney injury (hence the elevated creatinine).\n\n\n### Expected Urine Finding  \nThe hallmark urine finding in ethylene glycol poisoning is **calcium oxalate crystals**. These crystals typically appear as:  \n- **Envelope-shaped** (calcium oxalate dihydrate, the most common form in this context)  \n- Or **needle-shaped/dumbbell-shaped** (calcium oxalate monohydrate)  \n\n\n**Answer:** Calcium oxalate crystals (envelope-shaped or needle-shaped).  \n\n(Note: If the options include \"envelope-shaped calcium oxalate crystals,\" that is the most specific classic finding.)\n\n\n**Final Answer:** Calcium oxalate crystals (envelope-shaped).  \n\n\\boxed{Calcium oxalate crystals (envelope-shaped)}",
    "expected_answer": "Calcium oxalate crystals",
    "time": 12.200277090072632,
    "answer_length": 1232,
    "retrieval_time": 0.018225908279418945,
    "generation_time": 12.175726175308228
  },
  {
    "question": "A 17-year-old girl comes to the physician because of an 8-month history of severe acne vulgaris over her face, upper back, arms, and buttocks. Treatment with oral antibiotics and topical combination therapy with benzoyl peroxide and retinoid has not completely resolved her symptoms. Examination shows oily skin with numerous comedones, pustules, and scarring over the face and upper back. Long-term therapy is started with combined oral contraceptive pills. This medication decreases the patient's risk developing of which of the following conditions?",
    "answer": "To answer this question, we analyze the effects of combined oral contraceptive pills (COCs) and their protective benefits, particularly in the context of the patient’s scenario:\n\n\n### Key Background:  \nCOCs contain estrogen and progestin. Their protective effects include:  \n- Suppressing ovulation (reducing risk of ovarian cancer and ectopic pregnancy).  \n- Increasing sex hormone-binding globulin (SHBG) (lowering free testosterone, which improves acne).  \n- Thinning the endometrium (reducing endometrial cancer risk).  \n- Thickening cervical mucus (reducing pelvic inflammatory disease [PID] risk).  \n- Reducing menstrual blood loss (lowering iron-deficiency anemia risk).  \n\n\n### Most Likely Answer:  \n**Ovarian cancer** is a well-documented condition for which COCs reduce risk significantly (up to 50% after 5 years of use, with protection persisting decades after discontinuation). This is a common and high-yield answer in such contexts.\n\n\n**Answer:** Ovarian cancer.  \n\n(Note: If endometrial cancer were an option, it is also a valid protective effect, but ovarian cancer is more frequently tested in this scenario.)",
    "expected_answer": "Ovarian cancer",
    "time": 17.584556102752686,
    "answer_length": 1127,
    "retrieval_time": 0.012687921524047852,
    "generation_time": 17.572818279266357
  },
  {
    "question": "A 48-year-old female presents for a follow-up appointment to discuss her ultrasound results. She presented with a lump in her neck 2 weeks ago. On examination, a thyroid nodule was present; the nodule was fixed, immobile, and non-tender. Ultrasound showed a hypoechoic nodule with a size of 2 cm. Histological examination of a fine needle biopsy was performed and cytological examination reported a likely suspicion of neoplasia. CT scan is performed to check for any lesions in the bones and/or lungs, common metastatic sites in this condition. Treatment with radioiodine therapy is planned after near-total thyroidectomy. Considering this tumor, which of the following is the most likely initial metastatic site in this patient?",
    "answer": "To determine the most likely initial metastatic site, we first identify the type of thyroid neoplasm described:  \n\n### Key Clinical Clues:  \n- The tumor is iodine-avid (treated with radioiodine after thyroidectomy), ruling out anaplastic (non-responsive) and medullary (non-iodine avid) thyroid carcinoma.  \n- The most common iodine-avid thyroid cancers are **papillary thyroid carcinoma (PTC)** (most prevalent) and follicular thyroid carcinoma (FTC).  \n\n\n### Metastatic Patterns:  \n- **Papillary thyroid carcinoma**: Spreads primarily via the lymphatic system. **Regional cervical lymph nodes** (central compartment: pretracheal/paratracheal; lateral neck: jugular chain) are the initial metastatic site in up to 50-70% of cases, even in early-stage disease.  \n- **Follicular thyroid carcinoma**: Spreads hematogenously (bone, lung) but is less common than PTC.  \n\n\n### Conclusion:  \nSince PTC is the most likely diagnosis here, the **initial metastatic site** is regional cervical lymph nodes.  \n\n\n**Answer: Cervical lymph nodes** (or regional lymph nodes of the neck).  \n\n(Note: If options included \"cervical lymph nodes\" or similar, this would be the correct choice.)  \nFinal Answer: \\boxed{Cervical lymph nodes}",
    "expected_answer": "Inferior thyroid arteries",
    "time": 28.972134828567505,
    "answer_length": 1217,
    "retrieval_time": 0.017582178115844727,
    "generation_time": 28.946660041809082
  },
  {
    "question": "A 39-year-old man presents to his primary care physician because he has been having severe headaches and fever for the last 2 days. He also says his right eyelid has been painlessly swelling and is starting to block his vision from that eye. He recently returned from a tour of the world where he visited Thailand, Ethiopia, and Brazil. Otherwise his past medical history is unremarkable. On presentation, his temperature is 102°F (38.8°C), blood pressure is 126/81 mmHg, pulse is 125/min, and respirations are 13/min. Physical exam reveals a nontender swelling of the right eyelid, lymphadenopathy, and an indurated red patch with surrounding erythema and local swelling on his left leg. Which of the following drugs should be used to treat this patient's condition?",
    "answer": "To determine the appropriate treatment, we analyze the patient’s key clinical features and travel history:\n\n\n### **Key Clinical Clues**  \n- **Fever, headache**: Systemic inflammatory response.  \n- **Indurated red patch (eschar-like lesion) on left leg**: Suggests an arthropod bite site (chiggers/ticks).  \n- **Lymphadenopathy**: Common in infections transmitted by arthropods.  \n- **Painless right eyelid swelling**: May reflect ocular involvement (e.g., conjunctivitis or lymphatic spread).  \n- **Travel to Thailand, Ethiopia, Brazil**: Tropical regions where **scrub typhus** (Orientia tsutsugamushi, chigger-transmitted) or **spotted fever group rickettsioses** (e.g., Boutonneuse fever, tick-transmitted) are endemic.  \n\n\n### **Diagnosis**  \nThe constellation of eschar, fever, lymphadenopathy, and tropical travel points to a **rickettsial infection** (scrub typhus or spotted fever). Both are caused by obligate intracellular bacteria.  \n\n\n### **Treatment**  \n**Doxycycline** is the first-line therapy for all rickettsial infections, including scrub typhus and spotted fevers. It is highly effective against these intracellular pathogens and is well-tolerated in adults.  \n\n\n**Answer: Doxycycline**\n\n\n\\boxed{Doxycycline}",
    "expected_answer": "Benznidazole",
    "time": 21.743662118911743,
    "answer_length": 1227,
    "retrieval_time": 0.11518096923828125,
    "generation_time": 21.71840000152588
  },
  {
    "question": "A 10-year-old Caucasian female with Turner's syndrome underwent an abdominal imaging study and was discovered that the poles of her kidneys were fused inferiorly. Normal ascension of kidney during embryological development would be prevented by which of the following anatomical structures?",
    "answer": "To answer this question, we first identify the renal anomaly described: **fused inferior poles of the kidneys** (horseshoe kidney).  \n\n\n### Key Embryological Context:  \nThe kidneys originate in the pelvic region and ascend to their normal abdominal position during development. For horseshoe kidneys, the fused lower pole gets **trapped by an anatomical structure** that blocks further ascent.  \n\n\n### Critical Structure Preventing Ascension:  \nThe **inferior mesenteric artery (IMA)** runs anterior to the aorta at the level where the horseshoe kidney attempts to ascend. The fused lower pole cannot pass beneath or above the IMA, halting its ascent at a lower-than-normal position.  \n\n\nAnswer: Inferior mesenteric artery.",
    "expected_answer": "Inferior mesenteric artery",
    "time": 8.648223161697388,
    "answer_length": 723,
    "retrieval_time": 0.011416912078857422,
    "generation_time": 8.622076272964478
  },
  {
    "question": "A 34-year-old woman is assaulted and suffers a number of stab wounds to her abdomen. Bystanders call paramedics and she is subsequently taken to the nearest hospital. On arrival to the emergency department, her vitals are T: 36 deg C, HR: 110 bpm, BP: 100/60, RR: 12, SaO2: 99%. A FAST and abdominal CT are promptly obtained which are demonstrated in Figures A and B, respectively. Her chart demonstrates no other medical problems and vaccinations/boosters up to date. The patient is diagnosed with a Grade V splenic laceration and is immediately brought to the OR for emergent splenectomy. The splenectomy is successfully performed with removal of the damaged spleen (Figure C). Following the operation, the patient should receive which of the following vaccines: (I) H. influenzae (II) Tetanus (III) N. meningitidis (IV) S. pneumoniae (V) Hepatitis B",
    "answer": "To determine the appropriate post-splenectomy vaccines, we focus on **encapsulated bacteria** (the spleen plays a critical role in clearing these pathogens) and exclude vaccines not indicated for asplenia or already up-to-date per the patient’s history.\n\n\n### Key Background:  \nAsplenic patients are at high risk for infections with encapsulated organisms. The core vaccines recommended for this population target these pathogens.  \n\n### Analysis of Options:  \n- **I) H. influenzae**: Encapsulated → Recommended.  \n- **II) Tetanus**: The patient’s vaccinations/boosters are up-to-date, and splenectomy alone does not require tetanus (tetanus is wound-related, not asplenia-specific). → Not needed.  \n- **III) N. meningitidis**: Encapsulated → Recommended.  \n- **IV) S. pneumoniae**: Encapsulated → Recommended (the most critical vaccine for asplenia).  \n- **V) Hepatitis B**: Not indicated for asplenia (it targets non-encapsulated viruses and is for blood exposure risks). → Not needed.  \n\n\n**Answer: I, III, IV**\n\n\n\\boxed{I, III, IV}",
    "expected_answer": "I, III, IV",
    "time": 17.513688802719116,
    "answer_length": 1035,
    "retrieval_time": 0.018133878707885742,
    "generation_time": 17.487520933151245
  },
  {
    "question": "Researchers are studying the inheritance pattern of mutations in the cystic fibrosis transmembrane regulator (CFTR) gene, the gene responsible for cystic fibrosis. It is believed that, in addition to the commonly found ΔF508 mutation, a novel mutation in this gene is found in a particular population under study. Which of the following would most likely suggest that these two loci have a high probability of being closely linked?",
    "answer": "To determine if two loci (mutations) are closely linked, the key indicator is a **low recombination frequency between them** (significantly less than 50%).  \n\nRecombination frequency measures how often two genes assort independently. For closely linked genes, they are located near each other on the same chromosome, so crossing over between them is rare. This results in the two mutations being **inherited together (co-inherited) much more frequently than expected by chance** (i.e., they do not assort independently).  \n\n\n**Answer:** A low recombination frequency (significantly below 50%) between the ΔF508 mutation and the novel mutation, or consistent co-inheritance of the two mutations in most cases (e.g., in family studies or population haplotype analysis).  \n\n(Note: If specific options were provided, the correct choice would align with this logic—e.g., \"the two mutations are inherited together in >90% of offspring\" or \"recombination frequency between the loci is <5%\".)\n\n\n**Final Answer**  \nThe recombination frequency between the two loci is significantly lower than 50% (or equivalent wording indicating co-inheritance more often than independent assortment).  \n\n(If formatted as a concise statement for a standard question: **A low recombination frequency between the two mutations**.)  \n\n\\boxed{A low recombination frequency between the two loci}",
    "expected_answer": "LOD Score > 3",
    "time": 19.831139087677002,
    "answer_length": 1365,
    "retrieval_time": 0.011088132858276367,
    "generation_time": 19.803467988967896
  },
  {
    "question": "A 28-year-old woman returns to the clinic to follow up on a recent abnormal cervical biopsy that demonstrated cervical intraepithelial neoplasia (CIN) I. The patient is quite anxious about the implications of this diagnosis. Her physical examination is within normal limits. Her vital signs do not show any abnormalities at this time. Her past medical, family, and social histories are all non-contributory. Which of the following is the appropriate management of a newly diagnosed CIN I in a 24-year-old patient?",
    "answer": "The appropriate management for a newly diagnosed cervical intraepithelial neoplasia (CIN) I in a 24-year-old patient is **observation with close follow-up**, given the high likelihood of spontaneous regression (60-80% of cases resolve within 1-2 years in younger individuals).  \n\nRecommended follow-up includes:  \n- Repeat cervical cytology (Pap smear) plus HPV testing every 6 months for up to 2 years; OR  \n- Colposcopy at 12 months.  \n\nIf the lesion persists beyond 2 years, further evaluation (e.g., repeat biopsy) or treatment (e.g., LEEP, cryotherapy) may be considered, but immediate intervention is not indicated for newly diagnosed CIN I in this age group.\n\n\n**Answer:** Observation with follow-up via repeat co-testing (Pap + HPV) at 6 and 12 months or colposcopy at 12 months.  \n(Concise version: Observation with close follow-up testing.)",
    "expected_answer": "Close observation, pap smear screening at 6 and 12 months, and HPV DNA testing at 12 months",
    "time": 15.105783939361572,
    "answer_length": 850,
    "retrieval_time": 0.013622045516967773,
    "generation_time": 15.081875324249268
  },
  {
    "question": "A clinical researcher is interested in creating a new drug for HIV patients. Darunavir has been particularly efficacious in recent patients; however, some have experienced an increased incidence of hyperglycemia. A new drug called DN501 is developed with the same mechanism of action as darunavir but fewer side effects. Which of the following is the mechanism of action of DN501?",
    "answer": "To determine the mechanism of action of DN501, we first note that it shares the same mechanism as darunavir.  \n\nDarunavir is a well-known **HIV protease inhibitor** (a class of antiretroviral drugs identified by the \"-navir\" suffix). HIV protease is critical for cleaving large viral polyproteins (e.g., Gag-Pol) into functional, smaller proteins needed to assemble mature, infectious viral particles. Without active protease, newly produced virions remain non-infectious.  \n\n\n**Answer:** DN501 inhibits the HIV protease enzyme, preventing the cleavage of viral polyproteins into functional components required for viral maturation. This blocks the production of infectious HIV particles.  \n\n(Concise version: Inhibition of HIV protease.)",
    "expected_answer": "Inhibits viral assembly",
    "time": 8.191906690597534,
    "answer_length": 738,
    "retrieval_time": 0.07818293571472168,
    "generation_time": 8.167030096054077
  },
  {
    "question": "A 58-year-old white man with hypertension and type 2 diabetes mellitus comes to the physician because of a 3-month history of a painless lesion on his lower lip. He has smoked one pack of cigarettes daily for 20 years. He has worked as a fruit picker for the past 25 years. His current medications include captopril and metformin. Examination of the oral cavity shows a single ulcer near the vermillion border. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the key clinical features and risk factors:\n\n\n### **Key Clinical Features & Risk Factors**  \n- **Lesion characteristics**: 3-month painless ulcer on the **vermilion border of the lower lip** (classic location for a specific malignancy).  \n- **Risk factors**:  \n  - 20 pack-year smoking history (tobacco exposure).  \n  - 25 years as a fruit picker (chronic **UV sun exposure**—a major risk factor for lip malignancies).  \n  - Older age (58 years, increased risk of epithelial malignancies).  \n\n\n### **Differential Diagnosis Elimination**  \n- **Aphthous ulcers**: Painful, recurrent, and typically inside the mouth (not vermilion border).  \n- **Herpes simplex**: Painful blisters/ulcers, recurrent, and acute (not chronic 3 months).  \n- **Candidiasis**: White plaques (thrush), not ulcers.  \n- **Leukoplakia**: White patches (not ulcers).  \n- **Basal cell carcinoma**: Affects sun-exposed skin but rarely involves the vermilion border (more common on facial skin).  \n\n\n### **Most Likely Diagnosis**  \n**Squamous cell carcinoma (SCC) of the lip**:  \nSCC of the lower lip is strongly associated with tobacco use and chronic UV exposure. It presents as a painless ulcer/eroded lesion on the vermilion border in older adults—matching this patient’s profile.\n\n\n**Answer: Squamous cell carcinoma of the lip** (or simply \"squamous cell carcinoma\" if the context implies lip location).  \n\n\\boxed{Squamous cell carcinoma}",
    "expected_answer": "Squamous cell carcinoma",
    "time": 16.111906051635742,
    "answer_length": 1461,
    "retrieval_time": 0.01422119140625,
    "generation_time": 16.08653497695923
  },
  {
    "question": "An investigator is studying the effect of drug X on the retinoblastoma (Rb) gene on chromosome 13 in endometrial cells. Endometrial cells obtained from study participants are plated on growth media and the distribution of cell cycle phase is measured with flow cytometry. Drug X, which is known to activate cyclin-dependent kinase 4, is administered to all the cells, and the distribution of cell cycle phase is measured again 1 hour later. Which of the following is most likely to result from the action of drug X on the Rb gene?",
    "answer": "To answer this question, we need to connect the role of CDK4, Rb protein, and the cell cycle:\n\n\n### Key Background  \nThe retinoblastoma (Rb) protein is a critical regulator of the **G1 → S phase transition**:  \n- In unphosphorylated form, Rb binds to the transcription factor E2F, preventing E2F from activating genes required for DNA synthesis (S phase entry).  \n- Cyclin D-CDK4 complexes **phosphorylate Rb**. Phosphorylated Rb releases E2F, allowing E2F to drive expression of S-phase genes.  \n\n\n### Effect of Drug X  \nDrug X activates CDK4. This leads to:  \n1. Increased phosphorylation of Rb.  \n2. Dissociation of Rb from E2F.  \n3. E2F-mediated activation of S-phase genes → cells exit G1 and enter S phase.  \n\n\n### Flow Cytometry Outcome  \nActivation of CDK4 shifts the cell cycle distribution:  \n- **Decreased percentage of cells in G1 phase** (since they exit G1).  \n- **Increased percentage of cells in S phase** (since they enter DNA synthesis).  \n\n\n**Answer:** A decrease in the number of cells in the G1 phase and an increase in the number of cells in the S phase.\n\n\n\\boxed{Decreased G1 phase cells and increased S phase cells}",
    "expected_answer": "Initiation of S phase",
    "time": 17.975255966186523,
    "answer_length": 1139,
    "retrieval_time": 0.012334823608398438,
    "generation_time": 17.949827671051025
  },
  {
    "question": "A 65-year-old man presents with painless swelling of the neck over the past week. He also says he has been having intermittent fevers and severe night sweats which require a change of bed sheets the next day. His past medical history is significant for human immunodeficiency virus (HIV) diagnosed 10 years ago with which he admits to not always being compliant with his antiretroviral medication. The patient reports a 20-pack-year smoking history but no alcohol or recreational drug use. A review of systems is significant for a 6 kg (13.2 lb) unintentional weight loss over the past 2 months. The vital signs include: temperature 37.8℃ (100.0℉) and blood pressure 120/75 mm Hg. On physical examination, there are multiple non-tender swollen lymph nodes averaging 2 cm in diameter that is palpable in the anterior and posterior triangles of the neck bilaterally. Axillary and inguinal lymphadenopathy is present on the right side. A cardiopulmonary exam is unremarkable. The spleen size is 16 cm on percussion. Laboratory studies show the following:\nHemoglobin 9 g/dL\nMean corpuscular volume 88 μm3\nLeukocyte count 18,000/mm3\nPlatelet count 130,000/mm3\n    Serum creatinine 1.1 mg/dL\nSerum lactate dehydrogenase 1,000 U/L\nAn excisional biopsy of a superficial axillary lymph node on the right is performed and a histopathologic analysis confirms the most likely diagnosis. Which of the following is the next best diagnostic step in the workup of this patient?",
    "answer": "To determine the next best diagnostic step, we first identify the most likely diagnosis and then outline the standard workup for that condition.\n\n\n### **Step 1: Identify the Diagnosis**  \nThe patient is an HIV-positive (non-compliant) man with:  \n- **B symptoms**: Fever, night sweats, unintentional weight loss.  \n- **Lymphadenopathy**: Bilateral neck, right axillary/inguinal nodes.  \n- **Splenomegaly**: 16cm (enlarged).  \n- **Lab abnormalities**: Anemia, elevated LDH (marker of aggressive cell turnover).  \n\nThese findings are consistent with **aggressive B-cell non-Hodgkin lymphoma (NHL)**, most commonly **diffuse large B-cell lymphoma (DLBCL)** (the most frequent aggressive NHL in HIV patients).\n\n\n### **Step 2: Next Diagnostic Step After Confirmation**  \nAfter histopathologic confirmation of lymphoma, staging is critical. For HIV-associated NHL, **CNS involvement is common** (up to 30% of cases) due to immunodeficiency. Even without neurological symptoms, lumbar puncture (LP) is mandatory to rule out leptomeningeal disease, as this affects treatment (intrathecal chemotherapy if involved).\n\n\n### **Answer**  \nLumbar puncture (cerebrospinal fluid analysis for cytology, flow cytometry, and biochemical markers).\n\n\n**Final Answer:** Lumbar puncture.  \n\n\\boxed{Lumbar puncture}",
    "expected_answer": "Hepatitis C virus antibodies",
    "time": 46.04225993156433,
    "answer_length": 1291,
    "retrieval_time": 0.016499996185302734,
    "generation_time": 46.02149820327759
  },
  {
    "question": "In order to assess the feasibility and evaluate the outcomes of cerclage wiring as a supportive approach to osteosynthesis in femur fractures, a group of orthopedic surgeons studied 14 patients with primary and periprosthetic fractures of the thigh bone. Parameters such as patient demographic, type of implant, number of wires used, fracture union rate, and potential complications were thoroughly recorded and analyzed in all the patients, with a mean duration of patient follow-up of 16 months. Union was achieved in all patients with a mean duration of 90 days, and there were no complications found in patients included in the study. The authors were satisfied with their findings and, due to the prospective nature of their research, submitted their study to a journal as a cohort study (which they noted in the study title as well). However, the journal editor returned the article, suggesting that it should be submitted as a case series instead. The editor made this suggestion to the authors for which of the following reasons?",
    "answer": "To determine why the editor suggested reclassifying the study as a case series instead of a cohort study, we first clarify the key differences between these two study designs:\n\n\n### Key Definitions  \n- **Cohort study**: An observational study that compares **two or more groups (cohorts)** defined by exposure to an intervention (e.g., cerclage wiring vs. no cerclage wiring). It follows these groups over time to assess outcomes (e.g., fracture union, complications) and requires a comparison between exposed and unexposed groups.  \n- **Case series**: A descriptive study that reports on a **single group of patients** receiving a specific intervention or with a specific condition. It lacks a comparison group and only describes outcomes in the studied patients.  \n\n\n### Application to the Study  \nThe study included 14 patients who all received cerclage wiring as supportive osteosynthesis. There is no mention of a comparison group (e.g., patients who did not receive cerclage wiring, or those treated with an alternative method). Without a comparison cohort, the study cannot meet the criteria for a cohort study.  \n\n\n**Answer**: The study lacked a comparison group (it only included a single group of patients receiving the intervention, which is characteristic of a case series, not a cohort study).\n\n\n\\boxed{The study lacked a comparison group}",
    "expected_answer": "Lack of risk calculation",
    "time": 14.60044002532959,
    "answer_length": 1352,
    "retrieval_time": 0.018848896026611328,
    "generation_time": 14.573135137557983
  },
  {
    "question": "A 67-year-old woman presents from home hospice with a change in her mental status. She has seemed more confused lately and is unable to verbalize her symptoms. Her temperature is 102°F (38.9°C), blood pressure is 117/65 mmHg, pulse is 110/min, respirations are 19/min, and oxygen saturation is 95% on room air. Physical exam is notable for a right upper quadrant mass that elicits discomfort when palpated. Ultrasound is notable for pericholecystic fluid and gallbladder wall thickening without any gallstones. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the key clinical and imaging findings:\n\n\n### **Key Clinical Features**  \n- 67-year-old woman in **home hospice** (debilitated/critically ill state).  \n- Fever (102°F), tachycardia (110/min), confusion (systemic inflammation).  \n- Tender right upper quadrant (RUQ) mass.  \n\n\n### **Key Imaging Findings**  \n- Ultrasound: **Pericholecystic fluid**, **gallbladder wall thickening** (classic for cholecystitis), **no gallstones**.  \n\n\n### **Differential Diagnosis**  \nCholecystitis (inflammation of the gallbladder) has two subtypes:  \n1. **Calculous cholecystitis**: Caused by gallstones blocking the cystic duct (requires stones on imaging).  \n2. **Acalculous cholecystitis**: Occurs in **debilitated/critically ill patients** (hospice, ICU, sepsis) with no stones. It arises from gallbladder stasis, ischemia, or inflammation.  \n\n\n### **Conclusion**  \nThe absence of gallstones, combined with the hospice setting and classic cholecystitis findings (wall thickening, pericholecystic fluid, fever, tender RUQ mass), confirms **acalculous cholecystitis**.\n\n\n**Answer: Acalculous cholecystitis**",
    "expected_answer": "Acalculous cholecystitis",
    "time": 11.7967050075531,
    "answer_length": 1140,
    "retrieval_time": 0.07512378692626953,
    "generation_time": 11.78502869606018
  },
  {
    "question": "A 35-year-old female is brought to the emergency department after being found unconscious. The patient is found to have a blood glucose level of 35 mg/dL. Hgb A1c was found to be 5.1%. C-peptide level was found to be decreased. The patient returned to her baseline after glucose replacement. She states that she has never had an episode like this before. She has no significant past medical history but reports a family history of diabetes in her mother. She states that she has been undergoing a difficult divorce over the past few months. What is the likely cause of this patient's condition?",
    "answer": "To determine the likely cause of the patient’s hypoglycemia, let’s analyze the key findings and connect them to potential etiologies:\n\n\n### **Key Clinical Findings Recap**  \n- **Hypoglycemia**: Blood glucose = 35 mg/dL (severe).  \n- **Normal Hgb A1c (5.1%)**: Rules out chronic diabetes mellitus.  \n- **Decreased C-peptide**: Critical clue—C-peptide is co-secreted with endogenous insulin. Low C-peptide indicates insulin is not produced by the pancreas.  \n- **No prior episodes, stressful context (difficult divorce)**: Suggests a situational trigger for intentional behavior.  \n\n\n### **Key Differential for Hypoglycemia in Non-Diabetics**  \nCauses of insulin-mediated hypoglycemia (the most likely here, given rapid response to glucose) are split into:  \n1. **Endogenous insulin overproduction**: Insulinoma (high insulin + high C-peptide) or sulfonylurea use (stimulates pancreas → high insulin + high C-peptide).  \n2. **Exogenous insulin use**: Insulin from external sources (e.g., self-administration) → high insulin levels but **low C-peptide** (pancreas is not secreting insulin, so no C-peptide is released).  \n\n\n### **Conclusion**  \nThe patient’s low C-peptide confirms exogenous insulin use. The stressful divorce context (psychological distress) points to **factitious disorder**—intentional self-administration of insulin to induce illness (for attention or emotional relief).\n\n\n**Answer: Factitious hypoglycemia due to exogenous insulin administration.**",
    "expected_answer": "Factitious disorder",
    "time": 19.931274890899658,
    "answer_length": 1467,
    "retrieval_time": 0.013277053833007812,
    "generation_time": 19.904775857925415
  },
  {
    "question": "A 45-year-old man presents to the physician with complaints of increased urinary frequency and decreasing volumes for the past 2 months. He does not complain of any pain during urination. He is frustrated that he has to wake up 2 or 3 times per night to urinate even though he tried reducing the amount of water he consumes before bed and made some other dietary changes without any improvement. He has no family history of prostate disease. Physical examination is negative for any suprapubic mass or tenderness, and there is no costovertebral angle tenderness. Which of the following is the best next step in the management of this patient?",
    "answer": "To address this question, we analyze the patient’s presentation and follow standard guidelines for lower urinary tract symptoms (LUTS) in men:\n\n\n### Key Patient Features  \n- 45-year-old man with **increased urinary frequency, decreasing volumes, and nocturia** (2-3x/night)  \n- No pain on urination, no suprapubic/CVA tenderness, no family history of prostate disease  \n\n\n### Common Causes of LUTS in Middle-Aged Men  \nBenign Prostatic Hyperplasia (BPH) is the most likely cause, even in younger middle-aged men. Other considerations (e.g., overactive bladder) require ruling out prostate-related issues first.  \n\n\n### Standard Workup for LUTS  \nPer the American Urological Association (AUA) guidelines, initial evaluation for LUTS includes:  \n1. Focused history (AUA symptom score)  \n2. **Physical exam (including Digital Rectal Exam [DRE] to assess prostate size/consistency)**  \n3. Urinalysis (rule out infection/hematuria)  \n4. Optional serum PSA  \n\nThe patient’s physical exam, as described, only mentions suprapubic and CVA findings—**it does not include DRE** (a critical component for evaluating the prostate in men with LUTS).  \n\n\n### Best Next Step  \nThe next essential step is to perform a **Digital Rectal Exam (DRE)** to assess the prostate for signs of BPH (enlargement, smooth texture) or other abnormalities (e.g., nodules suggestive of cancer).  \n\n\n**Answer: Digital Rectal Exam**",
    "expected_answer": "Digital rectal examination",
    "time": 37.8127338886261,
    "answer_length": 1397,
    "retrieval_time": 0.0124969482421875,
    "generation_time": 37.786492347717285
  },
  {
    "question": "A 48-year-old woman with chronic tension headaches comes to the physician because of several episodes of bilateral flank pain and reddish urine within the past month. Current medications include aspirin, which she takes almost daily for headaches. Her temperature is 37.4°C (99.3°F) and her blood pressure is 150/90 mm Hg. Physical examination shows costovertebral tenderness to percussion bilaterally. Laboratory studies show a hemoglobin concentration of 10.2 g/dL and serum creatinine concentration of 2.4 mg/dL. Urine studies show:\nUrine\nProtein\n3+\nRBC > 16/hpf\nWBC 2/hpf\nThere are no casts or dysmorphic RBCs visualized on microscopic analysis of the urine. Which of the following is the most likely underlying cause of this patient's hematuria?\"",
    "answer": "To determine the most likely underlying cause of the patient’s hematuria, we analyze the key clinical findings and their correlation with chronic aspirin use:\n\n\n### **Key Clinical Features**  \n- **Chronic aspirin use**: Daily intake for tension headaches.  \n- **Symptoms**: Bilateral flank pain, reddish urine (hematuria).  \n- **Vitals/Exam**: Mild fever, hypertension (150/90 mmHg), bilateral costovertebral tenderness (CVA).  \n- **Labs**: Anemia (Hb=10.2 g/dL), renal insufficiency (creatinine=2.4 mg/dL).  \n- **Urinalysis**: Proteinuria (3+), hematuria (RBC>16/hpf), no dysmorphic RBCs or casts.  \n\n\n### **Differential Diagnosis Elimination**  \n- **Glomerulonephritis**: Unlikely—lacks dysmorphic RBCs or RBC casts.  \n- **Kidney stones**: Unlikely—bilateral pain is rare, no colicky pain or crystals.  \n- **Pyelonephritis**: Unlikely—minimal WBCs, no WBC casts, low fever.  \n\n\n### **Classic Diagnosis: Analgesic Nephropathy**  \nChronic aspirin use (a salicylate with NSAID properties) causes **analgesic nephropathy**, characterized by:  \n1. **Papillary necrosis**: Medullary ischemia (COX inhibition reduces renal medullary blood flow) leads to sloughing of renal papillae.  \n2. **Chronic interstitial nephritis**: Long-term damage to renal interstitium.  \n\nPapillary necrosis directly causes hematuria (bleeding from necrotic tissue) and bilateral flank pain (sloughed papillae irritate the ureter). Renal insufficiency, hypertension, and anemia result from chronic kidney damage.  \n\n\n**Answer: Analgesic nephropathy (secondary to chronic aspirin use)**  \n\n*(Note: If options include \"renal papillary necrosis\", this is the direct cause of hematuria, but the underlying systemic cause is analgesic nephropathy.)*\n\n\n**Final Answer**  \nRenal papillary necrosis due to analgesic nephropathy  \n\n(Or, if options list \"Analgesic nephropathy\", that is the correct choice.)  \n\n\\boxed{Analgesic nephropathy}",
    "expected_answer": "Vasoconstriction of the medullary vessels",
    "time": 38.62641406059265,
    "answer_length": 1903,
    "retrieval_time": 0.018513917922973633,
    "generation_time": 38.609925985336304
  },
  {
    "question": "A 37-year-old primigravid woman at 12 weeks' gestation comes to the emergency department because of vaginal bleeding and dull suprapubic pain for 3 hours. She has had spotting during the last 3 days. Her medications include folic acid and a multivitamin. She has smoked one pack of cigarettes daily for 15 years. Her temperature is 37°C (98.6°F), pulse is 110/min, and blood pressure is 89/65 mm Hg. Pelvic examination shows a dilated cervical os and a uterus consistent in size with an 11-week gestation. Ultrasonography shows an embryo of 4 cm in crown-rump length and no fetal cardiac activity. Which of the following is the most appropriate next step in management?",
    "answer": "To determine the most appropriate next step, we first categorize the miscarriage type and assess the patient’s clinical status:\n\n\n### Step 1: Categorize the Miscarriage  \nThe patient has:  \n- **Vaginal bleeding + suprapubic pain**  \n- **Dilated cervical os** (key: miscarriage cannot be stopped)  \n- **Uterus smaller than dates** (11 weeks vs 12 weeks LMP)  \n- **No fetal cardiac activity** (embryo is dead)  \n- **Embryo still present** (ultrasound confirms embryo, so products of conception are not expelled yet)  \n\nThis fits an **inevitable miscarriage** (open os, products retained, miscarriage unavoidable).  \n\n\n### Step 2: Assess Hemodynamic Stability  \nThe patient has:  \n- Tachycardia (110/min)  \n- Hypotension (89/65 mmHg)  \n\nThese indicate **hemodynamic compromise** (likely due to ongoing bleeding).  \n\n\n### Step 3: Management of Inevitable Miscarriage in Unstable Patients  \nFor hemodynamically unstable patients with inevitable miscarriage, **urgent surgical evacuation** (dilation and curettage, D&C) is indicated to stop bleeding and stabilize the patient.  \n\nMedical management (e.g., misoprostol) or expectant management are reserved for stable patients, not those with hypovolemia/tachycardia.  \n\n\n**Answer: Dilation and curettage (D&C)**\n\n\n\\boxed{Dilation and curettage}",
    "expected_answer": "Dilation and curettage",
    "time": 25.486722707748413,
    "answer_length": 1288,
    "retrieval_time": 0.01689314842224121,
    "generation_time": 25.462913036346436
  },
  {
    "question": "A 17-year-old female accidentally eats a granola bar manufactured on equipment that processes peanuts. She develops type I hypersensitivity-mediated histamine release, resulting in pruritic wheals on the skin. Which of the following layers of this patient's skin would demonstrate histologic changes on biopsy of her lesions?",
    "answer": "To answer this question, we first link the clinical scenario (urticaria/hives from type I hypersensitivity) to its histologic basis:\n\n\n### Key Background  \nUrticaria (pruritic wheals) arises from **mast cell degranulation** (triggered by IgE in type I hypersensitivity), releasing histamine. Histamine causes vasodilation and increased permeability of small blood vessels in the dermis, leading to edema (fluid accumulation) in the dermal tissue.\n\n\n### Skin Layer Analysis  \n- **Epidermis**: Normal in urticaria (no primary changes here).  \n- **Papillary dermis**: The upper, loose connective tissue layer of the dermis (adjacent to the epidermis). This layer is highly susceptible to edema due to its loose structure—**this is where the edema in urticaria occurs**.  \n- **Reticular dermis**: Deeper, dense connective tissue layer; not the primary site of edema in urticaria.  \n- **Hypodermis**: Subcutaneous tissue; not involved in urticarial lesions.  \n\n\n### Conclusion  \nThe histologic changes (edema) are most prominent in the **papillary dermis**.\n\n\n**Answer: Papillary dermis** (assuming this is an option; if options include \"dermis\" broadly, that is also correct, but papillary dermis is more specific).\n\n\n\\boxed{Papillary dermis}",
    "expected_answer": "Dermis",
    "time": 17.563090085983276,
    "answer_length": 1238,
    "retrieval_time": 0.07282185554504395,
    "generation_time": 17.535866022109985
  },
  {
    "question": "A 4-year-old girl is brought to the emergency department with a persistent cough, fever, and vomiting. The past year the child has been admitted to the hospital 3 times with pneumonia. For the past 1 week, the child has been experiencing thick purulent cough and says that her chest feels ‘heavy’. Her stools have been loose and foul-smelling over the past week. Her parents are also concerned that she has not gained much weight due to her frequent hospital visits. She was born at 39 weeks gestation via spontaneous vaginal delivery and is up to date on all vaccines and is meeting all developmental milestones. On physical exam, the temperature is 39.1°C (102.4°F). She appears lethargic and uncomfortable. Crackles are heard in the lower lung bases, with dullness to percussion. A small nasal polyp is also present on inspection. Which of the following is the most likely cause for the girl’s symptoms?",
    "answer": "The most likely cause for the girl’s symptoms is **cystic fibrosis (CF)**.  \n\n\n### Key Reasoning:  \nThe patient’s clinical presentation aligns with classic CF manifestations:  \n1. **Recurrent respiratory infections**: 3 pneumonia admissions in 1 year, thick purulent cough, crackles/dullness on lung exam (due to impaired mucus clearance and chronic infection).  \n2. **Pancreatic insufficiency**: Loose, foul-smelling stools (fat malabsorption from lack of pancreatic enzymes) and failure to gain weight (nutrient malabsorption).  \n3. **Nasal polyps**: A common extra-pulmonary finding in CF.  \n\n\nOther conditions (e.g., primary ciliary dyskinesia) do not explain the pancreatic insufficiency or failure to thrive seen here. Thus, cystic fibrosis is the most probable diagnosis.\n\n\n**Answer: Cystic fibrosis**",
    "expected_answer": "Dysfunction in a transmembrane regulator",
    "time": 13.578617095947266,
    "answer_length": 808,
    "retrieval_time": 0.01845717430114746,
    "generation_time": 13.551101207733154
  },
  {
    "question": "A 48-year-old man seeks evaluation at a clinic with a complaint of breathlessness for the past couple of weeks. He says that he finds it difficult to walk a few blocks and has to rest. He also complains of a cough for the past 3 months, which is dry and hacking in nature. The medical history is relevant for an idiopathic arrhythmia for which he takes amiodarone daily. He is a non-smoker and does not drink alcohol. He denies any use of illicit drugs. The vital signs are as follows: heart rate 98/min, respiratory rate 16/min, temperature 37.6°C (99.68°F), and blood pressure 132/70 mm Hg. The physical examination is significant for inspiratory crackles over the lung bases. An echocardiogram shows a normal ejection fraction. A chest radiograph is performed and shown below. Which of the following findings will most likely be noted on spirometry?",
    "answer": "To determine the most likely spirometry finding, we analyze the case and connect it to known pathophysiology:\n\n\n### Key Case Observations  \nThe patient has:  \n- **Amiodarone use**: A well-documented cause of **interstitial lung disease (ILD)** (pulmonary fibrosis/hypersensitivity pneumonitis).  \n- Symptoms/signs consistent with ILD: Dry cough, dyspnea, inspiratory crackles, mild fever, and normal ejection fraction (ruling out heart failure).  \n\n\n### Spirometry Pattern for Restrictive Lung Disease (ILD)  \nILD is a **restrictive lung disorder** (impaired lung expansion due to reduced compliance). Spirometry findings for restrictive disease include:  \n- **Decreased Forced Vital Capacity (FVC)**: Reduced total volume of air exhaled after maximal inspiration.  \n- **Decreased Forced Expiratory Volume in 1 second (FEV₁)**: But this reduction is proportional to FVC.  \n- **Normal or elevated FEV₁/FVC ratio**: Typically >70% (no airway obstruction; the problem is lung expansion, not airflow limitation).  \n\n\n### Conclusion  \nThe most likely spirometry finding is a **restrictive defect** characterized by reduced FVC, reduced FEV₁, and a normal or increased FEV₁/FVC ratio.\n\n\n**Answer:** Restrictive pattern with decreased FVC, decreased FEV₁, and normal FEV₁/FVC ratio.  \n\n(Note: If specific options were provided, the correct choice would align with this restrictive profile.)  \n\n\\boxed{Reduced FVC, reduced FEV₁, and normal FEV₁/FVC ratio}",
    "expected_answer": "Decreased FEV1 and FVC with normal FEV1/FVC ratio",
    "time": 21.240982055664062,
    "answer_length": 1447,
    "retrieval_time": 0.016438961029052734,
    "generation_time": 21.216516733169556
  },
  {
    "question": "A 2,300 g (5 lb) male newborn is delivered to a 29-year-old primigravid woman. The mother has HIV and received triple antiretroviral therapy during pregnancy. Her HIV viral load was 678 copies/mL 1 week prior to delivery. Labor was uncomplicated. Apgar scores were 7 and 8 at 1 and 5 minutes respectively. Physical examination of the newborn shows no abnormalities. Which of the following is the most appropriate next step in the management of this infant?",
    "answer": "To answer this question, we analyze the key clinical details and apply standard guidelines for managing HIV-exposed newborns:\n\n\n### **Key Clinical Context**  \n- **Maternal factors**: 29-year-old primigravida with HIV, received triple ART during pregnancy, but **viral load was detectable (678 copies/mL)** 1 week before delivery (not suppressed, as suppressed is typically <50 copies/mL).  \n- **Newborn**: Term (implied by uncomplicated labor, Apgar 7/8), no physical abnormalities.  \n\n\n### **Guidelines for HIV-Exposed Newborns**  \nThe priority for HIV-exposed infants is **immediate antiretroviral prophylaxis** to prevent vertical transmission. The choice of prophylaxis depends on maternal viral load:  \n- If maternal viral load is **detectable (>50 copies/mL)** (as here), the infant requires **combination antiretroviral prophylaxis** (not monotherapy) to reduce transmission risk.  \n- Prophylaxis should start **within 6-12 hours of birth** (delaying is harmful).  \n\n\n### **Eliminating Incorrect Options**  \n- **Waiting for HIV testing**: Wrong—prophylaxis must start immediately, not after test results.  \n- **Monotherapy (e.g., zidovudine alone)**: Insufficient for detectable maternal viral load.  \n- **No prophylaxis**: Dangerous, even if mom received ART (viral load was not suppressed).  \n\n\n**Answer**: Administer combination antiretroviral prophylaxis immediately after birth.  \n\n(Note: Typical combination regimens include zidovudine + lamivudine + nevirapine for 6 weeks, per AAP/WHO guidelines.)\n\n\n\\boxed{Administer combination antiretroviral prophylaxis immediately}",
    "expected_answer": "Administer zidovudine",
    "time": 36.61361885070801,
    "answer_length": 1584,
    "retrieval_time": 0.011955976486206055,
    "generation_time": 36.58664393424988
  },
  {
    "question": "A 60-year-old woman presents to a physician for worsening shortness of breath and increasing abdominal distention over the last 3 months. She says that the shortness of breath is worse on exertion and improves with rest. While she could previously walk to the nearby store for her groceries, she now has to drive because she gets ''winded'' on the way. The patient was diagnosed with diabetes 5 years ago and is compliant with her medications. The medical history is otherwise unremarkable. The physical examination reveals gross ascites and visibly engorged periumbilical veins. Bilateral pitting edema is noted around the ankles. The finger-prick blood glucose level is 100 mg/dL. What is the mechanism of action of the anti-diabetic medication this patient is most likely taking?",
    "answer": "To determine the mechanism of action of the patient’s anti-diabetic medication, we first connect her clinical findings to potential medication side effects and then identify the drug class:\n\n\n### Key Clinical Clues  \nThe patient has **fluid retention** (bilateral ankle edema, gross ascites) and a history of diabetes. Among anti-diabetic drugs, **thiazolidinediones (TZDs)** (e.g., pioglitazone, rosiglitazone) are well-known to cause fluid retention (via increased sodium reabsorption in the collecting duct and vascular permeability), which aligns with her symptoms.\n\n\n### Mechanism of Action of TZDs  \nTZDs act by **activating peroxisome proliferator-activated receptor gamma (PPAR-γ)**, a nuclear receptor. This activation:  \n- Enhances insulin sensitivity in peripheral tissues (adipose, skeletal muscle, liver)  \n- Regulates gene expression involved in glucose uptake, lipid metabolism, and adipocyte differentiation  \n\nThis improves glycemic control but may lead to fluid retention as a side effect.\n\n\n**Answer:** Activation of peroxisome proliferator-activated receptor gamma (PPAR-γ) to increase insulin sensitivity in adipose tissue, skeletal muscle, and liver.  \n\n\\boxed{Activation of peroxisome proliferator-activated receptor gamma (PPAR-\\gamma)}",
    "expected_answer": "Increased gene expression of GLUT-4",
    "time": 15.775238990783691,
    "answer_length": 1260,
    "retrieval_time": 0.01605987548828125,
    "generation_time": 15.747514724731445
  },
  {
    "question": "A 15-year-old girl comes to the physician because of episodic pelvic pain radiating to her back and thighs for 4 months. The pain occurs a few hours before her menstrual period and lasts for 2 days. She has been taking ibuprofen, which has provided some relief. Menses have occurred at regular 28-day intervals since menarche at the age of 12 years and last for 5 to 6 days. She is sexually active with two male partners and uses condoms inconsistently. Vital signs are within normal limits. Physical examination shows no abnormalities. Which of the following is the most likely cause of this patient's symptoms?",
    "answer": "The most likely cause of this patient’s symptoms is **primary dysmenorrhea**.\n\n\n### Key Reasoning:  \nPrimary dysmenorrhea is painful menstruation without underlying pelvic pathology, driven by excessive prostaglandin release leading to uterine contractions. The patient’s symptoms align perfectly:  \n- Cyclic pain occurring hours before menstruation and lasting 2 days.  \n- Pain radiating to the back/thighs (classic for prostaglandin-mediated uterine cramping).  \n- Relief with ibuprofen (an NSAID that blocks prostaglandin synthesis).  \n\nOther potential causes are less likely:  \n- **Pelvic inflammatory disease (PID):** Would typically present with abnormal discharge, fever, or pelvic tenderness (absent here).  \n- **Endometriosis:** A secondary cause of dysmenorrhea, but usually associated with progressive pain, dyspareunia, or infertility (not seen in this case).  \n- **Ovarian cysts:** Cause acute, non-cyclic pain (e.g., rupture/torsion) rather than premenstrual cyclic pain.  \n\nPrimary dysmenorrhea is common in adolescents, especially as ovulatory cycles become regular (which occurs a few years after menarche, consistent with her 3-year history of menses and recent onset of pain).\n\n\n**Answer:** Primary dysmenorrhea.",
    "expected_answer": "Endometrial sloughing and uterine contractions mediated by prostaglandin",
    "time": 18.404032945632935,
    "answer_length": 1231,
    "retrieval_time": 0.33455610275268555,
    "generation_time": 18.378392934799194
  },
  {
    "question": "A 25-year-old male is hospitalized for acute agitation, photophobia, and dysphagia. His parents report that he has been experiencing flu-like symptoms for one week prior to hospital admission. Five weeks ago, the patient was in Mexico, where he went on several spelunking expeditions with friends. The patient ultimately becomes comatose and dies. Autopsy of brain tissue suggests a viral infection. The likely causal virus spreads to the central nervous system (CNS) in the following manner:",
    "answer": "To determine the causal virus and its route to the CNS, let’s analyze the key clues and connect them to viral pathophysiology:\n\n\n### **Step 1: Identify the causal virus**  \nThe patient’s history (spelunking in Mexico, flu-like prodrome followed by neurological symptoms: agitation, photophobia, dysphagia [a hallmark of hydrophobia], coma, death) and autopsy finding of viral brain infection point to **rabies virus**. Spelunking is a risk factor for exposure to bats (the primary reservoir of rabies in this setting), and rabies classically progresses to fatal encephalitis with these symptoms.\n\n\n### **Step 2: Route of rabies virus to the CNS**  \nRabies virus spreads to the CNS via the following pathway:  \n1. The virus enters the body (e.g., bat saliva via a bite/scratch or aerosolized droplets).  \n2. It replicates locally in muscle cells.  \n3. It invades peripheral nerves at the **neuromuscular junction**.  \n4. It travels **retrogradely along axons** (against the direction of nerve impulse flow) from peripheral nerves to the spinal cord and brain (CNS).  \n\n\n### **Final Answer**  \nThe virus spreads to the CNS via **retrograde axonal transport along peripheral nerve fibers** (from the site of entry to the spinal cord and brain).\n\n\n**Answer:** The virus travels retrogradely along axons of peripheral nerves to reach the central nervous system.",
    "expected_answer": "Retrograde migration up peripheral nerve axons",
    "time": 14.341181993484497,
    "answer_length": 1356,
    "retrieval_time": 0.014450788497924805,
    "generation_time": 14.315003871917725
  },
  {
    "question": "A 19-year-old Caucasian male presents to your office with hypopigmented skin. He undergoes a skin biopsy and is found to have an absence of melanocytes in the epidermis. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the key findings: **hypopigmented skin** and **absence of melanocytes in the epidermis**.  \n\n### Key Differentiations:  \n- **Albinism**: Caused by defects in melanin synthesis (e.g., tyrosinase deficiency), but melanocytes are still present in the epidermis.  \n- **Vitiligo**: An autoimmune condition where melanocytes are destroyed, leading to complete absence of melanocytes in affected epidermal areas.  \n\nSince the biopsy shows no melanocytes, the diagnosis is **vitiligo**.  \n\n**Answer: Vitiligo**",
    "expected_answer": "Vitiligo",
    "time": 8.49601674079895,
    "answer_length": 553,
    "retrieval_time": 0.008005857467651367,
    "generation_time": 8.472681999206543
  },
  {
    "question": "A 51-year-old man presents for a routine check-up. He has no complaints. At his last annual visit, his physical and laboratory tests were unremarkable. His past medical history is significant for hypercholesterolemia, well managed with rosuvastatin, and hypertension, well managed with hydrochlorothiazide. His current medications also include aspirin. The patient is afebrile, and his vital signs are within normal limits. Physical examination is unremarkable. His laboratory tests are significant for the following:\nWBC 29,500/mm3\nHematocrit 26.1%\nHemoglobin 9.1 g/dL\nPlatelet count 298,000/mm3\nA peripheral blood smear and differential shows 92% small normocytic lymphocytes. The patient’s diagnosis in confirmed by bone marrow biopsy and flow cytometry. He is monitored through regular follow-up visits. Three years after the initial diagnosis, the patient presents with swollen cervical and axillary lymph nodes, unintentional weight loss of 4.5 kg (approx. 10 lb), and “rib pain” on his right side. On physical examination, there is palpable, firm, non-tender cervical and axillary lymphadenopathy bilaterally. He also has moderate splenomegaly, which, when palpated, elicits pain. Which of the following is the best treatment for this patient’s most likely diagnosis?",
    "answer": "To determine the best treatment, we first identify the patient’s diagnosis and progression:\n\n\n### Step 1: Initial Diagnosis  \nThe patient’s initial labs show **marked lymphocytosis** (WBC 29,500/mm³ with 92% small normocytic lymphocytes), anemia, and normal platelets. This, plus bone marrow biopsy/flow cytometry confirmation, is consistent with **Chronic Lymphocytic Leukemia (CLL)**. Early asymptomatic CLL is managed with watchful waiting, which aligns with his initial monitoring.\n\n\n### Step 2: Progression to Symptomatic Disease  \nThree years later, the patient has:  \n- Unintentional weight loss (B symptom), lymphadenopathy, splenomegaly, and rib pain.  \nThese indicate **active CLL requiring treatment** (watchful waiting is no longer appropriate).\n\n\n### Step 3: Best Treatment for Symptomatic CLL  \nFor **fit patients (young, no significant comorbidities)** like this 51-year-old, the standard frontline treatment for symptomatic CLL (without high-risk cytogenetics like 17p deletion) is **FCR combination therapy**:  \n- **F**ludarabine (purine analog), **C**yclophosphamide (alkylating agent), **R**ituximab (anti-CD20 monoclonal antibody).  \n\nTargeted therapies (e.g., ibrutinib, a BTK inhibitor) are preferred for patients with high-risk features (17p deletion), but FCR remains a gold standard for fit patients without these abnormalities.\n\n\n**Answer: Fludarabine, Cyclophosphamide, Rituximab (FCR)**\n\n\n\\boxed{Fludarabine, Cyclophosphamide, Rituximab}",
    "expected_answer": "Fludarabinern",
    "time": 30.309531927108765,
    "answer_length": 1465,
    "retrieval_time": 0.020077943801879883,
    "generation_time": 30.283946990966797
  },
  {
    "question": "A 62-year-old woman is evaluated because of a 3-day history of headache, nausea, and decreased urination. Laboratory studies show:\nSerum\nNa+ 136 mEq/L\nK+ 3.2 mEq/L\nCl- 115 mEq/L\nMg2+ 1.4 mEq/L\nUrine\npH 7.0\nArterial blood gas analysis on room air shows a pH of 7.28 and a HCO3- concentration of 14 mEq/L. Prolonged treatment with which of the following drugs would best explain this patient's findings?\"",
    "answer": "To solve this question, we analyze the patient’s lab findings and link them to drug-induced renal tubular acidosis (RTA):\n\n\n### **Step 1: Summarize Key Findings**  \n- **Metabolic acidosis**: Arterial pH = 7.28 (acidosis), serum HCO₃⁻ =14 mEq/L (low).  \n- **Hyperchloremic**: Serum Cl⁺=115 mEq/L (high), normal anion gap (AG=7, calculated as Na⁺-(Cl⁺+HCO₃⁻)).  \n- **Hypokalemia**: Serum K⁺=3.2 mEq/L (low).  \n- **Alkaline urine**: pH=7.0 (failure to acidify urine in acidosis).  \n\n\n### **Step 2: Identify the Type of RTA**  \nThese findings are classic for **Type 1 (distal) RTA**:  \n- Defect in distal tubule H⁺ secretion → alkaline urine (even in acidosis).  \n- Hypokalemia: Distal tubule compensates for reduced H⁺ excretion by increasing K⁺ secretion.  \n- Hyperchloremic metabolic acidosis (normal AG).  \n\n\n### **Step3: Drug-Induced Type1 RTA**  \nProlonged use of **amphotericin B** is a well-known cause of Type1 RTA. It damages the distal tubule’s ability to secrete H⁺, leading to the observed findings.  \n\n\n**Answer: Amphotericin B**\n\n\n\\boxed{Amphotericin B}",
    "expected_answer": "Amphotericin B",
    "time": 33.72025990486145,
    "answer_length": 1064,
    "retrieval_time": 0.011710166931152344,
    "generation_time": 33.69698619842529
  },
  {
    "question": "A 21-year-old male presents to his primary care provider for fatigue. He reports that he graduated from college last month and returned 3 days ago from a 2 week vacation to Vietnam and Cambodia. For the past 2 days, he has developed a worsening headache, malaise, and pain in his hands and wrists. The patient has a past medical history of asthma managed with albuterol as needed. He is sexually active with both men and women, and he uses condoms “most of the time.” On physical exam, the patient’s temperature is 102.5°F (39.2°C), blood pressure is 112/66 mmHg, pulse is 105/min, respirations are 12/min, and oxygen saturation is 98% on room air. He has tenderness to palpation over his bilateral metacarpophalangeal joints and a maculopapular rash on his trunk and upper thighs. Tourniquet test is negative. Laboratory results are as follows:\n\nHemoglobin: 14 g/dL\nHematocrit: 44%\nLeukocyte count: 3,200/mm^3\nPlatelet count: 112,000/mm^3\n\nSerum:\nNa+: 142 mEq/L\nCl-: 104 mEq/L\nK+: 4.6 mEq/L\nHCO3-: 24 mEq/L\nBUN: 18 mg/dL\nGlucose: 87 mg/dL\nCreatinine: 0.9 mg/dL\nAST: 106 U/L\nALT: 112 U/L\nBilirubin (total): 0.8 mg/dL\nBilirubin (conjugated): 0.3 mg/dL\n\nWhich of the following is the most likely diagnosis in this patient?",
    "answer": "To determine the most likely diagnosis, we analyze the patient’s clinical presentation, travel history, and lab findings:\n\n\n### **Key Clinical Features**  \n- **Travel history**: Recent trip to Vietnam/Cambodia (Southeast Asia, endemic for dengue, chikungunya).  \n- **Symptoms**: Fever (102.5°F), headache, malaise, bilateral metacarpophalangeal joint pain, maculopapular rash (trunk/upper thighs).  \n- **Labs**: Leukopenia (3,200/mm³), mild thrombocytopenia (112,000/mm³), elevated AST/ALT (liver involvement).  \n- **Tourniquet test**: Negative (rules out severe dengue hemorrhagic fever but not classic dengue).  \n\n\n### **Differential Diagnosis**  \n1. **Dengue Fever**:  \n   - Incubation: 3-14 days (matches timing: symptoms onset ~1 day post-return, consistent with infection late in the trip).  \n   - Classic symptoms: Fever, headache, arthralgias (breakbone fever), rash, leukopenia, thrombocytopenia, elevated liver enzymes.  \n   - Tourniquet test may be negative in early/classic dengue (positive in severe cases).  \n\n2. **Chikungunya**:  \n   - Similar symptoms (fever, joint pain, rash) but joint pain is typically more severe/persistent. However, no distinguishing feature here to prioritize over dengue.  \n\n3. **Zika**:  \n   - Conjunctivitis is a key feature (absent here), and rash is often pruritic. Less likely.  \n\n4. **Malaria**:  \n   - Cyclical fever, anemia (absent here), no rash/joint pain. Ruled out.  \n\n5. **Typhoid**:  \n   - Rose spots (not maculopapular), gastrointestinal symptoms (absent). Ruled out.  \n\n\n### **Conclusion**  \nDengue fever is the most likely diagnosis given the endemic region, clinical syndrome, and lab abnormalities.\n\n\n**Answer: Dengue fever**",
    "expected_answer": "Chikungunya",
    "time": 41.75285291671753,
    "answer_length": 1685,
    "retrieval_time": 0.07402396202087402,
    "generation_time": 41.72806406021118
  },
  {
    "question": "Three days after admission to the intensive care unit for septic shock and bacteremia from a urinary tract infection, a 34-year-old woman has persistent hypotension. Her blood cultures are positive for Escherichia coli, for which she has been receiving appropriate antibiotics since admission. She has no history of any serious illness. She does not use illicit drugs. Current medications include norepinephrine, ceftriaxone, and acetaminophen. She appears well. Her temperature is 37.5°C (99.5°F), heart rate is 96/min, and blood pressure is 85/55 mm Hg. Examination of the back shows costovertebral tenderness bilaterally. Examination of the thyroid gland shows no abnormalities. Laboratory studies show:\n  Hospital day 1 Hospital day 3\nLeukocyte count 18,500/mm3 10,300/mm3\nHemoglobin 14.1 mg/dL 13.4 mg/dL\nSerum\nCreatinine 1.4 mg/dL 0.9 mg/dL\nFasting glucose 95 mg/dL 100 mg/dL\nTSH   1.8 µU/mL\nT3, free   0.1 ng/dL\nT4, free   0.9 ng/dL\nRepeat blood cultures are negative. A chest X-ray shows no abnormalities. Which of the following is the most appropriate treatment?",
    "answer": "To determine the most appropriate treatment, we analyze the key clinical findings and their implications:\n\n\n### **Key Clinical Context**  \n- 34-year-old woman with septic shock (E. coli UTI) on appropriate antibiotics (repeat cultures negative) but persistent hypotension requiring norepinephrine.  \n- Thyroid function tests: **normal TSH (1.8 µU/mL)**, **very low free T3 (0.1 ng/dL)**, and **low-normal free T4 (0.9 ng/dL)**.  \n\n\n### **Interpretation of Thyroid Tests**  \nThese results are consistent with **euthyroid sick syndrome (NTIS)**, a common adaptation to critical illness. NTIS does **not require thyroid hormone replacement** (studies show no benefit from levothyroxine or liothyronine in this setting).  \n\n\n### **Persistent Hypotension in Septic Shock**  \nDespite resolving infection, persistent hypotension refractory to vasopressors (norepinephrine) suggests **relative adrenal insufficiency**—a frequent complication of septic shock. This is the primary cause of her ongoing hemodynamic instability.  \n\n\n### **Appropriate Treatment**  \nHydrocortisone is the standard therapy for relative adrenal insufficiency in septic shock, as it improves hemodynamic stability and reduces vasopressor requirements.\n\n\n**Answer: Hydrocortisone**",
    "expected_answer": "Treating the underlying illness",
    "time": 31.75961709022522,
    "answer_length": 1247,
    "retrieval_time": 0.020869731903076172,
    "generation_time": 31.73407292366028
  }
]